[
  {
    "src": "A mean transient increase in body temperature of about 1\u00b0C, in some pigs up to 3\u00b0C, may occur in the first 24 hours after vaccination.",
    "display_src": "A mean transient increase in body temperature of about 1\u00b0C, in some pigs up to 3\u00b0C, may occur in the first 24 hours after vaccination.",
    "ref": "Ein vor\u00fcbergehender Anstieg der K\u00f6rpertemperatur um durchschnittlich etwa 1 \u00b0C, bei einigen Schweinen um bis zu 3 \u00b0C, kann in den ersten 24 Stunden nach der Impfung auftreten.",
    "show_ref": false
  },
  {
    "src": "Package containing one or four pre-filled syringe(s) of a 150 \u00b5g Nespo solution for injection in 0.3 ml (500 \u00b5g/ ml).",
    "display_src": "Package containing one or four pre-filled syringe(s) of a 150 \u00b5g Nespo solution for injection in 0.3 ml (500 \u00b5g/ ml).",
    "ref": "Eine Packung enth\u00e4lt eine bzw. vier Fertigspritze(n) mit 150 \u03bcg Nespo Injektionsl\u00f6sung in 0,3 ml",
    "show_ref": false
  },
  {
    "src": "Do not use ZYPREXA after the expiry date, which is stated on the carton.",
    "display_src": "Do not use ZYPREXA after the expiry date, which is stated on the carton.",
    "ref": "Sie d\u00fcrfen ZYPREXA nach dem auf dem Umkarton angegebenen Verfalldatum nicht mehr anwenden.",
    "show_ref": false
  },
  {
    "src": "Each pre-filled pen contains 60 micrograms of darbepoetin alfa in 0.3 ml (200 \u00b5g/ ml).",
    "display_src": "Each pre-filled pen contains 60 micrograms of darbepoetin alfa in 0.3 ml (200 \u00b5g/ ml).",
    "ref": "Jeder vorgef\u00fcllte Injektor enth\u00e4lt 60 Mikrogramm Darbepoetin alfa in 0,3 ml (200 \u00b5g/ml).",
    "show_ref": false
  },
  {
    "src": "Each 1 g vial contains 1g ceftriaxone (as hydrated disodium).",
    "display_src": "Each 1 g vial contains 1g ceftriaxone (as hydrated disodium).",
    "ref": "Jede 1 g Durchstechflasche enth\u00e4lt 1g Ceftriaxon (als Dinatrium-Hydrat).",
    "show_ref": false
  },
  {
    "src": "The occurrence of suicidal behaviour is inherent in psychotic illnesses and mood disorders and in some cases has been reported early after initiation or switch of antipsychotic therapy, including treatment with aripiprazole (see section 4.8).",
    "display_src": "The occurrence of suicidal behaviour is inherent in psychotic illnesses and mood disorders and in some cases has been reported early after initiation or switch of antipsychotic therapy, including treatment with aripiprazole (see section 4.8).",
    "ref": "Das Auftreten von suizidalem Verhalten geh\u00f6rt zu psychotischen Erkrankungen und affektiven St\u00f6rungen und wurde in einigen F\u00e4llen nach Beginn oder nach Wechsel einer antipsychotischen Therapie berichtet, auch bei Behandlung mit Aripiprazol (siehe Abschnitt 4.8).",
    "show_ref": false
  },
  {
    "src": "Dexrazoxane displays biphasic elimination kinetics.",
    "display_src": "Dexrazoxane displays biphasic elimination kinetics.",
    "ref": "Dexrazoxan zeigt eine biphasische Eliminationskinetik.",
    "show_ref": false
  },
  {
    "src": "Clinical efficacy has been demonstrated across the range 111-185 MBq.",
    "display_src": "Clinical efficacy has been demonstrated across the range 111-185 MBq.",
    "ref": "Die klinische Wirksamkeit wurde mit Aktivit\u00e4ten von 111 bis 185 MBq belegt.",
    "show_ref": false
  },
  {
    "src": "\u2022 one sterile injection needle (e. g.",
    "display_src": "\u2022 one sterile injection needle (e. g.",
    "ref": "\u2022 eine sterile Injektionsnadel (z.B.",
    "show_ref": false
  },
  {
    "src": "Stroke1, Syncope, Transient ischaemic attacks1, Migraine",
    "display_src": "Stroke1, Syncope, Transient ischaemic attacks1, Migraine",
    "ref": "Schlaganfall 1, Synkope, vor\u00fcbergehende isch\u00e4mische Attacken1, Migr\u00e4ne",
    "show_ref": false
  },
  {
    "src": "Enurace has been officially authorised since 2000 (since 1995 available in the Netherlands).",
    "display_src": "Enurace has been officially authorised since 2000 (since 1995 available in the Netherlands).",
    "ref": "Enurace ist seit dem Jahr 2000 offiziell zugelassen (und seit 1995 in den Niederlanden erh\u00e4ltlich).",
    "show_ref": false
  },
  {
    "src": "Reproductive toxicity studies with fesoterodine in animals show minor embryotoxicity (see section 5.3).",
    "display_src": "Reproductive toxicity studies with fesoterodine in animals show minor embryotoxicity (see section 5.3).",
    "ref": "Tierexperimentelle Studien zur Reproduktionstoxizit\u00e4t mit Fesoterodin zeigen eine geringe Embryotoxizit\u00e4t (siehe Abschnitt 5.3).",
    "show_ref": false
  },
  {
    "src": "This information will be updated as final data become available.",
    "display_src": "This information will be updated as final data become available.",
    "ref": "Diese Informationen werden nach Vorliegen der Abschlussberichte aktualisiert.",
    "show_ref": false
  },
  {
    "src": "CARTON OF 1 TRIPLE PACK (3 VIALS/ 3 PFS) AS AN INTERMEDIATE PACK OF A TITRATION PACK OF 4 TRIPLE PACKS \u2013 TREATMENT DAYS 13, 15, 17",
    "display_src": "CARTON OF 1 TRIPLE PACK (3 VIALS/ 3 PFS) AS AN INTERMEDIATE PACK OF A TITRATION PACK OF 4 TRIPLE PACKS \u2013 TREATMENT DAYS 13, 15, 17",
    "ref": "FALTSCHACHTEL EINER DREIERPACKUNG (3 DURCHSTECHFLASCHEN/3 FERTIGSPRITZEN) ALS ZWISCHENVERPACKUNG EINER AUFDOSIERUNGSPACKUNG MIT 4 DREIERPACKUNGEN \u2013 BEHANDLUNGSTAGE 13, 15, 17",
    "show_ref": false
  },
  {
    "src": "If you are not sure what the side effects below are, you should ask your doctor to explain them to you in more detail.",
    "display_src": "If you are not sure what the side effects below are, you should ask your doctor to explain them to you in more detail.",
    "ref": "44 Wenn Sie sich \u00fcber die nachfolgend genannten Nebenwirkungen nicht sicher sind, bitten Sie Ihren Arzt, sie Ihnen n\u00e4her zu erkl\u00e4ren.",
    "show_ref": false
  },
  {
    "src": "The ADRs have been limited to those earlier reported for bimatoprost and timolol.",
    "display_src": "The ADRs have been limited to those earlier reported for bimatoprost and timolol.",
    "ref": "Die UAWs beschr\u00e4nken sich auf die bereits f\u00fcr Bimatoprost und Timolol berichteten UAWs.",
    "show_ref": false
  },
  {
    "src": "How Zometa is given Zometa is given as an infusion into a vein which should last no less than 15 minutes and should be administered as a single intravenous solution in a separate infusion line.",
    "display_src": "How Zometa is given Zometa is given as an infusion into a vein which should last no less than 15 minutes and should be administered as a single intravenous solution in a separate infusion line.",
    "ref": "Wie Zometa anzuwenden ist Zometa wird als Infusion \u00fcber mindestens 15 Minuten in eine Vene angewendet und sollte als gesonderte intraven\u00f6se L\u00f6sung in einer getrennten Infusionslinie verabreicht werden.",
    "show_ref": false
  },
  {
    "src": "ed Pack sizes of 1, 2 or 12",
    "display_src": "ed Pack sizes of 1, 2 or 12",
    "ref": "Packungen mit 1, 2 oder 12 Durchstechflaschen. ng Oder",
    "show_ref": false
  },
  {
    "src": "QUESTIONS AND ANSWERS ON THE WITHDRAWAL OF THE MARKETING APPLICATION for AFLUNOV Common name:",
    "display_src": "QUESTIONS AND ANSWERS ON THE WITHDRAWAL OF THE MARKETING APPLICATION for AFLUNOV Common name:",
    "ref": "FRAGEN UND ANTWORTEN ZUR R\u00dcCKNAHME DES ANTRAGS AUF GENEHMIGUNG F\u00dcR DAS INVERKEHRBRINGEN von AFLUNOV Gebr\u00e4uchliche Bezeichnung:",
    "show_ref": false
  },
  {
    "src": "Take a tablet as soon as you remember and then continue as before.",
    "display_src": "Take a tablet as soon as you remember and then continue as before.",
    "ref": "Nehmen Sie eine Tablette, sobald es Ihnen auff\u00e4llt, und fahren Sie dann wie gewohnt fort.",
    "show_ref": false
  },
  {
    "src": "Injection site inflammation, injection site reaction, influenza-like symptoms",
    "display_src": "Injection site inflammation, injection site reaction, influenza-like symptoms",
    "ref": "Entz\u00fcndungen der Injektionsstelle, Hautreaktionen an der Injektionsstelle, grippe\u00e4hnliche Symptome",
    "show_ref": false
  },
  {
    "src": "Each tablet contains 300 mg of irbesartan and 12.5 mg of hydrochlorothiazide.",
    "display_src": "Each tablet contains 300 mg of irbesartan and 12.5 mg of hydrochlorothiazide.",
    "ref": "Jede Tablette enth\u00e4lt 300 mg Irbesartan und 12,5 mg Hydrochlorothiazid.",
    "show_ref": false
  },
  {
    "src": "Espa\u00f1a Actelion Pharmaceuticals Espa\u00f1a S.L.",
    "display_src": "Espa\u00f1a Actelion Pharmaceuticals Espa\u00f1a S.L.",
    "ref": "63 Espa\u00f1a Actelion Pharmaceuticals Espa\u00f1a S.L.",
    "show_ref": false
  },
  {
    "src": "At week 48 the proportion of subjects with HIV RNA < 50 copies/ ml were 63%, 80% and 86% for the ZDV/ 3TC/ ABC, ZDV/ 3TC/ EFV and ZDV/ 3TC/ ABC/ EFV arms, respectively.",
    "display_src": "At week 48 the proportion of subjects with HIV RNA < 50 copies/ ml were 63%, 80% and 86% for the ZDV/ 3TC/ ABC, ZDV/ 3TC/ EFV and ZDV/ 3TC/ ABC/ EFV arms, respectively.",
    "ref": "Nach 48 Wochen betrug die Quote der Patienten mit einer HIV-RNA von < 50 Kopien/ml 63%, 80% und 86% in den Armen mit ZDV/3TC/ABC, ZDV/3TC/EFV und ZDV/3TC/ABC/EFV.",
    "show_ref": false
  },
  {
    "src": "How should I give SINGULAIR granules to my child?",
    "display_src": "How should I give SINGULAIR granules to my child?",
    "ref": "Wie soll ich SINGULAIR Granulat meinem Kind verabreichen?",
    "show_ref": false
  },
  {
    "src": "However, in patients with mild to moderate renal impairment (creatinine clearance \u2265 30 ml/ min but < 60 ml/ min) this fixed dose combination should be administered with caution.",
    "display_src": "However, in patients with mild to moderate renal impairment (creatinine clearance \u2265 30 ml/ min but < 60 ml/ min) this fixed dose combination should be administered with caution.",
    "ref": "Dennoch sollte diese fixe Kombination bei Patienten mit leichter bis m\u00e4\u00dfiger Nierenfunktionsst\u00f6rung (Kreatininclearance \u2265 30 ml/min, aber < 60 ml/min) mit Vorsicht angewendet werden.",
    "show_ref": false
  },
  {
    "src": "NeoRecormon Multidose is provided as a lyophilisate vial and solvent ampoule for solution for injection.",
    "display_src": "NeoRecormon Multidose is provided as a lyophilisate vial and solvent ampoule for solution for injection.",
    "ref": "NeoRecormon Multidose ist als Durchstechflasche mit Lyophilisat und Ampulle mit L\u00f6sungsmittel zur Herstellung einer Injektionsl\u00f6sung erh\u00e4ltlich.",
    "show_ref": false
  },
  {
    "src": "Each film-coated tablet contains 250 mg levetiracetam.",
    "display_src": "Each film-coated tablet contains 250 mg levetiracetam.",
    "ref": "Eine Filmtablette enth\u00e4lt 250 mg Levetiracetam.",
    "show_ref": false
  },
  {
    "src": "Insulin Human Winthrop Comb 15 100 IU/ ml suspension for injection in a pre-filled pen.",
    "display_src": "Insulin Human Winthrop Comb 15 100 IU/ ml suspension for injection in a pre-filled pen.",
    "ref": "Insulin Human Winthrop Comb 15 100 I.E./ml Injektionssuspension in einem Fertigpen",
    "show_ref": false
  },
  {
    "src": "On a proposal from a Committee, the Agency may appoint experts to provide additional expertise and establish ad hoc or permanent working parties on the basis of a mandate agreed upon by the Committees.",
    "display_src": "On a proposal from a Committee, the Agency may appoint experts to provide additional expertise and establish ad hoc or permanent working parties on the basis of a mandate agreed upon by the Committees.",
    "ref": "(+44-171)418 84 16 E-Mail: mail@emea.eudra.org http://www.eurdra.org/emea.html uf Vorschlag eines Ausschusses kann die Agentur Sachverst\u00e4ndige mit der Erstellung zus\u00e4tzlicher Gutachten beauftragen und auf der Grundlage eines durch die Aussch\u00fcsse vereinbarten Mandats sowohl st\u00e4ndige als auch Ad-hoc-Arbeitsgruppen bilden.",
    "show_ref": false
  },
  {
    "src": "Ventricular extrasystoles Bradycardia",
    "display_src": "Ventricular extrasystoles Bradycardia",
    "ref": "Ventrikul\u00e4re Extrasystolen Bradykardie",
    "show_ref": false
  },
  {
    "src": "Turn the vial and syringe upside down and draw the correct insulin dose into the syringe.",
    "display_src": "Turn the vial and syringe upside down and draw the correct insulin dose into the syringe.",
    "ref": "Drehen Sie die Durchstechflasche und die Spritze auf den Kopf und ziehen Sie die richtige Insulindosis in die Spritze auf.",
    "show_ref": false
  },
  {
    "src": "The majority of SPRYCEL-treated patients experienced adverse reactions at some time.",
    "display_src": "The majority of SPRYCEL-treated patients experienced adverse reactions at some time.",
    "ref": "Bei der Mehrheit der mit SPRYCEL behandelten Patienten traten zu irgendeinem Zeitpunkt Nebenwirkungen auf.",
    "show_ref": false
  },
  {
    "src": "The most common adverse reactions are infusion-related symptoms, such as fever and chills, usually following the first infusion of Herceptin.",
    "display_src": "The most common adverse reactions are infusion-related symptoms, such as fever and chills, usually following the first infusion of Herceptin.",
    "ref": "Die h\u00e4ufigsten Nebenwirkungen umfassen infusionsbedingte Symptome wie Fieber und Sch\u00fcttelfrost, die gew\u00f6hnlich nach der ersten Infusion von Herceptin auftreten.",
    "show_ref": false
  },
  {
    "src": "Elderly INVANZ works well and is well tolerated by most older and younger adult patients.",
    "display_src": "Elderly INVANZ works well and is well tolerated by most older and younger adult patients.",
    "ref": "INVANZ ist bei den meisten erwachsenen Patienten \u2013 sowohl \u00e4lteren als auch j\u00fcngeren \u2013 gleicherma\u00dfen gut wirksam und vertr\u00e4glich.",
    "show_ref": false
  },
  {
    "src": "Irbesartan Krka at a dose of 150 mg once daily generally provides a better 24 hour blood pressure control than 75 mg.",
    "display_src": "Irbesartan Krka at a dose of 150 mg once daily generally provides a better 24 hour blood pressure control than 75 mg.",
    "ref": "Bei einer Dosierung von 150 mg ein Mal t\u00e4glich wird mit Irbesartan Krka im Allgemeinen eine bessere Blutdruckkontrolle \u00fcber 24 Stunden erreicht als mit 75 mg.",
    "show_ref": false
  },
  {
    "src": "Mimpara is used in patients with serious kidney disease who need dialysis to clear their blood of waste products.",
    "display_src": "Mimpara is used in patients with serious kidney disease who need dialysis to clear their blood of waste products.",
    "ref": "Mimpara wird bei Patienten mit schwerer Niereninsuffizienz angewendet, die sich einer Dialyse unterziehen m\u00fcssen, um ihr Blut von Abfallstoffen zu reinigen.",
    "show_ref": false
  },
  {
    "src": "The necessity of resuspending the NovoMix 70 suspension immediately before use is to be stressed to the patient.",
    "display_src": "The necessity of resuspending the NovoMix 70 suspension immediately before use is to be stressed to the patient.",
    "ref": "Der Patient ist gezielt auf die Notwendigkeit hinzuweisen, NovoMix 70 Suspension unmittelbar vor Gebrauch zu resuspendieren.",
    "show_ref": false
  },
  {
    "src": "Atripla and paroxetine can be co-administered without dose adjustment.",
    "display_src": "Atripla and paroxetine can be co-administered without dose adjustment.",
    "ref": "Atripla und Paroxetin k\u00f6nnen ohne Dosisanpassung gleichzeitig angewendet werden.",
    "show_ref": false
  },
  {
    "src": "Since higher exposure levels could not be tested in animals due to the severity of maternal toxicity, the teratogenic potential of lamotrigine has not been characterised above clinical exposure.",
    "display_src": "Since higher exposure levels could not be tested in animals due to the severity of maternal toxicity, the teratogenic potential of lamotrigine has not been characterised above clinical exposure.",
    "ref": "Da aufgrund der Schwere der maternalen Toxizit\u00e4t keine h\u00f6heren Dosen an Tieren getestet werden konnten, wurde das teratogene Potenzial von Lamotrigin oberhalb der klinischen Exposition nicht bestimmt.",
    "show_ref": false
  },
  {
    "src": "1 pre-filled syringe containing 40 mg adalimumab 1 alcohol pad",
    "display_src": "1 pre-filled syringe containing 40 mg adalimumab 1 alcohol pad",
    "ref": "1 Fertigspritze enth\u00e4lt 40 mg Adalimumab 1 Alkoholtupfer",
    "show_ref": false
  },
  {
    "src": "11 In a pharmacokinetic study of celecoxib 200 mg administered once daily in healthy volunteers, genotyped as either CYP2C9*1/ *1, CYP2C9*1/ *3, or CYP2C9*3/ *3, the median Cmax and AUC 0-24 of celecoxib on day 7 were approximately 4-fold and 7-fold, respectively, in subjects genotyped as CYP2C9*3/ *3 compared to other genotypes.",
    "display_src": "11 In a pharmacokinetic study of celecoxib 200 mg administered once daily in healthy volunteers, genotyped as either CYP2C9*1/ *1, CYP2C9*1/ *3, or CYP2C9*3/ *3, the median Cmax and AUC 0-24 of celecoxib on day 7 were approximately 4-fold and 7-fold, respectively, in subjects genotyped as CYP2C9*3/ *3 compared to other genotypes.",
    "ref": "In einer pharmakokinetischen Studie, in der gesunde Probanden mit dem Genotyp CYP2C9*1/*1, CYP2C9*1/*3 oder CYP2C9*3/*3 einmal t\u00e4glich 200 mg Celecoxib erhielten, war bei den Personen mit dem Genotyp CYP2C9*3/*3 im Vergleich zu den anderen Genotypen die mediane Cmax bzw. die AUC0-24 von Celecoxib am Tag 7 um etwa das 4-fache bzw.",
    "show_ref": false
  },
  {
    "src": "Kinzalkomb 40 mg/ 12.5 mg tablets telmisartan/ hydrochlorothiazide",
    "display_src": "Kinzalkomb 40 mg/ 12.5 mg tablets telmisartan/ hydrochlorothiazide",
    "ref": "Kinzalkomb 40 mg/12,5 mg Tabletten Telmisartan/Hydrochlorothiazid",
    "show_ref": false
  },
  {
    "src": "In bitches where gonadal function has been successsfully prevented for a period of 12 months, then a second treatment may be administered at that time for continued prevention of oestrus.",
    "display_src": "In bitches where gonadal function has been successsfully prevented for a period of 12 months, then a second treatment may be administered at that time for continued prevention of oestrus.",
    "ref": "H\u00fcndinnen, bei denen die Gonadenfunktion erfolgreich 12 Monate lang unterdr\u00fcckt wurde, kann nach diesem Zeitpunkt zur kontinuierlichen L\u00e4ufigkeitsunterdr\u00fcckung ein zweites Implantat verabreicht werden.",
    "show_ref": false
  },
  {
    "src": "What TAXOTERE looks like and contents of the pack TAXOTERE 20 mg concentrate for solution for infusion is a clear viscous, yellow to brown-yellow solution.",
    "display_src": "What TAXOTERE looks like and contents of the pack TAXOTERE 20 mg concentrate for solution for infusion is a clear viscous, yellow to brown-yellow solution.",
    "ref": "Wie TAXOTERE aussieht und Inhalt der Packung TAXOTERE 20 mg Konzentrat zur Herstellung einer Infusionsl\u00f6sung ist eine klare, viskose, gelbe bis braun-gelbe L\u00f6sung.",
    "show_ref": false
  },
  {
    "src": "EU/ 1/ 04/ 283/ 002 EU/ 1/ 04/ 283/ 003 EU/ 1/ 04/ 283/ 004 EU/ 1/ 04/ 283/ 005 EU/ 1/ 04/ 283/ 006",
    "display_src": "EU/ 1/ 04/ 283/ 002 EU/ 1/ 04/ 283/ 003 EU/ 1/ 04/ 283/ 004 EU/ 1/ 04/ 283/ 005 EU/ 1/ 04/ 283/ 006",
    "ref": "18 EU/1/04/283/002 EU/1/04/283/003 EU/1/04/283/004 EU/1/04/283/005 EU/1/04/283/006",
    "show_ref": false
  },
  {
    "src": "Carton 100 micrograms powder and solvent for solution for injection",
    "display_src": "Carton 100 micrograms powder and solvent for solution for injection",
    "ref": "Karton 100 Mikrogramm Pulver und L\u00f6sungsmittel zur Herstellung einer Injektionsl\u00f6sung",
    "show_ref": false
  },
  {
    "src": "Byetta is given by injection under the skin of the thigh, the abdomen (tummy) or the upper arm, using the injection pen.",
    "display_src": "Byetta is given by injection under the skin of the thigh, the abdomen (tummy) or the upper arm, using the injection pen.",
    "ref": "Byetta wird mit dem Fertigpen unter die Haut des Oberschenkels, Abdomens (Bauchs) oder Oberarms gespritzt.",
    "show_ref": false
  },
  {
    "src": "Yellow fever vaccine associated neurotropic disease Very rarely, yellow fever vaccine-associated neurotropic disease (YEL-AND) has been reported following vaccination, with sequelae or with fatal outcome in some cases (see section 4.8).",
    "display_src": "Yellow fever vaccine associated neurotropic disease Very rarely, yellow fever vaccine-associated neurotropic disease (YEL-AND) has been reported following vaccination, with sequelae or with fatal outcome in some cases (see section 4.8).",
    "ref": "Gelbfieber-Impfstoff-assoziierte neurotrope Erkrankungen Sehr selten wurde nach Gabe des Impfstoffs \u00fcber F\u00e4lle von Gelbfieber-Impfstoff-assoziierten neurotropen Erkrankungen (YEL-AND*) mit Folgesch\u00e4den oder in Einzelf\u00e4llen mit t\u00f6dlichem Ausgang berichtet (siehe Abschnitt 4.8).",
    "show_ref": false
  },
  {
    "src": "Nutritional management Protein restriction and arginine supplementation may be indicated in case of low protein tolerance.",
    "display_src": "Nutritional management Protein restriction and arginine supplementation may be indicated in case of low protein tolerance.",
    "ref": "Ern\u00e4hrungsverhalten Im Falle einer geringen Proteintoleranz kann eine Einschr\u00e4nkung der Proteinaufnahme und Argininerg\u00e4nzung angezeigt sein.",
    "show_ref": false
  },
  {
    "src": "In such patients the risk of treatment should be considered in relation to possible benefit and clinical monitoring is recommended.",
    "display_src": "In such patients the risk of treatment should be considered in relation to possible benefit and clinical monitoring is recommended.",
    "ref": "Bei solchen Patienten muss das Risiko einer Behandlung in Relation zu dem m\u00f6glichen Nutzen in Betracht gezogen werden und eine klinische \u00dcberwachung wird empfohlen.",
    "show_ref": false
  },
  {
    "src": "Severe and life-threatening skin reactions, including fatal cases, have occurred in patients treated with VIRAMUNE mainly during the first 6 weeks of therapy.",
    "display_src": "Severe and life-threatening skin reactions, including fatal cases, have occurred in patients treated with VIRAMUNE mainly during the first 6 weeks of therapy.",
    "ref": "Schwere und lebensbedrohliche Auswirkungen auf die Haut, einschlie\u00dflich letaler Verl\u00e4ufe, sind haupts\u00e4chlich w\u00e4hrend der ersten 6 Wochen der Behandlung mit VIRAMUNE vorgekommen.",
    "show_ref": false
  },
  {
    "src": "These women should be counselled to take contraceptive measures and must be advised to immediately stop taking deferiprone if they become pregnant or plan to become pregnant (see section 4.3).",
    "display_src": "These women should be counselled to take contraceptive measures and must be advised to immediately stop taking deferiprone if they become pregnant or plan to become pregnant (see section 4.3).",
    "ref": "Ferner m\u00fcssen sie angehalten werden, Deferipron beim Eintritt oder bei der Planung einer Schwangerschaft unverz\u00fcglich abzusetzen (siehe Abschnitt 4.3).",
    "show_ref": false
  },
  {
    "src": "The choice of route should depend on the individual clinical circumstance.",
    "display_src": "The choice of route should depend on the individual clinical circumstance.",
    "ref": "Die Applikationsart sollte entsprechend der individuellen klinischen Umst\u00e4nde gew\u00e4hlt werden.",
    "show_ref": false
  },
  {
    "src": "No. of responders",
    "display_src": "No. of responders",
    "ref": "Anzahl der Responder Ansprechrate",
    "show_ref": false
  },
  {
    "src": "If a waiting period of up to approximately 2 years under reliable contraception is considered unpractical, prophylactic institution of a washout procedure may be advisable.",
    "display_src": "If a waiting period of up to approximately 2 years under reliable contraception is considered unpractical, prophylactic institution of a washout procedure may be advisable.",
    "ref": "Ist eine Wartezeit von bis zu etwa 2 Jahren mit verl\u00e4sslichem Empf\u00e4ngnisschutz nicht praktikabel, kann die vorsorgliche Einleitung von Auswaschma\u00dfnahmen ratsam sein.",
    "show_ref": false
  },
  {
    "src": "The tremor often disappears without needing to stop the treatment.",
    "display_src": "The tremor often disappears without needing to stop the treatment.",
    "ref": "Das Zittern verschwindet h\u00e4ufig, ohne dass die Behandlung beendet werden muss.",
    "show_ref": false
  },
  {
    "src": "au inadequate response to previous therapy, and the main measure of effectiveness was the change in symptoms after 12 weeks of treatment.",
    "display_src": "au inadequate response to previous therapy, and the main measure of effectiveness was the change in symptoms after 12 weeks of treatment.",
    "ref": "die vorhergehende Therapie nur unzureichend angesprochen, und der Hauptindikator f\u00fcr die Wirksamkeit war die Ver\u00e4nderung der Symptome nach einer Behandlungsdauer von 12 Wochen. ich",
    "show_ref": false
  },
  {
    "src": "Dose adjustment is not considered necessary in subjects with reduced UGT1A1 activity due to genetic polymorphism.",
    "display_src": "Dose adjustment is not considered necessary in subjects with reduced UGT1A1 activity due to genetic polymorphism.",
    "ref": "Eine Dosisanpassung bei Patienten mit reduzierter UGT1A1-Aktivit\u00e4t aufgrund des genetischen Polymorphismus wird nicht als notwendig erachtet.",
    "show_ref": false
  },
  {
    "src": "The pigs should be re-vaccinated every 6 months.",
    "display_src": "The pigs should be re-vaccinated every 6 months.",
    "ref": "Die Schweine sollten alle 6 Monate eine Wiederholungsimpfung erhalten.",
    "show_ref": false
  },
  {
    "src": "Adverse reactions reported in patients who received Xiliarx 50 mg in combination with a sulphonylurea in double-blind studies (N=170)",
    "display_src": "Adverse reactions reported in patients who received Xiliarx 50 mg in combination with a sulphonylurea in double-blind studies (N=170)",
    "ref": "Nebenwirkungen bei Patienten, die Xiliarx 50 mg in Kombination mit einem Sulfonylharnstoff in Doppelblind-Studien erhielten (N=170)",
    "show_ref": false
  },
  {
    "src": "For the full list of all side effects reported with Aranesp, see the Package Leaflet.",
    "display_src": "For the full list of all side effects reported with Aranesp, see the Package Leaflet.",
    "ref": "Die vollst\u00e4ndige Auflistung der im Zusammenhang mit Aranesp berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.",
    "show_ref": false
  },
  {
    "src": "GlaxoSmithKline GmbH & Co. KG Theresienh\u00f6he 11 80339 M\u00fcnchen Germany",
    "display_src": "GlaxoSmithKline GmbH & Co. KG Theresienh\u00f6he 11 80339 M\u00fcnchen Germany",
    "ref": "GlaxoSmithKline GmbH & Co.KG Theresienh\u00f6he 11 80339 M\u00fcnchen Germany",
    "show_ref": false
  },
  {
    "src": "corneal erosion, keratitis, eyelid pain, eye allergy, conjunctival oedema, eyelid oedema, eyelids pruritus",
    "display_src": "corneal erosion, keratitis, eyelid pain, eye allergy, conjunctival oedema, eyelid oedema, eyelids pruritus",
    "ref": "Hornhauterosion, Keratitis, Augenlidschmerz, Augenallergie, Bindehaut\u00f6deme, Augenlid\u00f6dem, Augenlidpruritus",
    "show_ref": false
  },
  {
    "src": "48 Treatment of symptomatic anaemia in adult and paediatric chronic renal failure patients:",
    "display_src": "48 Treatment of symptomatic anaemia in adult and paediatric chronic renal failure patients:",
    "ref": "53 Behandlung der symptomatischen An\u00e4mie bei erwachsenen Patienten und Kindern mit chronischer Nierenerkrankung:",
    "show_ref": false
  },
  {
    "src": "What Sonata looks like and contents of the pack",
    "display_src": "What Sonata looks like and contents of the pack",
    "ref": "Wie Sonata aussieht und Inhalt der Packung",
    "show_ref": false
  },
  {
    "src": "NovoMix 30 can also be used with other antidiabetic medicines that can be taken by mouth in combination with insulin, but it should only be used with pioglitazone once the patient \u2019 s risk of fluid-related side effects has been evaluated.",
    "display_src": "NovoMix 30 can also be used with other antidiabetic medicines that can be taken by mouth in combination with insulin, but it should only be used with pioglitazone once the patient \u2019 s risk of fluid-related side effects has been evaluated.",
    "ref": "NovoMix 30 kann auch mit anderen Antidiabetes- Arzneimitteln kombiniert werden, die in Kombination mit Insulin oral eingenommen werden, darf aber erst nach Absch\u00e4tzung des Risikos f\u00fcr fl\u00fcssigkeitsbezogene Nebenwirkungen zusammen mit Pioglitazon eingesetzt werden.",
    "show_ref": false
  },
  {
    "src": "(Dogs and Cats) 2.5 kg 5 kg 10 kg 20 kg 40 kg 60 kg",
    "display_src": "(Dogs and Cats) 2.5 kg 5 kg 10 kg 20 kg 40 kg 60 kg",
    "ref": "K\u00f6rpergewicht (Hund und Katze) 2,5 kg 5 kg 10 kg 20 kg 40 kg 60 kg",
    "show_ref": false
  },
  {
    "src": "In study BR.21, the median time to onset of rash was 8 days, and the median time to onset of diarrhoea was 12 days.",
    "display_src": "In study BR.21, the median time to onset of rash was 8 days, and the median time to onset of diarrhoea was 12 days.",
    "ref": "In der Studie BR.21 betrug die mediane Zeitspanne bis zum Auftreten eines Ausschlags 8 Tage und bis zum Auftreten von Diarrh\u00f6 12 Tage.",
    "show_ref": false
  },
  {
    "src": "Patients using CSII should be comprehensively instructed in the use of the pump system and use the correct reservoir and tubing for the pump (see section 6.6).",
    "display_src": "Patients using CSII should be comprehensively instructed in the use of the pump system and use the correct reservoir and tubing for the pump (see section 6.6).",
    "ref": "Patienten, die CSII verwenden, m\u00fcssen umfassend in den Gebrauch des Pumpensystems eingewiesen werden und das richtige Reservoir sowie den richtigen Schlauch f\u00fcr die Pumpe benutzen (siehe Abschnitt 6.6).",
    "show_ref": false
  },
  {
    "src": "Zalasta 7.5 mg tablets Olanzapine",
    "display_src": "Zalasta 7.5 mg tablets Olanzapine",
    "ref": "Zalasta 7,5 mg Tabletten Olanzapin",
    "show_ref": false
  },
  {
    "src": "Stada Arzneimittel Stadastrasse 2-18 DE-61118 Bad Vilbel Germany",
    "display_src": "Stada Arzneimittel Stadastrasse 2-18 DE-61118 Bad Vilbel Germany",
    "ref": "Stada Arzneimittel Stadastrasse 2-18 DE-61118 Bad Vilbel Deutschland",
    "show_ref": false
  },
  {
    "src": "Centre de Biotechnologie 8, rue de l\u2019 Industrie F-68330 Huningue FRANCE",
    "display_src": "Centre de Biotechnologie 8, rue de l\u2019 Industrie F-68330 Huningue FRANCE",
    "ref": "Centre de Biotechnologie 8, rue de l\u2019 Industrie F-68330 Huningue FRANKREICH",
    "show_ref": false
  },
  {
    "src": "EU/ 1/ 97/ 049/ 011 14 tablets EU/ 1/ 97/ 049/ 004 28 tablets EU/ 1/ 97/ 049/ 005 56 tablets EU/ 1/ 97/ 049/ 014 56 x 1 tablets EU/ 1/ 97/ 049/ 006 98 tablets",
    "display_src": "EU/ 1/ 97/ 049/ 011 14 tablets EU/ 1/ 97/ 049/ 004 28 tablets EU/ 1/ 97/ 049/ 005 56 tablets EU/ 1/ 97/ 049/ 014 56 x 1 tablets EU/ 1/ 97/ 049/ 006 98 tablets",
    "ref": "EU/1/97/049/011 14 Tabletten EU/1/97/049/004 28 Tabletten EU/1/97/049/005 56 Tabletten EU/1/97/049/014 56 x 1 Tablette EU/1/97/049/006 98 Tabletten",
    "show_ref": false
  },
  {
    "src": "Rats, dogs and monkeys tolerated daily doses of 2, 2.5 and 8 mg/ kg/ d respectively without harmful effects.",
    "display_src": "Rats, dogs and monkeys tolerated daily doses of 2, 2.5 and 8 mg/ kg/ d respectively without harmful effects.",
    "ref": "Tagesdosen von 2, 2,5 und 8 mg/kg zeigten bei Ratten, Hunden bzw.",
    "show_ref": false
  },
  {
    "src": "What Bondenza 3 mg solution for injection in pre -filled syringes contains",
    "display_src": "What Bondenza 3 mg solution for injection in pre -filled syringes contains",
    "ref": "Was Bondenza 3 mg Injektionsl\u00f6sung in einer Fertigspritze enth\u00e4lt",
    "show_ref": false
  },
  {
    "src": "The possibility of interactions with commonly used medicinal products, including histamine liberating products, cannot be excluded.",
    "display_src": "The possibility of interactions with commonly used medicinal products, including histamine liberating products, cannot be excluded.",
    "ref": "Die M\u00f6glichkeit von Wechselwirkungen mit allgemein verwendeten Arzneimitteln einschlie\u00dflich Histamin freisetzenden Produkten kann jedoch nicht ausgeschlossen werden.",
    "show_ref": false
  },
  {
    "src": "The tablets should be swallowed whole.",
    "display_src": "The tablets should be swallowed whole.",
    "ref": "Die Tabletten sollten als Ganzes geschluckt werden.",
    "show_ref": false
  },
  {
    "src": "N Engl J Med 1987 Oct 22; 317(17):1098 (letter)",
    "display_src": "N Engl J Med 1987 Oct 22; 317(17):1098 (letter)",
    "ref": "N Engl J Med 1987 Oct 22;317(17):1098 (letter)",
    "show_ref": false
  },
  {
    "src": "Marked triglyceride elevation is a risk factor for development of pancreatitis.",
    "display_src": "Marked triglyceride elevation is a risk factor for development of pancreatitis.",
    "ref": "Auff\u00e4llige Triglyceridanstiege sind ein Risikofaktor f\u00fcr die Entwicklung einer Pankreatitis.",
    "show_ref": false
  },
  {
    "src": "If the patient experiences a loss of greater than 5 letters in visual acuity (ETDRS or one Snellen line equivalent), Lucentis should be administered.",
    "display_src": "If the patient experiences a loss of greater than 5 letters in visual acuity (ETDRS or one Snellen line equivalent), Lucentis should be administered.",
    "ref": "Falls der Patient einen Sehverlust von mehr als 5 Buchstaben aufweist (ETDRS oder \u00e4quivalent eine Snellen-Linie), sollte Lucentis verabreicht werden.",
    "show_ref": false
  },
  {
    "src": "- Patients with chronic wide-angle glaucoma may be treated with Stalevo with caution, provided",
    "display_src": "- Patients with chronic wide-angle glaucoma may be treated with Stalevo with caution, provided",
    "ref": "- Patienten mit chronischem Weitwinkelglaukom k\u00f6nnen vorsichtig mit Stalevo behandelt",
    "show_ref": false
  },
  {
    "src": "The main measure of effectiveness was the number of relapses that the patients had.",
    "display_src": "The main measure of effectiveness was the number of relapses that the patients had.",
    "ref": "Hauptindikator f\u00fcr die Wirksamkeit war die Anzahl der Sch\u00fcbe der Patienten.",
    "show_ref": false
  },
  {
    "src": "Congenital anomalies were reported in 14.5% of exposed pregnancies.",
    "display_src": "Congenital anomalies were reported in 14.5% of exposed pregnancies.",
    "ref": "In 14,5% dieser Schwangerschaften wurde \u00fcber kongenitale Anomalien berichtet.",
    "show_ref": false
  },
  {
    "src": "Flushing Flushing is the most common adverse reaction of Trevaclyn.",
    "display_src": "Flushing Flushing is the most common adverse reaction of Trevaclyn.",
    "ref": "Flush Flush ist die h\u00e4ufigste Nebenwirkung von Trevaclyn.",
    "show_ref": false
  },
  {
    "src": "One bag of 15g once daily for 1 - 3 days.",
    "display_src": "One bag of 15g once daily for 1 - 3 days.",
    "ref": "Ein Beutel zu 15 g einmal t\u00e4glich f\u00fcr 1-3 Tage.",
    "show_ref": false
  },
  {
    "src": "Do not let your family or friends start the IONSYS device for you.",
    "display_src": "Do not let your family or friends start the IONSYS device for you.",
    "ref": "Lassen Sie nicht Verwandte oder Freunde das IONSYS-Ger\u00e4t f\u00fcr Sie ausl\u00f6sen.",
    "show_ref": false
  },
  {
    "src": "ingredients of TOVIAZ (see section 2, \u201c Important information about some of the ingredients of TOVIAZ\u201d)",
    "display_src": "ingredients of TOVIAZ (see section 2, \u201c Important information about some of the ingredients of TOVIAZ\u201d)",
    "ref": "einen der sonstigen Bestandteile von TOVIAZ sind (siehe Abschnitt 2 \u201e Wichtige Informationen \u00fcber bestimmte sonstige Bestandteile von TOVIAZ\u201c)",
    "show_ref": false
  },
  {
    "src": "Pharmacokinetic studies with doxazosin in patients with renal impairment also showed no significant alterations compared to patients with normal renal function.",
    "display_src": "Pharmacokinetic studies with doxazosin in patients with renal impairment also showed no significant alterations compared to patients with normal renal function.",
    "ref": "Pharmakokinetische Studien mit Doxazosin an Patienten mit einer Nierenfunktionsst\u00f6rung zeigten ebenfalls keine bedeutenden Abweichungen gegen\u00fcber Patienten mit normaler Nierenfunktion.",
    "show_ref": false
  },
  {
    "src": "Starting other therapies during this interval will result in a concomitant exposure to natalizumab.",
    "display_src": "Starting other therapies during this interval will result in a concomitant exposure to natalizumab.",
    "ref": "Die Einleitung anderer Therapien in dieser Zeit wird zwangsl\u00e4ufig mit einer begleitenden Exposition gegen\u00fcber Natalizumab verbunden sein.",
    "show_ref": false
  },
  {
    "src": "Therefore, women of childbearing potential should not receive the treatment until pregnancy is excluded and should be advised to use a reliable contraceptive method.",
    "display_src": "Therefore, women of childbearing potential should not receive the treatment until pregnancy is excluded and should be advised to use a reliable contraceptive method.",
    "ref": "Daher d\u00fcrfen Frauen im geb\u00e4rf\u00e4higen Alter die Behandlung nicht erhalten bis eine Schwangerschaft ausgeschlossen werden kann, und sie sollten dazu angehalten werden, einen zuverl\u00e4ssigen Konzeptionsschutz zu verwenden.",
    "show_ref": false
  },
  {
    "src": "Retacrit should be given after the patient has received a dialysis session.",
    "display_src": "Retacrit should be given after the patient has received a dialysis session.",
    "ref": "Retacrit sollte dem Patienten nach einer Dialysesitzung gegeben werden.",
    "show_ref": false
  },
  {
    "src": "Capsule shell Gelatine Sodium laurilsulfate Yellow iron oxide (E172) Titanium dioxide (E171) Silicon dioxide (E551)",
    "display_src": "Capsule shell Gelatine Sodium laurilsulfate Yellow iron oxide (E172) Titanium dioxide (E171) Silicon dioxide (E551)",
    "ref": "Gelatine Natriumlaurylsulfat Eisenoxid gelb (E172), Titandioxid (E171) Siliciumdioxid (E551)",
    "show_ref": false
  },
  {
    "src": "Rare side effects are swelling and itching of the face, lips and mouth.",
    "display_src": "Rare side effects are swelling and itching of the face, lips and mouth.",
    "ref": "Seltene Nebenwirkungen sind Schwellungen und Jucken von Gesicht, Lippen und Mund.",
    "show_ref": false
  },
  {
    "src": "WHAT OPTISULIN IS AND WHAT IT IS USED FOR",
    "display_src": "WHAT OPTISULIN IS AND WHAT IT IS USED FOR",
    "ref": "WAS IST OPTISULIN UND WOF\u00dcR WIRD ES ANGEWENDET?",
    "show_ref": false
  },
  {
    "src": "Diarrhoea, vomiting, nausea, abdominal pain Mouth ulceration, stomatitis ulcerative, stomatitis, right upper quadrant pain, dyspepsia, glossitis, gastroesophogeal reflux, rectal disorder, gastrointestinal disorder, constipation, loose stools, toothache, tooth disorder",
    "display_src": "Diarrhoea, vomiting, nausea, abdominal pain Mouth ulceration, stomatitis ulcerative, stomatitis, right upper quadrant pain, dyspepsia, glossitis, gastroesophogeal reflux, rectal disorder, gastrointestinal disorder, constipation, loose stools, toothache, tooth disorder",
    "ref": "Diarrhoe, Erbrechen, \u00dcbelkeit, Abdominalschmerzen Geschw\u00fcre im Mund, ulzerative Stomatitis, Stomatitis, Schmerzen im oberen rechten Quadranten, Dyspepsie, Glossitis, gastro\u00f6sophagealer Reflux, rektale Erkrankung, gastrointestinale Erkrankung, Verstopfung, d\u00fcnner Stuhl, Zahnschmerzen, Beschwerden an den Z\u00e4hnen",
    "show_ref": false
  },
  {
    "src": "An internal competition will be conducted in 2000 to integrate the Agency\u2019s secretarial and clerical staff within the Regulations and rules applicable to officials and other servants of the European Communities.",
    "display_src": "An internal competition will be conducted in 2000 to integrate the Agency\u2019s secretarial and clerical staff within the Regulations and rules applicable to officials and other servants of the European Communities.",
    "ref": "2000 wird ein internes Auswahlverfahren zur Integration der Sekretariats- und B\u00fcromitarbeiter in den Geltungsbereich des Statuts der Beamten und sonstigen Bediensteten der Europ\u00e4ischen Gemeinschaften durchgef\u00fchrt.",
    "show_ref": false
  },
  {
    "src": "The inner sterile blister must be opened in a sterile operating room area.",
    "display_src": "The inner sterile blister must be opened in a sterile operating room area.",
    "ref": "Der innere sterile Blister muss im sterilen Bereich des Operationssaales ge\u00f6ffnet werden.",
    "show_ref": false
  },
  {
    "src": "- pain in the abdomen (stomach), caused by inflammation of the pancreas",
    "display_src": "- pain in the abdomen (stomach), caused by inflammation of the pancreas",
    "ref": "- Bauchschmerzen infolge einer Entz\u00fcndung der Bauchspeicheldr\u00fcse",
    "show_ref": false
  },
  {
    "src": "Patients who have problems with their liver may be at an elevated risk of liver damage when taking treatment for HIV infection.",
    "display_src": "Patients who have problems with their liver may be at an elevated risk of liver damage when taking treatment for HIV infection.",
    "ref": "Patienten mit Leberleiden haben m\u00f6glicherweise ein erh\u00f6htes Risiko f\u00fcr Lebersch\u00e4den, wenn sie mit Arzneimitteln gegen HIV-Infektionen behandelt werden.",
    "show_ref": false
  },
  {
    "src": "This dosage recommendation for 60 mg tablets applies to children over 12 years only if their body weight exceeds 50 kg.",
    "display_src": "This dosage recommendation for 60 mg tablets applies to children over 12 years only if their body weight exceeds 50 kg.",
    "ref": "Diese Dosierungsempfehlung f\u00fcr 60 mg-Tabletten gilt f\u00fcr Kinder \u00fcber 12 Jahre sofern ihr K\u00f6rpergewicht 50 kg \u00fcbersteigt.",
    "show_ref": false
  },
  {
    "src": "INFORMATION FOR THE USER Micardis 20 mg tablets Telmisartan",
    "display_src": "INFORMATION FOR THE USER Micardis 20 mg tablets Telmisartan",
    "ref": "INFORMATION F\u00dcR DEN ANWENDER Micardis 20 mg Tabletten Telmisartan",
    "show_ref": false
  },
  {
    "src": "1x1 dose, 2x1 dose, 20x1 dose Not all pack sizes may be marketed.",
    "display_src": "1x1 dose, 2x1 dose, 20x1 dose Not all pack sizes may be marketed.",
    "ref": "1x1 Dosis, 2x1 Dosis, 20x1 Dosis Es werden m\u00f6glicherweise nicht alle Packungsgr\u00f6\u00dfen in den Verkehr gebracht.",
    "show_ref": false
  },
  {
    "src": "Therefore, OPTRUMA should be used for osteoporosis treatment and prevention only after the treatment of breast cancer, including adjuvant therapy, has been completed.",
    "display_src": "Therefore, OPTRUMA should be used for osteoporosis treatment and prevention only after the treatment of breast cancer, including adjuvant therapy, has been completed.",
    "ref": "Deshalb soll OPTRUMA zur Osteoporose-Behandlung oder Pr\u00e4vention erst eingesetzt werden, wenn die Behandlung des Brustkrebs, einschlie\u00dflich der adjuvanten Therapie, abgeschlossen ist.",
    "show_ref": false
  },
  {
    "src": "The tablets are supplied in blister packs containing either 14, 28, 30, 50, 90 or 98 tablets.",
    "display_src": "The tablets are supplied in blister packs containing either 14, 28, 30, 50, 90 or 98 tablets.",
    "ref": "Die Tabletten sind in Blisterpackungen mit 14, 28, 30, 50, 90 oder 98 Tabletten erh\u00e4ltlich.",
    "show_ref": false
  },
  {
    "src": "Gastroenteritis Blood and lymphatic system disorders:",
    "display_src": "Gastroenteritis Blood and lymphatic system disorders:",
    "ref": "Gastroenteritis Erkrankungen des Blutes und des Lymphsystems:",
    "show_ref": false
  },
  {
    "src": "Most of the patients in the population pharmacokinetic analysis had normal renal function or mild renal impairment.",
    "display_src": "Most of the patients in the population pharmacokinetic analysis had normal renal function or mild renal impairment.",
    "ref": "In einer Analyse zur Populationspharmakokinetik hatten die meisten Patienten eine normale Nierenfunktion oder eine leichte Nierenfunktionsst\u00f6rung.",
    "show_ref": false
  },
  {
    "src": "Pregnancy and breast -feeding Do not take Arava if you are, or think you may be pregnant.",
    "display_src": "Pregnancy and breast -feeding Do not take Arava if you are, or think you may be pregnant.",
    "ref": "80 Schwangerschaft und Stillzeit Nehmen Sie Arava nicht ein, wenn Sie schwanger sind oder denken, dass Sie schwanger sein k\u00f6nnten.",
    "show_ref": false
  },
  {
    "src": "Use of the product may result in transient pruritus in cats.",
    "display_src": "Use of the product may result in transient pruritus in cats.",
    "ref": "Die Anwendung des Tierarzneimittels kann bei Katzen vor\u00fcbergehenden Juckreiz ausl\u00f6sen.",
    "show_ref": false
  },
  {
    "src": "(44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu \u00a9EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged What benefit has Luveris shown during the studies?",
    "display_src": "(44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu \u00a9EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged What benefit has Luveris shown during the studies?",
    "ref": "(44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea.europa.eu http://www.emea.europa.eu \u00a9EMEA 2006 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Wie wurde Luveris untersucht?",
    "show_ref": false
  },
  {
    "src": "If you experience some of the symptoms of lactic acidosis stop taking Janumet and consult a doctor immediately",
    "display_src": "If you experience some of the symptoms of lactic acidosis stop taking Janumet and consult a doctor immediately",
    "ref": "Wenn bei Ihnen einige der Symptome einer Laktatazidose auftreten, setzen Sie Janumet ab und wenden sich umgehend an einen Arzt",
    "show_ref": false
  },
  {
    "src": "Take the tablets exactly as your doctor has told you.",
    "display_src": "Take the tablets exactly as your doctor has told you.",
    "ref": "Nehmen Sie die Tabletten immer genau nach Anweisung des Arztes ein.",
    "show_ref": false
  },
  {
    "src": "The use of Norvir may be considered in pregnancy only when the benefits outweigh the risk to the foetus.",
    "display_src": "The use of Norvir may be considered in pregnancy only when the benefits outweigh the risk to the foetus.",
    "ref": "Die Anwendung von Norvir in der Schwangerschaft sollte nur in Betracht gezogen werden, wenn der Nutzen das Risiko f\u00fcr den Foetus \u00fcberwiegt.",
    "show_ref": false
  },
  {
    "src": "The plasma t1/ 2 of timolol is 4 hours after ocular administration of DuoTrav.",
    "display_src": "The plasma t1/ 2 of timolol is 4 hours after ocular administration of DuoTrav.",
    "ref": "Nach okul\u00e4rer Verabreichung von DuoTrav betr\u00e4gt die Plasmahalbwertzeit t\u00bd von Timolol 4 Stunden.",
    "show_ref": false
  },
  {
    "src": "Only your physician can administer Humalog by the intravenous route.",
    "display_src": "Only your physician can administer Humalog by the intravenous route.",
    "ref": "Ausschlie\u00dflich Ihr Arzt darf Humalog intraven\u00f6s in-",
    "show_ref": false
  },
  {
    "src": "It should be noted that suppression of TNF\u03b1 may mask symptoms of infection such as fever.",
    "display_src": "It should be noted that suppression of TNF\u03b1 may mask symptoms of infection such as fever.",
    "ref": "Es ist zu beachten, dass die Blockade des TNF\u03b1 die Symptome einer Infektion wie z.B.",
    "show_ref": false
  },
  {
    "src": "Cartridges containing Humalog Mix25 should be rotated in the palms of the hands ten times and inverted 180\u00b0 ten times immediately before use to resuspend the insulin until it appears uniformly cloudy or milky.",
    "display_src": "Cartridges containing Humalog Mix25 should be rotated in the palms of the hands ten times and inverted 180\u00b0 ten times immediately before use to resuspend the insulin until it appears uniformly cloudy or milky.",
    "ref": "a) Vorbereitung einer Dosierung Humalog Mix25 Patronen sollen unmittelbar vor Verwendung zwischen den Handfl\u00e4chen 10x gerollt und 10x um 180\u00b0 gedreht werden, um das Insulin bis zu einem einheitlich milchigen oder wolkigen Aussehen zu durchmischen.",
    "show_ref": false
  },
  {
    "src": "Karvezide 300 mg/ 25 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.",
    "display_src": "Karvezide 300 mg/ 25 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.",
    "ref": "Karvezide 300 mg/25 mg Filmtabletten stehen in Blisterpackungen zu 14, 28, 30, 56, 84, 90 oder 98 St\u00fcck zur Verf\u00fcgung.",
    "show_ref": false
  },
  {
    "src": "If you develop PRCA your Binocrit therapy will be discontinued and your doctor will decide how best to treat your anaemia.",
    "display_src": "If you develop PRCA your Binocrit therapy will be discontinued and your doctor will decide how best to treat your anaemia.",
    "ref": "Falls Sie unter Erythroblastopenie leiden, wird er Ihre Therapie mit Binocrit abbrechen und festlegen, wie Ihre An\u00e4mie am besten behandelt wird.",
    "show_ref": false
  },
  {
    "src": "This fill volume has been established during the development of TAXOTERE to compensate for liquid loss during preparation of the premix due to foaming, adhesion to the walls of the vial and \"dead-volume\".",
    "display_src": "This fill volume has been established during the development of TAXOTERE to compensate for liquid loss during preparation of the premix due to foaming, adhesion to the walls of the vial and \"dead-volume\".",
    "ref": "Dieses F\u00fcllvolumen wurde w\u00e4hrend der Entwicklung von TAXOTERE festgelegt, um einen Fl\u00fcssigkeitsverlust bei der Herstellung der Basisl\u00f6sung durch Schaumbildung, Haften an der Glasbeh\u00e4lterwand und \u00bbtotes Volumen\u00ab ausgleichen zu k\u00f6nnen.",
    "show_ref": false
  },
  {
    "src": "Oxyglobin is intended for single administration.",
    "display_src": "Oxyglobin is intended for single administration.",
    "ref": "Oxyglobin ist f\u00fcr die einmalige Anwendung vorgesehen.",
    "show_ref": false
  },
  {
    "src": "- if you are allergic (hypersensitive) to capecitabine or any of the other ingredients of Xeloda.",
    "display_src": "- if you are allergic (hypersensitive) to capecitabine or any of the other ingredients of Xeloda.",
    "ref": "- wenn Sie \u00fcberempfindlich (allergisch) gegen Capecitabin oder einen der sonstigen Bestandteile",
    "show_ref": false
  },
  {
    "src": "Tmax occurs after 3 hours in a fed state.",
    "display_src": "Tmax occurs after 3 hours in a fed state.",
    "ref": "Die Tmax wird in nicht n\u00fcchternem Zustand nach 3 Stunden erreicht.",
    "show_ref": false
  },
  {
    "src": "The dose of Tamiflu is 75 mg in adults and in children who weigh more than 40 kg.",
    "display_src": "The dose of Tamiflu is 75 mg in adults and in children who weigh more than 40 kg.",
    "ref": "Die Dosis von Tamiflu betr\u00e4gt 75 mg bei Erwachsenen und bei Kindern mit einem K\u00f6rpergewicht \u00fcber 40 kg.",
    "show_ref": false
  },
  {
    "src": "Each pre-filled syringe (0.5 ml) contains 22 micrograms (6 MIU) of interferon beta-1a.",
    "display_src": "Each pre-filled syringe (0.5 ml) contains 22 micrograms (6 MIU) of interferon beta-1a.",
    "ref": "Jede Fertigspritze (0,5 ml) enth\u00e4lt 22 Mikrogramm (6 M.I.E.) Interferon beta-1a.",
    "show_ref": false
  },
  {
    "src": "Treatment with Siklos and concomitant immunisation with live virus vaccines should only be performed if benefits clearly outweigh potential risks.",
    "display_src": "Treatment with Siklos and concomitant immunisation with live virus vaccines should only be performed if benefits clearly outweigh potential risks.",
    "ref": "Die Behandlung mit Siklos und gleichzeitige Immunisierung mit Lebendvirusvakzinen sollte nur dann durchgef\u00fchrt werden, wenn die Vorteile die potenziellen Risiken eindeutig \u00fcberwiegen.",
    "show_ref": false
  },
  {
    "src": "Pfizer Limited, Ramsgate Rd, Sandwich, Kent, CT13 9NJ, United Kingdom.",
    "display_src": "Pfizer Limited, Ramsgate Rd, Sandwich, Kent, CT13 9NJ, United Kingdom.",
    "ref": "Pfizer Limited, Ramsgate Rd, Sandwich, Kent, CT13 9NJ, Vereinigtes K\u00f6nigreich",
    "show_ref": false
  },
  {
    "src": "Adults (1,500 mg/ m2) N=103 (%)",
    "display_src": "Adults (1,500 mg/ m2) N=103 (%)",
    "ref": "Erwachsene (1.500 mg/m2) N=103 (%)",
    "show_ref": false
  },
  {
    "src": "alli 60 mg hard capsules Orlistat",
    "display_src": "alli 60 mg hard capsules Orlistat",
    "ref": "alli 60 mg Hartkapseln Orlistat",
    "show_ref": false
  },
  {
    "src": "At the site of injection you may get a reaction, where the skin may be red, swollen or hurt when touched.",
    "display_src": "At the site of injection you may get a reaction, where the skin may be red, swollen or hurt when touched.",
    "ref": "An der Injektionsstelle kann es zu Reaktionen kommen, in deren Folge sich die Haut r\u00f6tet, anschwillt oder bei Ber\u00fchrung schmerzt.",
    "show_ref": false
  },
  {
    "src": "Responses were also determined by a composite score of five clinical signs (surface area, erythema, plaque elevation, scaling and hypo/ hyperpigmentation) which also considered all extracutaneous CTCL manifestations.",
    "display_src": "Responses were also determined by a composite score of five clinical signs (surface area, erythema, plaque elevation, scaling and hypo/ hyperpigmentation) which also considered all extracutaneous CTCL manifestations.",
    "ref": "Das Ansprechen wurde dar\u00fcber hinaus durch eine zusammengesetzte Bewertungsskala von f\u00fcnf klinischen Anzeichen (Oberfl\u00e4che, Erythem, Erh\u00f6hung der Plaques, Schuppung und Hypo-/Hyperpigmentierung), durch die auch alle extrakutanen CTCL- Manifestationen in Betracht gezogen wurden, bestimmt.",
    "show_ref": false
  },
  {
    "src": "Administration (Intravenous Injection):",
    "display_src": "Administration (Intravenous Injection):",
    "ref": "Verabreichung (intraven\u00f6se Injektion):",
    "show_ref": false
  },
  {
    "src": "Insulin Human Winthrop Comb 25 100 IU/ml suspension for injection in a vial Insulin human",
    "display_src": "Insulin Human Winthrop Comb 25 100 IU/ml suspension for injection in a vial Insulin human",
    "ref": "Insulin Human Winthrop Comb 25 100 I.E./ml Injektionssuspension in einer Durchstechflasche Insulin human",
    "show_ref": false
  },
  {
    "src": "At a therapeutic dosage (one Trizivir tablet twice daily) in patients, the mean (CV) steady-state Cmax of abacavir, lamivudine and zidovudine in plasma are 3.49 \u00b5g/ ml (45%), 1.33 \u00b5g/ ml (33%) and 1.56 \u00b5g/ ml (83%), respectively.",
    "display_src": "At a therapeutic dosage (one Trizivir tablet twice daily) in patients, the mean (CV) steady-state Cmax of abacavir, lamivudine and zidovudine in plasma are 3.49 \u00b5g/ ml (45%), 1.33 \u00b5g/ ml (33%) and 1.56 \u00b5g/ ml (83%), respectively.",
    "ref": "In therapeutischer Dosierung (eine Filmtablette Trizivir zweimal t\u00e4glich) bei Patienten betrugen die mittleren Cmax-Werte (Variationskoeffizient) f\u00fcr Abacavir, Lamivudin und Zidovudin im Steady-State 3,49 \u00b5g/ml (45%), 1,33 \u00b5g/ml (33%) und 1,56 \u00b5g/ml (83%).",
    "show_ref": false
  },
  {
    "src": "It is not known whether aprepitant is excreted in human milk; therefore, breast-feeding is not recommended during treatment with EMEND.",
    "display_src": "It is not known whether aprepitant is excreted in human milk; therefore, breast-feeding is not recommended during treatment with EMEND.",
    "ref": "Es ist nicht bekannt, ob Aprepitant beim Menschen in die Muttermilch \u00fcbergeht; deshalb wird w\u00e4hrend der Behandlung mit EMEND Stillen nicht empfohlen.",
    "show_ref": false
  },
  {
    "src": "Ciprofloxacin has been shown to cause arthropathy in weight-bearing joints of immature animals.",
    "display_src": "Ciprofloxacin has been shown to cause arthropathy in weight-bearing joints of immature animals.",
    "ref": "Im Tierversuch konnte gezeigt werden, dass Ciprofloxacin an den gewichttragenden Gelenken von Jungtieren Arthropathien verursacht.",
    "show_ref": false
  },
  {
    "src": "100 ml clear glass vial containing 100 ml of solution; rubber stopper and crimp cap.",
    "display_src": "100 ml clear glass vial containing 100 ml of solution; rubber stopper and crimp cap.",
    "ref": "100 ml Durchstechflasche (Klarglas) mit 100 ml L\u00f6sung; Gummistopfen und B\u00f6rdelkappe.",
    "show_ref": false
  },
  {
    "src": "The main metabolic pathway is glucuronidation of entacapone and its active metabolite, the cis-isomer, which accounts for about 5% of plasma total amount.",
    "display_src": "The main metabolic pathway is glucuronidation of entacapone and its active metabolite, the cis-isomer, which accounts for about 5% of plasma total amount.",
    "ref": "Der haupts\u00e4chliche Stoffwechselweg ist die Glucuronidierung von Entacapon und dessen aktivem Metaboliten, dem cis-Isomer, das etwa 5% der Gesamtmenge im Plasma ausmacht.",
    "show_ref": false
  },
  {
    "src": "- phenothiazine derivatives (used to treat psychiatric disorders),",
    "display_src": "- phenothiazine derivatives (used to treat psychiatric disorders),",
    "ref": "- Phenothiazin-Abk\u00f6mmlinge (zur Behandlung psychiatrischer Beschwerden),",
    "show_ref": false
  },
  {
    "src": "As expected for a prostacyclin, iloprost produced haemodynamic effects (vasodilatation, reddening of skin, hypotension, inhibition of platelet function, respiratory distress) and general signs of intoxication such as apathy, gait disturbances, and postural changes.",
    "display_src": "As expected for a prostacyclin, iloprost produced haemodynamic effects (vasodilatation, reddening of skin, hypotension, inhibition of platelet function, respiratory distress) and general signs of intoxication such as apathy, gait disturbances, and postural changes.",
    "ref": "Wie f\u00fcr ein Prostacyclin-Analogon zu erwarten, rief Iloprost h\u00e4modynamische Wirkungen (Vasodilatation, Hautr\u00f6tung, Hypotonie, Hemmung der Thrombozytenfunktion, Atemnot) und allgemeine Zeichen einer Intoxikation wie Apathie, Gangst\u00f6rungen und Haltungsver\u00e4nderungen hervor.",
    "show_ref": false
  },
  {
    "src": "Bilirubin increases to > 3 \u00d7 ULN were associated with aminotransferase increases (> 3 \u00d7 ULN) in 2 of 658 (0.3%) of patients treated with bosentan.",
    "display_src": "Bilirubin increases to > 3 \u00d7 ULN were associated with aminotransferase increases (> 3 \u00d7 ULN) in 2 of 658 (0.3%) of patients treated with bosentan.",
    "ref": "Erh\u00f6hte Bilirubinwerte auf > 3 \u00d7 ONW waren bei 2 von 658 (0,3%) der mit Bosentan behandelten Patienten mit Erh\u00f6hungen der Aminotransferasewerte (> 3 \u00d7 ONW) assoziiert.",
    "show_ref": false
  },
  {
    "src": "Rituximab has been designed to target an antigen called CD20, which is present on the surface of all B-lymphocytes.",
    "display_src": "Rituximab has been designed to target an antigen called CD20, which is present on the surface of all B-lymphocytes.",
    "ref": "Rituximab ist gegen ein Antigen mit der Bezeichnung CD20 gerichtet, das auf der Oberfl\u00e4che aller B- Lymphozyten vorhanden ist.",
    "show_ref": false
  },
  {
    "src": "Taste disturbance b",
    "display_src": "Taste disturbance b",
    "ref": "Beeintr\u00e4chtigung des Geschmackssinns b",
    "show_ref": false
  },
  {
    "src": "\u2022 Do not remove the stopper \u2022 Clean the stopper with an antiseptic swab \u2022 Put the vial on a flat surface.",
    "display_src": "\u2022 Do not remove the stopper \u2022 Clean the stopper with an antiseptic swab \u2022 Put the vial on a flat surface.",
    "ref": "53 \u2022 Entfernen Sie nicht den Gummistopfen. \u2022 Reinigen Sie den Stopfen mit einem antiseptischen Tupfer. \u2022 Stellen Sie die Durchstechflasche auf eine ebene Oberfl\u00e4che.",
    "show_ref": false
  },
  {
    "src": "For the smaller vessels, SonoVue led to better quality scans when looking at the blood flow in breast and liver lesions.",
    "display_src": "For the smaller vessels, SonoVue led to better quality scans when looking at the blood flow in breast and liver lesions.",
    "ref": "Bei kleineren Gef\u00e4\u00dfen f\u00fchrte SonoVue zu Aufnahmen mit besserer Qualit\u00e4t, wenn der Blutfluss in Brust- und Leberl\u00e4sionen untersucht wurde.",
    "show_ref": false
  },
  {
    "src": "Myocet doxorubicin HCl, Myocet liposomes and Myocet buffer.",
    "display_src": "Myocet doxorubicin HCl, Myocet liposomes and Myocet buffer.",
    "ref": "Myocet- Doxorubicin-HCl, Myocet-Liposomen und Myocet-Puffer.",
    "show_ref": false
  },
  {
    "src": "Some patients may already benefit at a daily dose of 20 mg.",
    "display_src": "Some patients may already benefit at a daily dose of 20 mg.",
    "ref": "Bei einigen Patienten kann bereits bei einer Tagesdosis von 20 mg eine ausreichende Wirkung erzielt werden.",
    "show_ref": false
  },
  {
    "src": "WHAT VELCADE IS AND WHAT IT IS USED FOR",
    "display_src": "WHAT VELCADE IS AND WHAT IT IS USED FOR",
    "ref": "WAS IST VELCADE UND WOF\u00dcR WIRD ES ANGEWENDET?",
    "show_ref": false
  },
  {
    "src": "In the absence of human serum, the mean IC50 of lopinavir was 6.5 nM against several HIV-1 clinical isolates.",
    "display_src": "In the absence of human serum, the mean IC50 of lopinavir was 6.5 nM against several HIV-1 clinical isolates.",
    "ref": "In Abwesenheit von Humanserum war die durchschnittliche IC50 von Lopinavir gegen verschiedene klinische HIV-1-Isolate 6,5 nM.",
    "show_ref": false
  },
  {
    "src": "In HBV combination assays in cell culture, abacavir, didanosine, lamivudine, stavudine, tenofovir or zidovudine were not antagonistic to the anti-HBV activity of entecavir over a wide range of concentrations.",
    "display_src": "In HBV combination assays in cell culture, abacavir, didanosine, lamivudine, stavudine, tenofovir or zidovudine were not antagonistic to the anti-HBV activity of entecavir over a wide range of concentrations.",
    "ref": "In Zellkultur zeigten sich in HBV-Kombinations-Assays Abacavir, Didanosin, Lamivudin, Stavudin, Tenofovir oder Zidovudin als nicht-antagonistisch gegen die anti-HBV-Aktivit\u00e4t von Entecavir in einem weit gef\u00e4cherten Konzentrationsbereich.",
    "show_ref": false
  },
  {
    "src": "Why has OPATANOL been approved?",
    "display_src": "Why has OPATANOL been approved?",
    "ref": "Warum wurde OPATANOL zugelassen?",
    "show_ref": false
  },
  {
    "src": "ProStrakan Ltd submitted applications for Rapinyl and associated names, 50\u00b5g, 100\u00b5g, 200\u00b5g, 300\u00b5g, 400\u00b5g, 600\u00b5g, 800\u00b5g, sublingual tablets.",
    "display_src": "ProStrakan Ltd submitted applications for Rapinyl and associated names, 50\u00b5g, 100\u00b5g, 200\u00b5g, 300\u00b5g, 400\u00b5g, 600\u00b5g, 800\u00b5g, sublingual tablets.",
    "ref": "ProStrakan Ltd reichte Antr\u00e4ge f\u00fcr Rapinyl und damit verbundene Bezeichnungen, 50\u00b5g, 100\u00b5g, 200\u00b5g, 300\u00b5g, 400\u00b5g, 600\u00b5g, 800\u00b5g, Sublingualtabletten ein.",
    "show_ref": false
  },
  {
    "src": "The study population consisted of 8,556 postmenopausal women with osteoporosis as defined by low BMD (vertebral or hip BMD at least 2.5 standard deviations below the mean value for healthy young women).",
    "display_src": "The study population consisted of 8,556 postmenopausal women with osteoporosis as defined by low BMD (vertebral or hip BMD at least 2.5 standard deviations below the mean value for healthy young women).",
    "ref": "Die Studienpopulation bestand aus 8.556 postmenopausalen Frauen, die mit einem niedrigen BMD (Wirbel- oder H\u00fcft-BMD von mindestens 2,5 Standardabweichungen unterhalb des Mittelwertes f\u00fcr gesunde junge Frauen) definitionsgem\u00e4\u00df unter Osteoporose litten.",
    "show_ref": false
  },
  {
    "src": "EXP {month/ year} Use within one hour after reconstitution",
    "display_src": "EXP {month/ year} Use within one hour after reconstitution",
    "ref": "Verw. bis {Monat/Jahr} Nach Aufl\u00f6sung oder Rekonstitution innerhalb von einer Stunde aufbrauchen.",
    "show_ref": false
  },
  {
    "src": "Following the administration of a double dose in chickens and ducks, no adverse reactions other than those described in section 4.6 have been observed.",
    "display_src": "Following the administration of a double dose in chickens and ducks, no adverse reactions other than those described in section 4.6 have been observed.",
    "ref": "Nach Verabreichung der doppelten Dosis bei H\u00fchnern und Pekintenten wurden keine anderen Nebenwirkungen beobachtet als unter Abschnitt 4.6 beschrieben.",
    "show_ref": false
  },
  {
    "src": "The physician should be consulted when using other medications in addition to Liprolog Mix25.",
    "display_src": "The physician should be consulted when using other medications in addition to Liprolog Mix25.",
    "ref": "20 Die zus\u00e4tzliche Anwendung weiterer Arzneimittel neben Liprolog Mix25 muss mit dem Arzt abge- stimmt werden.",
    "show_ref": false
  },
  {
    "src": "The Committee for Medicinal products for Human Use (CHMP) concluded that Tarceva had shown that it is effective in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen, although there was not enough justification for, or data on its use in patients whose tumours are EGFR-negative.",
    "display_src": "The Committee for Medicinal products for Human Use (CHMP) concluded that Tarceva had shown that it is effective in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen, although there was not enough justification for, or data on its use in patients whose tumours are EGFR-negative.",
    "ref": "Der Ausschuss f\u00fcr Humanarzneimittel (CHMP) gelangte zu dem Schluss, dass sich Tarceva bei der Behandlung von Patienten mit lokal fortgeschrittenem oder metastasiertem nicht-kleinzelligem Lungenkarzinom nach Versagen von mindestens einer vorherigen Chemotherapie als wirksam erwiesen hat, obwohl die Begr\u00fcndung f\u00fcr bzw. die Daten \u00fcber die Anwendung bei Patienten mit EGFR-negativem Tumor nicht ausreichten.",
    "show_ref": false
  },
  {
    "src": "Measure 94 ml of purified water in a graduated cylinder.",
    "display_src": "Measure 94 ml of purified water in a graduated cylinder.",
    "ref": "Messen Sie 94 ml gereinigtes Wasser in einem Messzylinder ab.",
    "show_ref": false
  },
  {
    "src": "Flebogammadif 50 mg/ ml solution for infusion",
    "display_src": "Flebogammadif 50 mg/ ml solution for infusion",
    "ref": "Flebogammadif 50 mg/ml Infusionsl\u00f6sung",
    "show_ref": false
  },
  {
    "src": "The summary of opinion of the Committee for Orphan Medicinal Products for Ceplene is available here.",
    "display_src": "The summary of opinion of the Committee for Orphan Medicinal Products for Ceplene is available here.",
    "ref": "Die Zusammenfassung des Gutachtens des Ausschusses f\u00fcr Arzneimittel f\u00fcr seltene Leiden zu Ceplene finden Sie hier.",
    "show_ref": false
  },
  {
    "src": "The other ingredients are microcrystalline cellulose, sodium starch glycollate and magnesium stearate in the core of the tablet.",
    "display_src": "The other ingredients are microcrystalline cellulose, sodium starch glycollate and magnesium stearate in the core of the tablet.",
    "ref": "Die sonstigen Bestandteile sind mikrokristalline Cellulose, Poly(O-carboxymethyl)st\u00e4rke-Natriumsalz und Magnesiumstearat im Tablettenkern.",
    "show_ref": false
  },
  {
    "src": "The Applicant further considered the current bridging strategy to be appropriate for the approval of Rapinyl over the 100-800\u00b5g dose range for the treatment of BTP in patients as Rapinyl delivers fentanyl within a plasma concentration range already established as safe and effective.",
    "display_src": "The Applicant further considered the current bridging strategy to be appropriate for the approval of Rapinyl over the 100-800\u00b5g dose range for the treatment of BTP in patients as Rapinyl delivers fentanyl within a plasma concentration range already established as safe and effective.",
    "ref": "Der Antragsteller hielt dar\u00fcber hinaus die derzeitige \u00dcberbr\u00fcckungsstrategie f\u00fcr die Genehmigung von Rapinyl \u00fcber den Dosisbereich von 100-800 \u00b5g zur Behandlung von BTP bei Patienten f\u00fcr geeignet, da die Sicherheit und Wirksamkeit des Plasmakonzentrationsbereichs des \u00fcber Rapinyl verabreichten Fentanyls bereits erwiesen sind.",
    "show_ref": false
  },
  {
    "src": "In placebo-controlled studies, bosentan-related decreases in haemoglobin concentration were not progressive, and stabilised after the first 4\u2013 12 weeks of treatment.",
    "display_src": "In placebo-controlled studies, bosentan-related decreases in haemoglobin concentration were not progressive, and stabilised after the first 4\u2013 12 weeks of treatment.",
    "ref": "In plazebokontrollierten Studien waren die mit Bosentan in Zusammenhang stehenden erniedrigten H\u00e4moglobinkonzentrationen nicht progredient und stabilisierten sich innerhalb der ersten 4 bis 12 Wochen nach Behandlungsbeginn.",
    "show_ref": false
  },
  {
    "src": "4 Cladribine may strongly impair the patient\u2019 s performance.",
    "display_src": "4 Cladribine may strongly impair the patient\u2019 s performance.",
    "ref": "Cladribin kann gro\u00dfen Einfluss auf die Leistungsf\u00e4higkeit des Patienten haben.",
    "show_ref": false
  },
  {
    "src": "4 mg/ kg twice daily for 7 days).",
    "display_src": "4 mg/ kg twice daily for 7 days).",
    "ref": "4 mg/kg zweimal t\u00e4glich f\u00fcr sieben Tage).",
    "show_ref": false
  },
  {
    "src": "th Like all medicines, Protopy can cause side effects, although not everybody gets them.",
    "display_src": "th Like all medicines, Protopy can cause side effects, although not everybody gets them.",
    "ref": "Wie alle Arzneimittel kann Protopy Nebenwirkungen haben, die aber nicht bei jedem auftreten m\u00fcssen. ei",
    "show_ref": false
  },
  {
    "src": "As general advice to minimise the risk for skin cancer, exposure to sunlight and ultra-violet (UV) light should be limited by wearing protective clothing and using a sunscreen with a high protection factor.",
    "display_src": "As general advice to minimise the risk for skin cancer, exposure to sunlight and ultra-violet (UV) light should be limited by wearing protective clothing and using a sunscreen with a high protection factor.",
    "ref": "16 grunds\u00e4tzlich geraten, sich nur begrenzt und mit sch\u00fctzender Kleidung dem Sonnen- und Ultraviolett (UV)-Licht auszusetzen und ein Sonnenschutzmittel mit hohem Lichtschutzfaktor zu benutzen.",
    "show_ref": false
  },
  {
    "src": "IntronA is used as an add-on to anticancer treatments, \u2022 carcinoid tumour (a tumour of the endocrine system that produces hormones), \u2022 malignant melanoma (a type of skin cancer affecting cells called melanocytes).",
    "display_src": "IntronA is used as an add-on to anticancer treatments, \u2022 carcinoid tumour (a tumour of the endocrine system that produces hormones), \u2022 malignant melanoma (a type of skin cancer affecting cells called melanocytes).",
    "ref": "IntronA wird zusammen mit anderen Krebsmedikamenten verabreicht; \u2022 des Karzinoids (eines Tumors des endokrinen Systems, das Hormone produziert); \u2022 des malignen Melanoms (einer bestimmten Art von Hautkrebs, der die so genannten Melanozyten betrifft).",
    "show_ref": false
  },
  {
    "src": "Children Rivastigmine is not recommended for use in children.",
    "display_src": "Children Rivastigmine is not recommended for use in children.",
    "ref": "Kinder Rivastigmin wird nicht empfohlen f\u00fcr die Anwendung bei Kindern.",
    "show_ref": false
  },
  {
    "src": "The risk of developing inhibitors is correlated to the exposure to factor VIII, this risk being highest within the first 20 exposure days.",
    "display_src": "The risk of developing inhibitors is correlated to the exposure to factor VIII, this risk being highest within the first 20 exposure days.",
    "ref": "Das Risiko einer Inhibitorentwicklung korreliert mit dem Umfang der Anwendung von Faktor VIII, wobei das Risiko innerhalb der ersten 20 Expositionstage am gr\u00f6\u00dften ist.",
    "show_ref": false
  },
  {
    "src": "5.8 Overdose (signs, emergency procedures, antidotes) (if necessary)",
    "display_src": "5.8 Overdose (signs, emergency procedures, antidotes) (if necessary)",
    "ref": "5.8 \u00dcberdosierung (Symptome, Notfallma\u00dfnahmen, Gegenmittel)",
    "show_ref": false
  },
  {
    "src": "KG Emil-von-Behring-Strasse 76 D-35041 Marburg GERMANY",
    "display_src": "KG Emil-von-Behring-Strasse 76 D-35041 Marburg GERMANY",
    "ref": "KG Emil-von-Behring-Stra\u00dfe 76 35041 Marburg DEUTSCHLAND",
    "show_ref": false
  },
  {
    "src": "Don\u2019 t stop Telzir without advice Take Telzir for as long as your doctor recommends.",
    "display_src": "Don\u2019 t stop Telzir without advice Take Telzir for as long as your doctor recommends.",
    "ref": "Beenden Sie die Einnahme von Telzir nicht ohne Empfehlung Ihres Arztes Setzen Sie die Einnahme von Telzir solange fort, wie es Ihr Arzt empfiehlt.",
    "show_ref": false
  },
  {
    "src": "When ritonavir is co-administered, the effect on hormonal contraceptive concentrations cannot be predicted, therefore, alternative methods of contraception are also recommended.",
    "display_src": "When ritonavir is co-administered, the effect on hormonal contraceptive concentrations cannot be predicted, therefore, alternative methods of contraception are also recommended.",
    "ref": "Die Wirkung einer zus\u00e4tzlichen Verabreichung von Ritonavir auf hormonelle Kontrazeptiva ist nicht voraussagbar, daher werden ebenso alternative Methoden zur Empf\u00e4ngnisverh\u00fctung empfohlen.",
    "show_ref": false
  },
  {
    "src": "EMEA/CVMP/115/01",
    "display_src": "EMEA/CVMP/115/01",
    "ref": "EMEA/CVMP/115/01 EMEA/CVMP/115/01",
    "show_ref": false
  },
  {
    "src": "It is not recommended to take Circadin if you are pregnant or suspect that you may be pregnant.",
    "display_src": "It is not recommended to take Circadin if you are pregnant or suspect that you may be pregnant.",
    "ref": "Die Einnahme von Circadin wird nicht empfohlen wenn Sie schwanger sind oder vermuten schwanger zu sein.",
    "show_ref": false
  },
  {
    "src": "The European Commission granted a marketing authorisation valid throughout the European Union for Mirapexin on 23 February 1998.",
    "display_src": "The European Commission granted a marketing authorisation valid throughout the European Union for Mirapexin on 23 February 1998.",
    "ref": "Februar 1998 erteilte die Europ\u00e4ische Kommission eine Genehmigung f\u00fcr das Inverkehrbringen von Mirapexin in der gesamten Europ\u00e4ischen Union.",
    "show_ref": false
  },
  {
    "src": "Steady-state is achieved between 6-10 days after once daily dosing with \u2248 2 times accumulation.",
    "display_src": "Steady-state is achieved between 6-10 days after once daily dosing with \u2248 2 times accumulation.",
    "ref": "Steady-state wird zwischen 6 - 10 Tagen nach einmal t\u00e4glicher Gabe erreicht, mit \u2248 2facher Akkumulation.",
    "show_ref": false
  },
  {
    "src": "Usually the adverse reactions caused by entacapone are mild to moderate.",
    "display_src": "Usually the adverse reactions caused by entacapone are mild to moderate.",
    "ref": "Die durch Entacapon verursachten Nebenwirkungen sind in der Regel leicht bis mittelschwer.",
    "show_ref": false
  },
  {
    "src": "Olanzapine Teva is not for patients who are under 18 years.",
    "display_src": "Olanzapine Teva is not for patients who are under 18 years.",
    "ref": "Olanzapin Teva wird f\u00fcr Patienten unter 18 Jahren nicht empfohlen.",
    "show_ref": false
  },
  {
    "src": "In the post-marketing period rare cases of unexplained hepatic cirrhosis were reported after prolonged therapy with Tracleer in patients with multiple co-morbidities and drug therapies.",
    "display_src": "In the post-marketing period rare cases of unexplained hepatic cirrhosis were reported after prolonged therapy with Tracleer in patients with multiple co-morbidities and drug therapies.",
    "ref": "Nach Markteinf\u00fchrung wurden bei Patienten mit multiplen Begleiterkrankungen und Begleitmedikationen seltene F\u00e4lle von ungekl\u00e4rter Leberzirrhose nach langandauernder Behandlung mit Tracleer berichtet.",
    "show_ref": false
  },
  {
    "src": "This medicinal product has been authorised under \u201c Exceptional circumstances\u201d.",
    "display_src": "This medicinal product has been authorised under \u201c Exceptional circumstances\u201d.",
    "ref": "Dieses Arzneimittel wurde unter \u201e au\u00dfergew\u00f6hnlichen Umst\u00e4nden\u201c zugelassen.",
    "show_ref": false
  },
  {
    "src": "Apidra 100 Units/ ml solution for injection in a vial Insulin glulisine",
    "display_src": "Apidra 100 Units/ ml solution for injection in a vial Insulin glulisine",
    "ref": "Apidra 100 Einheiten/ml Injektionsl\u00f6sung in einer Durchstechflasche Insulinglulisin",
    "show_ref": false
  },
  {
    "src": "Temsirolimus was not genotoxic in a battery of in vitro (bacterial reverse mutation in Salmonella typhimurium and Escherichia coli, forward mutation in mouse lymphoma cells, and chromosome aberrations in Chinese hamster ovary cells) and in vivo (mouse micronucleus) assays.",
    "display_src": "Temsirolimus was not genotoxic in a battery of in vitro (bacterial reverse mutation in Salmonella typhimurium and Escherichia coli, forward mutation in mouse lymphoma cells, and chromosome aberrations in Chinese hamster ovary cells) and in vivo (mouse micronucleus) assays.",
    "ref": "Temsirolimus war in einer Reihe von in vitro (bakterielle reverse Mutation bei Salmonella typhimurium und Escherichia coli, Vorw\u00e4rtsmutation bei Maus-Lymphomzellen und",
    "show_ref": false
  },
  {
    "src": "Humira 40 mg solution for injection in pre-filled pen",
    "display_src": "Humira 40 mg solution for injection in pre-filled pen",
    "ref": "Humira 40 mg Injektionsl\u00f6sung im vorgef\u00fcllten Pen (Injektor, vorgef\u00fcllt/FertigPEN)",
    "show_ref": false
  },
  {
    "src": "In patients with secondary hyperparathyroidism Renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 \u2013 dihydroxy Vitamin D3 or one of its analogues to lower the intact parathyroid hormone (iPTH) levels.",
    "display_src": "In patients with secondary hyperparathyroidism Renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 \u2013 dihydroxy Vitamin D3 or one of its analogues to lower the intact parathyroid hormone (iPTH) levels.",
    "ref": "Renagel sollte bei Patienten mit sekund\u00e4rem Hyperparathyreoidismus innerhalb einer Mehrfachtherapie verwendet werden, die zur Senkung des intakten Parathormon (iPTH)-Niveaus Kalziumzus\u00e4tze, 1,25-Dihydroxy- Vitamin D3 oder einen Analogstoff desselben enthalten k\u00f6nnte.",
    "show_ref": false
  },
  {
    "src": "Oxidative degradation of the morpholinone moiety and hydrolysis of the amide bonds are the major sites of biotransformation.",
    "display_src": "Oxidative degradation of the morpholinone moiety and hydrolysis of the amide bonds are the major sites of biotransformation.",
    "ref": "Der oxidative Abbau des Morpholino Ringes und die Hydrolyse der Amidbindungen sind die Hauptwege der Biotransformation.",
    "show_ref": false
  },
  {
    "src": "11 MBq [90Y]- radiolabelled Zevalin per kg body weight up to a maximum of 1200 MBq.",
    "display_src": "11 MBq [90Y]- radiolabelled Zevalin per kg body weight up to a maximum of 1200 MBq.",
    "ref": "[90Y]-markiertes Zevalin pro kg K\u00f6rpergewicht, bis zu einer Maximaldosis von 1200 MBq.",
    "show_ref": false
  },
  {
    "src": "Based on the review of the data and the company\u2019 s response to the CHMP list of questions at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Voraxaze could not have been approved for the adjunctive treatment of patients experiencing or at risk of methotrexate toxicity.",
    "display_src": "Based on the review of the data and the company\u2019 s response to the CHMP list of questions at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Voraxaze could not have been approved for the adjunctive treatment of patients experiencing or at risk of methotrexate toxicity.",
    "ref": "Auf Grundlage der gepr\u00fcften Daten und der Antwort des Herstellers auf die Fragenliste des CHMP bestanden zum Zeitpunkt der R\u00fccknahme seitens des CHMP einige Bedenken und der CHMP war der vorl\u00e4ufigen Ansicht, dass Voraxaze nicht zur Zusatzbehandlung von Patienten mit Methotrexat- Toxizit\u00e4t bzw. einem Risiko dazu zugelassen werden k\u00f6nnte.",
    "show_ref": false
  },
  {
    "src": "Subjects were grouped according to baseline creatinine clearance (> 80 ml/ min as normal function; 50-80 ml/ min as mild impairment; 30-49 ml/ min as moderate impairment; < 30 ml/ min as severe impairment; < 15 ml/ min as functionally anephric requiring haemodialysis).",
    "display_src": "Subjects were grouped according to baseline creatinine clearance (> 80 ml/ min as normal function; 50-80 ml/ min as mild impairment; 30-49 ml/ min as moderate impairment; < 30 ml/ min as severe impairment; < 15 ml/ min as functionally anephric requiring haemodialysis).",
    "ref": "Die Probanden wurden dabei auf Basis der Kreatinin-Clearance (Clcr) bei Studienbeginn gruppiert (normale Nierenfunktion bei Werten > 80 ml/min; leichte Nierenfunktionsst\u00f6rung bei 50 - 80 ml/min; mittelgradige Funktionsst\u00f6rung bei 30-49 ml/min, schwerwiegende Funktionsst\u00f6rung bei < 30 ml/min sowie h\u00e4modialysepflichtige funktionale Anephrie bei < 15 ml/min).",
    "show_ref": false
  },
  {
    "src": "Other very common side effects",
    "display_src": "Other very common side effects",
    "ref": "Andere sehr h\u00e4ufige Nebenwirkungen",
    "show_ref": false
  },
  {
    "src": "Each dispersible tablet contains 125 mg deferasirox.",
    "display_src": "Each dispersible tablet contains 125 mg deferasirox.",
    "ref": "1 Tablette zur Herstellung einer Suspension zum Einnehmen enth\u00e4lt 125 mg Deferasirox.",
    "show_ref": false
  },
  {
    "src": "atmadisc forte 50\u00b5g/ 500\u00b5g Diskus",
    "display_src": "atmadisc forte 50\u00b5g/ 500\u00b5g Diskus",
    "ref": "atmadisc forte 50\u00b5g/500\u00b5g Diskus",
    "show_ref": false
  },
  {
    "src": "The cream is applied in a thin layer to the affected areas of skin before sleeping, so that it remains on the skin for a suitable length of time (about eight hours) before being washed off.",
    "display_src": "The cream is applied in a thin layer to the affected areas of skin before sleeping, so that it remains on the skin for a suitable length of time (about eight hours) before being washed off.",
    "ref": "Die Creme ist vor dem Schlafengehen d\u00fcnnschichtig auf die betroffenen Hautfl\u00e4chen aufzutragen, damit sie gen\u00fcgend lange (etwa acht Stunden) auf der Haut verbleibt, bevor sie abgewaschen wird.",
    "show_ref": false
  },
  {
    "src": "How to take Volibris It is best to take your tablet at the same time each day.",
    "display_src": "How to take Volibris It is best to take your tablet at the same time each day.",
    "ref": "Wie Volibris einzunehmen ist Am besten nehmen Sie Ihre Tablette jeden Tag zur gleichen Zeit ein.",
    "show_ref": false
  },
  {
    "src": "Each IONSYS system contains 10.8 mg fentanyl hydrochloride equivalent to 9.7 mg of fentanyl and delivers 40 micrograms fentanyl per dose, to a maximum of 3.2 mg (80 doses).",
    "display_src": "Each IONSYS system contains 10.8 mg fentanyl hydrochloride equivalent to 9.7 mg of fentanyl and delivers 40 micrograms fentanyl per dose, to a maximum of 3.2 mg (80 doses).",
    "ref": "Jedes IONSYS-System enth\u00e4lt 10,8 mg Fentanylhydrochlorid entsprechend 9,7 mg Fentanyl und setzt pro Dosis 40 Mikrogramm Fentanyl frei, bis zu einem Maximum von 3,2 mg (80 Dosen).",
    "show_ref": false
  },
  {
    "src": "\u00d6sterreich Amgen GmbH Tel: +43 (0) 1 50 217",
    "display_src": "\u00d6sterreich Amgen GmbH Tel: +43 (0) 1 50 217",
    "ref": "Amgen GmbH Tel: +43 (0) 1 50 217",
    "show_ref": false
  },
  {
    "src": "Adverse reactions from clinical trials where saquinavir was boosted with ritonavir",
    "display_src": "Adverse reactions from clinical trials where saquinavir was boosted with ritonavir",
    "ref": "Nebenwirkungen aus klinischen Studien mit Ritonavir-geboostetem Saquinavir",
    "show_ref": false
  },
  {
    "src": "In the event of human exposure to the active ingredient of the vaccine, seek medical advice immediately and show the package leaflet or the label to the physician.",
    "display_src": "In the event of human exposure to the active ingredient of the vaccine, seek medical advice immediately and show the package leaflet or the label to the physician.",
    "ref": "Bei Kontakt mit dem arzneilich wirksamen Bestandteil des Impfstoffes ist unverz\u00fcglich ein Arzt zu Rate zu ziehen und die Packungsbeilage oder das Etikett dem Arzt zeigen.",
    "show_ref": false
  },
  {
    "src": "* ICH=intracranial haemorrhage.",
    "display_src": "* ICH=intracranial haemorrhage.",
    "ref": "* ICH = Intrakranielle Blutung (intracranial haemorrhage)",
    "show_ref": false
  },
  {
    "src": "BV P. O. Box 75 6920 Ab Duiven The Netherlands",
    "display_src": "BV P. O. Box 75 6920 Ab Duiven The Netherlands",
    "ref": "BV P.O.Box 75 6920 Ab Duiven The Netherlands",
    "show_ref": false
  },
  {
    "src": "In all studies, the main measure of effectiveness was the change in the Visual Analog Scale of Pain Intensity (VASPI).",
    "display_src": "In all studies, the main measure of effectiveness was the change in the Visual Analog Scale of Pain Intensity (VASPI).",
    "ref": "In allen Studien war der Hauptindikator der Wirksamkeit die \u00c4nderung auf der visuellen Analogskala der Schmerzintensit\u00e4t (VASPI).",
    "show_ref": false
  },
  {
    "src": "Anaphylaxis and Stevens Johnson syndrome",
    "display_src": "Anaphylaxis and Stevens Johnson syndrome",
    "ref": "Anaphylaxie und Stevens-Johnson-Syndrom",
    "show_ref": false
  },
  {
    "src": "Compared with placebo, Orplatna did not increase overall survival time, and the small improvement seen in progression-free survival was not considered relevant in the absence of a benefit in terms of overall survival time.",
    "display_src": "Compared with placebo, Orplatna did not increase overall survival time, and the small improvement seen in progression-free survival was not considered relevant in the absence of a benefit in terms of overall survival time.",
    "ref": "Im Vergleich zu Placebo erh\u00f6hte Orplatna die Gesamt\u00fcberlebenszeit nicht, und die geringf\u00fcgigen Verbesserungen bei der progressionsfreien \u00dcberlebenszeit wurden als nicht relevant erachtet, da ein Nutzen in Bezug auf die Gesamt\u00fcberlebenszeit nicht festzustellen war.",
    "show_ref": false
  },
  {
    "src": "They are supplied in perforated unit dose blisters packed in cartons containing 14, 28, or 49 orodispersible tablets.",
    "display_src": "They are supplied in perforated unit dose blisters packed in cartons containing 14, 28, or 49 orodispersible tablets.",
    "ref": "Die Blisterpackungen sind in Faltschachteln mit 14, 28 oder 49 Schmelztabletten verpackt.",
    "show_ref": false
  },
  {
    "src": "Each vial contains nominally 1000 IU* human coagulation factor VIII (rDNA), octocog alfa**.",
    "display_src": "Each vial contains nominally 1000 IU* human coagulation factor VIII (rDNA), octocog alfa**.",
    "ref": "Jede Flasche enth\u00e4lt nominal 1000 I.E.* rekombinanter Blutgerinnungsfaktor VIII (rDNS) Octocog alfa**.",
    "show_ref": false
  },
  {
    "src": "This lowers the heart\u2019 s need for oxygen especially in the situations when an angina attack is more likely to happen.",
    "display_src": "This lowers the heart\u2019 s need for oxygen especially in the situations when an angina attack is more likely to happen.",
    "ref": "Dies reduziert den Sauerstoffbedarf des Herzens, vor allem in Situationen in denen das Auftreten von Angina pectoris Anf\u00e4llen wahrscheinlich ist.",
    "show_ref": false
  },
  {
    "src": "Cataract formation was observed in some animals after a relatively long period of intense inflammation, suggesting that the lens changes were secondary to severe inflammation.",
    "display_src": "Cataract formation was observed in some animals after a relatively long period of intense inflammation, suggesting that the lens changes were secondary to severe inflammation.",
    "ref": "In einigen Tieren wurde nach einer relativ lang andauernden starken Entz\u00fcndung die Bildung einer Katarakt beobachtet, was die Vermutung nahe legt, dass die Linsenver\u00e4nderungen die Folge einer",
    "show_ref": false
  },
  {
    "src": "STEP BY STEP GUIDE TO USING ARIXTRA",
    "display_src": "STEP BY STEP GUIDE TO USING ARIXTRA",
    "ref": "SCHRITT-F\u00dcR-SCHRITT-ANLEITUNG ZUR ANWENDUNG VON ARIXTRA",
    "show_ref": false
  },
  {
    "src": "Make sure the arrow is in the centre of the dose window as shown.",
    "display_src": "Make sure the arrow is in the centre of the dose window as shown.",
    "ref": "Stellen Sie sicher, dass sich der Pfeil in der Mitte des Dosisfensters befindet \u2013 so wie es in der Abbildung ge- zeigt ist.",
    "show_ref": false
  },
  {
    "src": "Because the disorder is variable in its expression, other organ system signs and symptoms not noted here may occur.",
    "display_src": "Because the disorder is variable in its expression, other organ system signs and symptoms not noted here may occur.",
    "ref": "Da sich diese Erkrankung verschiedenartig ausdr\u00fcckt, k\u00f6nnen Anzeichen und Symptome in anderen Organsystemen auftreten, die hier nicht angegeben sind.",
    "show_ref": false
  },
  {
    "src": "It is unknown whether cladribine is excreted in human milk.",
    "display_src": "It is unknown whether cladribine is excreted in human milk.",
    "ref": "Es ist nicht bekannt, ob Cladribin in die Muttermilch \u00fcbertritt.",
    "show_ref": false
  },
  {
    "src": "Adverse reactions reported with the use of irbesartan alone General disorders and administration site conditions:",
    "display_src": "Adverse reactions reported with the use of irbesartan alone General disorders and administration site conditions:",
    "ref": "Nebenwirkungen, die bei der Anwendung von Irbesartan allein berichtet wurden Allgemeine Erkrankungen und Beschwerden am Anwendungsort",
    "show_ref": false
  },
  {
    "src": "Oral candidiasis Pharyngitis Oral pustule",
    "display_src": "Oral candidiasis Pharyngitis Oral pustule",
    "ref": "Orale Candidose Pharyngitis Orale Pustelbildung",
    "show_ref": false
  },
  {
    "src": "Details of the operation of the surveillance programme/registry shall be agreed with the National Competent Authorities in each Member State.",
    "display_src": "Details of the operation of the surveillance programme/registry shall be agreed with the National Competent Authorities in each Member State.",
    "ref": "Details zur Funktionsweise des \u00dcberwachungssystems/Registers m\u00fcssen in jedem Mitgliedsstaat mit den jeweils zust\u00e4ndigen Beh\u00f6rden vereinbart werden.",
    "show_ref": false
  },
  {
    "src": "The Applicant considered that the overall data demonstrate that spacer use results in the same high extent of in vitro equivalence as inhaler testing without this device.",
    "display_src": "The Applicant considered that the overall data demonstrate that spacer use results in the same high extent of in vitro equivalence as inhaler testing without this device.",
    "ref": "Dem Antragsteller zufolge zeigen die Gesamtdaten, dass die Anwendung der Inhalationshilfe zu einer In- vitro-\u00c4quivalenz in gleich hohem Umfang f\u00fchrt, wie die Pr\u00fcfung der Inhalatoren ohne diese Hilfsvorrichtung.",
    "show_ref": false
  },
  {
    "src": "Other information about Netvax:",
    "display_src": "Other information about Netvax:",
    "ref": "Weitere Informationen \u00fcber Netvax:",
    "show_ref": false
  },
  {
    "src": "Only a clear solution without any particles should be used.",
    "display_src": "Only a clear solution without any particles should be used.",
    "ref": "Nur eine klare L\u00f6sung frei von Partikeln darf verwendet werden.",
    "show_ref": false
  },
  {
    "src": "Individual responsiveness must be considered when treatment is initiated.",
    "display_src": "Individual responsiveness must be considered when treatment is initiated.",
    "ref": "Bei der Einleitung der Therapie ist die individuelle Ansprechbarkeit zu ber\u00fccksichtigen.",
    "show_ref": false
  },
  {
    "src": "The following substances may reduce insulin requirement:",
    "display_src": "The following substances may reduce insulin requirement:",
    "ref": "Die folgenden Substanzen k\u00f6nnen den Insulinbedarf senken:",
    "show_ref": false
  },
  {
    "src": "Like all medicines, Gadovist can cause side effects, although not everybody gets them.",
    "display_src": "Like all medicines, Gadovist can cause side effects, although not everybody gets them.",
    "ref": "Wie alle Arzneimittel kann Gadovist Nebenwirkungen haben, die aber nicht bei jedem auftreten m\u00fcssen.",
    "show_ref": false
  },
  {
    "src": "In the prevention of invasive fungal infections, the effectiveness of Posaconazole SP has been studied in 600 stem cell transplant patients with fluconazole as a comparator and 602 patients with blood or bone marrow cancer, comparing it to fluconazole or itraconazole.",
    "display_src": "In the prevention of invasive fungal infections, the effectiveness of Posaconazole SP has been studied in 600 stem cell transplant patients with fluconazole as a comparator and 602 patients with blood or bone marrow cancer, comparing it to fluconazole or itraconazole.",
    "ref": "Die Wirksamkeit von Posaconazole SP zur Vorbeugung gegen invasive Pilzinfektionen wurde bei 600 Patienten nach Stammzelltransplantation unter Verwendung von Fluconazol als Vergleichspr\u00e4parat und bei 602 Patienten mit Blut- oder Knochenmarkkrebs untersucht, bei denen Posaconazole SP mit Fluconazol oder Itraconazol verglichen wurde.",
    "show_ref": false
  },
  {
    "src": "This means that Alpheon was intended to be similar to a biological medicine already authorised in the EU which contains the same active substance (also known as the \u2018 reference medicine\u2019), Roferon-A.",
    "display_src": "This means that Alpheon was intended to be similar to a biological medicine already authorised in the EU which contains the same active substance (also known as the \u2018 reference medicine\u2019), Roferon-A.",
    "ref": "Dies bedeutet, dass Alpheon einem biologischen Arzneimittel namens Roferon-A mit dem gleichen arzneilich wirksamen Bestandteil \u00e4hneln sollte, das bereits in der EU zugelassen ist (auch \u201e Referenzarzneimittel\u201c genannt).",
    "show_ref": false
  },
  {
    "src": "\u25ba Inject the insulin under the skin.",
    "display_src": "\u25ba Inject the insulin under the skin.",
    "ref": "\u25ba Injizieren Sie das Insulin unter die Haut.",
    "show_ref": false
  },
  {
    "src": "It is recommended that pretreatment with corticosteroids be considered for patients in whom local tumour expansion may compromise vital anatomic structures.",
    "display_src": "It is recommended that pretreatment with corticosteroids be considered for patients in whom local tumour expansion may compromise vital anatomic structures.",
    "ref": "Es wird empfohlen bei Patienten, bei denen eine lokale Tumorexpansion lebenswichtige anatomische Strukturen beeintr\u00e4chtigen kann, eine Vorbehandlung mit Kortikosteroiden in Betracht zu ziehen.",
    "show_ref": false
  },
  {
    "src": "The ADDRESS trial did enrol 872 patients with multiple organ dysfunction.",
    "display_src": "The ADDRESS trial did enrol 872 patients with multiple organ dysfunction.",
    "ref": "In die ADDRESS-Studie waren 872 Patienten mit multiplem Organversagen eingeschlossen.",
    "show_ref": false
  },
  {
    "src": "Read all of this leaflet carefully before you start/ your child starts receiving this vaccine.",
    "display_src": "Read all of this leaflet carefully before you start/ your child starts receiving this vaccine.",
    "ref": "Lesen Sie die gesamte Packungsbeilage sorgf\u00e4ltig durch, bevor Sie oder Ihr Kind diesen Impfstoff erstmals erhalten.",
    "show_ref": false
  },
  {
    "src": "In a clinical study, the concomitant use of erlotinib with ketoconazole (200 mg orally twice daily for 5 days), a potent CYP3A4 inhibitor, resulted in an increase of erlotinib exposure (86% of AUC and 69% of Cmax).",
    "display_src": "In a clinical study, the concomitant use of erlotinib with ketoconazole (200 mg orally twice daily for 5 days), a potent CYP3A4 inhibitor, resulted in an increase of erlotinib exposure (86% of AUC and 69% of Cmax).",
    "ref": "In einer klinischen Studie hatte die gleichzeitige Gabe von Erlotinib und Ketoconazol (zweimal t\u00e4glich 200 mg oral \u00fcber 5 Tage), einem starken CYP3A4-Inhibitor, eine erh\u00f6hte Exposition gegen\u00fcber Erlotinib (AUC um 86% und Cmax um 69%) zur Folge.",
    "show_ref": false
  },
  {
    "src": "- Complicated urinary tract infections, including kidney infections and cases that have spread to the",
    "display_src": "- Complicated urinary tract infections, including kidney infections and cases that have spread to the",
    "ref": "- komplizierte Harnwegsinfektionen, einschlie\u00dflich Nierenbecken- und Niereninfektionen und",
    "show_ref": false
  },
  {
    "src": "The main measures of effectiveness were the time taken for symptoms to get worse and the number of patients whose symptoms got worse over 24 weeks.",
    "display_src": "The main measures of effectiveness were the time taken for symptoms to get worse and the number of patients whose symptoms got worse over 24 weeks.",
    "ref": "Die Hauptindikatoren f\u00fcr die Wirksamkeit waren die Zeit bis zur Verschlimmerung der Symptome und die Anzahl der Patienten, deren Symptome sich im Lauf von 24 Wochen verschlimmerten.",
    "show_ref": false
  },
  {
    "src": "Posology Orgalutran is used to prevent premature LH surges in patients undergoing COH.",
    "display_src": "Posology Orgalutran is used to prevent premature LH surges in patients undergoing COH.",
    "ref": "Dosierung Orgalutran wird zur Vermeidung eines vorzeitigen LH-Anstieges bei Patientinnen, die sich einer COH unterziehen, verabreicht.",
    "show_ref": false
  },
  {
    "src": "66 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING Trifold Blister for Cozaar 12.5 mg film-coated tablets Blister for Cozaar 50 mg film-coated tablets",
    "display_src": "66 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING Trifold Blister for Cozaar 12.5 mg film-coated tablets Blister for Cozaar 50 mg film-coated tablets",
    "ref": "62 MINDESTANGABEN AUF DER UNMITTELBAREN UMH\u00dcLLUNG Blisterkarte Blister f\u00fcr < Cozaar > 12,5 mg Filmtabletten Blister f\u00fcr < Cozaar > 50 mg Filmtabletten",
    "show_ref": false
  },
  {
    "src": "Blood tests may be neccessary if you take:",
    "display_src": "Blood tests may be neccessary if you take:",
    "ref": "Blutuntersuchungen k\u00f6nnen notwendig sein, wenn Sie:",
    "show_ref": false
  },
  {
    "src": "Keep your Liprolog Mix25 Pen in use at room temperature (below 30\u00b0C) for up to 28 days.",
    "display_src": "Keep your Liprolog Mix25 Pen in use at room temperature (below 30\u00b0C) for up to 28 days.",
    "ref": "Nach Anbruch k\u00f6nnen Sie Ihren Liprolog Mix25 Pen bis zu 28 Tage bei Raumtemperatur (unter 30\u00b0C) aufbewahren.",
    "show_ref": false
  },
  {
    "src": "These medicines are used for treating human immunodeficiency virus (HIV) infection.",
    "display_src": "These medicines are used for treating human immunodeficiency virus (HIV) infection.",
    "ref": "Diese Arzneimittel werden zur Behandlung der Infektion mit dem humanen Immundefizienz -Virus (HIV) eingesetzt.",
    "show_ref": false
  },
  {
    "src": "Some patients have had blood tests or symptoms indicating that their hepatitis has got worse after stopping Emtriva.",
    "display_src": "Some patients have had blood tests or symptoms indicating that their hepatitis has got worse after stopping Emtriva.",
    "ref": "Bei einigen Patienten zeigten Blutuntersuchungen oder Symptome eine Verschlechterung der Hepatitis nach dem Absetzen von Emtriva.",
    "show_ref": false
  },
  {
    "src": "If you forget to take Irbesartan Krka If you accidentally miss a daily dose, just take the next dose as normal.",
    "display_src": "If you forget to take Irbesartan Krka If you accidentally miss a daily dose, just take the next dose as normal.",
    "ref": "Wenn Sie die Einnahme von Irbesartan Krka vergessen haben Wenn Sie versehentlich vergessen haben, die t\u00e4gliche Dosis einzunehmen, sollten Sie die Behandlung wie verordnet fortsetzen.",
    "show_ref": false
  },
  {
    "src": "Studies in many different species show that praziquantel is rapidly metabolised in the liver.",
    "display_src": "Studies in many different species show that praziquantel is rapidly metabolised in the liver.",
    "ref": "Wie Studien an zahlreichen verschiedenen Tierarten belegen, wird Praziquantel schnell in der Leber metabolisiert.",
    "show_ref": false
  },
  {
    "src": "Danmark Bayer A/ S Tlf: +45-45-23 50 00",
    "display_src": "Danmark Bayer A/ S Tlf: +45-45-23 50 00",
    "ref": "Danmark Bayer A/S Tlf: +45-45-23 50 00",
    "show_ref": false
  },
  {
    "src": "The most common side effect (affects 1 to 10 patients in 100) reported with clopidogrel is bleeding.",
    "display_src": "The most common side effect (affects 1 to 10 patients in 100) reported with clopidogrel is bleeding.",
    "ref": "In der Kategorie h\u00e4ufige Nebenwirkungen (treten bei 1 bis 10 Patienten von 100 auf) wurden Blutungen am h\u00e4ufigsten berichtet.",
    "show_ref": false
  },
  {
    "src": "What Luminity is and what it is used for 2.",
    "display_src": "What Luminity is and what it is used for 2.",
    "ref": "Was ist Luminity und wof\u00fcr wird es angewendet?",
    "show_ref": false
  },
  {
    "src": "A dose of 1.4 mg/ m2 body surface area per day (0.045 - 0.050 mg/ kg body weight per day) is recommended.",
    "display_src": "A dose of 1.4 mg/ m2 body surface area per day (0.045 - 0.050 mg/ kg body weight per day) is recommended.",
    "ref": "Eine Dosierung von 1,4 mg/m2 K\u00f6rperoberfl\u00e4che pro Tag (0,045 - 0,050 mg/kg K\u00f6rpergewicht pro Tag) wird empfohlen.",
    "show_ref": false
  },
  {
    "src": "In addition, some patients may experience convulsions, which may be associated with these allergic reactions.",
    "display_src": "In addition, some patients may experience convulsions, which may be associated with these allergic reactions.",
    "ref": "Dar\u00fcber hinaus k\u00f6nnen bei manchen Patienten Kr\u00e4mpfe auftreten, die im Zusammenhang mit diesen allergischen Reaktionen stehen k\u00f6nnen.",
    "show_ref": false
  },
  {
    "src": "In the dose finding studythe seroprotection rate, seroconversion rate and seroconversion factor against H5N1 drift variants 21 days after the second dose were as follows:",
    "display_src": "In the dose finding studythe seroprotection rate, seroconversion rate and seroconversion factor against H5N1 drift variants 21 days after the second dose were as follows:",
    "ref": "In der Dosisfindungsstudie waren die Seroprotektionsrate, die Serokonversionsrate und der Serokonversionsfaktor gegen H5N1-Drift-Varianten 21 Tage nach der zweiten Impfdosis wie folgt:",
    "show_ref": false
  },
  {
    "src": "The solvent vial is intended for single use only and the remaining water for injections in the vial after withdrawal of the volume required for reconstitution has to be discarded.",
    "display_src": "The solvent vial is intended for single use only and the remaining water for injections in the vial after withdrawal of the volume required for reconstitution has to be discarded.",
    "ref": "Die Durchstechflasche mit L\u00f6sungsmittel ist nur zum einmaligen Gebrauch bestimmt und das in der Durchstechflasche verbliebene Wasser f\u00fcr Injektionszwecke muss nach der Entnahme der zur Rekonstitution ben\u00f6tigten Menge verworfen werden.",
    "show_ref": false
  },
  {
    "src": "Fabrazyme was originally authorised under \u2018 Exceptional Circumstances\u2019, because, as the disease is rare, limited information was available at the time of approval.",
    "display_src": "Fabrazyme was originally authorised under \u2018 Exceptional Circumstances\u2019, because, as the disease is rare, limited information was available at the time of approval.",
    "ref": "Fabrazyme wurde urspr\u00fcnglich unter \u201e au\u00dfergew\u00f6hnlichen Umst\u00e4nden\u201c zugelassen, da aufgrund der Seltenheit der Erkrankung zum Zeitpunkt der Genehmigung Informationen nur begrenzt zur Verf\u00fcgung standen.",
    "show_ref": false
  },
  {
    "src": "What Olanzapine Mylan looks like and contents of the pack",
    "display_src": "What Olanzapine Mylan looks like and contents of the pack",
    "ref": "Wie OLANZAPIN MYLAN aussieht und Inhalt der Packung",
    "show_ref": false
  },
  {
    "src": "Each film-coated tablet contains 200 mg of sorafenib (as tosylate).",
    "display_src": "Each film-coated tablet contains 200 mg of sorafenib (as tosylate).",
    "ref": "Jede Filmtablette enth\u00e4lt 200 mg Sorafenib (als Tosilat).",
    "show_ref": false
  },
  {
    "src": "In HIV infected patients at steady state, mean Cmax, mean Cmin, and mean AUC were linear with 200 mg, 400 mg, and 600 mg daily doses.",
    "display_src": "In HIV infected patients at steady state, mean Cmax, mean Cmin, and mean AUC were linear with 200 mg, 400 mg, and 600 mg daily doses.",
    "ref": "140 Bei HIV-infizierten Patienten waren die mittleren Cmax-, Cmin- und AUC-Werte mit Tagesdosen von 200 mg, 400 mg und 600 mg im Steady-state linear.",
    "show_ref": false
  },
  {
    "src": "ed Trudexa 40 mg solution for injection in pre-filled pen Adalimumab",
    "display_src": "ed Trudexa 40 mg solution for injection in pre-filled pen Adalimumab",
    "ref": "en Trudexa 40 mg Injektionsl\u00f6sung im FertigPEN (vorgef\u00fcllter Injektor) - zur einmaligen Injektion - Adalimumab",
    "show_ref": false
  },
  {
    "src": "The veterinary medicinal product is a fixed combination of three active substances (corticosteroid, antifungal and antibiotic):",
    "display_src": "The veterinary medicinal product is a fixed combination of three active substances (corticosteroid, antifungal and antibiotic):",
    "ref": "Das Tierarzneimittel ist eine Kombination aus drei Wirkstoffen (Corticosteroid, Antimykotikum und Antibiotikum).",
    "show_ref": false
  },
  {
    "src": "In preclinical studies, pregabalin has been shown to cross the blood brain barrier in mice, rats, and monkeys.",
    "display_src": "In preclinical studies, pregabalin has been shown to cross the blood brain barrier in mice, rats, and monkeys.",
    "ref": "Pr\u00e4klinische Studien haben gezeigt, dass Pregabalin die Blut-Hirn-Schranke bei M\u00e4usen, Ratten und Affen \u00fcberwindet.",
    "show_ref": false
  },
  {
    "src": "It is recommended to reconstitute the product immediately prior to use.",
    "display_src": "It is recommended to reconstitute the product immediately prior to use.",
    "ref": "Es wird empfohlen, das Produkt erst unmittelbar vor dem Gebrauch aufzul\u00f6sen.",
    "show_ref": false
  },
  {
    "src": "Avaglim is not recommended for people aged under 18, as the safety and effectiveness are not known.",
    "display_src": "Avaglim is not recommended for people aged under 18, as the safety and effectiveness are not known.",
    "ref": "Die Anwendung von Avaglim bei Patienten unter 18 Jahren wird nicht empfohlen, da keine Daten zur Sicherheit und Wirksamkeit bei dieser Altersgruppe vorliegen.",
    "show_ref": false
  },
  {
    "src": "In very rare cases, impairment of liver function (e. g. with cholestasis and jaundice) may develop, as well as hepatitis which may progress to liver failure.",
    "display_src": "In very rare cases, impairment of liver function (e. g. with cholestasis and jaundice) may develop, as well as hepatitis which may progress to liver failure.",
    "ref": "In sehr seltenen F\u00e4llen kann sich eine Leberfunktionsst\u00f6rung (z.B. mit Cholestase und Ikterus) sowie eine Hepatitis entwickeln, die zu einer Leberinsuffizienz fortschreiten kann.",
    "show_ref": false
  },
  {
    "src": "PSURs The PSUR cycle of Fertavid will correspond to the one attributed to the cross-referred product, Puregon, until otherwise specified.",
    "display_src": "PSURs The PSUR cycle of Fertavid will correspond to the one attributed to the cross-referred product, Puregon, until otherwise specified.",
    "ref": "PSURs Der PSUR Zyklus von Fertavid wird mit jenem von Puregon, dem Produkt, auf das Bezug genommen wird, \u00fcbereinstimmen, sofern nicht anders vereinbart.",
    "show_ref": false
  },
  {
    "src": "When the injection is done, a diamond (\u2666) or arrow (\u2192) must be seen in the centre of the dose window.",
    "display_src": "When the injection is done, a diamond (\u2666) or arrow (\u2192) must be seen in the centre of the dose window.",
    "ref": "Nach der Injektion muss der Diamant (\u2666) oder der Pfeil (\u2192) in der Mitte des Dosisfensters zu sehen sein.",
    "show_ref": false
  },
  {
    "src": "After you have had chickenpox, the virus that caused it stays in your body in nerve cells.",
    "display_src": "After you have had chickenpox, the virus that caused it stays in your body in nerve cells.",
    "ref": "Nach einer Windpocken-Erkrankung verbleibt das Virus, das die Windpocken ausgel\u00f6st hat, in den Nervenzellen Ihres K\u00f6rpers.",
    "show_ref": false
  },
  {
    "src": "Store and transport refrigerated (2\u00baC- 8\u00baC).",
    "display_src": "Store and transport refrigerated (2\u00baC- 8\u00baC).",
    "ref": "Gek\u00fchlt (2 \u00b0C \u2013 8 \u00b0C) lagern und transportieren.",
    "show_ref": false
  },
  {
    "src": "The EMEA with its network of national regulatory authorities is an excellent example how we operate and collaborate within the European Union.",
    "display_src": "The EMEA with its network of national regulatory authorities is an excellent example how we operate and collaborate within the European Union.",
    "ref": "Die EMEA mit ihrem Netzwerk nationaler Zulassungsbeh\u00f6rden ist ein ausgezeichnetes Beispiel f\u00fcr unser gemeinsames Wirken im Rahmen der Europ\u00e4ischen Union.",
    "show_ref": false
  },
  {
    "src": "Insufficient responsiveness to monotherapy was not an inclusion criteria.",
    "display_src": "Insufficient responsiveness to monotherapy was not an inclusion criteria.",
    "ref": "Ungen\u00fcgende Ansprechbarkeit auf eine Monotherapie war kein Einschlusskriterium.",
    "show_ref": false
  },
  {
    "src": "What is the risk associated with IONSYS?",
    "display_src": "What is the risk associated with IONSYS?",
    "ref": "Welches Risiko ist mit IONSYS verbunden?",
    "show_ref": false
  },
  {
    "src": "In addition, the observed/ expected analysis could not provide evidence for a cause and effect relationship between SUDs and vaccination with Hexavac.",
    "display_src": "In addition, the observed/ expected analysis could not provide evidence for a cause and effect relationship between SUDs and vaccination with Hexavac.",
    "ref": "Daneben konnte die aufmerksam verfolgte/erwartete Analyse keinen Nachweis f\u00fcr einen Ursache-Wirkungs- Zusammenhang zwischen SUDs und der Impfung mit Hexavac liefern.",
    "show_ref": false
  },
  {
    "src": "Evoltra may not be suitable for you.",
    "display_src": "Evoltra may not be suitable for you.",
    "ref": "Evoltra ist m\u00f6glicherweise nicht f\u00fcr Sie geeignet.",
    "show_ref": false
  },
  {
    "src": "PREZISTA must be taken in combination with a low dose of ritonavir and other anti-HIV medicines.",
    "display_src": "PREZISTA must be taken in combination with a low dose of ritonavir and other anti-HIV medicines.",
    "ref": "PREZISTA muss in Kombination mit einer geringen Dosis von Ritonavir und anderen Anti-HIV-Medikamenten eingenommen werden.",
    "show_ref": false
  },
  {
    "src": "Our work with the national authorities of central and eastern European countries continued in 2000 through the Pan-European Regulatory Forum.",
    "display_src": "Our work with the national authorities of central and eastern European countries continued in 2000 through the Pan-European Regulatory Forum.",
    "ref": "Unsere Zusammenarbeit mit den nationalen Beh\u00f6rden mittel- und osteurop\u00e4ischer L\u00e4nder wurde 2000 durch das Pan-European Regulatory Forum fortgesetzt.",
    "show_ref": false
  },
  {
    "src": "A medical history of thymic disease (see sections 4.3 and 4.4) has been identified as a risk factor for YEL-AVD.",
    "display_src": "A medical history of thymic disease (see sections 4.3 and 4.4) has been identified as a risk factor for YEL-AVD.",
    "ref": "Eine Thymuserkrankung in der Anamnese (siehe Abschnitte 4.3 und 4.4) wurde als Risikofaktor f\u00fcr YEL-AVD identifiziert.",
    "show_ref": false
  },
  {
    "src": "Econor 1% premix contains valnemulin in the form of valnemulin hydrochloride.",
    "display_src": "Econor 1% premix contains valnemulin in the form of valnemulin hydrochloride.",
    "ref": "Econor 1% Arzneimittel-Vormischung enth\u00e4lt Valnemulin in Form von Valnemulinhydrochlorid.",
    "show_ref": false
  },
  {
    "src": "Tramontana, 44 ES-28223 Pozuelo de Alarcon Madrid, Spain",
    "display_src": "Tramontana, 44 ES-28223 Pozuelo de Alarcon Madrid, Spain",
    "ref": "Tramontana, 44 ES-28223 Pozuelo de Alarcon Madrid, Spanien",
    "show_ref": false
  },
  {
    "src": "In animal studies, erythropoietin has been shown to decrease foetal body weight, delay ossification and increase foetal mortality when given in weekly doses of approximately 20 times the recommended human weekly dose.",
    "display_src": "In animal studies, erythropoietin has been shown to decrease foetal body weight, delay ossification and increase foetal mortality when given in weekly doses of approximately 20 times the recommended human weekly dose.",
    "ref": "In Tierversuchen mit ann\u00e4hernd der 20-fachen der zur Anwendung beim Menschen empfohlenen Wochendosis f\u00fchrte Erythropoetin zu vermindertem f\u00f6talem K\u00f6rpergewicht, zu einer Verz\u00f6gerung der Ossifikation und zu einem Anstieg der f\u00f6talen Sterblichkeit.",
    "show_ref": false
  },
  {
    "src": "Telfanyl 100 microgram/ hr Transdermal patch (pending)",
    "display_src": "Telfanyl 100 microgram/ hr Transdermal patch (pending)",
    "ref": "Telfanyl 100 microgram/hr Transdermal patch (pending)",
    "show_ref": false
  },
  {
    "src": "- if you suffer from low potassium levels",
    "display_src": "- if you suffer from low potassium levels",
    "ref": "- wenn Ihr Kaliumspiegel niedrig ist",
    "show_ref": false
  },
  {
    "src": "Before treatment with Rapilysin, make sure your doctor knows if you",
    "display_src": "Before treatment with Rapilysin, make sure your doctor knows if you",
    "ref": "Rapilysin darf nicht angewendet werden Vor der Behandlung mit Rapilysin muss Ihr Arzt wissen, wenn Sie",
    "show_ref": false
  },
  {
    "src": "Men who have been given Zevalin and who could become fathers must use reliable contraception during and for a year after stopping treatment.",
    "display_src": "Men who have been given Zevalin and who could become fathers must use reliable contraception during and for a year after stopping treatment.",
    "ref": "Zeugungsf\u00e4hige M\u00e4nner, die Zevalin erhalten haben, m\u00fcssen w\u00e4hrend der Behandlung und bis zu einem Jahr nach Abschluss der Zevalin-Behandlung zuverl\u00e4ssige Verh\u00fctungsma\u00dfnahmen anwenden.",
    "show_ref": false
  },
  {
    "src": "Dilute the total volume of the reconstituted Remicade solution dose to 250 ml with sodium chloride 9 mg/ml (0.9%) solution for infusion.",
    "display_src": "Dilute the total volume of the reconstituted Remicade solution dose to 250 ml with sodium chloride 9 mg/ml (0.9%) solution for infusion.",
    "ref": "Verd\u00fcnnen Sie das Gesamtvolumen der aufgel\u00f6sten Remicade-Dosis auf 250 ml in Natriumchlorid-Infusionsl\u00f6sung 9 mg/ml (0,9%).",
    "show_ref": false
  },
  {
    "src": "Insulin Human Winthrop should be given before meals.",
    "display_src": "Insulin Human Winthrop should be given before meals.",
    "ref": "Insulin Human Winthrop sollte vor einer Mahlzeit verabreicht werden.",
    "show_ref": false
  },
  {
    "src": "Transfer to Insuman Comb 50",
    "display_src": "Transfer to Insuman Comb 50",
    "ref": "Umstellung auf Insuman Comb 50",
    "show_ref": false
  },
  {
    "src": "Use only clear and colourless solutions.",
    "display_src": "Use only clear and colourless solutions.",
    "ref": "Nur klare und farblose L\u00f6sung verwenden.",
    "show_ref": false
  },
  {
    "src": "A 20% improvement in scores was seen in 48 to 52% of the patients using Neupro and in 19 to 30% of those using placebo.",
    "display_src": "A 20% improvement in scores was seen in 48 to 52% of the patients using Neupro and in 19 to 30% of those using placebo.",
    "ref": "Zu einer Verbesserung der Werte um 20% kam es bei 48% bis 52% der Patienten, die Neupro nahmen, gegen\u00fcber 19% bis 30% der Patienten, die Placebo nahmen.",
    "show_ref": false
  },
  {
    "src": "If the condition persists or worsens, seek medical attention.",
    "display_src": "If the condition persists or worsens, seek medical attention.",
    "ref": "Falls dieser Zustand andauert oder sich verschlechtert, begeben Sie sich in \u00e4rztliche Behandlung.",
    "show_ref": false
  },
  {
    "src": "Splenic enlargement was reported to be related to filgrastim therapy in < 3% of patients.",
    "display_src": "Splenic enlargement was reported to be related to filgrastim therapy in < 3% of patients.",
    "ref": "\u00dcber eine mit der Therapie mit Filgrastim in Zusammenhang stehende Milzvergr\u00f6\u00dferung wurde bei < 3% der Patienten berichtet.",
    "show_ref": false
  },
  {
    "src": "** insufficient data, only two patients available with samples Haematological response criteria (all responses to be confirmed after \u2265 4 weeks):",
    "display_src": "** insufficient data, only two patients available with samples Haematological response criteria (all responses to be confirmed after \u2265 4 weeks):",
    "ref": "** unzureichende Daten, nur 2 Patienten mit Proben verf\u00fcgbar Kriterien f\u00fcr die h\u00e4matologische Remission (Remission best\u00e4tigt nach \u2265 4 Wochen):",
    "show_ref": false
  },
  {
    "src": "Cartons contain 56 or 112 film-coated tablets.",
    "display_src": "Cartons contain 56 or 112 film-coated tablets.",
    "ref": "Die Packungen enthalten 56 oder 112 Filmtabletten.",
    "show_ref": false
  },
  {
    "src": "- The other ingredients are sucrose, calcium chloride dihydrate, L-histidine, polysorbate 80 and",
    "display_src": "- The other ingredients are sucrose, calcium chloride dihydrate, L-histidine, polysorbate 80 and",
    "ref": "- Die sonstigen Bestandteile sind Sucrose, Calciumchlorid-Dihydrat, L-Histidin, Polysorbat 80",
    "show_ref": false
  },
  {
    "src": "During treatment, you should tell the medical staff if you feel unwell.",
    "display_src": "During treatment, you should tell the medical staff if you feel unwell.",
    "ref": "W\u00e4hrend der Behandlung sollten Sie das medizinische Personal informieren, wenn Sie sich nicht wohl f\u00fchlen.",
    "show_ref": false
  },
  {
    "src": "One hundred and three (103) children received monthly palivizumab injections for the first time, and 119 children received palivizumab for two consecutive seasons.",
    "display_src": "One hundred and three (103) children received monthly palivizumab injections for the first time, and 119 children received palivizumab for two consecutive seasons.",
    "ref": "Einhundertunddrei (103) Kinder erhielten zum ersten Mal monatlich Palivizumab-Injektionen, und 119 Kinder erhielten Palivizumab f\u00fcr zwei aufeinanderfolgende Saisons.",
    "show_ref": false
  },
  {
    "src": "In people with non-Hodgkin\u2019 s lymphoma, the body produces too many abnormal lymphocytes, which do not work properly and which can displace healthy cells in the bone marrow (where most new blood cells are formed) and in the blood.",
    "display_src": "In people with non-Hodgkin\u2019 s lymphoma, the body produces too many abnormal lymphocytes, which do not work properly and which can displace healthy cells in the bone marrow (where most new blood cells are formed) and in the blood.",
    "ref": "Patienten mit einem Non-Hodgkin-Lymphom produzieren zu viele abnorme Lymphozyten, die ihre Funktion nicht ordnungsgem\u00e4\u00df erf\u00fcllen und die gesunde Zellen im Knochenmark, wo die meisten neuen Blutzellen gebildet werden, und im Blut verdr\u00e4ngen k\u00f6nnen.",
    "show_ref": false
  },
  {
    "src": "Olanzapine was started at 2.5 mg/ day and titrated to a maximum of 15 mg/ day based on investigator judgement.",
    "display_src": "Olanzapine was started at 2.5 mg/ day and titrated to a maximum of 15 mg/ day based on investigator judgement.",
    "ref": "Die Olanzapin- Behandlung wurde mit 2,5 mg/Tag begonnen und entsprechend der Beurteilung des Pr\u00fcfarztes auf h\u00f6chstens 15 mg/Tag titriert.",
    "show_ref": false
  },
  {
    "src": "Patients must be instructed to remove contact lenses prior to application of TRAVATAN and wait 15 minutes after instillation of the dose before reinsertion.",
    "display_src": "Patients must be instructed to remove contact lenses prior to application of TRAVATAN and wait 15 minutes after instillation of the dose before reinsertion.",
    "ref": "Patienten m\u00fcssen angewiesen werden, weiche Kontaktlinsen vor der Anwendung von TRAVATAN zu entfernen und diese fr\u00fchestens 15 Minuten nach der Anwendung wieder einzusetzen.",
    "show_ref": false
  },
  {
    "src": "A slightly higher incidence of ECG abnormalities, primarily sinus bradycardia, has been reported in patients treated with tadalafil once a day as compared with placebo.",
    "display_src": "A slightly higher incidence of ECG abnormalities, primarily sinus bradycardia, has been reported in patients treated with tadalafil once a day as compared with placebo.",
    "ref": "Verglichen mit Placebo gab es in der Gruppe, die einmal t\u00e4glich mit Tadalafil behandelt wurde, eine etwas h\u00f6here Inzidenz von EKG Abnormalit\u00e4ten, in erster Linie Sinusbradykardie.",
    "show_ref": false
  },
  {
    "src": "\u0395\u03bb\u03bb\u03ac\u03b4\u03b1 Baxter Hellas EPE \u0395\u03b8\u03bd\u03ac\u03c1\u03c7\u03bf\u03c5 \u039c\u03b1\u03ba\u03b1\u03c1\u03af\u03bf\u03c5 34 \u0397\u03bb\u03b9\u03bf\u03cd\u03c0\u03bf\u03bb\u03b7 GR \u2013 163 41 \u0391\u03b8\u03ae\u03bd\u03b1 \u03a4\u03b7\u03bb: + 30 210 99 87 000",
    "display_src": "\u0395\u03bb\u03bb\u03ac\u03b4\u03b1 Baxter Hellas EPE \u0395\u03b8\u03bd\u03ac\u03c1\u03c7\u03bf\u03c5 \u039c\u03b1\u03ba\u03b1\u03c1\u03af\u03bf\u03c5 34 \u0397\u03bb\u03b9\u03bf\u03cd\u03c0\u03bf\u03bb\u03b7 GR \u2013 163 41 \u0391\u03b8\u03ae\u03bd\u03b1 \u03a4\u03b7\u03bb: + 30 210 99 87 000",
    "ref": "\u0395\u03bb\u03bb\u03ac\u03b4\u03b1 Baxter Hellas EPE \u0395\u03b8\u03bd\u03ac\u03c1\u03c7\u03bf\u03c5 \u039c\u03b1\u03ba\u03b1\u03c1\u03af\u03bf\u03c5 34 \u0397\u03bb\u03b9\u03bf\u03cd\u03c0\u03bf\u03bb\u03b7 GR \u2013 163 41 \u0391\u03b8\u03ae\u03bd\u03b1 \uf020\u03a4\u03b7\u03bb: + 30-210-99 87 000",
    "show_ref": false
  },
  {
    "src": "FABLYN significantly decreased the incidence of new radiographic vertebral fractures (excluding worsening of previous fractures) from 9.3% for placebo to 5.6% for FABLYN (relative risk reduction = 41%, p < 0.0001).",
    "display_src": "FABLYN significantly decreased the incidence of new radiographic vertebral fractures (excluding worsening of previous fractures) from 9.3% for placebo to 5.6% for FABLYN (relative risk reduction = 41%, p < 0.0001).",
    "ref": "FABLYN senkte die Inzidenz neuer Wirbelfrakturen im R\u00f6ntgenbild (ausgeschlossen waren Verschlimmerungen bestehender Frakturen) von 9,3% unter Plazebo auf 5,6% unter FABLYN (Senkung des relativen Risikos = 41%, p < 0,0001).",
    "show_ref": false
  },
  {
    "src": "Each box contains one TAXOTERE vial (20 mg) and one corresponding solvent for TAXOTERE vial in a blister pack.",
    "display_src": "Each box contains one TAXOTERE vial (20 mg) and one corresponding solvent for TAXOTERE vial in a blister pack.",
    "ref": "Jede Schachtel enth\u00e4lt eine TAXOTERE-Durchstechflasche (20 mg) und eine dazugeh\u00f6rige TAXOTERE L\u00f6sungsmittel-Durchstechflasche in einer Blisterpackung.",
    "show_ref": false
  },
  {
    "src": "The European system for the authorisation and supervision of medicines, and the EMEA as part of that system, enters 2002 with a number of challenges ahead of it, building on initiatives begun in 2001 and on new enterprises to be undertaken in 2002.",
    "display_src": "The European system for the authorisation and supervision of medicines, and the EMEA as part of that system, enters 2002 with a number of challenges ahead of it, building on initiatives begun in 2001 and on new enterprises to be undertaken in 2002.",
    "ref": "Das europ\u00e4ische System f\u00fcr die Genehmigung und \u00dcberwachung von Arzneimitteln und die EMEA als Teil dieses Systems haben im Jahr 2002 eine Reihe bedeutender Aufgaben zu l\u00f6sen, die sowohl eine Weiterf\u00fchrung der 2001 eingeleiteten Initiativen als auch die Inangriffnahme neuer Vorhaben erfordern.",
    "show_ref": false
  },
  {
    "src": "112 Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51",
    "display_src": "112 Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51",
    "ref": "120 Latvija sanofi-aventis Latvia SIA Tel: +371 67 33 24 51",
    "show_ref": false
  },
  {
    "src": "Each capsule contains 294 mg of anhydrous lactose.",
    "display_src": "Each capsule contains 294 mg of anhydrous lactose.",
    "ref": "Jede Kapsel enth\u00e4lt 294 mg Lactose.",
    "show_ref": false
  },
  {
    "src": "0.35 mg: white, oval, with bevelled edges, both sides scored, with imprint \"P8\" on both halves of one side of the tablet.",
    "display_src": "0.35 mg: white, oval, with bevelled edges, both sides scored, with imprint \"P8\" on both halves of one side of the tablet.",
    "ref": "0,35 mg: wei\u00df, oval, mit abgeschr\u00e4gten Kanten, beidseitiger Bruchkerbe, einseitiger Pr\u00e4gung \u201e P8\u201c auf beiden H\u00e4lften der Tablette.",
    "show_ref": false
  },
  {
    "src": "Treatment should be discontinued in these patients.",
    "display_src": "Treatment should be discontinued in these patients.",
    "ref": "Bei diesen Patienten sollte die Therapie abgebrochen werden.",
    "show_ref": false
  },
  {
    "src": "The dose should be reduced or treatment interrupted if a patient develops kidney or liver problems.",
    "display_src": "The dose should be reduced or treatment interrupted if a patient develops kidney or liver problems.",
    "ref": "2/3 Patient Nieren- oder Leberprobleme, sollte die Dosis reduziert bzw. die Behandlung unterbrochen werden.",
    "show_ref": false
  },
  {
    "src": "Spain France The Netherlands United Kingdom",
    "display_src": "Spain France The Netherlands United Kingdom",
    "ref": "\u00d6sterreich Deutschland Spanien Frankreich Niederlande Vereinigtes K\u00f6nigreich",
    "show_ref": false
  },
  {
    "src": "After the needle is inserted, let go of the skin and slowly push the plunger all the way down to inject RELISTOR.",
    "display_src": "After the needle is inserted, let go of the skin and slowly push the plunger all the way down to inject RELISTOR.",
    "ref": "Nachdem die Nadel sitzt, lassen Sie die Haut los und dr\u00fccken Sie den Kolben langsam vollst\u00e4ndig nach unten, um RELISTOR zu injizieren.",
    "show_ref": false
  },
  {
    "src": "For infusion, the reconstituted solution should be diluted to a volume of 25 ml or greater with normal saline or dextrose 50 mg/ ml (5%).",
    "display_src": "For infusion, the reconstituted solution should be diluted to a volume of 25 ml or greater with normal saline or dextrose 50 mg/ ml (5%).",
    "ref": "Zur Infusion sollte die gebrauchsfertige L\u00f6sung auf ein Volumen von 25 ml oder mehr mit isotonischer Kochsalzl\u00f6sung oder Dextrosel\u00f6sung 50 mg/ml (5%) verd\u00fcnnt werden.",
    "show_ref": false
  },
  {
    "src": "Recommended dosage in adults (including the elderly)",
    "display_src": "Recommended dosage in adults (including the elderly)",
    "ref": "Empfohlene Dosierung bei Erwachsenen (einschlie\u00dflich \u00e4ltere Patienten)",
    "show_ref": false
  },
  {
    "src": "Rosiglitazone dose adjustment within the recommended posology or changes in diabetic treatment should be considered (see section 4.5).",
    "display_src": "Rosiglitazone dose adjustment within the recommended posology or changes in diabetic treatment should be considered (see section 4.5).",
    "ref": "Eine Anpassung der Rosiglitazondosierung innerhalb der Dosierungsempfehlung oder eine \u00c4nderung der Diabetesbehandlung sollte erwogen werden (siehe Abschnitt 4.5).",
    "show_ref": false
  },
  {
    "src": "- The other excipients are anhydrous lactose, magnesium stearate, gelatin, silicon dioxide, sodium",
    "display_src": "- The other excipients are anhydrous lactose, magnesium stearate, gelatin, silicon dioxide, sodium",
    "ref": "- Die sonstigen Bestandteile sind Lactose (wasserfrei), Magnesiumstearat, Gelatine, Siliciumdioxid,",
    "show_ref": false
  },
  {
    "src": "Each 10 ml vial contains 200 mg tocilizumab (20 mg/ml).",
    "display_src": "Each 10 ml vial contains 200 mg tocilizumab (20 mg/ml).",
    "ref": "Jede 10-ml-Durchstechflasche enth\u00e4lt 200 mg Tocilizumab (20 mg/ml).",
    "show_ref": false
  },
  {
    "src": "The Committee decided that ZIMULTI\u2019 s benefits are greater than its risks when used, in addition to diet and exercise, to treat obese patients and overweight patients with risk factors such as type 2 diabetes or dyslipidaemia.",
    "display_src": "The Committee decided that ZIMULTI\u2019 s benefits are greater than its risks when used, in addition to diet and exercise, to treat obese patients and overweight patients with risk factors such as type 2 diabetes or dyslipidaemia.",
    "ref": "Der Ausschuss entschied, dass die Vorteile von ZIMULTI gegen\u00fcber den Risiken \u00fcberwiegen, wenn das Arzneimittel zus\u00e4tzlich zu einer Di\u00e4t und Bewegung zur Behandlung von Patienten mit Adipositas und \u00fcbergewichtigen Patienten mit ne",
    "show_ref": false
  },
  {
    "src": "The effects of Atriance were first tested in experimental models before being studied in humans.",
    "display_src": "The effects of Atriance were first tested in experimental models before being studied in humans.",
    "ref": "Die Wirkungen von Atriance wurden zun\u00e4chst in Versuchsmodellen getestet, bevor sie an Menschen untersucht wurden.",
    "show_ref": false
  },
  {
    "src": "EMADINE is supplied in 5 ml and 10 ml opaque plastic DROP-TAINER bottles.",
    "display_src": "EMADINE is supplied in 5 ml and 10 ml opaque plastic DROP-TAINER bottles.",
    "ref": "EMADINE ist in milchig-wei\u00dfen Tropfflaschen (DROPTAINER) aus Kunststoff zu 5 ml und 10 ml erh\u00e4ltlich.",
    "show_ref": false
  },
  {
    "src": "Luxembourg/ Luxemburg Eli Lilly Benelux S. A. / N. V.",
    "display_src": "Luxembourg/ Luxemburg Eli Lilly Benelux S. A. / N. V.",
    "ref": "Luxembourg/Luxemburg Eli Lilly Benelux S.A./N.V.",
    "show_ref": false
  },
  {
    "src": "CELSENTRI does not cure HIV infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS.",
    "display_src": "CELSENTRI does not cure HIV infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS.",
    "ref": "CELSENTRI heilt weder die HIV-Infektion noch AIDS, kann aber die Sch\u00e4den am Immunsystem und die Entwicklung von Infektionen und Krankheiten in Zusammenhang mit AIDS hinausz\u00f6gern.",
    "show_ref": false
  },
  {
    "src": "The letter from the company notifying the EMEA of the withdrawal of the application is available here.",
    "display_src": "The letter from the company notifying the EMEA of the withdrawal of the application is available here.",
    "ref": "Das Schreiben des Unternehmens an die EMEA \u00fcber die R\u00fccknahme des Antrags finden Sie hier.",
    "show_ref": false
  },
  {
    "src": "\u2666 Very common (these may occur with 1 in 10 doses or more of the vaccine): \u2022 Headache",
    "display_src": "\u2666 Very common (these may occur with 1 in 10 doses or more of the vaccine): \u2022 Headache",
    "ref": "\u2666 Sehr h\u00e4ufig (Diese k\u00f6nnen bei 1 oder mehr von 10 Impfdosen auftreten): \u2022 Kopfschmerzen \u2022 M\u00fcdigkeit \u2022 Schmerzen, R\u00f6tung, Schwellung oder Verh\u00e4rtung an der Injektionsstelle \u2022 Fieber \u2022 Muskel- und Gelenkschmerzen",
    "show_ref": false
  },
  {
    "src": "In the MRP United Kingdom is the Reference Member State (RMS) and Austria, Belgium, Denmark, Finland, France, Greece, Germany, Italy, Ireland, Iceland, Luxembourg, The Netherlands, Portugal, Spain and Sweden are Concerned Member States (CMS).",
    "display_src": "In the MRP United Kingdom is the Reference Member State (RMS) and Austria, Belgium, Denmark, Finland, France, Greece, Germany, Italy, Ireland, Iceland, Luxembourg, The Netherlands, Portugal, Spain and Sweden are Concerned Member States (CMS).",
    "ref": "In dem MRP ist das Vereinigte K\u00f6nigreich der Referenzmitgliedstaat (RMS) und \u00d6sterreich, Belgien, D\u00e4nemark, Finnland, Frankreich, Griechenland, Deutschland, Italien, Irland, Island, Luxemburg, die Niederlande, Portugal, Spanien und Schweden sind die betroffenen Mitgliedstaaten.",
    "show_ref": false
  },
  {
    "src": "Sverige KRKA Sverige AB Tel: + 46 8 643 67 66 United Kingdom KRKA Pharma Dublin, Ltd.",
    "display_src": "Sverige KRKA Sverige AB Tel: + 46 8 643 67 66 United Kingdom KRKA Pharma Dublin, Ltd.",
    "ref": "KRKA Sverige AB Tel: + 46 8 643 67 66 United Kingdom KRKA Pharma Dublin, Ltd.",
    "show_ref": false
  },
  {
    "src": "Deficiencies of iron, folic acid or vitamin B12 reduce the effectiveness of ESAs and should therefore be corrected.",
    "display_src": "Deficiencies of iron, folic acid or vitamin B12 reduce the effectiveness of ESAs and should therefore be corrected.",
    "ref": "Ein Mangel an Eisen, Fols\u00e4ure oder Vitamin B12 vermindert die Wirkung von EPOs und sollte deshalb korrigiert werden.",
    "show_ref": false
  },
  {
    "src": "Women of childbearing potential Women of childbearing potential must use adequate contraception to prevent pregnancy and continue its use for at least 6 months after the last Remicade treatment.",
    "display_src": "Women of childbearing potential Women of childbearing potential must use adequate contraception to prevent pregnancy and continue its use for at least 6 months after the last Remicade treatment.",
    "ref": "Frauen im geb\u00e4rf\u00e4higen Alter Frauen im geb\u00e4rf\u00e4higen Alter m\u00fcssen eine ad\u00e4quate Empf\u00e4ngnisverh\u00fctung anwenden und diese \u00fcber mindestens 6 Monate nach der letzten Remicade-Behandlung fortf\u00fchren.",
    "show_ref": false
  },
  {
    "src": "Limited clinical pharmacology data are available for patients below the age of 4 years.",
    "display_src": "Limited clinical pharmacology data are available for patients below the age of 4 years.",
    "ref": "Es sind nur begrenzte klinisch-pharmakologische Daten bei Patienten unter 4 Jahren verf\u00fcgbar.",
    "show_ref": false
  },
  {
    "src": "The 12-month patient survival rates were 96.9% for Advagraf and 97.5% for Prograf; in the Advagraf arm 10 patients died (3 female, 7 male) and in the Prograf arm 8 patients died (3 female, 5 male).",
    "display_src": "The 12-month patient survival rates were 96.9% for Advagraf and 97.5% for Prograf; in the Advagraf arm 10 patients died (3 female, 7 male) and in the Prograf arm 8 patients died (3 female, 5 male).",
    "ref": "Die Patienten-\u00dcberlebensraten nach 12 Monaten lagen bei 96,9% f\u00fcr Advagraf und 97,5% f\u00fcr Prograf; im Advagraf-Arm traten 10 (3 Frauen, 7 M\u00e4nner) und im Prograf-Arm 8 (3 Frauen, 5 M\u00e4nner) Todesf\u00e4lle auf.",
    "show_ref": false
  },
  {
    "src": "Additionally the overall risk of rash appears to be strongly associated with:",
    "display_src": "Additionally the overall risk of rash appears to be strongly associated with:",
    "ref": "62 Au\u00dferdem scheint das Risiko eines Hautausschlages generell in engem Zusammenhang zu stehen mit:",
    "show_ref": false
  },
  {
    "src": "Solvent 1.2 ml pre-filled syringe (type I glass) with 1.2 ml solvent.",
    "display_src": "Solvent 1.2 ml pre-filled syringe (type I glass) with 1.2 ml solvent.",
    "ref": "17 L\u00f6sungsmittel 1,2 ml-Fertigspritze (Typ I-Glas) mit 1,2 ml L\u00f6sungsmittel.",
    "show_ref": false
  },
  {
    "src": "Imprida 5 mg/ 160 mg film-coated tablets amlodipine/ valsartan",
    "display_src": "Imprida 5 mg/ 160 mg film-coated tablets amlodipine/ valsartan",
    "ref": "Imprida 5 mg/160 mg Filmtabletten Amlodipin/Valsartan",
    "show_ref": false
  },
  {
    "src": "It is not known whether somatropin is excreted in human milk.",
    "display_src": "It is not known whether somatropin is excreted in human milk.",
    "ref": "Es ist nicht bekannt, ob Somatropin in die Muttermilch \u00fcbergeht.",
    "show_ref": false
  },
  {
    "src": "Soliris 300 mg concentrate for solution for infusion",
    "display_src": "Soliris 300 mg concentrate for solution for infusion",
    "ref": "Soliris 300 mg Konzentrat zur Herstellung einer Infusionsl\u00f6sung",
    "show_ref": false
  },
  {
    "src": "If large quantities have been ingested, gastric lavage is indicated, followed by activated charcoal and sodium-sulphate.",
    "display_src": "If large quantities have been ingested, gastric lavage is indicated, followed by activated charcoal and sodium-sulphate.",
    "ref": "Wenn gro\u00dfe Mengen eingenommen wurden, ist eine Magensp\u00fclung mit anschlie\u00dfender Gabe von Aktivkohle und Natriumsulfat angezeigt.",
    "show_ref": false
  },
  {
    "src": "Mice were maintained for an additional 12 weeks for a total of 52 weeks.",
    "display_src": "Mice were maintained for an additional 12 weeks for a total of 52 weeks.",
    "ref": "Die M\u00e4use wurden weitere 12 Wochen bis zu einer Gesamtdauer von 52 Wochen weiterbeobachtet.",
    "show_ref": false
  },
  {
    "src": "Starting at week 16, placebo patients were switched to infliximab and all patients subsequently received 5 mg/ kg infliximab every 8 weeks up to week 46.",
    "display_src": "Starting at week 16, placebo patients were switched to infliximab and all patients subsequently received 5 mg/ kg infliximab every 8 weeks up to week 46.",
    "ref": "Ab Woche 16 wurden die Patienten der Placebogruppe auf Infliximab umgestellt, und alle Patienten erhielten dann Infliximab 5 mg/kg alle 8 Wochen bis Woche 46.",
    "show_ref": false
  },
  {
    "src": "At steady state, peak-to-trough fluctuations in darifenacin concentrations are small (PTF:",
    "display_src": "At steady state, peak-to-trough fluctuations in darifenacin concentrations are small (PTF:",
    "ref": "Im Steady- State sind die Peak-to-Trough-Fluktuationen der Darifencin-Konzentrationen gering (PTF:",
    "show_ref": false
  },
  {
    "src": "Brief contact of the animal with water on one or two occasions between monthly treatments is unlikely to significantly reduce the efficacy of the product.",
    "display_src": "Brief contact of the animal with water on one or two occasions between monthly treatments is unlikely to significantly reduce the efficacy of the product.",
    "ref": "Ein kurzer ein- bis zweimaliger Kontakt des Tieres mit Wasser zwischen monatlichen Behandlungen schr\u00e4nkt die Wirksamkeit des Tierarzneimittels vermutlich nicht ma\u00dfgeblich ein.",
    "show_ref": false
  },
  {
    "src": "For 6 months following Foscan treatment avoid prolonged direct sunlight exposure of the injection site arm.",
    "display_src": "For 6 months following Foscan treatment avoid prolonged direct sunlight exposure of the injection site arm.",
    "ref": "F\u00fcr 6 Monate nach der Foscangabe sollte der Injektionsarm nicht f\u00fcr l\u00e4ngere Zeit direktem Sonnenlicht ausgesetzt sein.",
    "show_ref": false
  },
  {
    "src": "No significant difference was seen in the STEMI population.",
    "display_src": "No significant difference was seen in the STEMI population.",
    "ref": "Es gab keine signifikanten Unterschiede in der STEMI Population.",
    "show_ref": false
  },
  {
    "src": "Specific comments and particular caution regarding meningitis, elevations of creatine kinase, and CNS adverse events can be found in Section 4.4.",
    "display_src": "Specific comments and particular caution regarding meningitis, elevations of creatine kinase, and CNS adverse events can be found in Section 4.4.",
    "ref": "Spezielle Anmerkungen und besondere Vorsichtsma\u00dfnahmen im Hinblick auf Meningitis, Erh\u00f6hungen der Kreatinkinase und unerw\u00fcnschte Ereignisse auf das ZNS finden sich im Abschnitt 4.4.",
    "show_ref": false
  },
  {
    "src": "Yentreve is a medicine containing the active substance duloxetine.",
    "display_src": "Yentreve is a medicine containing the active substance duloxetine.",
    "ref": "Yentreve ist ein Arzneimittel, das den Wirkstoff Duloxetin enth\u00e4lt.",
    "show_ref": false
  },
  {
    "src": "In the second trial, no delay in the time to disability progression was seen.",
    "display_src": "In the second trial, no delay in the time to disability progression was seen.",
    "ref": "In der zweiten Studie war keine Verz\u00f6gerung der Zeit bis zum Fortschreiten der Behinderung zu beobachten.",
    "show_ref": false
  },
  {
    "src": "6.5 Nature and contents of container Me",
    "display_src": "6.5 Nature and contents of container Me",
    "ref": "en 6.5 Art und Inhalt des Beh\u00e4ltnisses",
    "show_ref": false
  },
  {
    "src": "Kineret is for use in adults only (age 18 years and over).",
    "display_src": "Kineret is for use in adults only (age 18 years and over).",
    "ref": "Kineret ist ausschlie\u00dflich zur Anwendung bei Erwachsenen (18 Jahre und \u00e4lter) bestimmt.",
    "show_ref": false
  },
  {
    "src": "- a family history of osteoporosis",
    "display_src": "- a family history of osteoporosis",
    "ref": "- Osteoporose in der Familiengeschichte",
    "show_ref": false
  },
  {
    "src": "For HPS, only serious adverse events were recorded as well as myalgia, increases in serum transaminases and CK.",
    "display_src": "For HPS, only serious adverse events were recorded as well as myalgia, increases in serum transaminases and CK.",
    "ref": "In HPS wurden nur Myalgie und Anstiege der Serum-Transaminasen und des CK-Wertes sowie schwerwiegende Nebenwirkungen dokumentiert.",
    "show_ref": false
  },
  {
    "src": "Respiratory disorders occurred more frequently in abatacept-treated patients than in placebo-treated patients (10.8% vs.",
    "display_src": "Respiratory disorders occurred more frequently in abatacept-treated patients than in placebo-treated patients (10.8% vs.",
    "ref": "Zu Erkrankungen der Atemwege kam es h\u00e4ufiger bei mit Abatacept behandelten Patienten als bei Patienten, die mit Placebo behandelt wurden (10,8% im Vergleich zu 5,9%); dazu z\u00e4hlten eine Verschlimmerung der COPD und Dyspnoe.",
    "show_ref": false
  },
  {
    "src": "For children weighing at least 30 kg, the recommended oral dose of Epivir is 1 x 150 mg tablet twice a day, approximately 12 hours apart.",
    "display_src": "For children weighing at least 30 kg, the recommended oral dose of Epivir is 1 x 150 mg tablet twice a day, approximately 12 hours apart.",
    "ref": "F\u00fcr Kinder mit einem K\u00f6rpergewicht von mindestens 30 kg betr\u00e4gt die empfohlene Dosis von Epivir zum Einnehmen eine 150 mg Tablette zweimal am Tag im Abstand von etwa 12 Stunden.",
    "show_ref": false
  },
  {
    "src": "But you must use it only if it looks like water.",
    "display_src": "But you must use it only if it looks like water.",
    "ref": "Sie d\u00fcrfen es aber nur dann verwenden, wenn es wie Wasser aussieht.",
    "show_ref": false
  },
  {
    "src": "Reduction of IOP in man starts within approximately 2 hours after administration and maximum effect is reached after 12 hours.",
    "display_src": "Reduction of IOP in man starts within approximately 2 hours after administration and maximum effect is reached after 12 hours.",
    "ref": "Beim Menschen tritt die Senkung des intraokul\u00e4ren Drucks ungef\u00e4hr 2 Stunden nach dem Eintropfen ein, die maximale Wirkung ist nach 12 Stunden erreicht.",
    "show_ref": false
  },
  {
    "src": "Viale Citt\u00e0 d\u2019 Europa 681 - 00144 Roma Italy",
    "display_src": "Viale Citt\u00e0 d\u2019 Europa 681 - 00144 Roma Italy",
    "ref": "Viale Citt\u00e0 d\u2019 Europa 681 - 00144 Roma Italien",
    "show_ref": false
  },
  {
    "src": "CORTAVANCE 0.584 mg/ ml cutaneous spray solution for dogs",
    "display_src": "CORTAVANCE 0.584 mg/ ml cutaneous spray solution for dogs",
    "ref": "CORTAVANCE 0,584 mg/ml, Spray (L\u00f6sung) zur Anwendung auf der Haut f\u00fcr Hunde",
    "show_ref": false
  },
  {
    "src": "Yentreve should not be used with monoamine oxidase inhibitors (a group of antidepressants), fluvoxamine (another antidepressant), or ciprofloxacin or enoxacin (types of antibiotic).",
    "display_src": "Yentreve should not be used with monoamine oxidase inhibitors (a group of antidepressants), fluvoxamine (another antidepressant), or ciprofloxacin or enoxacin (types of antibiotic).",
    "ref": "Yentreve darf nicht zusammen mit Monoaminooxidase-Hemmern (einer anderen Gruppe von Antidepressiva), Fluvoxamin (einem anderen Antidepressivum), Ciprofloxacin oder Enoxacin (Antibiotika) angewendet werden.",
    "show_ref": false
  },
  {
    "src": "- cerebrovascular disease",
    "display_src": "- cerebrovascular disease",
    "ref": "- cerebrovaskul\u00e4re Erkrankungen",
    "show_ref": false
  },
  {
    "src": "Prior to initiation of therapy, an internal pump must be rinsed three times with 2 ml of Prialt at 25 \u03bc g/ ml.",
    "display_src": "Prior to initiation of therapy, an internal pump must be rinsed three times with 2 ml of Prialt at 25 \u03bc g/ ml.",
    "ref": "Vor Beginn der Therapie muss eine interne Pumpe dreimal mit 2 ml Prialt in einer Konzentration von 25 \u03bc g/ml gesp\u00fclt werden.",
    "show_ref": false
  },
  {
    "src": "A statistically significant improvement of the clinically relevant symptoms (pain and dyspnoea) associated with malignant pleural mesothelioma in the ALIMTA/ cisplatin arm (212 patients) versus the cisplatin arm alone (218 patients) was demonstrated using the Lung Cancer Symptom Scale.",
    "display_src": "A statistically significant improvement of the clinically relevant symptoms (pain and dyspnoea) associated with malignant pleural mesothelioma in the ALIMTA/ cisplatin arm (212 patients) versus the cisplatin arm alone (218 patients) was demonstrated using the Lung Cancer Symptom Scale.",
    "ref": "Eine statistisch signifikante Verbesserung der klinisch relevanten Symptome (Schmerzen und Dyspnoe) im Zusammenhang mit dem malignen Pleuramesotheliom wurde bei Anwendung der Lun- genkrebssymptomskala im ALIMTA/Cisplatin-Arm (212 Patienten) gegen\u00fcber dem alleinigen Cispla- tin-Arm (218 Patienten) gezeigt.",
    "show_ref": false
  },
  {
    "src": "4 vials + 4 pre-filled syringes + 8 needles",
    "display_src": "4 vials + 4 pre-filled syringes + 8 needles",
    "ref": "4 Durchstechflaschen + 4 Fertigspritzen + 8 Nadeln",
    "show_ref": false
  },
  {
    "src": "esk\u00e1 republika Eli Lilly R, s. r. o.",
    "display_src": "esk\u00e1 republika Eli Lilly R, s. r. o.",
    "ref": "esk\u00e1 republika Eli Lilly R, s.r.o.",
    "show_ref": false
  },
  {
    "src": "Novem contains meloxicam, which belongs to a class of medicines called non-steroidal anti- inflammatory drugs (NSAIDs).",
    "display_src": "Novem contains meloxicam, which belongs to a class of medicines called non-steroidal anti- inflammatory drugs (NSAIDs).",
    "ref": "Novem enth\u00e4lt Meloxicam, das zu der Gruppe der nicht steroidalen Antiphlogistika (NSAIDs) geh\u00f6rt.",
    "show_ref": false
  },
  {
    "src": "Place the tablet in the dog \"s mouth.",
    "display_src": "Place the tablet in the dog \"s mouth.",
    "ref": "Tablette in den Fang des Hundes legen.",
    "show_ref": false
  },
  {
    "src": "Tablets are packaged in opaque pvc/ aluminium blister cards.",
    "display_src": "Tablets are packaged in opaque pvc/ aluminium blister cards.",
    "ref": "RILUTEK- Tabletten sind in opaken PVC/Alu-Blistern verpackt.",
    "show_ref": false
  },
  {
    "src": "Concomitant administration resulted in increased impairment of attention, memory and co-ordination compared to zolpidem alone. \u2022 Circadin has been co-administered in studies with thioridazine and imipramine, active substances which affect the central nervous system.",
    "display_src": "Concomitant administration resulted in increased impairment of attention, memory and co-ordination compared to zolpidem alone. \u2022 Circadin has been co-administered in studies with thioridazine and imipramine, active substances which affect the central nervous system.",
    "ref": "Die gleichzeitige Anwendung hatte im Vergleich zur alleinigen Anwendung von Zolpidem eine vermehrte Beeintr\u00e4chtigung der Aufmerksamkeit, Ged\u00e4chtnisleistsung und Koordination zur Folge. \u2022 Circadin wurde in Studien gleichzeitig mit Thioridazin und Imipramin angewendet, Wirkstoffen, die das zentrale Nervensystem beeinflussen.",
    "show_ref": false
  },
  {
    "src": "Taking Rebetol with food and drink Rebetol must be taken with food.",
    "display_src": "Taking Rebetol with food and drink Rebetol must be taken with food.",
    "ref": "Bei Einnahme von Rebetol zusammen mit Nahrungsmitteln und Getr\u00e4nken Rebetol ist mit der Nahrung einzunehmen.",
    "show_ref": false
  },
  {
    "src": "Patient weight (kg) 47 - 49 50 - 65",
    "display_src": "Patient weight (kg) 47 - 49 50 - 65",
    "ref": "Gewicht des Patienten (kg) 47 - 49 50 - 65",
    "show_ref": false
  },
  {
    "src": "- If you have heart failure.",
    "display_src": "- If you have heart failure.",
    "ref": "- Wenn Sie an einer Herzmuskelschw\u00e4che leiden.",
    "show_ref": false
  },
  {
    "src": "It is not known whether atazanavir is excreted in human milk.",
    "display_src": "It is not known whether atazanavir is excreted in human milk.",
    "ref": "Es ist nicht bekannt, ob Atazanavir beim Menschen in die Muttermilch ausgeschieden wird.",
    "show_ref": false
  },
  {
    "src": "Date: _______________________________",
    "display_src": "Date: _______________________________",
    "ref": "Datum: _________________________",
    "show_ref": false
  },
  {
    "src": "Due to the high proportion of premature discontinuation (42% of patients discontinued randomised treatment by week 48), no definitive conclusion can be drawn regarding the equivalence between the treatment regimens at week 48.",
    "display_src": "Due to the high proportion of premature discontinuation (42% of patients discontinued randomised treatment by week 48), no definitive conclusion can be drawn regarding the equivalence between the treatment regimens at week 48.",
    "ref": "Aufgrund des hohen Anteils vorzeitiger Abbr\u00fcche (42% der Patienten beendeten die randomisierte Behandlung bis Woche 48), kann keine definitive",
    "show_ref": false
  },
  {
    "src": "Characteristics in patients The pharmacokinetic properties of entacapone are similar in both young and elderly adults.",
    "display_src": "Characteristics in patients The pharmacokinetic properties of entacapone are similar in both young and elderly adults.",
    "ref": "Eigenschaften bei der Anwendung am Patienten Die Pharmakokinetik von Entacapon ist bei jungen und \u00e4lteren Erwachsenen vergleichbar.",
    "show_ref": false
  },
  {
    "src": "There are no adequate data from the use of ranolazine in pregnant women.",
    "display_src": "There are no adequate data from the use of ranolazine in pregnant women.",
    "ref": "Es liegen keine hinreichenden Daten f\u00fcr die Verwendung von Ranolazin bei Schwangeren vor.",
    "show_ref": false
  },
  {
    "src": "The Jarisch-Herxheimer reaction has been reported following cefuroxime axetil treatment of Lyme disease.",
    "display_src": "The Jarisch-Herxheimer reaction has been reported following cefuroxime axetil treatment of Lyme disease.",
    "ref": "Im Zusammenhang mit der Behandlung der Lyme-Borreliose mit Cefuroximaxetil wurde das Auftreten der Jarisch-Herxheimer-Reaktion beobachtet.",
    "show_ref": false
  },
  {
    "src": "The treatment with this medicine is not recommended for children and adolescents.",
    "display_src": "The treatment with this medicine is not recommended for children and adolescents.",
    "ref": "Die Behandlung mit diesem Arzneimittel wird f\u00fcr Kinder und Jugendliche nicht empfohlen.",
    "show_ref": false
  },
  {
    "src": "< Batch > < Lot > < BN > {number}",
    "display_src": "< Batch > < Lot > < BN > {number}",
    "ref": "< Ch.-B. > < Lot > {Nummer} gA",
    "show_ref": false
  },
  {
    "src": "Pseudo-ephedrine is a nasal decongestant, which exerts its sympathomimetic effects indirectly, predominantly through release of adrenergic mediators from postganglionic nerve terminals.",
    "display_src": "Pseudo-ephedrine is a nasal decongestant, which exerts its sympathomimetic effects indirectly, predominantly through release of adrenergic mediators from postganglionic nerve terminals.",
    "ref": "Pseudoephedrin ist ein nasales Dekongestionsmittel, dass seine sympathomimetischen Wirkungen indirekt und vorwiegend durch die Freigabe von adrenergischen Transmittern aus postganglion\u00e4ren Nervenenden zeigt.",
    "show_ref": false
  },
  {
    "src": "Romiplostim had no observed effect on the fertility of rats.",
    "display_src": "Romiplostim had no observed effect on the fertility of rats.",
    "ref": "Romiplostim zeigte keine Auswirkungen auf die Fertilit\u00e4t von Ratten.",
    "show_ref": false
  },
  {
    "src": "The clinical benefit of DULOXETINE BOEHRINGER INGELHEIM compared with placebo has not been demonstrated in women with mild SUI, defined in randomised trials as those with IEF < 14 per week.",
    "display_src": "The clinical benefit of DULOXETINE BOEHRINGER INGELHEIM compared with placebo has not been demonstrated in women with mild SUI, defined in randomised trials as those with IEF < 14 per week.",
    "ref": "Der klinische Nutzen von DULOXETINE BOEHRINGER INGELHEIM im Vergleich zu Placebo bei Frauen mit leichter Belastungsinkontinenz, die in den randomisierten Studien als IEF < 14 pro Woche definiert war, wurde nicht belegt.",
    "show_ref": false
  },
  {
    "src": "Two intramuscular injections at 48 hours interval",
    "display_src": "Two intramuscular injections at 48 hours interval",
    "ref": "Zwei intramuskul\u00e4re Injektionen im Abstand von 48 Stunden",
    "show_ref": false
  },
  {
    "src": "The lyophilised powder form of IntronA is to be reconstituted by adding 1 ml of water for injections to the vial.",
    "display_src": "The lyophilised powder form of IntronA is to be reconstituted by adding 1 ml of water for injections to the vial.",
    "ref": "Durch Zugabe von 1 ml Wasser f\u00fcr Injektionszwecke in die Durchstechflasche wird das lyophilisierte IntronA-Pulver gel\u00f6st.",
    "show_ref": false
  },
  {
    "src": "The risk/ benefit ratio of Lansoprazol AbZ-Pharma 15 mg, 30 mg is considered to be favourable provided that appropriate information regarding H. pylori eradication therapy are included in the SPC.",
    "display_src": "The risk/ benefit ratio of Lansoprazol AbZ-Pharma 15 mg, 30 mg is considered to be favourable provided that appropriate information regarding H. pylori eradication therapy are included in the SPC.",
    "ref": "Das Nutzen-Risiko-Verh\u00e4ltnis von Lansoprazol AbZ-Pharma 15 mg, 30 mg wird als g\u00fcnstig erachtet, sofern angemessene Informationen zur H. pylori-Eradikationtherapie in die SPC aufgenommen werden.",
    "show_ref": false
  },
  {
    "src": "The clinical studies presented for the treatment of salmonellosis, applying a daily dose of 2 X 30 mg/ kg bw to be administered over 10 days are exceedingly poor (few animals, poor results).",
    "display_src": "The clinical studies presented for the treatment of salmonellosis, applying a daily dose of 2 X 30 mg/ kg bw to be administered over 10 days are exceedingly poor (few animals, poor results).",
    "ref": "Die \u00fcber die Behandlung einer Salmonellose vorgelegten klinischen Studien, in denen eine Tagesdosis von 2 x 30 mg/kg K\u00f6rpergewicht \u00fcber 10 Tage angewandt wurde, sind \u00e4u\u00dferst mangelhaft (geringe Anzahl an Tieren, d\u00fcrftige Ergebnisse).",
    "show_ref": false
  },
  {
    "src": "Arava should not be used in people who may be hypersensitive (allergic) to leflunomide or to any of the other ingredients.",
    "display_src": "Arava should not be used in people who may be hypersensitive (allergic) to leflunomide or to any of the other ingredients.",
    "ref": "Arava darf bei Patienten, die m\u00f6glicherweise \u00fcberempfindlich (allergisch) auf Leflunomid oder einen der anderen Bestandteile reagieren, nicht angewendet werden.",
    "show_ref": false
  },
  {
    "src": "Caution is therefore advised when ViraferonPeg treatment is initiated for chronic hepatitis in patients treated with medication with a narrow therapeutic window and sensitive to mild metabolic impairment of the liver.",
    "display_src": "Caution is therefore advised when ViraferonPeg treatment is initiated for chronic hepatitis in patients treated with medication with a narrow therapeutic window and sensitive to mild metabolic impairment of the liver.",
    "ref": "Deshalb wird zur Vorsicht geraten, wenn bei Patienten, die Medikamente mit geringer therapeutischer Breite erhalten und f\u00fcr leicht ausgepr\u00e4gte Stoffwechselst\u00f6rungen der Leber empf\u00e4nglich sind, die Behandlung einer chronischen Hepatitis mit ViraferonPeg initiiert wird.",
    "show_ref": false
  },
  {
    "src": "In a thorough QT study, rufinamide produced a decrease in QTc interval proportional to concentration.",
    "display_src": "In a thorough QT study, rufinamide produced a decrease in QTc interval proportional to concentration.",
    "ref": "In einer eingehenden Studie zur QT-Zeit bewirkte Rufinamid eine Abnahme des QTc-Intervalls proportional zur Konzentration.",
    "show_ref": false
  },
  {
    "src": "Ferring GmbH Wittland 11 D-24109 Kiel Germany",
    "display_src": "Ferring GmbH Wittland 11 D-24109 Kiel Germany",
    "ref": "Ferring GmbH Wittland 11 D-24109 Kiel Deutschland",
    "show_ref": false
  },
  {
    "src": "- You are considering stopping CYMBALTA (see section 3).",
    "display_src": "- You are considering stopping CYMBALTA (see section 3).",
    "ref": "- Sie \u00fcberlegen, CYMBALTA abzusetzen (siehe Abschnitt 3).",
    "show_ref": false
  },
  {
    "src": "Try always to keep familiar with your warning symptoms.",
    "display_src": "Try always to keep familiar with your warning symptoms.",
    "ref": "Versuchen Sie stets auf Ihre Warnzeichen zu achten.",
    "show_ref": false
  },
  {
    "src": "Haemorrhage has been observed rarely in patients treated with SUTENT (see section 4.4).",
    "display_src": "Haemorrhage has been observed rarely in patients treated with SUTENT (see section 4.4).",
    "ref": "H\u00e4morrhagien wurden selten bei mit SUTENT behandelten Patienten beobachtet (siehe Abschnitt 4.4).",
    "show_ref": false
  },
  {
    "src": "For subcutaneous injection after reconstitution with 1.2 ml of solvent.",
    "display_src": "For subcutaneous injection after reconstitution with 1.2 ml of solvent.",
    "ref": "Zur subkutanen Injektion nach Herstellung der Injektionsl\u00f6sung mit 1,2 ml L\u00f6sungsmittel.",
    "show_ref": false
  },
  {
    "src": "The amount of radioactivity is calculated according to the planned time of injection to the patient, to obtain a single patient dose of 555 \u2013 740 MBq from the entire reconstituted vial.",
    "display_src": "The amount of radioactivity is calculated according to the planned time of injection to the patient, to obtain a single patient dose of 555 \u2013 740 MBq from the entire reconstituted vial.",
    "ref": "Die Radioaktivit\u00e4t wird so berechnet, da\u00df zum geplanten Zeitpunkt der Injektion aus dem gesamten rekonstituierten Inhalt der Durchstechflasche eine einzige Patientendosis von 555 - 740 MBq zur Verabreichung an den Patienten zur Verf\u00fcgung steht.",
    "show_ref": false
  },
  {
    "src": "35 \u2013 Recent major surgery \u2013 Recent bleeding (e. g. in brain, stomach/ intestine, eye, lung) \u2013 Obvious signs of bleeding \u2013 Recent active peptic ulcer \u2013 Age > 65 years",
    "display_src": "35 \u2013 Recent major surgery \u2013 Recent bleeding (e. g. in brain, stomach/ intestine, eye, lung) \u2013 Obvious signs of bleeding \u2013 Recent active peptic ulcer \u2013 Age > 65 years",
    "ref": "37 \u2212 Herzinnenhautentz\u00fcndung \u2212 Fortgeschrittene Nierenerkrankung \u2212 Fortgeschrittene Blutungsneigung \u2212 Kurz zur\u00fcckliegender gro\u00dfer operativer Eingriff \u2212 Kurz zur\u00fcckliegende Blutungen (z.B. in Gehirn, Magen/Darm, Auge, Lunge) \u2212 Sichtbare Anzeichen von Blutungen \u2212 Kurz zur\u00fcckliegendes akutes Magen- oder Darmgeschw\u00fcr \u2212 Alter \u00fcber 65 Jahre.",
    "show_ref": false
  },
  {
    "src": "Injectable calcitonin may cause transient dizziness which may impair the reaction of the patient.",
    "display_src": "Injectable calcitonin may cause transient dizziness which may impair the reaction of the patient.",
    "ref": "Calcitonin zur Injektion kann vor\u00fcbergehend Schwindel hervorrufen wodurch die Reaktionsf\u00e4higkeit des Patienten beeintr\u00e4chtigt werden k\u00f6nnte.",
    "show_ref": false
  },
  {
    "src": "The active substance in Aloxi, palonosetron, is a \u2018 5HT3 antagonist\u2019.",
    "display_src": "The active substance in Aloxi, palonosetron, is a \u2018 5HT3 antagonist\u2019.",
    "ref": "Der Wirkstoff in Aloxi, Palonosetron, ist ein \u201e 5HT3-Antagonist\u201c.",
    "show_ref": false
  },
  {
    "src": "Clinically important (> 3 times upper normal limit) elevations in serum transaminases occurred in 0.8% patients on {PRODUCT NAME}.",
    "display_src": "Clinically important (> 3 times upper normal limit) elevations in serum transaminases occurred in 0.8% patients on {PRODUCT NAME}.",
    "ref": "Klinisch relevante Erh\u00f6hungen (um mehr als das 3fache des oberen Normwertes) der Transaminasen traten bei 0,8% der Patienten unter {HANDELSNAME}-Medikation auf.",
    "show_ref": false
  },
  {
    "src": "Carbaglu 200 mg dispersible tablets",
    "display_src": "Carbaglu 200 mg dispersible tablets",
    "ref": "Carbaglu 200 mg Tabletten zur Herstellung einer Suspension zum Einnehmen",
    "show_ref": false
  },
  {
    "src": "Aluminium hydroxide-magnesium hydroxide-simethicone antacid/ Efavirenz (30 mL single dose/ 400 mg single dose) Famotidine/ Efavirenz (40 mg single dose/ 400 mg single dose) ANTIANXIETY AGENTS",
    "display_src": "Aluminium hydroxide-magnesium hydroxide-simethicone antacid/ Efavirenz (30 mL single dose/ 400 mg single dose) Famotidine/ Efavirenz (40 mg single dose/ 400 mg single dose) ANTIANXIETY AGENTS",
    "ref": "ANTAZIDA Aluminiumhydroxid- Magnesiumhydroxid-Simeticon- Antazid/Efavirenz (30 ml Einmalgabe/400 mg Einmalgabe) Famotidin/Efavirenz (40 mg Einmalgabe/400 mg Einmalgabe)",
    "show_ref": false
  },
  {
    "src": "Side effects reported in clinical studies for patients treated with Rasilez HCT were:",
    "display_src": "Side effects reported in clinical studies for patients treated with Rasilez HCT were:",
    "ref": "Nebenwirkungen, die bei mit Rasilez HCT behandelten Patienten in klinischen Studien beobachtet wurden, waren:",
    "show_ref": false
  },
  {
    "src": "Doses of 8 mg/ kg of tocilizumab were given every four weeks as monotherapy.",
    "display_src": "Doses of 8 mg/ kg of tocilizumab were given every four weeks as monotherapy.",
    "ref": "Tocilizumab wurde in Dosen von 8 mg/kg alle vier Wochen als Monotherapie verabreicht.",
    "show_ref": false
  },
  {
    "src": "Administration and budget matters are described in Chapter 6.",
    "display_src": "Administration and budget matters are described in Chapter 6.",
    "ref": "Verwaltungs- und Haushaltsangelegenheiten werden in Kapitel 6 beschrieben.",
    "show_ref": false
  },
  {
    "src": "If you forget to use Insulin Human Winthrop Comb 50",
    "display_src": "If you forget to use Insulin Human Winthrop Comb 50",
    "ref": "Wenn Sie die Anwendung von Insulin Human Winthrop Comb 50 vergessen haben",
    "show_ref": false
  },
  {
    "src": "Since CRIXIVAN must be taken at intervals of 8 hours, a schedule convenient for the patient should be developed.",
    "display_src": "Since CRIXIVAN must be taken at intervals of 8 hours, a schedule convenient for the patient should be developed.",
    "ref": "Da CRIXIVAN alle 8 Stunden eingenommen werden muss, ist ein patientenfreundliches Einnahmeschema erforderlich.",
    "show_ref": false
  },
  {
    "src": "Both emtricitabine and tenofovir showed strain specific activity against HIV-2 and antiviral activity against HBV.",
    "display_src": "Both emtricitabine and tenofovir showed strain specific activity against HIV-2 and antiviral activity against HBV.",
    "ref": "Sowohl Emtricitabin als auch Tenofovir zeigten stammspezifische Aktivit\u00e4t gegen HIV-2 und antivirale Aktivit\u00e4t gegen HBV.",
    "show_ref": false
  },
  {
    "src": "\u00a9EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.",
    "display_src": "\u00a9EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.",
    "ref": "\u00a9EMEA 2006 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.",
    "show_ref": false
  },
  {
    "src": "- if the seal is broken.",
    "display_src": "- if the seal is broken.",
    "ref": "- wenn die Versiegelung aufgebrochen ist",
    "show_ref": false
  },
  {
    "src": "No specific studies have been performed to evaluate the hepatic, renal, lung, or gastrointestinal routes of excretion/elimination for Soliris.",
    "display_src": "No specific studies have been performed to evaluate the hepatic, renal, lung, or gastrointestinal routes of excretion/elimination for Soliris.",
    "ref": "Es wurden keine speziellen Studien zur Untersuchung der hepatischen, renalen, pulmonalen oder gastrointestinalen Ausscheidungs-/Eliminationswege f\u00fcr Soliris durchgef\u00fchrt.",
    "show_ref": false
  },
  {
    "src": "The reported frequencies for these events as well as the rates of discontinuation due to any adverse reactions were similar in patients receiving CELSENTRI 300 mg twice daily + OBT (Optimised Background Therapy) compared to those receiving OBT alone.",
    "display_src": "The reported frequencies for these events as well as the rates of discontinuation due to any adverse reactions were similar in patients receiving CELSENTRI 300 mg twice daily + OBT (Optimised Background Therapy) compared to those receiving OBT alone.",
    "ref": "Die H\u00e4ufigkeit, mit der diese Ereignisse berichtet wurden, war, ebenso wie die nebenwirkungsbedingte Abbruchrate unter CELSENTRI 300 mg zweimal t\u00e4glich plus optimierte Basistherapie (= OBT) vergleichbar mit der unter der OBT alleine.",
    "show_ref": false
  },
  {
    "src": "Experience in patients above 60 years is limited.",
    "display_src": "Experience in patients above 60 years is limited.",
    "ref": "Erfahrungen mit Patienten \u00fcber 60 Jahren sind begrenzt.",
    "show_ref": false
  },
  {
    "src": "Naglazyme has been authorised under \u2018 Exceptional Circumstances\u2019.",
    "display_src": "Naglazyme has been authorised under \u2018 Exceptional Circumstances\u2019.",
    "ref": "Naglazyme wurde unter \u201e au\u00dfergew\u00f6hnlichen Umst\u00e4nden\u201c zugelassen.",
    "show_ref": false
  },
  {
    "src": "In both arms, quality of life measured by the EORTC questionnaire was comparable and stable during treatment and follow-up.",
    "display_src": "In both arms, quality of life measured by the EORTC questionnaire was comparable and stable during treatment and follow-up.",
    "ref": "In beiden Behandlungsarmen war die Lebensqualit\u00e4t, kontrolliert anhand des EORTC-Fragebogens, vergleichbar und ver\u00e4nderte sich w\u00e4hrend der Behandlung und der Nachbeobachtung nicht.",
    "show_ref": false
  },
  {
    "src": "Limited information exists on the persistence of the immune response after primary vaccination with Quintanrix as well as on the immunogenicity of booster doses.",
    "display_src": "Limited information exists on the persistence of the immune response after primary vaccination with Quintanrix as well as on the immunogenicity of booster doses.",
    "ref": "6 Es liegen nur begrenzte Informationen zur Persistenz der Immunantwort nach der Grundimmunisierung und zur Immunogenit\u00e4t der Auffrischimpfung mit Quintanrix vor.",
    "show_ref": false
  },
  {
    "src": "110 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.",
    "display_src": "110 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.",
    "ref": "116 Falls weitere Informationen \u00fcber das Arzneimittel gew\u00fcnscht werden, setzen Sie sich bitte mit dem \u00f6rtlichen Vertreter des Pharmazeutischen Unternehmers in Verbindung.",
    "show_ref": false
  },
  {
    "src": "Mixtard 50 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)",
    "display_src": "Mixtard 50 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)",
    "ref": "Mixtard 50 NovoLet 100 I.E./ml Injektionssuspension in einem Fertigpen Insulin human (r-DNS)",
    "show_ref": false
  },
  {
    "src": "Rare reports of severe allergic (anaphylactic) reactions after injection of a conventional preparation containing the Botulinum toxin type A complex have been received.",
    "display_src": "Rare reports of severe allergic (anaphylactic) reactions after injection of a conventional preparation containing the Botulinum toxin type A complex have been received.",
    "ref": "Selten sind Berichte \u00fcber schwere allergische (anaphylaktische) Reaktionen nach der Injektion eines herk\u00f6mmlichen Pr\u00e4parates mit dem Botulinumtoxin Typ A - Komplex eingegangen.",
    "show_ref": false
  },
  {
    "src": "The needle is only sterile on the first use.",
    "display_src": "The needle is only sterile on the first use.",
    "ref": "Die Injektionsnadel ist nur beim ersten Gebrauch steril.",
    "show_ref": false
  },
  {
    "src": "Pergoveris is not indicated if you are pregnant or are breast-feeding.",
    "display_src": "Pergoveris is not indicated if you are pregnant or are breast-feeding.",
    "ref": "Pergoveris ist nicht angzeigt, wenn Sie schwanger sind oder Ihr Kind stillen.",
    "show_ref": false
  },
  {
    "src": "No dose adjustment for either medicinal product is necessary when zidovudine is administered in combination with amprenavir.",
    "display_src": "No dose adjustment for either medicinal product is necessary when zidovudine is administered in combination with amprenavir.",
    "ref": "Eine Dosisanpassung f\u00fcr eines der Arzneimittel ist nicht erforderlich, wenn Zidovudin in Kombination mit Amprenavir angewendet wird.",
    "show_ref": false
  },
  {
    "src": "You may have problems with your bones Some people taking combination therapy for HIV develop a condition called osteonecrosis.",
    "display_src": "You may have problems with your bones Some people taking combination therapy for HIV develop a condition called osteonecrosis.",
    "ref": "M\u00f6glicherweise auftretende Probleme mit Ihren Knochen Einigen Patienten, die eine Kombinationstherapie gegen HIV erhalten, entwickeln eine so genannte Osteonekrose.",
    "show_ref": false
  },
  {
    "src": "How Vimpat is given to you Vimpat is administered as an infusion into a vein (intravenously) by a healthcare professional.",
    "display_src": "How Vimpat is given to you Vimpat is administered as an infusion into a vein (intravenously) by a healthcare professional.",
    "ref": "Vimpat wird Ihnen von medizinischem Fachpersonal als Infusion in eine Vene (intraven\u00f6s) verabreicht.",
    "show_ref": false
  },
  {
    "src": "If this change occurs, the most definitive test for anthracycline myocardial injury, i. e., endomyocardial biopsy, must be considered.",
    "display_src": "If this change occurs, the most definitive test for anthracycline myocardial injury, i. e., endomyocardial biopsy, must be considered.",
    "ref": "Wenn diese Ver\u00e4nderung auftritt, muss die Durchf\u00fchrung des aussagekr\u00e4ftigsten Tests einer Anthrazyklin-induzierten Myokard- Sch\u00e4digung, die Endomyokard-Biopsie, in Erw\u00e4gung gezogen werden.",
    "show_ref": false
  },
  {
    "src": "The doctor should check the response every four to six weeks and adjust the dose if needed.",
    "display_src": "The doctor should check the response every four to six weeks and adjust the dose if needed.",
    "ref": "Der Arzt sollte das Ansprechen auf die Behandlung alle vier bis sechs Wochen \u00fcberpr\u00fcfen und, falls erforderlich, die Dosis anpassen.",
    "show_ref": false
  },
  {
    "src": "Renal impairment: end stage renal disease (ESRD) patients receiving dialysis had a 2-fold higher duloxetine Cmax and AUC values compared to healthy subjects.",
    "display_src": "Renal impairment: end stage renal disease (ESRD) patients receiving dialysis had a 2-fold higher duloxetine Cmax and AUC values compared to healthy subjects.",
    "ref": "Dialysepflichtige Patienten mit terminaler Niereninsuffizienz hatten eine 2-fach h\u00f6here cmax und AUC von Duloxetin verglichen mit gesunden Probanden.",
    "show_ref": false
  },
  {
    "src": "Approximately 70% of patients treated with Rebif can expect to experience the typical interferon flu-like syndrome within the first six months after starting treatment.",
    "display_src": "Approximately 70% of patients treated with Rebif can expect to experience the typical interferon flu-like syndrome within the first six months after starting treatment.",
    "ref": "Bei etwa 70% der mit Rebif behandelten Patienten tritt innerhalb der ersten sechs Monate nach Behandlungsbeginn das typische durch Interferon hervorgerufene grippe\u00e4hnliche Syndrom auf.",
    "show_ref": false
  },
  {
    "src": "- black iron oxide (E 172)",
    "display_src": "- black iron oxide (E 172)",
    "ref": "- schwarzes Eisenoxid (E 172).",
    "show_ref": false
  },
  {
    "src": "Rasagiline pharmacokinetics are linear with dose over the range of 0.5-2 mg.",
    "display_src": "Rasagiline pharmacokinetics are linear with dose over the range of 0.5-2 mg.",
    "ref": "Rasagilin zeigt im Bereich von 0,5-2 mg ein Dosis-lineares pharmakokinetisches Verhalten.",
    "show_ref": false
  },
  {
    "src": "6.6 Instructions for use/ and handling, and disposal",
    "display_src": "6.6 Instructions for use/ and handling, and disposal",
    "ref": "6.6 Hinweise f\u00fcr den Gebrauch und die Handhabung und Entsorgung",
    "show_ref": false
  },
  {
    "src": "Ritonavir inhibits CYP3A, thereby increasing the plasma concentrations of darunavir considerably.",
    "display_src": "Ritonavir inhibits CYP3A, thereby increasing the plasma concentrations of darunavir considerably.",
    "ref": "Ritonavir hemmt CYP3A, was zu einem betr\u00e4chtlichen Anstieg der Darunavir-Plasmakonzentration f\u00fchrt.",
    "show_ref": false
  },
  {
    "src": "Method of administration Reconstituted Simulect can be administered as an intravenous bolus injection or as an intravenous infusion over 20\u2013 30 minutes.",
    "display_src": "Method of administration Reconstituted Simulect can be administered as an intravenous bolus injection or as an intravenous infusion over 20\u2013 30 minutes.",
    "ref": "Art der Anwendung Rekonstituiertes Simulect kann als intraven\u00f6se Bolusinjektion oder als intraven\u00f6se Infusion \u00fcber eine Dauer von 20\u2013 30 Minuten gegeben werden.",
    "show_ref": false
  },
  {
    "src": "A number of trials were carried out in both the laboratory and in the field in order to assess the efficacy of the product.",
    "display_src": "A number of trials were carried out in both the laboratory and in the field in order to assess the efficacy of the product.",
    "ref": "Um die Wirksamkeit des Produkts beurteilen zu k\u00f6nnen, wurde eine Reihe von Labor- und Feldversuchen durchgef\u00fchrt.",
    "show_ref": false
  },
  {
    "src": "\u2022 if you are allergic (hypersensitive) to palifermin\u201a any other ingredients of Kepivance, or to Escherichia coli derived proteins.",
    "display_src": "\u2022 if you are allergic (hypersensitive) to palifermin\u201a any other ingredients of Kepivance, or to Escherichia coli derived proteins.",
    "ref": "\u2022 wenn Sie \u00fcberempfindlich (allergisch) gegen Palifermin, einen der sonstigen Bestandteile von Kepivance oder aus Escherichia coli hergestellten Proteinen sind.",
    "show_ref": false
  },
  {
    "src": "In these patients an upper limit of 12 g/ dl (7.5 mmol/ l) should be aimed for, unless severe symptoms (e. g. angina) dictate otherwise.",
    "display_src": "In these patients an upper limit of 12 g/ dl (7.5 mmol/ l) should be aimed for, unless severe symptoms (e. g. angina) dictate otherwise.",
    "ref": "Ei n oberer Grenzwert von 12 g/dl (7,5 mmol/l) sollte bei diesen Patienten angestrebt werden, es sei denn, schwere Symptome, wie z.B.",
    "show_ref": false
  },
  {
    "src": "Kinzalkomb is available in blister packs containing 14, 28, 56, or 98 tablets, or unit dose blister packs containing 28 x 1 tablets",
    "display_src": "Kinzalkomb is available in blister packs containing 14, 28, 56, or 98 tablets, or unit dose blister packs containing 28 x 1 tablets",
    "ref": "Kinzalkomb steht in Blisterpackungen zu 14, 28, 56, oder 98 Tabletten, sowie in Einzeldosen- Blisterpackungen mit 28 x 1 Tablette zur Verf\u00fcgung.",
    "show_ref": false
  },
  {
    "src": "One International Unit of BeneFIX showed a mean 0.75 IU/ dl (range 0.3 to 1.4 IU/ dl) increase in the circulating level of factor IX.",
    "display_src": "One International Unit of BeneFIX showed a mean 0.75 IU/ dl (range 0.3 to 1.4 IU/ dl) increase in the circulating level of factor IX.",
    "ref": "Eine Internationale Einheit BeneFIX zeigte einen mittleren Anstieg von 0,75 I.E./dl (Streuung 0,3 - 1,4 I.E./dl) des im Blut zirkulierenden Faktor IX.",
    "show_ref": false
  },
  {
    "src": "The data provided by the applicant show that Enurace 50 is an effective medicinal product for treatment of urinary incontinence in ovariohysterectomised bitches.",
    "display_src": "The data provided by the applicant show that Enurace 50 is an effective medicinal product for treatment of urinary incontinence in ovariohysterectomised bitches.",
    "ref": "Die vom Antragsteller vorgelegten Daten belegen, dass Enurace 50 ein wirksames Arzneimittel zur Behandlung von Harninkontinenz bei H\u00fcndinnen mit erfolgter Ovariohysterektomie ist.",
    "show_ref": false
  },
  {
    "src": "What benefit has Mirapexin shown during the studies?",
    "display_src": "What benefit has Mirapexin shown during the studies?",
    "ref": "Welchen Nutzen hat Mirapexin in diesen Studien gezeigt?",
    "show_ref": false
  },
  {
    "src": "Administration of atipamezole after dexmedetomidine rapidly reverses the effects and thus shortens the recovery period.",
    "display_src": "Administration of atipamezole after dexmedetomidine rapidly reverses the effects and thus shortens the recovery period.",
    "ref": "4 Die Verabreichung von Atipamezol nach Dexmedetomidin kehrt die Wirkungen rasch um und verk\u00fcrzt so die Wiederherstellungsphase.",
    "show_ref": false
  },
  {
    "src": "Samples must be immersed in an ice/ water bath.",
    "display_src": "Samples must be immersed in an ice/ water bath.",
    "ref": "Die Proben m\u00fcssen in ein Eiswasserbad gestellt werden.",
    "show_ref": false
  },
  {
    "src": "The patient may store Fertavid at or below 25 \u00b0C for a single period of not more than 3 months.",
    "display_src": "The patient may store Fertavid at or below 25 \u00b0C for a single period of not more than 3 months.",
    "ref": "De Patient kann Fertavid einmalig f\u00fcr einen Zeitraum von maximal 3 Monaten bei oder unterhalb von 25 \u00b0C aufbewahren.",
    "show_ref": false
  },
  {
    "src": "The active substance in Docetaxel Winthrop, docetaxel, belongs to the group of anticancer medicines known as the taxanes.",
    "display_src": "The active substance in Docetaxel Winthrop, docetaxel, belongs to the group of anticancer medicines known as the taxanes.",
    "ref": "Der arzneilich wirksame Bestandteil von Docetaxel Winthrop, Docetaxel, geh\u00f6rt zu der Gruppe der Arzneimittel zur Krebstherapie, die als Taxane bezeichnet werden.",
    "show_ref": false
  },
  {
    "src": "However, the pharmacokinetic and pharmacodynamic data as well as clinical data for the use of lansoprazole in children are available in the literature.",
    "display_src": "However, the pharmacokinetic and pharmacodynamic data as well as clinical data for the use of lansoprazole in children are available in the literature.",
    "ref": "In der Literatur stehen jedoch die pharmakokinetischen und pharmakodynamischen Daten sowie klinische Daten zur Anwendung von Lansoprazol bei Kindern zur Verf\u00fcgung.",
    "show_ref": false
  },
  {
    "src": "Alcohol concentrations (mean maximum blood concentration 0.08%) were not affected by co- administration with tadalafil (10 mg or 20 mg).",
    "display_src": "Alcohol concentrations (mean maximum blood concentration 0.08%) were not affected by co- administration with tadalafil (10 mg or 20 mg).",
    "ref": "Alkohol-Konzentrationen (mittlere maximale Blutkonzentration 0,8 \u2030) wurden durch gleichzeitige Gabe von Tadalafil (10 mg oder 20 mg) nicht beeinflusst.",
    "show_ref": false
  },
  {
    "src": "Adults and children over 12 years:",
    "display_src": "Adults and children over 12 years:",
    "ref": "Erwachsene und Kinder \u00fcber 12 Jahre:",
    "show_ref": false
  },
  {
    "src": "For the treatment of kidney disease, Irbesartan BMS was studied in two large studies involving a total of 2,326 patients with type 2 diabetes.",
    "display_src": "For the treatment of kidney disease, Irbesartan BMS was studied in two large studies involving a total of 2,326 patients with type 2 diabetes.",
    "ref": "Bei Nierenerkrankung wurde Irbesartan BMS au\u00dferdem in zwei gro\u00dfen Studien an insgesamt 2 326 Patienten mit Typ-2-Diabetes untersucht.",
    "show_ref": false
  },
  {
    "src": "To prepare the PegIntron solution, insert the needle through the rubber top of the PegIntron vial and gently place the needle tip against the glass wall of the vial without touching the cleaned top of the vial with your hands.",
    "display_src": "To prepare the PegIntron solution, insert the needle through the rubber top of the PegIntron vial and gently place the needle tip against the glass wall of the vial without touching the cleaned top of the vial with your hands.",
    "ref": "Um die PegIntron-L\u00f6sung zuzubereiten, durchstechen Sie nun mit der Nadel den Gummistopfen der PegIntron-Durchstechflasche und plazieren die Nadelspitze sanft an der Glasinnenwand der Durchstechflasche, ohne dabei die gereinigte Oberseite der Durchstechflasche mit Ihren H\u00e4nden zu ber\u00fchren.",
    "show_ref": false
  },
  {
    "src": "NRTIs (nucleoside reverse transcriptase inhibitors), NNRTIs (non -nucleoside reverse transcriptase inhibitors), CCR5 antagonists and FIs (fusion inhibitors)).",
    "display_src": "NRTIs (nucleoside reverse transcriptase inhibitors), NNRTIs (non -nucleoside reverse transcriptase inhibitors), CCR5 antagonists and FIs (fusion inhibitors)).",
    "ref": "NRTIs (Nukleosidische Reverse-Transkriptasehemmer), NNRTIs (Nicht-Nukleosidische Reverse-Transkriptasehemmer), CCR5-Antagonisten und FIs (Fusionshemmer)), angewendet werden.",
    "show_ref": false
  },
  {
    "src": "If intravenous administration is impossible, naloxone hydrochloride can also be given intramuscularly or subcutaneously.",
    "display_src": "If intravenous administration is impossible, naloxone hydrochloride can also be given intramuscularly or subcutaneously.",
    "ref": "Ist eine intraven\u00f6se Verabreichung nicht m\u00f6glich, kann Naloxonhydrochlorid auch intramuskul\u00e4r oder subkutan gegeben werden.",
    "show_ref": false
  },
  {
    "src": "In a placebo-controlled study of 16 weeks duration, BYETTA (n=121) or placebo (n=112) was added to existing thiazolidinedione treatment, with or without metformin.",
    "display_src": "In a placebo-controlled study of 16 weeks duration, BYETTA (n=121) or placebo (n=112) was added to existing thiazolidinedione treatment, with or without metformin.",
    "ref": "In einer placebokontrollierten, 16-w\u00f6chigen Studie wurde BYETTA (n=121) oder Placebo (n=112) zus\u00e4tzlich zu einer bestehenden Thiazolidindionbehandlung mit oder ohne Metformin gegeben.",
    "show_ref": false
  },
  {
    "src": "1 injection needle (20 gauge) 1 hypodermic injection needle (27 gauge) 2 alcohol swabs.",
    "display_src": "1 injection needle (20 gauge) 1 hypodermic injection needle (27 gauge) 2 alcohol swabs.",
    "ref": "1 Injektionsnadel (20 Gauge) 1 Injektionsnadel zur subkutanen Injektion (27 Gauge) 2 Alkoholtupfer.",
    "show_ref": false
  },
  {
    "src": "What Kaletra looks like and contents of the pack",
    "display_src": "What Kaletra looks like and contents of the pack",
    "ref": "144 Wie Kaletra aussieht und Inhalt der Packung",
    "show_ref": false
  },
  {
    "src": "Therefore, signs of scoliosis should be monitored during treatment with somatropin.",
    "display_src": "Therefore, signs of scoliosis should be monitored during treatment with somatropin.",
    "ref": "Aus diesem Grund sollten w\u00e4hrend der Behandlung mit Somatropin Anzeichen einer Skoliose \u00fcberwacht werden.",
    "show_ref": false
  },
  {
    "src": "Exposure to darunavir was higher in HIV-1 infected patients than in healthy subjects.",
    "display_src": "Exposure to darunavir was higher in HIV-1 infected patients than in healthy subjects.",
    "ref": "Die Darunavir-Exposition war bei den HIV-infizierten Patienten h\u00f6her als bei den gesunden Probanden.",
    "show_ref": false
  },
  {
    "src": "Kidney transplantation To date there is no experience of the safe use of Copalia in patients who have had a recent kidney transplantation.",
    "display_src": "Kidney transplantation To date there is no experience of the safe use of Copalia in patients who have had a recent kidney transplantation.",
    "ref": "Nierentransplantation Bisher gibt es keine Erfahrungen zur sicheren Anwendung von Copalia bei Patienten, die vor kurzem eine Nierentransplantation hatten.",
    "show_ref": false
  },
  {
    "src": "Petechial, parenchymal, subarachnoid, subdural, and stroke with haemorrhagic transformation.",
    "display_src": "Petechial, parenchymal, subarachnoid, subdural, and stroke with haemorrhagic transformation.",
    "ref": "Petechial, parenchymal, subarachnoidal, subdural und Schlaganfall mit sekund\u00e4rer Einblutung.",
    "show_ref": false
  },
  {
    "src": "Insuman Rapid may also be administered intravenously.",
    "display_src": "Insuman Rapid may also be administered intravenously.",
    "ref": "Insuman Rapid kann auch intraven\u00f6s verabreicht werden.",
    "show_ref": false
  },
  {
    "src": "Liquid is constantly being drained out of the eye and new liquid is made to replace this.",
    "display_src": "Liquid is constantly being drained out of the eye and new liquid is made to replace this.",
    "ref": "Diese Fl\u00fcssigkeit wird st\u00e4ndig aus dem Auge abgeleitet und durch neue Fl\u00fcssigkeit ersetzt.",
    "show_ref": false
  },
  {
    "src": "In contrast to adult dogs, juvenile dogs appeared to be more sensitive to peripheral nerve lesions as compared to skeletal myopathy.",
    "display_src": "In contrast to adult dogs, juvenile dogs appeared to be more sensitive to peripheral nerve lesions as compared to skeletal myopathy.",
    "ref": "Im Gegensatz zu erwachsenen Hunden schienen juvenile Hunde f\u00fcr L\u00e4sionen der peripheren Nerven anf\u00e4lliger zu sein als f\u00fcr Skelettmyopathie.",
    "show_ref": false
  },
  {
    "src": "Abseamed 8000 IU/ 0.8 ml solution for injection in a pre-filled syringe",
    "display_src": "Abseamed 8000 IU/ 0.8 ml solution for injection in a pre-filled syringe",
    "ref": "Abseamed 8000 I.E./0,8 ml Injektionsl\u00f6sung in einer Fertigspritze",
    "show_ref": false
  },
  {
    "src": "Dosage adjustments of statins may be required (refer to the Summary of Product Characteristics for the statin).",
    "display_src": "Dosage adjustments of statins may be required (refer to the Summary of Product Characteristics for the statin).",
    "ref": "Anpassungen der Statindosis k\u00f6nnen notwendig werden (siehe Zusammenfassung der Merkmale des Arzneimittels f\u00fcr das",
    "show_ref": false
  },
  {
    "src": "Dose adjustment of warfarin may be required.",
    "display_src": "Dose adjustment of warfarin may be required.",
    "ref": "Dosisanpassung von Warfarin kann erforderlich sein.",
    "show_ref": false
  },
  {
    "src": "A value below 1 in combination with a P value below 0.025 indicates superiority of len/dex over placebo/dex b:",
    "display_src": "A value below 1 in combination with a P value below 0.025 indicates superiority of len/dex over placebo/dex b:",
    "ref": "Ein Wert unter 1 in Kombination mit einem p-Wert unter 0,025 zeigt die \u00dcberlegenheit von Len/Dex \u00fcber Placebo/Dex. b:",
    "show_ref": false
  },
  {
    "src": "- The active substance is daptomycin.",
    "display_src": "- The active substance is daptomycin.",
    "ref": "- Der Wirkstoff ist Daptomycin.",
    "show_ref": false
  },
  {
    "src": "Interactions between the individual components of Atripla and other medicinal products",
    "display_src": "Interactions between the individual components of Atripla and other medicinal products",
    "ref": "Wechselwirkungen zwischen den einzelnen Bestandteilen von Atripla und anderen Arzneimitteln",
    "show_ref": false
  },
  {
    "src": "Package containing one or four pre-filled pens of a 10 \u00b5g Aranesp solution for injection in 0.4 ml (25 \u00b5g/ ml).",
    "display_src": "Package containing one or four pre-filled pens of a 10 \u00b5g Aranesp solution for injection in 0.4 ml (25 \u00b5g/ ml).",
    "ref": "Eine Packung enth\u00e4lt einen bzw. vier vorgef\u00fcllte(n) Injektor(en) mit 10 \u03bc g Aranesp Injektionsl\u00f6sung in 0,4 ml (25 \u00b5g/ml).",
    "show_ref": false
  },
  {
    "src": "The concomitant systemic administration of phenytoin to patients receiving high-dose busulfan has been reported to increase busulfan clearance, due to induction of glutathion-S-transferase.",
    "display_src": "The concomitant systemic administration of phenytoin to patients receiving high-dose busulfan has been reported to increase busulfan clearance, due to induction of glutathion-S-transferase.",
    "ref": "Es wurde berichtet, dass m\u00f6glicherweise aufgrund der Induktion der Glutathion-S-Transferase die gleichzeitige systemische Gabe von Phenytoin bei Patienten, die Busulfan hochdosiert erhielten, die Busulfan-Clearance erh\u00f6hte.",
    "show_ref": false
  },
  {
    "src": "Therefore, in patients with renal impairment tenofovir disoproxil fumarate should only be used if the potential benefits of treatment are considered to outweigh the potential risks.",
    "display_src": "Therefore, in patients with renal impairment tenofovir disoproxil fumarate should only be used if the potential benefits of treatment are considered to outweigh the potential risks.",
    "ref": "Tenofovirdisoproxilfumarat sollte deshalb bei Patienten mit Nierenfunktionsst\u00f6rung nur eingesetzt werden, wenn der m\u00f6gliche Nutzen der Behandlung das m\u00f6gliche Risiko \u00fcberwiegt.",
    "show_ref": false
  },
  {
    "src": "a) 5.6.1997 b) 23.2.1998 c) OJ L 53, 24.2.1998",
    "display_src": "a) 5.6.1997 b) 23.2.1998 c) OJ L 53, 24.2.1998",
    "ref": "a) 05.06.97 b) 23.02.98 c) OJ L 53, 24.2.1998",
    "show_ref": false
  },
  {
    "src": "The full EPAR for Tasigna can be found here.",
    "display_src": "The full EPAR for Tasigna can be found here.",
    "ref": "Den vollst\u00e4ndigen Wortlaut des EPAR f\u00fcr Tasigna finden Sie hier.",
    "show_ref": false
  },
  {
    "src": "VFEND should not be used in people who may be hypersensitive (allergic) to voriconazole or any of the other ingredients.",
    "display_src": "VFEND should not be used in people who may be hypersensitive (allergic) to voriconazole or any of the other ingredients.",
    "ref": "VFEND darf nicht bei Patienten angewendet werden, die m\u00f6glicherweise \u00fcberempfindlich (allergisch) gegen\u00fcber Voriconazol oder einem der sonstigen Bestandteile sind.",
    "show_ref": false
  },
  {
    "src": "If VIAGRA is taken with food, the onset of activity may be delayed compared to the fasted state (see section 5.2).",
    "display_src": "If VIAGRA is taken with food, the onset of activity may be delayed compared to the fasted state (see section 5.2).",
    "ref": "Wenn VIAGRA zusammen mit Nahrung eingenommen wird, kann der Wirkungseintritt im Vergleich zur N\u00fcchterneinnahme verz\u00f6gert sein (siehe Abschnitt 5.2).",
    "show_ref": false
  },
  {
    "src": "which is an ester, theoretically corresponds to maximally 5.9 mg of sucrose when fully hydrolysed.",
    "display_src": "which is an ester, theoretically corresponds to maximally 5.9 mg of sucrose when fully hydrolysed.",
    "ref": "Sucrosemonopalmitat, eine Esterverbindung, entsprechen theoretisch, wenn vollst\u00e4ndig aufgel\u00f6st, maximal 5,9 mg Sucrose (Saccharose).",
    "show_ref": false
  },
  {
    "src": "Other in vitro tests for detection of gene mutation did not demonstrate genotoxic activity.",
    "display_src": "Other in vitro tests for detection of gene mutation did not demonstrate genotoxic activity.",
    "ref": "Andere In-vitro-Untersuchungen zur Detektion von Genmutationen ergaben keinen Hinweis auf Genotoxizit\u00e4t.",
    "show_ref": false
  },
  {
    "src": "- if you are allergic (hypersensitive) to rivaroxaban or any of the other ingredients of Xarelto.",
    "display_src": "- if you are allergic (hypersensitive) to rivaroxaban or any of the other ingredients of Xarelto.",
    "ref": "- wenn Sie \u00fcberempfindlich (allergisch) gegen Rivaroxaban oder einen der sonstigen",
    "show_ref": false
  },
  {
    "src": "This medicinal product should be administered by a healthcare professional and under appropriate medical supervision.",
    "display_src": "This medicinal product should be administered by a healthcare professional and under appropriate medical supervision.",
    "ref": "Dieses Arzneimittel muss von medizinischem Fachpersonal verabreicht werden und unter angemesse- ner \u00e4rztlicher Aufsicht.",
    "show_ref": false
  },
  {
    "src": "Before you administer Cetrotide yourself, please read the following instructions carefully",
    "display_src": "Before you administer Cetrotide yourself, please read the following instructions carefully",
    "ref": "Bevor Sie sich Cetrotide selbst verabreichen, lesen Sie bitte sorgf\u00e4ltig die nachfolgenden Anleitungen",
    "show_ref": false
  },
  {
    "src": "Gadovist should not be prepared until immediately before use.",
    "display_src": "Gadovist should not be prepared until immediately before use.",
    "ref": "Gadovist erst unmittelbar vor der Anwendung vorbereiten.",
    "show_ref": false
  },
  {
    "src": "In particular, sildenafil has greater than 4,000-fold selectivity for PDE5 over PDE3, the cAMP-specific phosphodiesterase isoform involved in the control of cardiac contractility.",
    "display_src": "In particular, sildenafil has greater than 4,000-fold selectivity for PDE5 over PDE3, the cAMP-specific phosphodiesterase isoform involved in the control of cardiac contractility.",
    "ref": "Insbesondere hat Sildenafil eine mehr als 4.000fach h\u00f6here Selektivit\u00e4t f\u00fcr PDE5 im Vergleich zu PDE3, dem an der Steuerung der kardialen Kontraktilit\u00e4t beteiligten, cAMP-spezifischen Phosphodiesterase-Isoenzym.",
    "show_ref": false
  },
  {
    "src": "(44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu \u00a9EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged How has Inovelon been studied?",
    "display_src": "(44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu \u00a9EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged How has Inovelon been studied?",
    "ref": "(44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea.europa.eu http://www.emea.europa.eu \u00a9EMEA 2007 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged der Zellen steuern.",
    "show_ref": false
  },
  {
    "src": "ge Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 2",
    "display_src": "ge Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 2",
    "ref": "zu Haemophilus influenzae Typ b Polysaccharid (Polyribosylribitolphosphat)2",
    "show_ref": false
  },
  {
    "src": "By blocking the protein Yarvitan decreases the absorption of fats from the gut.",
    "display_src": "By blocking the protein Yarvitan decreases the absorption of fats from the gut.",
    "ref": "Durch die Blockade des Eiwei\u00dfstoffs verringert Yarvitan die Resorption von Fetten aus dem Darm.",
    "show_ref": false
  },
  {
    "src": "These parameters return to normal in the week following the last injection. \u2022 transient fatigue during the treatment, in cats only.",
    "display_src": "These parameters return to normal in the week following the last injection. \u2022 transient fatigue during the treatment, in cats only.",
    "ref": "Diese Parameter normalisieren sich innerhalb einer Woche nach der letzten Injektion. \u2022 Vor\u00fcbergehende M\u00fcdigkeit w\u00e4hrend der Behandlung, ausschlie\u00dflich bei Katzen.",
    "show_ref": false
  },
  {
    "src": "\u2022 CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT no",
    "display_src": "\u2022 CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT no",
    "ref": "\u2022 BEDINGUNGEN ODER EINSCHR\u00c4NKUNGEN HINSICHTLICH DER SICHEREN UND WIRKSAMEN ANWENDUNG DES ARZNEIMITTELS ni",
    "show_ref": false
  },
  {
    "src": "COX is a key enzyme in pathways of arachidonic acid metabolism.",
    "display_src": "COX is a key enzyme in pathways of arachidonic acid metabolism.",
    "ref": "COX ist ein Schl\u00fcsselenzym des Arachidons\u00e4uremetabolismus.",
    "show_ref": false
  },
  {
    "src": "Nonafact is used to replace the missing factor IX, it corrects the factor IX deficiency and gives temporary control of the bleeding disorder.",
    "display_src": "Nonafact is used to replace the missing factor IX, it corrects the factor IX deficiency and gives temporary control of the bleeding disorder.",
    "ref": "Nonafact wird verwendet, um den fehlenden Faktor IX zu ersetzen; es korrigiert den Faktor IX-Mangel und erm\u00f6glicht eine vor\u00fcbergehende Kontrolle der Blutungsst\u00f6rung.",
    "show_ref": false
  },
  {
    "src": "Saquinavir AUC \u2191 82% (90% CI 44-131%) Saquinavir Cmax \u2191 75% (90% CI 38-123%) Ritonavir \u2194",
    "display_src": "Saquinavir AUC \u2191 82% (90% CI 44-131%) Saquinavir Cmax \u2191 75% (90% CI 38-123%) Ritonavir \u2194",
    "ref": "Saquinavir AUC \u2191 82% (90% CI 44 - 131%) Saquinavir Cmax \u2191 75% (90% CI 38 - 123%) Ritonavir \u2194",
    "show_ref": false
  },
  {
    "src": "REYATAZ/ ritonavir should not be used in combination with medicinal products that are substrates of CYP3A4 and have a narrow therapeutic index.",
    "display_src": "REYATAZ/ ritonavir should not be used in combination with medicinal products that are substrates of CYP3A4 and have a narrow therapeutic index.",
    "ref": "REYATAZ/Ritonavir darf nicht in Kombination mit Arzneimitteln verwendet werden, die ein Substrat von CYP3A4 sind und eine enge therapeutische Breite haben.",
    "show_ref": false
  },
  {
    "src": "The partnership between the EMEA, national authorities and the European Union institutions is central to the successful functioning of the European authorisation procedure.",
    "display_src": "The partnership between the EMEA, national authorities and the European Union institutions is central to the successful functioning of the European authorisation procedure.",
    "ref": "Die Partnerschaft zwischen der EMEA, den nationalen Beh\u00f6rden und den Institutionen der Europ\u00e4ischen Union ist die wichtigste Voraussetzung f\u00fcr eine erfolgreiche Anwendung des europ\u00e4ischen Zulassungsverfahrens.",
    "show_ref": false
  },
  {
    "src": "- blue, with number \u201c 4\u201d (treatment days 19, 21 and 23; 0.25, 0.5, 0.75 and 1-ml syringe",
    "display_src": "- blue, with number \u201c 4\u201d (treatment days 19, 21 and 23; 0.25, 0.5, 0.75 and 1-ml syringe",
    "ref": "- blau, mit der Zahl \u201e 4\u201d (Behandlungstage 19, 21 und 23; 0,25-, 0,5-, 0,75- und 1-ml",
    "show_ref": false
  },
  {
    "src": "Mean change in visual acuity from baseline to month 24 in study FVF3192g (PIER)",
    "display_src": "Mean change in visual acuity from baseline to month 24 in study FVF3192g (PIER)",
    "ref": "Durchschnittliche Ver\u00e4nderung des Visus vom Ausgangswert im Laufe von 24 Monaten in der Studie FVF3192g (PIER)",
    "show_ref": false
  },
  {
    "src": "If the dog requires shampooing, it is better to do so before applying the veterinary medicinal product.",
    "display_src": "If the dog requires shampooing, it is better to do so before applying the veterinary medicinal product.",
    "ref": "Es ist besser den Hund zu shampoonieren, falls das erforderlich ist, bevor das Tierarzneimittel aufgetragen wird.",
    "show_ref": false
  },
  {
    "src": "This may be the case during total parenteral nutrition and severe malabsorption disorders.",
    "display_src": "This may be the case during total parenteral nutrition and severe malabsorption disorders.",
    "ref": "Dies kann bei vollst\u00e4ndiger parenteraler Ern\u00e4hrung und schweren Malabsorptionsst\u00f6rungen der Fall sein.",
    "show_ref": false
  },
  {
    "src": "Pre-treatment with other anti-inflammatory substances may result in additional or increased adverse effects.",
    "display_src": "Pre-treatment with other anti-inflammatory substances may result in additional or increased adverse effects.",
    "ref": "Eine Vorbehandlung mit anderen Antiphlogistika kann zu zus\u00e4tzlichen oder verst\u00e4rkten Nebenwirkungen f\u00fchren.",
    "show_ref": false
  },
  {
    "src": "In controlled clinical trials, maximum metformin plasma levels (Cmax) did not exceed 4 \u00b5g/ml, even at maximum doses.",
    "display_src": "In controlled clinical trials, maximum metformin plasma levels (Cmax) did not exceed 4 \u00b5g/ml, even at maximum doses.",
    "ref": "In kontrollierten klinischen Studien lagen die maximalen Metformin-Plasmaspiegel (Cmax) auch unter maximalen Dosen nicht \u00fcber 4 \u00b5g/ml.",
    "show_ref": false
  },
  {
    "src": "Sorafenib therapy should be discontinued (see section 4.8).",
    "display_src": "Sorafenib therapy should be discontinued (see section 4.8).",
    "ref": "Die Sorafenib- Behandlung ist zu unterbrechen (siehe Abschnitt 4.8).",
    "show_ref": false
  },
  {
    "src": "Treatment is continued for two to three weeks after the operation.",
    "display_src": "Treatment is continued for two to three weeks after the operation.",
    "ref": "Die Behandlung wird nach der Operation zwei bis drei Wochen lang fortgesetzt.",
    "show_ref": false
  },
  {
    "src": "Parareg should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.",
    "display_src": "Parareg should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.",
    "ref": "Parareg sollte w\u00e4hrend der Schwangerschaft nur angewendet werden, wenn der potentielle Nutzen das potentielle Risiko f\u00fcr den Fetus rechtfertigt.",
    "show_ref": false
  },
  {
    "src": "Patients should be under close medical supervision during the Visudyne infusion.",
    "display_src": "Patients should be under close medical supervision during the Visudyne infusion.",
    "ref": "Patienten sollten w\u00e4hrend der Visudyne-Infusion engmaschig medizinisch \u00fcberwacht werden.",
    "show_ref": false
  },
  {
    "src": "2 mg dispersible/ chewable tablets - where this is the lowest marketed strength: < * If the calculated daily dose in patients taking valproate is 1 mg or more but less than 2 mg, then Lamictal 2 mg dispersible/ chewable tablets may be taken on alternate days for the first two weeks.",
    "display_src": "2 mg dispersible/ chewable tablets - where this is the lowest marketed strength: < * If the calculated daily dose in patients taking valproate is 1 mg or more but less than 2 mg, then Lamictal 2 mg dispersible/ chewable tablets may be taken on alternate days for the first two weeks.",
    "ref": "Kautabletten \u2013 wo dies die niedrigste vertriebene Wirkst\u00e4rke ist: < * Wenn die berechnete Tagesdosis bei Patienten, die Valproat einnehmen, 1 mg oder mehr, aber weniger als 2 mg betr\u00e4gt, k\u00f6nnen die Lamictal 2 mg Tabletten zur Herstellung einer Suspension zum Einnehmen bzw.",
    "show_ref": false
  },
  {
    "src": "Interaction studies with these agents have only been performed in adults.",
    "display_src": "Interaction studies with these agents have only been performed in adults.",
    "ref": "Wechselwirkungsstudien mit diesen Wirkstoffen wurden nur bei Erwachsenen durchgef\u00fchrt.",
    "show_ref": false
  },
  {
    "src": "There was no significant difference in any of these parameters over time up to 6 months after transplantation.",
    "display_src": "There was no significant difference in any of these parameters over time up to 6 months after transplantation.",
    "ref": "Es wurden keine signifikanten \u00c4nderungen dieser Parameter \u00fcber einen Zeitraum von 6 Monaten nach der Transplantation festgestellt.",
    "show_ref": false
  },
  {
    "src": "26 Treatment of symptomatic anaemia in adult and paediatric chronic renal failure patients:",
    "display_src": "26 Treatment of symptomatic anaemia in adult and paediatric chronic renal failure patients:",
    "ref": "29 Behandlung der symptomatischen An\u00e4mie bei erwachsenen Patienten und Kindern mit chronischer Nierenerkrankung:",
    "show_ref": false
  },
  {
    "src": "In clinical trials, selevamer has been shown to be effective in reducing serum phosphorus in patients receiving haemodialysis or peritoneal dialysis.",
    "display_src": "In clinical trials, selevamer has been shown to be effective in reducing serum phosphorus in patients receiving haemodialysis or peritoneal dialysis.",
    "ref": "In klinischen Studien erwies sich Sevelamer als wirksam zur Senkung des Serumphosphatspiegels bei Patienten, die eine H\u00e4modialyse oder eine Peritonealdialyse erhalten.",
    "show_ref": false
  },
  {
    "src": "Pediatric use There is no relevant indication for use of Fareston in children.",
    "display_src": "Pediatric use There is no relevant indication for use of Fareston in children.",
    "ref": "P\u00e4diatrische Anwendung Es gibt keine relevante Indikation f\u00fcr den Einsatz von Fareston bei Kindern.",
    "show_ref": false
  },
  {
    "src": "In assisted reproductive techniques, there is an increased risk of OHSS with a serum estradiol > 3000 pg/ ml (11000 pmol/ l) and 20 or more follicles of 12 mm or more in diameter.",
    "display_src": "In assisted reproductive techniques, there is an increased risk of OHSS with a serum estradiol > 3000 pg/ ml (11000 pmol/ l) and 20 or more follicles of 12 mm or more in diameter.",
    "ref": "Bei assistierten Reproduktionstechniken besteht ein h\u00f6heres Risiko der Entwicklung eines OHSS, wenn Serum\u00f6stradiolspiegel h\u00f6her als 3000 pg/ml (11000 pmol/l) und 20 oder mehr Follikel mit einem Durchmesser von 12 mm oder mehr vorliegen.",
    "show_ref": false
  },
  {
    "src": "Tumour types included were Ewing's Sarcoma/ primitive neuroectodermal tumour, neuroblastoma, osteoblastoma, and rhabdomyosarcoma.",
    "display_src": "Tumour types included were Ewing's Sarcoma/ primitive neuroectodermal tumour, neuroblastoma, osteoblastoma, and rhabdomyosarcoma.",
    "ref": "Die Tumorentit\u00e4ten beinhalteten Ewing-Sarkom/primitiver neuroektodermaler Tumor, Neuroblastom, Osteoblastom und Rhabdomyosarkom.",
    "show_ref": false
  },
  {
    "src": "100% (95% CI: - 1858.0;100), 100% (95% CI:",
    "display_src": "100% (95% CI: - 1858.0;100), 100% (95% CI:",
    "ref": "100% (95% KI: -1858,0;100), 100% (95% KI:",
    "show_ref": false
  },
  {
    "src": "To avoid injection of air and ensure proper dosing: \u2022 Hold Mixtard 50 NovoLet with the needle pointing upwards \u2022 Tap the cartridge gently with your finger a few times.",
    "display_src": "To avoid injection of air and ensure proper dosing: \u2022 Hold Mixtard 50 NovoLet with the needle pointing upwards \u2022 Tap the cartridge gently with your finger a few times.",
    "ref": "Gehen Sie folgenderma\u00dfen vor, um die Injektion von Luft zu vermeiden und eine korrekte Dosierung sicherzustellen: \u2022 Halten Sie Mixtard 50 NovoLet mit der Injektionsnadel nach oben \u2022 Klopfen Sie ein paar Mal mit dem Finger leicht gegen die Patrone.",
    "show_ref": false
  },
  {
    "src": "Take paracetamol or ibuprofen half an hour before your Avonex injection and continue taking it for up to a day.",
    "display_src": "Take paracetamol or ibuprofen half an hour before your Avonex injection and continue taking it for up to a day.",
    "ref": "Nehmen Sie eine halbe Stunde vor Ihrer Avonex-Injektion Paracetamol oder Ibuprofen und nehmen Sie es bis zu einem Tag lang weiter.",
    "show_ref": false
  },
  {
    "src": "To maintain the immunity, a single injection of one dose should be carried out 2 \u2013 4 weeks before each subsequent farrowing.",
    "display_src": "To maintain the immunity, a single injection of one dose should be carried out 2 \u2013 4 weeks before each subsequent farrowing.",
    "ref": "Zur Aufrechterhaltung der Immunit\u00e4t sollte eine einmalige Impfung mit einer Dosis 2 \u2013 4 Wochen vor jedem folgenden Abferkeln durchgef\u00fchrt werden.",
    "show_ref": false
  },
  {
    "src": "Why has Corlentor been approved?",
    "display_src": "Why has Corlentor been approved?",
    "ref": "Warum wurde Corlentor zugelassen?",
    "show_ref": false
  },
  {
    "src": "Each tablet of Karvezide 300 mg/ 12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide.",
    "display_src": "Each tablet of Karvezide 300 mg/ 12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide.",
    "ref": "Jede Tablette Karvezide 300 mg/12,5 mg enth\u00e4lt 300 mg Irbesartan und 12,5 mg Hydrochlorothiazid.",
    "show_ref": false
  },
  {
    "src": "There are no data with CELVAPAN using the subcutaneous route.",
    "display_src": "There are no data with CELVAPAN using the subcutaneous route.",
    "ref": "Es liegen keine Daten zur subkutanen Verabreichung von CELVAPAN vor.",
    "show_ref": false
  },
  {
    "src": "What solvent vial contains 13% (w/ w) ethanol 95% in water for injections.",
    "display_src": "What solvent vial contains 13% (w/ w) ethanol 95% in water for injections.",
    "ref": "Was die L\u00f6sungsmittel-Durchstechflasche enth\u00e4lt 13 Gew.-% Ethanol 95% in Wasser f\u00fcr Injektionszwecke",
    "show_ref": false
  },
  {
    "src": "The treated area can be covered with a sterile bandage or gauze dressing.",
    "display_src": "The treated area can be covered with a sterile bandage or gauze dressing.",
    "ref": "Die behandelte Hautfl\u00e4che kann mit einem sterilen Verband oder einem Gazeverband abgedeckt werden.",
    "show_ref": false
  },
  {
    "src": "Groups of 4 animals (2 male and 2 female) were slaughtered at 1, 7, 14, 21, and 36 days after the final injection.",
    "display_src": "Groups of 4 animals (2 male and 2 female) were slaughtered at 1, 7, 14, 21, and 36 days after the final injection.",
    "ref": "Gruppen von je 4 Tieren (2 m\u00e4nnliche und 2 weibliche Tiere) wurden 1, 7, 14, 21 und 36 Tage nach der letzten Injektion geschlachtet.",
    "show_ref": false
  },
  {
    "src": "In a second study, mice were administered zidovudine at doses up to 40 mg/ kg for 24 months, with exposure beginning prenatally on gestation day 10.",
    "display_src": "In a second study, mice were administered zidovudine at doses up to 40 mg/ kg for 24 months, with exposure beginning prenatally on gestation day 10.",
    "ref": "In einer zweiten Studie wurde Zidovudin 24 Monate lang in Dosen bis zu 40 mg/kg an M\u00e4use verabreicht, wobei die Verabreichung am 10.",
    "show_ref": false
  },
  {
    "src": "Abnormal laboratory values for liver Change in sense of smell, numbness in mouth or lips, impaired hearing Cold sweat, rash Decrease in blood pressure upon standing Decreased or loss of consciousness Disorientation Feeling of coldness in hands and legs Hives, allergic skin reaction Impotence Inflammation of pancreas or intestine Loss of memory Throat tightness",
    "display_src": "Abnormal laboratory values for liver Change in sense of smell, numbness in mouth or lips, impaired hearing Cold sweat, rash Decrease in blood pressure upon standing Decreased or loss of consciousness Disorientation Feeling of coldness in hands and legs Hives, allergic skin reaction Impotence Inflammation of pancreas or intestine Loss of memory Throat tightness",
    "ref": "Anormale Laborwerte f\u00fcr die Leber Ver\u00e4ndertes Geruchsempfinden, Taubheit an Mund oder Lippen, eingeschr\u00e4nktes H\u00f6rverm\u00f6gen Kalter Schwei\u00df, Ausschlag Abfallender Blutdruck beim Stehen Schwinden oder Verlust des Bewusstseins Desorientiertheit K\u00e4ltegef\u00fchl in H\u00e4nden und Beinen Nesselausschlag, allergische Hautreaktion Impotenz Entz\u00fcndung von Bauchspeicheldr\u00fcse oder Darm Ged\u00e4chtnisverlust Engegef\u00fchl im Rachen",
    "show_ref": false
  },
  {
    "src": "Corlentor 5 mg film-coated tablets ivabradine",
    "display_src": "Corlentor 5 mg film-coated tablets ivabradine",
    "ref": "Corlentor 5 mg Filmtabletten Ivabradin",
    "show_ref": false
  },
  {
    "src": "Sirolimus: in renal transplant patients, concomitant administration of CellCept and CsA resulted in reduced MPA exposures by 30-50% compared with patients receiving the combination of sirolimus and similar doses of CellCept (see also section 4.4).",
    "display_src": "Sirolimus: in renal transplant patients, concomitant administration of CellCept and CsA resulted in reduced MPA exposures by 30-50% compared with patients receiving the combination of sirolimus and similar doses of CellCept (see also section 4.4).",
    "ref": "Bei Nierentransplantationspatienten f\u00fchrte die gleichzeitige Verabreichung von CellCept und CsA zu einem Abfall der MPA-Exposition um 30 - 50% im Vergleich zu Patienten, welche die Kombination Sirolimus und vergleichbare Dosen von CellCept erhielten (siehe auch Abschnitt 4.4).",
    "show_ref": false
  },
  {
    "src": "Your doctor will tell you when you can stop using Filgrastim HEXAL.",
    "display_src": "Your doctor will tell you when you can stop using Filgrastim HEXAL.",
    "ref": "Ihr Arzt wird Ihnen mitteilen, wann Sie die Anwendung von Filgrastim HEXAL beenden k\u00f6nnen.",
    "show_ref": false
  },
  {
    "src": "- The active substance of Tarceva is erlotinib.",
    "display_src": "- The active substance of Tarceva is erlotinib.",
    "ref": "- Der Wirkstoff von Tarceva ist Erlotinib.",
    "show_ref": false
  },
  {
    "src": "Metacam 1 mg chewable tablets for dogs Meloxicam",
    "display_src": "Metacam 1 mg chewable tablets for dogs Meloxicam",
    "ref": "Metacam 1 mg Kautabletten f\u00fcr Hunde Meloxicam",
    "show_ref": false
  },
  {
    "src": "Administration of ramipril to patients with hypertension leads to a reduction in supine and standing blood pressure without a compensatory rise in heart rate.",
    "display_src": "Administration of ramipril to patients with hypertension leads to a reduction in supine and standing blood pressure without a compensatory rise in heart rate.",
    "ref": "Die Gabe von Ramipril f\u00fchrt bei Patienten mit Hypertonie zu einer Senkung des Blutdrucks im Liegen und im Stehen, ohne dass die Herzfrequenz kompensatorisch ansteigt.",
    "show_ref": false
  },
  {
    "src": "RoActemra is not recommended for use in children or adolescents under 18 years of age.",
    "display_src": "RoActemra is not recommended for use in children or adolescents under 18 years of age.",
    "ref": "RoActemra wird nicht f\u00fcr die Behandlung von Kindern und Jugendlichen unter 18 Jahren empfohlen.",
    "show_ref": false
  },
  {
    "src": "10 mg loratadine + 240 mg pseudoephedri ne",
    "display_src": "10 mg loratadine + 240 mg pseudoephedri ne",
    "ref": "10 mg loratadine + 240 mg pseudoeph edrine",
    "show_ref": false
  },
  {
    "src": "HDPE bottles of 100 or 300 tablets.",
    "display_src": "HDPE bottles of 100 or 300 tablets.",
    "ref": "HDPE Flaschen mit 100 oder 300 Tabletten.",
    "show_ref": false
  },
  {
    "src": "The most common side effect with Biograstim (seen in more than 1 patient in 10) is musculoskeletal pain (pain in the muscles and bones).",
    "display_src": "The most common side effect with Biograstim (seen in more than 1 patient in 10) is musculoskeletal pain (pain in the muscles and bones).",
    "ref": "Die h\u00e4ufigste Nebenwirkung von Biograstim (beobachtet bei mehr als 1 von 10 Patienten) sind Schmerzen des Bewegungsapparates (Schmerzen in den Muskeln und Knochen).",
    "show_ref": false
  },
  {
    "src": "If you forget to take NovoNorm",
    "display_src": "If you forget to take NovoNorm",
    "ref": "Wenn Sie die Einnahme von NovoNorm vergessen haben",
    "show_ref": false
  },
  {
    "src": "A total of 174 patients received dasatinib 70 mg twice daily (161 resistant and 13 intolerant to imatinib).",
    "display_src": "A total of 174 patients received dasatinib 70 mg twice daily (161 resistant and 13 intolerant to imatinib).",
    "ref": "Insgesamt erhielten 174 Patienten zweimal t\u00e4glich 70 mg Dasatinib (161 resistent und 13 intolerant gegen\u00fcber Imatinib).",
    "show_ref": false
  },
  {
    "src": "RotaTeq is an oral vaccine that helps protect infants and young children against gastroenteritis (diarrhoea and vomiting) caused by rotavirus infection.",
    "display_src": "RotaTeq is an oral vaccine that helps protect infants and young children against gastroenteritis (diarrhoea and vomiting) caused by rotavirus infection.",
    "ref": "RotaTeq ist ein Schluckimpfstoff, der hilft, S\u00e4uglinge und Kleinkinder vor Gastroenteritis (Durchfall und Erbrechen), ausgel\u00f6st durch eine Infektion mit Rotaviren, zu sch\u00fctzen.",
    "show_ref": false
  },
  {
    "src": "If you suffer from Fabry disease a fat substance, called globotriaosylceramide (GL-3), is not removed from the cells of your body and starts to accumulate in the walls of the blood vessels of your organs.",
    "display_src": "If you suffer from Fabry disease a fat substance, called globotriaosylceramide (GL-3), is not removed from the cells of your body and starts to accumulate in the walls of the blood vessels of your organs.",
    "ref": "Wenn Sie an Morbus Fabry leiden, wird eine Fettsubstanz, das sogenannte Globotriaosylceramid (GL-3), nicht aus den K\u00f6rperzellen entfernt und reichert sich in den Blutgef\u00e4\u00dfw\u00e4nden der Organe an.",
    "show_ref": false
  },
  {
    "src": "24 hours when stored below 25\u00b0C and protected from light.",
    "display_src": "24 hours when stored below 25\u00b0C and protected from light.",
    "ref": "24 Stunden, wenn es unter 25 \u00b0C und vor Licht gesch\u00fctzt gelagert wird.",
    "show_ref": false
  },
  {
    "src": "Co-administration of ribavirin and didanosine is not recommended.",
    "display_src": "Co-administration of ribavirin and didanosine is not recommended.",
    "ref": "Die gleichzeitige Anwendung von Ribavirin und Didanosin wird nicht empfohlen.",
    "show_ref": false
  },
  {
    "src": "Liver transplant recipients: there are limited data on efficacy and safety of entecavir in liver transplant recipients.",
    "display_src": "Liver transplant recipients: there are limited data on efficacy and safety of entecavir in liver transplant recipients.",
    "ref": "Die Datenlage zur Wirksamkeit und Sicherheit von Entecavir bei Lebertransplantatempf\u00e4ngern ist begrenzt.",
    "show_ref": false
  },
  {
    "src": "Liprolog KwikPen takes effect rapidly and has a shorter duration of activity (2 to 5 hours) given subcutaneously as compared with regular insulin.",
    "display_src": "Liprolog KwikPen takes effect rapidly and has a shorter duration of activity (2 to 5 hours) given subcutaneously as compared with regular insulin.",
    "ref": "Liprolog KwikPen ist, verglichen mit Normalinsulin, bei subkutaner Anwendung ein Pr\u00e4parat mit rascherem Wirkungseintritt und k\u00fcrzerer Wirkdauer (2 bis 5 Stunden).",
    "show_ref": false
  },
  {
    "src": "56 x 1 tablets PVC/ PVDC/ Aluminium perforated unit dose blisters",
    "display_src": "56 x 1 tablets PVC/ PVDC/ Aluminium perforated unit dose blisters",
    "ref": "56 x 1 Tabletten PVC/PVDC/Aluminium, perforierter Blister zur Abgabe von Einzeldosen",
    "show_ref": false
  },
  {
    "src": "The following table provides a guide for factor VIII minimum blood levels.",
    "display_src": "The following table provides a guide for factor VIII minimum blood levels.",
    "ref": "Die folgende Tabelle enth\u00e4lt Richtwerte f\u00fcr minimale Faktor VIII-Blutspiegel.",
    "show_ref": false
  },
  {
    "src": "SevoFlo should be administered via a vaporiser specifically calibrated for use with sevoflurane so that the concentration delivered can be accurately controlled.",
    "display_src": "SevoFlo should be administered via a vaporiser specifically calibrated for use with sevoflurane so that the concentration delivered can be accurately controlled.",
    "ref": "SevoFlo soll mit einem Verdampfer verabreicht werden, der speziell f\u00fcr Sevofluran geeicht ist, damit die verabreichte Konzentration genau kontrolliert werden kann.",
    "show_ref": false
  },
  {
    "src": "DUKORAL suspension Oral use.",
    "display_src": "DUKORAL suspension Oral use.",
    "ref": "DUKORAL Suspension Zum Einnehmen.",
    "show_ref": false
  },
  {
    "src": "Lysodren 500 mg tablets Mitotane",
    "display_src": "Lysodren 500 mg tablets Mitotane",
    "ref": "Lysodren 500 mg Tabletten Mitotan",
    "show_ref": false
  },
  {
    "src": "After single oral administration of radiolabeled pimecrolimus in healthy subjects, unchanged pimecrolimus was the major active substance-related component in blood and there were numerous minor metabolites of moderate polarity that appeared to be products of O-demethylations and oxygenation.",
    "display_src": "After single oral administration of radiolabeled pimecrolimus in healthy subjects, unchanged pimecrolimus was the major active substance-related component in blood and there were numerous minor metabolites of moderate polarity that appeared to be products of O-demethylations and oxygenation.",
    "ref": "Nach oraler Gabe einer Einzel-Dosis von radioaktiv markiertem Pimecrolimus an gesunde Probanden war nicht-verstoffwechseltes Pimecrolimus die haupts\u00e4chlich im Blut vorkommende und vom Wirkstoff herr\u00fchrende Substanz, und es fanden sich zahlreiche unbedeutende Metaboliten mit m\u00e4\u00dfiger Polarit\u00e4t, die O-Demethylierungs- und Oxygenierungsprodukten zugeordnet wurden.",
    "show_ref": false
  },
  {
    "src": "Zalasta 5 mg orodispersible tablets Olanzapine",
    "display_src": "Zalasta 5 mg orodispersible tablets Olanzapine",
    "ref": "Zalasta 5 mg Schmelztabletten Olanzapin",
    "show_ref": false
  },
  {
    "src": "2 8 Deutschland Baxter Deutschland GmbH Im Breitspiel 13 D-69126 Heidelberg Tel: + 49 6221 397 0",
    "display_src": "2 8 Deutschland Baxter Deutschland GmbH Im Breitspiel 13 D-69126 Heidelberg Tel: + 49 6221 397 0",
    "ref": "Deutschland Baxter Deutschland GmbH Im Breitspiel 13 D-69126 Heidelberg Tel.: + 49 6221 397 0",
    "show_ref": false
  },
  {
    "src": "Rheumatoid arthritis is a disease of the joints.",
    "display_src": "Rheumatoid arthritis is a disease of the joints.",
    "ref": "Rheumatoide Arthritis ist eine Erkrankung der Gelenke.",
    "show_ref": false
  },
  {
    "src": "Cardiac left ventricular function decrease (G3/ 4:",
    "display_src": "Cardiac left ventricular function decrease (G3/ 4:",
    "ref": "linksventrikul\u00e4re Funktionsst\u00f6rung (G3/4:",
    "show_ref": false
  },
  {
    "src": "Taking TRITACE with other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription (including herbal medicines).",
    "display_src": "Taking TRITACE with other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription (including herbal medicines).",
    "ref": "Bei Einnahme von TRITACE mit anderen Arzneimitteln Bitte informieren Sie Ihren Arzt oder Apotheker, wenn Sie andere Arzneimittel einnehmen bzw. vor Kurzem eingenommen haben, auch wenn es sich um nicht verschreibungspflichtige Arzneimittel (einschl. pflanzlicher Mittel) handelt.",
    "show_ref": false
  },
  {
    "src": "WHAT NOXAFIL IS AND WHAT IT IS USED FOR",
    "display_src": "WHAT NOXAFIL IS AND WHAT IT IS USED FOR",
    "ref": "WAS IST NOXAFIL UND WOF\u00dcR WIRD ES ANGEWENDET?",
    "show_ref": false
  },
  {
    "src": "As with all bisphosphonates, patients taking Zometa may be at risk of osteonecrosis (death of bone tissue) in the jaw.",
    "display_src": "As with all bisphosphonates, patients taking Zometa may be at risk of osteonecrosis (death of bone tissue) in the jaw.",
    "ref": "Wie bei allen Bisphosphonaten besteht f\u00fcr Patienten, die Zometa anwenden, ein Risiko f\u00fcr Osteonekrose (Absterben von Knochengewebe) im Kieferknochen.",
    "show_ref": false
  },
  {
    "src": "DO NOT take MIRAPEXIN",
    "display_src": "DO NOT take MIRAPEXIN",
    "ref": "MIRAPEXIN darf nicht eingenommen werden,",
    "show_ref": false
  },
  {
    "src": "A total of 1291 serious reports were received where palivizumab had been administered as indicated and the duration of therapy was within one season.",
    "display_src": "A total of 1291 serious reports were received where palivizumab had been administered as indicated and the duration of therapy was within one season.",
    "ref": "Insgesamt wurden 1291 schwerwiegende Berichte bekannt, bei denen Palivizumab wie angezeigt verabreicht wurde und die Therapiedauer innerhalb einer Saison lag.",
    "show_ref": false
  },
  {
    "src": "Small amounts of air may be present in the needle and insulin reservoir during normal use.",
    "display_src": "Small amounts of air may be present in the needle and insulin reservoir during normal use.",
    "ref": "In der Nadel und im Insulinbeh\u00e4lter k\u00f6nnen w\u00e4hrend des normalen Gebrauchs Luftblasen auftreten.",
    "show_ref": false
  },
  {
    "src": "Naxcel differs from other similar cephalosporin antibiotics as it stays in the pig\u2019 s body for a longer time after it has been injected.",
    "display_src": "Naxcel differs from other similar cephalosporin antibiotics as it stays in the pig\u2019 s body for a longer time after it has been injected.",
    "ref": "Naxcel unterscheidet sich von \u00e4hnlichen Cephalosporin-Antibiotika, da es nach der Injektion noch lange im K\u00f6rper des Schweines verbleibt.",
    "show_ref": false
  },
  {
    "src": "INFORMATION FOR THE USER Tandemact 45 mg/ 4 mg tablets",
    "display_src": "INFORMATION FOR THE USER Tandemact 45 mg/ 4 mg tablets",
    "ref": "Tandemact 45 mg/4 mg Tabletten Pioglitazon/Glimepirid",
    "show_ref": false
  },
  {
    "src": "Lyophilisate and solvent for solution for injection.",
    "display_src": "Lyophilisate and solvent for solution for injection.",
    "ref": "Lyophilisat und L\u00f6sungsmittel zur Herstellung einer Injektionsl\u00f6sung.",
    "show_ref": false
  },
  {
    "src": "Few pre-clinical data are available with respect to reproductive toxicity (see section 5.3).",
    "display_src": "Few pre-clinical data are available with respect to reproductive toxicity (see section 5.3).",
    "ref": "Hinsichtlich der Reproduktionstoxizit\u00e4t sind nur wenige pr\u00e4klinische Daten verf\u00fcgbar (siehe Abschnitt 5.3).",
    "show_ref": false
  },
  {
    "src": "Hypersensitivity reactions and allergic reactions occurred in some cases after the first administration of ciprofloxacin.",
    "display_src": "Hypersensitivity reactions and allergic reactions occurred in some cases after the first administration of ciprofloxacin.",
    "ref": "In Einzelf\u00e4llen traten bereits nach Erstanwendung von Ciprofloxacin \u00dcberempfindlichkeitsreaktionen und allergische Reaktionen auf.",
    "show_ref": false
  },
  {
    "src": "How do I prepare my Tevagrastim injection?",
    "display_src": "How do I prepare my Tevagrastim injection?",
    "ref": "Wie bereite ich meine Tevagrastim-Injektion vor?",
    "show_ref": false
  },
  {
    "src": "White hexagonal biconvex tablets, embossed with a sword logo on one side and \u201c N2\u201d on the reverse side.",
    "display_src": "White hexagonal biconvex tablets, embossed with a sword logo on one side and \u201c N2\u201d on the reverse side.",
    "ref": "Wei\u00dfe, hexagonale, bikonvexe Tabletten mit einem eingepr\u00e4gten Schwert-Logo auf der einen Seite und der Einpr\u00e4gung \u201e N2\u201c auf der anderen Seite.",
    "show_ref": false
  },
  {
    "src": "If you take more Irbesartan Winthrop than you should:",
    "display_src": "If you take more Irbesartan Winthrop than you should:",
    "ref": "Wenn Sie eine gr\u00f6\u00dfere Menge von Irbesartan Winthrop eingenommen haben, als Sie sollten:",
    "show_ref": false
  },
  {
    "src": "10 vials + 10 ampoules",
    "display_src": "10 vials + 10 ampoules",
    "ref": "10 Durchstech- flaschen + 10 Ampullen",
    "show_ref": false
  },
  {
    "src": "The name of the medicine was changed to Icandra on 6 February 2009.",
    "display_src": "The name of the medicine was changed to Icandra on 6 February 2009.",
    "ref": "Februar 2009 wurde der Handelsname des Arzneimittels in Icandra ge\u00e4ndert",
    "show_ref": false
  },
  {
    "src": "The hazard ratio for the treatment effect was 0.58 (95% CI:",
    "display_src": "The hazard ratio for the treatment effect was 0.58 (95% CI:",
    "ref": "Die entsprechende Hazard-Ratio betrug 0,58 (95%-Konfidenzintervall [KI]:",
    "show_ref": false
  },
  {
    "src": "Teratogenic effects included exencephaly or encephalocele, absent/ reduced frontal and absent parietal bones.",
    "display_src": "Teratogenic effects included exencephaly or encephalocele, absent/ reduced frontal and absent parietal bones.",
    "ref": "Die teratogenen Effekte beinhalteten Exenzephalie oder Enzephalozele sowie fehlende/reduzierte frontale sowie fehlende parietale Knochen.",
    "show_ref": false
  },
  {
    "src": "doctor will closely monitor you during treatment.",
    "display_src": "doctor will closely monitor you during treatment.",
    "ref": "Ihr Arzt wird sie w\u00e4hrend der Behandlung sorgf\u00e4ltig \u00fcberwachen.",
    "show_ref": false
  },
  {
    "src": "It is extremely important that pregnant Wilson\u2019 s disease patients continue their therapy during pregnancy.",
    "display_src": "It is extremely important that pregnant Wilson\u2019 s disease patients continue their therapy during pregnancy.",
    "ref": "11 Es ist \u00e4u\u00dferst wichtig, dass Schwangere mit Morbus Wilson ihre Therapie w\u00e4hrend der Schwangerschaft fortsetzen.",
    "show_ref": false
  },
  {
    "src": "After an oral dose, the non-absorbed fraction recovered in faeces was 20-30%.",
    "display_src": "After an oral dose, the non-absorbed fraction recovered in faeces was 20-30%.",
    "ref": "Nach einer oralen Dosis betr\u00e4gt der nicht absorbierte und \u00fcber den F\u00e4zes ausgeschiedene Anteil 20 - 30%.",
    "show_ref": false
  },
  {
    "src": "Most patients experiencing virological failure with a regimen containing abacavir in a pivotal clinical trial with Combivir (fixed dose combination of lamivudine and zidovudine) showed either no NRTI-related changes from baseline (15%) or only M184V or M184I selection (78%).",
    "display_src": "Most patients experiencing virological failure with a regimen containing abacavir in a pivotal clinical trial with Combivir (fixed dose combination of lamivudine and zidovudine) showed either no NRTI-related changes from baseline (15%) or only M184V or M184I selection (78%).",
    "ref": "In einer Zulassungsstudie zeigten die meisten Patienten mit virologischem Versagen auf ein Abacavir-haltiges Schema mit Combivir (fixe Kombination aus Lamivudin und Zidovudin) entweder keine NRTI- bedingten Ver\u00e4nderungen im Vergleich zur Ausgangssituation (15%) oder lediglich eine Selektion von M184V- oder M184I-Mutationen (78%).",
    "show_ref": false
  },
  {
    "src": "- DNA vaccines for veterinary use",
    "display_src": "- DNA vaccines for veterinary use",
    "ref": "- DNA-Impfstoffe in der Tiermedizin",
    "show_ref": false
  },
  {
    "src": "The active side of the sponge, which is coated with fibrinogen and thrombin, is marked by a yellow colour.",
    "display_src": "The active side of the sponge, which is coated with fibrinogen and thrombin, is marked by a yellow colour.",
    "ref": "Die aktive Seite des Schwammes, die mit Fibrinogen und Thrombin beschichtet ist, ist mit gelber Farbe gekennzeichnet.",
    "show_ref": false
  },
  {
    "src": "The patient should take 20 drops (10 mg) per day for 7 days.",
    "display_src": "The patient should take 20 drops (10 mg) per day for 7 days.",
    "ref": "T\u00e4gliche Einnahme von 20 Tropfen (10 mg) \u00fcber 7 Tage.",
    "show_ref": false
  },
  {
    "src": "INFORMATION FOR THE USER VFEND 50 mg film-coated tablets VFEND 200 mg film-coated tablets Voriconazole",
    "display_src": "INFORMATION FOR THE USER VFEND 50 mg film-coated tablets VFEND 200 mg film-coated tablets Voriconazole",
    "ref": "VFEND 50 mg Filmtabletten VFEND 200 mg Filmtabletten Voriconazol",
    "show_ref": false
  },
  {
    "src": "59 (28) 34 (16) 72 (35)",
    "display_src": "59 (28) 34 (16) 72 (35)",
    "ref": "39 (19) 59 (28) 34 (16) 72 (35)",
    "show_ref": false
  },
  {
    "src": "Lantus 100 Units/ ml solution for injection in a cartridge for OptiClik Insulin glargine",
    "display_src": "Lantus 100 Units/ ml solution for injection in a cartridge for OptiClik Insulin glargine",
    "ref": "Lantus 100 Einheiten/ml Injektionsl\u00f6sung in einer Patrone f\u00fcr OptiClik Insulin glargin",
    "show_ref": false
  },
  {
    "src": "Pruban reduces the inflammation of the skin locally.",
    "display_src": "Pruban reduces the inflammation of the skin locally.",
    "ref": "Pruban hemmt die Entz\u00fcndung lokal auf der Haut.",
    "show_ref": false
  },
  {
    "src": "Concomitant administration of Thelin did not alter the pharmacokinetics of digoxin indicating no effect on the p-glycoprotein transporter",
    "display_src": "Concomitant administration of Thelin did not alter the pharmacokinetics of digoxin indicating no effect on the p-glycoprotein transporter",
    "ref": "Die gleichzeitige Gabe von Thelin ver\u00e4nderte die pharmakokinetischen Eigenschaften von Digoxin nicht, was auf das Ausbleiben einer Wirkung auf den p-Glycoprotein-Transporter hindeutet.",
    "show_ref": false
  },
  {
    "src": "A decrease or increase in the Xeomin dose is possible by administering a smaller or larger injection volume.",
    "display_src": "A decrease or increase in the Xeomin dose is possible by administering a smaller or larger injection volume.",
    "ref": "16 Eine Erh\u00f6hung oder Verringerung der Xeomin-Dosis ist m\u00f6glich, indem ein geringeres oder gr\u00f6\u00dferes Injektionsvolumen verwendet wird.",
    "show_ref": false
  },
  {
    "src": "Only five had malignant pain.",
    "display_src": "Only five had malignant pain.",
    "ref": "Nur f\u00fcnf hatten maligne Schmerzen.",
    "show_ref": false
  },
  {
    "src": "If you have symptoms of low blood sugar, take actions to increase your blood sugar level immediately.",
    "display_src": "If you have symptoms of low blood sugar, take actions to increase your blood sugar level immediately.",
    "ref": "Wenn Sie Anzeichen eines niedrigen Blutzuckers bemerken, unternehmen Sie sofort etwas, um Ihren Blutzuckerspiegel zu erh\u00f6hen.",
    "show_ref": false
  },
  {
    "src": "The preferred injection sites are the anterolateral area of the thigh in younger children and the deltoid area in older children, adolescents, and adults.",
    "display_src": "The preferred injection sites are the anterolateral area of the thigh in younger children and the deltoid area in older children, adolescents, and adults.",
    "ref": "Bei j\u00fcngeren Kindern wird der Impfstoff vorzugsweise in den anterolateralen Bereich des Oberschenkels und bei \u00e4lteren Kindern, Jugendlichen und Erwachsenen in den Bereich des M. deltoideus injiziert.",
    "show_ref": false
  },
  {
    "src": "Duration of MaHR (%; Kaplan-Meier Estimates)",
    "display_src": "Duration of MaHR (%; Kaplan-Meier Estimates)",
    "ref": "Dauer der MaHR (%; Kaplan-Meier-Methode)",
    "show_ref": false
  },
  {
    "src": "Fondaparinux should not be used in patients with severe renal impairment (creatinine clearance < 30 ml/ min) (See section 4.3).",
    "display_src": "Fondaparinux should not be used in patients with severe renal impairment (creatinine clearance < 30 ml/ min) (See section 4.3).",
    "ref": "42 Bei Patienten mit schwerer Nierenfunktionsst\u00f6rung (Kreatinin-Clearance < 30 ml/min) darf Fondaparinux nicht angewendet werden (siehe Abschnitt 4.3).",
    "show_ref": false
  },
  {
    "src": "or Medicinal product subject to restricted medical prescription (See Annex I:",
    "display_src": "or Medicinal product subject to restricted medical prescription (See Annex I:",
    "ref": "as Arzneimittel auf eingeschr\u00e4nkte \u00e4rztliche Verschreibung (siehe Anhang I:",
    "show_ref": false
  },
  {
    "src": "If no photosensitivity reaction (erythema, oedema, blistering) occurs within 24 hours, the patient can gradually resume normal outdoor activities, initially continuing to exercise caution and gradually allowing increased exposure.",
    "display_src": "If no photosensitivity reaction (erythema, oedema, blistering) occurs within 24 hours, the patient can gradually resume normal outdoor activities, initially continuing to exercise caution and gradually allowing increased exposure.",
    "ref": "Wenn keine Lichtempfindlichkeitsreaktion (Erythem, \u00d6dem, Blasenbildung) innerhalb von 24 Stunden auftritt, kann der Patient normale Au\u00dfenaktivit\u00e4ten allm\u00e4hlich wieder aufnehmen, wobei am Anfang weiterhin Vorsicht geboten ist und die Exposition gegen\u00fcber dem Licht nur allm\u00e4hlich zunehmen sollte.",
    "show_ref": false
  },
  {
    "src": "Nasolacrimal occlusion or gently closing the eyelid after instillation may help reduce the incidence of this effect (see also 4.2 Posology and method of administration).",
    "display_src": "Nasolacrimal occlusion or gently closing the eyelid after instillation may help reduce the incidence of this effect (see also 4.2 Posology and method of administration).",
    "ref": "Verschlie\u00dfen des Tr\u00e4nenkanals oder sanftes Schlie\u00dfen des Augenlids nach der Anwendung kann dazu beitragen, die H\u00e4ufigkeit dieses Effekts zu reduzieren (siehe auch 4.2 Dosierung, Art und Dauer der Anwendung).",
    "show_ref": false
  },
  {
    "src": "Hypercholesterolaemia Uncommon:",
    "display_src": "Hypercholesterolaemia Uncommon:",
    "ref": "Hypercholesterin\u00e4mie Gelegentlich:",
    "show_ref": false
  },
  {
    "src": "The following instructions should therefore be followed carefully.",
    "display_src": "The following instructions should therefore be followed carefully.",
    "ref": "Daher sollten die folgenden Anweisungen sorgf\u00e4ltig befolgt werden:",
    "show_ref": false
  },
  {
    "src": "OUTER CARTON TEXT Puregon 150 IU/ 0.18 ml 1 cartridge",
    "display_src": "OUTER CARTON TEXT Puregon 150 IU/ 0.18 ml 1 cartridge",
    "ref": "TEXT FALTSCHACHTEL Puregon 150 IE/0,18 ml 1 Patrone",
    "show_ref": false
  },
  {
    "src": "EU/ 2/ 97/ 004/ 020 100 tablets Blisters:",
    "display_src": "EU/ 2/ 97/ 004/ 020 100 tablets Blisters:",
    "ref": "EU/2/97/004/020 100 Tabletten Blister:",
    "show_ref": false
  },
  {
    "src": "Somnolence, dizziness, paresthesia, hypertonia Uncommon:",
    "display_src": "Somnolence, dizziness, paresthesia, hypertonia Uncommon:",
    "ref": "Somnolenz, Schwindel, Par\u00e4sthesien, Hypertonie gelegentlich:",
    "show_ref": false
  },
  {
    "src": "- if you are not able to completely empty your bladder (urinary retention)",
    "display_src": "- if you are not able to completely empty your bladder (urinary retention)",
    "ref": "- wenn Sie Ihre Blase nicht vollst\u00e4ndig entleeren k\u00f6nnen (Harnverhalt)",
    "show_ref": false
  },
  {
    "src": "White to off-white powder Solvent:",
    "display_src": "White to off-white powder Solvent:",
    "ref": "Wei\u00dfes bis fast wei\u00dfes Pulver L\u00f6sungsmittel:",
    "show_ref": false
  },
  {
    "src": "Lapatinib has also been shown in vitro to inhibit these efflux transporters, as well as the hepatic uptake transporter OATP 1B1, at clinically relevant concentrations (IC50 values were equal to 2.3 \u00b5g/ ml).",
    "display_src": "Lapatinib has also been shown in vitro to inhibit these efflux transporters, as well as the hepatic uptake transporter OATP 1B1, at clinically relevant concentrations (IC50 values were equal to 2.3 \u00b5g/ ml).",
    "ref": "Auch wurde f\u00fcr Lapatinib in vitro gezeigt, dass es diese Efflux- Transportproteine ebenso wie das die Aufnahme in die Leber vermittelnde Transportprotein OATP 1B1 in klinisch relevanten Konzentrationen hemmt (die IC50-Werte betrugen etwa 2,3 \u00b5g/ml).",
    "show_ref": false
  },
  {
    "src": "In the PURSUIT trial, INTEGRILIN was more effective than placebo in preventing death or further heart attacks during the 30 days after it was given.",
    "display_src": "In the PURSUIT trial, INTEGRILIN was more effective than placebo in preventing death or further heart attacks during the 30 days after it was given.",
    "ref": "In der PURSUIT-Studie verhinderte INTEGRILIN wirksamer als Placebo Todesf\u00e4lle oder weitere Herzinfarkte in den 30 Tagen nach der Verabreichung.",
    "show_ref": false
  },
  {
    "src": "Deutschland RIEMSER Arzneimittel AG An der Wiek 7 D- 17493 Greifswald \u2013 Insel Riems Tel: + 49 (0) 38351/ 76-0",
    "display_src": "Deutschland RIEMSER Arzneimittel AG An der Wiek 7 D- 17493 Greifswald \u2013 Insel Riems Tel: + 49 (0) 38351/ 76-0",
    "ref": "Deutschland RIEMSER Arzneimittel AG An der Wiek 7 D- 17493 Greifswald \u2013 Insel Riems Tel: + 49 (0) 38351/76-0",
    "show_ref": false
  },
  {
    "src": "ABBREVIATIONS FOR DAYS OF THE WEEK (PACK SIZES OF 14, 28, 56, 84 AND 98 TABLETS ONLY)",
    "display_src": "ABBREVIATIONS FOR DAYS OF THE WEEK (PACK SIZES OF 14, 28, 56, 84 AND 98 TABLETS ONLY)",
    "ref": "ABK\u00dcRZUNGEN F\u00dcR DIE WOCHENTAGE (NUR F\u00dcR PACKUNGSGR\u00d6\u00dfEN MIT 14, 28, 56, 84 UND 98 TABLETTEN)",
    "show_ref": false
  },
  {
    "src": "- if you have severe liver disease (see \u2018 Take special care with Agenerase\u2019).",
    "display_src": "- if you have severe liver disease (see \u2018 Take special care with Agenerase\u2019).",
    "ref": "- wenn Sie schwere Leberfunktionsst\u00f6rungen haben (siehe \u201e Besondere Vorsicht bei der",
    "show_ref": false
  },
  {
    "src": "Concomitant administration of etoricoxib with doses of acetylsalicylic acid above those for cardiovascular prophylaxis or with other NSAIDs is not recommended (see sections 5.1 and 4.4.).",
    "display_src": "Concomitant administration of etoricoxib with doses of acetylsalicylic acid above those for cardiovascular prophylaxis or with other NSAIDs is not recommended (see sections 5.1 and 4.4.).",
    "ref": "Die gleichzeitige Anwendung von Etoricoxib mit Acetylsalicyls\u00e4ure in h\u00f6heren Dosen als den zur kardiovaskul\u00e4ren Prophylaxe empfohlenen oder mit anderen NSAR wird nicht empfohlen (siehe 5.1 und 4.4).",
    "show_ref": false
  },
  {
    "src": "Hycamtin 1 mg capsules are pink and imprinted with \u2018 Hycamtin\u2019 and \u2018 1 mg\u2019.",
    "display_src": "Hycamtin 1 mg capsules are pink and imprinted with \u2018 Hycamtin\u2019 and \u2018 1 mg\u2019.",
    "ref": "Hycamtin 1 mg Kapseln sind rosa und mit der Pr\u00e4gung \u201e Hycamtin \"und \u201e 1 mg\u201c versehen.",
    "show_ref": false
  },
  {
    "src": "During the course of treatment, appropriate determination of factor IX levels is advised to guide the dose to be administered and the frequency of repeated injections.",
    "display_src": "During the course of treatment, appropriate determination of factor IX levels is advised to guide the dose to be administered and the frequency of repeated injections.",
    "ref": "Im Verlauf der Behandlung ist eine entsprechende Bestimmung der Faktor-IX-Konzentrationen ratsam, um die zu verabreichende Dosis und die H\u00e4ufigkeit der wiederholten Injektionen zu ermitteln.",
    "show_ref": false
  },
  {
    "src": "Number of 200 mg capsules 3 capsulesa 4 capsulesb",
    "display_src": "Number of 200 mg capsules 3 capsulesa 4 capsulesb",
    "ref": "Anzahl der 200 mg Kapseln 3 Kapselna 4 Kapselnb",
    "show_ref": false
  },
  {
    "src": "Do not use in animals suffering from severe liver or kidney disease, oliguria or anuria.",
    "display_src": "Do not use in animals suffering from severe liver or kidney disease, oliguria or anuria.",
    "ref": "Nicht anwenden bei Tieren mit einer schweren Leber- oder Nierenerkrankung ,Oligurie oder Anurie.",
    "show_ref": false
  },
  {
    "src": "Patients hypersensitive to tetracycline class antibiotics may be hypersensitive to tigecycline.",
    "display_src": "Patients hypersensitive to tetracycline class antibiotics may be hypersensitive to tigecycline.",
    "ref": "Patienten mit einer \u00dcberempfindlichkeit gegen Antibiotika der Tetracyclin-Gruppe k\u00f6nnen \u00fcberempfindlich gegen Tigecyclin sein.",
    "show_ref": false
  },
  {
    "src": "United Kingdom GlaxoSmithKline UK Tel: + 44 (0)808 100 9997 customercontactuk@gsk.com",
    "display_src": "United Kingdom GlaxoSmithKline UK Tel: + 44 (0)808 100 9997 customercontactuk@gsk.com",
    "ref": "United Kingdom GlaxoSmithKline UK Tel: + 44 (0)808 100 9997",
    "show_ref": false
  },
  {
    "src": "Long-term studies to determine the carcinogenic potential of icatibant have not been conducted to date.",
    "display_src": "Long-term studies to determine the carcinogenic potential of icatibant have not been conducted to date.",
    "ref": "Langzeitstudien zur Bestimmung des karzinogenen Potenzials von Icatibant sind bislang nicht durchgef\u00fchrt worden.",
    "show_ref": false
  },
  {
    "src": "After Week 8, patients in the comparator arm who met the protocol defined criteria of initial lack of virologic response had the option of discontinuing treatment and switching over to APTIVUS/ ritonavir in a separate roll-over study.",
    "display_src": "After Week 8, patients in the comparator arm who met the protocol defined criteria of initial lack of virologic response had the option of discontinuing treatment and switching over to APTIVUS/ ritonavir in a separate roll-over study.",
    "ref": "19 Nach 8 Wochen hatten Patienten im Vergleichsarm, die die im Pr\u00fcfplan definierten Kriterien f\u00fcr ein initiales virologisches Nichtansprechen erf\u00fcllten, die Option, die Behandlung abzubrechen und in eine separate Roll-over-Studie mit APTIVUS/Ritonavir zu wechseln.",
    "show_ref": false
  },
  {
    "src": "A single 2.5-mg/ kg dose of DRAXXIN was effective in treating and preventing BRD in cattle and SRD in pigs.",
    "display_src": "A single 2.5-mg/ kg dose of DRAXXIN was effective in treating and preventing BRD in cattle and SRD in pigs.",
    "ref": "Eine einzelne 2,5-mg/kg-Dosis von DRAXXIN war bei der Behandlung und Pr\u00e4vention von BRD bei Rindern und SRD bei Schweinen wirksam.",
    "show_ref": false
  },
  {
    "src": "Schering-Plough Animal Health 33 Whakatiki Street Upper Hutt New Zealand",
    "display_src": "Schering-Plough Animal Health 33 Whakatiki Street Upper Hutt New Zealand",
    "ref": "Schering-Plough Animal Health 33 Whakatiki Street Upper Hutt Neuseeland",
    "show_ref": false
  },
  {
    "src": "Superficial vein thrombophlebitis occurred in a frequency of 1% in the raloxifene group and 0.6% in the placebo group.",
    "display_src": "Superficial vein thrombophlebitis occurred in a frequency of 1% in the raloxifene group and 0.6% in the placebo group.",
    "ref": "Eine oberfl\u00e4chliche Thrombophlebitis trat mit einer H\u00e4ufigkeit von 1% in der Raloxifen-Gruppe und 0,6% in der Placebo-Gruppe auf.",
    "show_ref": false
  },
  {
    "src": "In tocilizumab-treated patients, decreases in the levels of CRP to within normal ranges were seen as early as week 2, with decreases maintained while on treatment.",
    "display_src": "In tocilizumab-treated patients, decreases in the levels of CRP to within normal ranges were seen as early as week 2, with decreases maintained while on treatment.",
    "ref": "Bei den mit Tocilizumab behandelten Patienten zeigte sich bereits nach 2 Wochen ein R\u00fcckgang der CRP-Werte auf Werte innerhalb des Normalbereichs, der w\u00e4hrend der Behandlung andauerte.",
    "show_ref": false
  },
  {
    "src": "- Chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole",
    "display_src": "- Chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole",
    "ref": "- Chromoblastomykose und Myzetom bei Patienten, deren Erkrankung therapieresistent ist",
    "show_ref": false
  },
  {
    "src": "In general, the effective concentration and the concentration at which toxicity occurs increase with increasing tolerance to opioids.",
    "display_src": "In general, the effective concentration and the concentration at which toxicity occurs increase with increasing tolerance to opioids.",
    "ref": "Im Allgemeinen erh\u00f6ht sich die wirksame Konzentration und die Konzentration, bei der eine Toxizit\u00e4t auftritt, mit zunehmender Gew\u00f6hnung gegen\u00fcber Opioiden.",
    "show_ref": false
  },
  {
    "src": "Epoetin alfa HEXAL is given by injection into a vein (intravenously).",
    "display_src": "Epoetin alfa HEXAL is given by injection into a vein (intravenously).",
    "ref": "Epoetin alfa HEXAL wird als Injektion in eine Vene (intraven\u00f6s) gegeben.",
    "show_ref": false
  },
  {
    "src": "Therefore, a decision to continue/ discontinue breast-feeding or to continue/ discontinue therapy with Efexor depot should be made, taking into account the benefit of breast-feeding to the child and the benefit of Efexor depot therapy to the woman.",
    "display_src": "Therefore, a decision to continue/ discontinue breast-feeding or to continue/ discontinue therapy with Efexor depot should be made, taking into account the benefit of breast-feeding to the child and the benefit of Efexor depot therapy to the woman.",
    "ref": "Daher sollte die Entscheidung, ob gestillt/abgestillt oder ob die Therapie mit Efexor depot fortgesetzt/abgesetzt werden soll, unter Ber\u00fccksichtigung der Vorteile des Stillens f\u00fcr das Kind und des Nutzens der Therapie mit Efexor depot f\u00fcr die Mutter getroffen werden.",
    "show_ref": false
  },
  {
    "src": "Weight loss has been observed in approximately 60% of patients.",
    "display_src": "Weight loss has been observed in approximately 60% of patients.",
    "ref": "Bei etwa 60% der Patienten wurde eine Abnahme des K\u00f6rpergewichts beobachtet.",
    "show_ref": false
  },
  {
    "src": "Guidelines have been elaborated and adopted by CVMP 0 on the following topics:",
    "display_src": "Guidelines have been elaborated and adopted by CVMP 0 on the following topics:",
    "ref": "Zu den folgenden Themen wurden Leitlinien ausgearbeitet und vom CVMP verabschiedet:",
    "show_ref": false
  },
  {
    "src": "Slovensk\u00e1 republika Astellas Pharma s. r. o., organiza\u010d n\u00e1 zlo\u017e ka Galv\u00e1niho 15/ C SK-821 04 Bratislava 2 Tel: +421 2 4444 2157",
    "display_src": "Slovensk\u00e1 republika Astellas Pharma s. r. o., organiza\u010d n\u00e1 zlo\u017e ka Galv\u00e1niho 15/ C SK-821 04 Bratislava 2 Tel: +421 2 4444 2157",
    "ref": "Slovensk\u00e1 republika Astellas Pharma s.r.o., organiza\u010d n\u00e1 zlo\u017e ka Galv\u00e1niho 15/C SK- 821 04 Bratislava 2 Tel: +421 2 4444 2157",
    "show_ref": false
  },
  {
    "src": "Hypersensitivity to the active substance or excipient.",
    "display_src": "Hypersensitivity to the active substance or excipient.",
    "ref": "\u00dcberempfindlichkeit gegen den Wirkstoff oder den sonstigen Bestandteil.",
    "show_ref": false
  },
  {
    "src": "TESAVEL was also more effective than placebo when it was added to glimepiride (with and without metformin).",
    "display_src": "TESAVEL was also more effective than placebo when it was added to glimepiride (with and without metformin).",
    "ref": "Als Zusatzmedikament zu Glimepirid (mit oder ohne Metformin) war TESAVEL ebenfalls wirksamer als das Placebo.",
    "show_ref": false
  },
  {
    "src": "All ADRs reported in the intrathecal clinical trials with ziconotide (short- and long-term exposure) are listed below in order of frequency.",
    "display_src": "All ADRs reported in the intrathecal clinical trials with ziconotide (short- and long-term exposure) are listed below in order of frequency.",
    "ref": "Alle in klinischen Studien mit intrathekalem Ziconotid berichteten UAWs (Kurzzeit- und Langzeitexposition) sind nachstehend in der Reihenfolge der H\u00e4ufigkeit aufgelistet.",
    "show_ref": false
  },
  {
    "src": "Intramuscular Glass bottles 250ml or (hydrolytical subcutaneous Type II) with rubber stopper and aluminium cap",
    "display_src": "Intramuscular Glass bottles 250ml or (hydrolytical subcutaneous Type II) with rubber stopper and aluminium cap",
    "ref": "Durchstechflaschen 250 ml (Glastyp II) verschlossen mit einem Gummi- stopfen und einer Aluminiumkappe",
    "show_ref": false
  },
  {
    "src": "Axura should be given once a day, with or without food, at about the same time every day.",
    "display_src": "Axura should be given once a day, with or without food, at about the same time every day.",
    "ref": "Axura sollte einmal t\u00e4glich mit oder ohne Nahrung ungef\u00e4hr zur gleichen Zeit verabreicht werden.",
    "show_ref": false
  },
  {
    "src": "Close the bottle with the solvent and added granules, turn it on its side and shake vigorously for about 15 seconds.",
    "display_src": "Close the bottle with the solvent and added granules, turn it on its side and shake vigorously for about 15 seconds.",
    "ref": "Schlie\u00dfen Sie die Flasche mit dem L\u00f6sungsmittel und dem hinzugef\u00fcgten Granulat, drehen Sie sie auf die Seite und sch\u00fctteln Sie sie kr\u00e4ftig f\u00fcr circa 15 Sekunden.",
    "show_ref": false
  },
  {
    "src": "HDPE bottle with child resistant screw cap, fill mark (200 ml of solution after reconstitution) and measuring cup.",
    "display_src": "HDPE bottle with child resistant screw cap, fill mark (200 ml of solution after reconstitution) and measuring cup.",
    "ref": "HDPE-Flaschen mit kindersicherem Schraubverschlu\u00df (200 ml L\u00f6sung nach Bereitung) mit F\u00fcllmarke und Messbecher.",
    "show_ref": false
  },
  {
    "src": "Active peptic ulceration or gastrointestinal (GI) bleeding.",
    "display_src": "Active peptic ulceration or gastrointestinal (GI) bleeding.",
    "ref": "Aktive peptische Ulzera oder gastrointestinale (GI) Blutungen.",
    "show_ref": false
  },
  {
    "src": "if you are currently taking any of the following medicines:",
    "display_src": "if you are currently taking any of the following medicines:",
    "ref": "wenn Sie gegenw\u00e4rtig eines oder mehrere der folgenden Medikamente einnehmen:",
    "show_ref": false
  },
  {
    "src": "Marino Riva, Head of Unit, Administration, b.",
    "display_src": "Marino Riva, Head of Unit, Administration, b.",
    "ref": "Marino Riva, Leiter des Referats Verwaltung, geboren am 6.",
    "show_ref": false
  },
  {
    "src": "Where accepted a locally established recommendation for a CD4 cell count threshold may be used additionally to support the decision whether the vaccination is indicated.",
    "display_src": "Where accepted a locally established recommendation for a CD4 cell count threshold may be used additionally to support the decision whether the vaccination is indicated.",
    "ref": "Sofern es zul\u00e4ssig ist, kann eine \u00f6rtlich geltende Empfehlung in Bezug auf den Schwellenwert der CD4-Zellzahl zus\u00e4tzlich f\u00fcr die Entscheidung dar\u00fcber hinzugezogen werden, ob eine Impfung angezeigt ist.",
    "show_ref": false
  },
  {
    "src": "21 hard capsules 42 hard capsules 84 hard capsules",
    "display_src": "21 hard capsules 42 hard capsules 84 hard capsules",
    "ref": "21 Hartkapseln 42 Hartkapseln 84 Hartkapseln",
    "show_ref": false
  },
  {
    "src": "Plasma concentrations of intact orlistat were non-measurable (< 5 ng/ ml) 8 hours following oral administration of orlistat 360 mg.",
    "display_src": "Plasma concentrations of intact orlistat were non-measurable (< 5 ng/ ml) 8 hours following oral administration of orlistat 360 mg.",
    "ref": "Plasmakonzentrationen von nicht metabolisiertem Orlistat waren 8 Stunden nach der oralen Gabe von 360 mg Orlistat nicht messbar (< 5 ng/ml).",
    "show_ref": false
  },
  {
    "src": "Tablet film-coat Poly(vinyl alcohol) \u2013 partially hydrolyzed Macrogol 3350 Titanium dioxide (E171) Talc Sunset yellow FCF (E110)",
    "display_src": "Tablet film-coat Poly(vinyl alcohol) \u2013 partially hydrolyzed Macrogol 3350 Titanium dioxide (E171) Talc Sunset yellow FCF (E110)",
    "ref": "Tabletten\u00fcberzug Polyvinylalkohol \u2013 teilhydrolysiert Macrogol 3350 Titandioxid (E171) Talkum Gelborange S (E110)",
    "show_ref": false
  },
  {
    "src": "Do not use in animals less than 10 weeks.",
    "display_src": "Do not use in animals less than 10 weeks.",
    "ref": "Nicht bei Tieren im Alter unter 10 Wochen anwenden.",
    "show_ref": false
  },
  {
    "src": "EU/ 1/ 98/ 089/ 011 (14 tablets) EU/ 1/ 98/ 089/ 012 (28 tablets) EU/ 1/ 98/ 089/ 020 (30 tablets) EU/ 1/ 98/ 089/ 013 (56 tablets) EU/ 1/ 98/ 089/ 019 (90 tablets) EU/ 1/ 98/ 089/ 014 (98 tablets)",
    "display_src": "EU/ 1/ 98/ 089/ 011 (14 tablets) EU/ 1/ 98/ 089/ 012 (28 tablets) EU/ 1/ 98/ 089/ 020 (30 tablets) EU/ 1/ 98/ 089/ 013 (56 tablets) EU/ 1/ 98/ 089/ 019 (90 tablets) EU/ 1/ 98/ 089/ 014 (98 tablets)",
    "ref": "EU/1/98/089/011 (14 Tabletten) EU/1/98/089/012 (28 Tabletten) EU/1/98/089/020 (30 Tabletten) EU/1/98/089/013 (56 Tabletten) EU/1/98/089/019 (90 Tabletten) EU/1/98/089/014 (98 Tabletten)",
    "show_ref": false
  },
  {
    "src": "It is normally used in combination with other anti- HIV medicines.",
    "display_src": "It is normally used in combination with other anti- HIV medicines.",
    "ref": "Dieses Arzneimittel wird \u00fcblicherweise zur Anwendung zusammen mit anderen Arzneimitteln gegen HIV verschrieben.",
    "show_ref": false
  },
  {
    "src": "36% (103/ 285) 44% (41/ 94) 33% (62/ 189)",
    "display_src": "36% (103/ 285) 44% (41/ 94) 33% (62/ 189)",
    "ref": "36% (103/285) 44% (41/94) 33% (62/189)",
    "show_ref": false
  },
  {
    "src": "The metabolism of rasagiline proceeds through two main pathways:",
    "display_src": "The metabolism of rasagiline proceeds through two main pathways:",
    "ref": "Der Stoffwechsel von Rasagilin verl\u00e4uft \u00fcber zwei Hauptwege:",
    "show_ref": false
  },
  {
    "src": "Animal studies do not indicate direct harmful effects with respect to pregnancy, embryonal / foetal development, parturition or postnatal development (see section 5.3).",
    "display_src": "Animal studies do not indicate direct harmful effects with respect to pregnancy, embryonal / foetal development, parturition or postnatal development (see section 5.3).",
    "ref": "Tierexperimentelle Studien lassen nicht auf direkte sch\u00e4dliche Auswirkungen auf Schwangerschaft, embryonale/fetale Entwicklung, Geburt oder postnatale Entwicklung schlie\u00dfen (siehe Abschnitt 5.3).",
    "show_ref": false
  },
  {
    "src": "Animal studies do not indicate direct or indirect harmful effects of emtricitabine or tenofovir disoproxil fumarate with respect to pregnancy, embryonal/ foetal development, parturition or postnatal development (see section 5.3).",
    "display_src": "Animal studies do not indicate direct or indirect harmful effects of emtricitabine or tenofovir disoproxil fumarate with respect to pregnancy, embryonal/ foetal development, parturition or postnatal development (see section 5.3).",
    "ref": "Tierexperimentelle Studien lassen nicht auf direkte oder indirekte sch\u00e4dliche Auswirkungen von Emtricitabin oder Tenofovirdisoproxilfumarat auf Schwangerschaft, embryonale/fetale Entwicklung, Geburt oder postnatale Entwicklung schlie\u00dfen (siehe Abschnitt 5.3).",
    "show_ref": false
  },
  {
    "src": "The duration of immunity is up to 3 months.",
    "display_src": "The duration of immunity is up to 3 months.",
    "ref": "Die Immunit\u00e4tsdauer betr\u00e4gt bis zu 3 Monate.",
    "show_ref": false
  },
  {
    "src": "When you first take Viani Diskus out of the box, it will be in the closed position.",
    "display_src": "When you first take Viani Diskus out of the box, it will be in the closed position.",
    "ref": "Wenn Sie Ihren Viani Diskus zum ersten Mal aus dem Umkarton nehmen, ist er in geschlossener Stellung.",
    "show_ref": false
  },
  {
    "src": "No effects on male or female fertility have been observed in reproductive toxicity studies in rats (see section 5.3).",
    "display_src": "No effects on male or female fertility have been observed in reproductive toxicity studies in rats (see section 5.3).",
    "ref": "Es wurden keine Auswirkungen auf die m\u00e4nnliche oder weibliche Fertilit\u00e4t in reproduktionstoxikologischen Studien bei Ratten beobachtet (siehe Abschnitt 5.3).",
    "show_ref": false
  },
  {
    "src": "Respiratory: increase in breath rhythm, respiratory failure, alveolar haemorrhages, asthma, collapse of small portions of the lung, fluid around the lung.",
    "display_src": "Respiratory: increase in breath rhythm, respiratory failure, alveolar haemorrhages, asthma, collapse of small portions of the lung, fluid around the lung.",
    "ref": "Erh\u00f6hung des Atemrhythmus, Atemst\u00f6rung, alveol\u00e4re Blutungen, Asthma, Zusammensinken von kleinen Teilen der Lunge, Fl\u00fcssigkeitsansammlung um die Lunge.",
    "show_ref": false
  },
  {
    "src": "Imatinib is also an inhibitor of the receptor tyrosine kinases for platelet-derived growth factor (PDGF), PDGF-R, and stem cell factor (SCF), c-Kit, and inhibits PDGF- and SCF-mediated cellular events.",
    "display_src": "Imatinib is also an inhibitor of the receptor tyrosine kinases for platelet-derived growth factor (PDGF), PDGF-R, and stem cell factor (SCF), c-Kit, and inhibits PDGF- and SCF-mediated cellular events.",
    "ref": "Imatinib hemmt auch die Tyrosinkinase-Aktivit\u00e4t des PDGF-Rezeptors (platelet-derived growth factor, PDGF) und des Rezeptors f\u00fcr Stammzellfaktor (stem cell factor, SCF), c-Kit, und inhibiert PDGF- und SCF-vermittelte zellul\u00e4re Reaktionen.",
    "show_ref": false
  },
  {
    "src": "124 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.",
    "display_src": "124 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.",
    "ref": "132 Falls weitere Informationen \u00fcber das Arzneimittel gew\u00fcnscht werden, setzen Sie sich bitte mit dem \u00f6rtlichen Vertreter des Pharmazeutischen Unternehmers in Verbindung.",
    "show_ref": false
  },
  {
    "src": "Since this difference is not considered to be clinically relevant, the combination of PREZISTA co-administered with 100 mg ritonavir and nevirapine can be used without dose adjustments.",
    "display_src": "Since this difference is not considered to be clinically relevant, the combination of PREZISTA co-administered with 100 mg ritonavir and nevirapine can be used without dose adjustments.",
    "ref": "Da dieser Unterschied als klinisch nicht relevant betrachtet wird, ist eine Kombination aus der gleichzeitigen Anwendung von PREZISTA und 100 mg Ritonavir mit Nevirapin ohne Dosisanpassungen m\u00f6glich.",
    "show_ref": false
  },
  {
    "src": "How to use ReFacto AF 4.",
    "display_src": "How to use ReFacto AF 4.",
    "ref": "Wie ist ReFacto AF anzuwenden?",
    "show_ref": false
  },
  {
    "src": "This investigative clinical trial assay performed in a central laboratory utilised a 0 to 3+ scale.",
    "display_src": "This investigative clinical trial assay performed in a central laboratory utilised a 0 to 3+ scale.",
    "ref": "Dieser Assay der klinischen Pr\u00fcfung wurde in einem zentralen Laboratorium durchgef\u00fchrt, wobei eine Skala von 0 bis 3+ verwendet wurde.",
    "show_ref": false
  },
  {
    "src": "Characteristically, the cough is non- productive, persistent and resolves after discontinuation of therapy.",
    "display_src": "Characteristically, the cough is non- productive, persistent and resolves after discontinuation of therapy.",
    "ref": "Charakteristisch ist der Husten nicht produktiv, nicht anhaltend und verschwindet nach Absetzen der Therapie wieder.",
    "show_ref": false
  },
  {
    "src": "For patients with moderate renal impairment who experience adverse events that are not tolerable, dosing may be reduced to 1 mg once daily.",
    "display_src": "For patients with moderate renal impairment who experience adverse events that are not tolerable, dosing may be reduced to 1 mg once daily.",
    "ref": "Bei Patienten mit m\u00e4\u00dfiger Niereninsuffizienz, bei denen nicht tolerierbare Nebenwirkungen auftreten, kann die Dosierung auf 1 mg einmal t\u00e4glich verringert werden.",
    "show_ref": false
  },
  {
    "src": "In such cases, thyroid function should be investigated in order to identify a possible thyroid impairment linked to mitotane treatment.",
    "display_src": "In such cases, thyroid function should be investigated in order to identify a possible thyroid impairment linked to mitotane treatment.",
    "ref": "In derartigen F\u00e4llen muss die Schilddr\u00fcsenfunktion \u00fcberpr\u00fcft werden, um eine m\u00f6gliche Schilddr\u00fcsenerkrankung in Verbindung mit der Mitotan-Behandlung zu erkennen.",
    "show_ref": false
  },
  {
    "src": "Always use Humalog Mix25 KwikPen exactly as your doctor has told you.",
    "display_src": "Always use Humalog Mix25 KwikPen exactly as your doctor has told you.",
    "ref": "Wenden Sie Humalog Mix25 KwikPen immer genau nach Anweisung des Arztes an.",
    "show_ref": false
  },
  {
    "src": "Luveris contains the active substance lutropin alfa.",
    "display_src": "Luveris contains the active substance lutropin alfa.",
    "ref": "Luveris enth\u00e4lt den arzneilich wirksamen Bestandteil Lutropin alfa.",
    "show_ref": false
  },
  {
    "src": "White capsules with \u201c OGT 918\u201d printed in black on the cap and \u201c 100\u201d printed in black on the body.",
    "display_src": "White capsules with \u201c OGT 918\u201d printed in black on the cap and \u201c 100\u201d printed in black on the body.",
    "ref": "Wei\u00dfe Kapseln mit dem schwarzen Aufdruck \u201c OGT 918\u201d auf dem Kapseloberteil und dem schwarzen Aufdruck \u201c 100\u201d auf dem Kapselunterteil.",
    "show_ref": false
  },
  {
    "src": "A case of possible CELSENTRI-induced hepatotoxicity with allergic features has been reported in a study in healthy volunteers.",
    "display_src": "A case of possible CELSENTRI-induced hepatotoxicity with allergic features has been reported in a study in healthy volunteers.",
    "ref": "In einer Studie mit gesunden Probanden wurde ein Fall einer m\u00f6glicherweise durch CELSENTRI ausgel\u00f6sten Hepatotoxizit\u00e4t mit allergischen Merkmalen berichtet.",
    "show_ref": false
  },
  {
    "src": "Riquent is a solution for injection that contains 50 mg/ ml of the active substance abetimus.",
    "display_src": "Riquent is a solution for injection that contains 50 mg/ ml of the active substance abetimus.",
    "ref": "Riquent ist eine Injektionsl\u00f6sung, die 50 mg/ml des Wirkstoffs Abetimus enth\u00e4lt.",
    "show_ref": false
  },
  {
    "src": "Fendrix is available in packs of 1 with or without separate needle and in pack size of 10 without needles.",
    "display_src": "Fendrix is available in packs of 1 with or without separate needle and in pack size of 10 without needles.",
    "ref": "Fendrix ist in Packungen zu 1 mit oder ohne separate(r) Nadel/Kan\u00fcle und in Packungen zu 10 ohne Nadeln/Kan\u00fclen erh\u00e4ltlich.",
    "show_ref": false
  },
  {
    "src": "Telzir 50 mg/ ml oral suspension.",
    "display_src": "Telzir 50 mg/ ml oral suspension.",
    "ref": "Telzir 50 mg/ml Suspension zum Einnehmen",
    "show_ref": false
  },
  {
    "src": "No comparative studies have been undertaken in children or adolescents.",
    "display_src": "No comparative studies have been undertaken in children or adolescents.",
    "ref": "Es wurden keine Vergleichsstudien bei Kindern oder Jugendlichen durchgef\u00fchrt.",
    "show_ref": false
  },
  {
    "src": "Common but generally asymptomatic cases of splenomegaly and very rare cases of splenic rupture have been reported in healthy donors and patients following administration of G-CSFs (see section 4.4).",
    "display_src": "Common but generally asymptomatic cases of splenomegaly and very rare cases of splenic rupture have been reported in healthy donors and patients following administration of G-CSFs (see section 4.4).",
    "ref": "Nach Gabe von G-CSFs wurden bei gesunden Spendern und Patienten h\u00e4ufig Splenomegalien, die aber im Allgemeinen asymptomatisch verliefen, sowie in sehr seltenen F\u00e4llen Milzrupturen beschrieben (siehe Abschnitt 4.4).",
    "show_ref": false
  },
  {
    "src": "Emtricitabine and tenofovir individually and in combination have shown activity against HBV in pharmacodynamic studies (see section 5.1).",
    "display_src": "Emtricitabine and tenofovir individually and in combination have shown activity against HBV in pharmacodynamic studies (see section 5.1).",
    "ref": "In pharmakodynamischen Studien haben Emtricitabin und Tenofovir einzeln und in Kombination eine Aktivit\u00e4t gegen HBV gezeigt (siehe Abschnitt 5.1).",
    "show_ref": false
  },
  {
    "src": "Deutschland Pfizer Pharma GmbH Tel: +49 (0)30 550055-51000",
    "display_src": "Deutschland Pfizer Pharma GmbH Tel: +49 (0)30 550055-51000",
    "ref": "Deutschland Pfizer Pharma GmbH Tel: + 49 (0)30 550055-51000",
    "show_ref": false
  },
  {
    "src": "51 Treatment with Ziagen has not been shown to reduce the risk of passing HIV infection on to others by sexual contact or by blood transfer.",
    "display_src": "51 Treatment with Ziagen has not been shown to reduce the risk of passing HIV infection on to others by sexual contact or by blood transfer.",
    "ref": "Beachten Sie, dass die Behandlung mit Ziagen das Risiko einer \u00dcbertragung von HIV auf andere durch Sexualkontakt oder durch Kontamination mit Blut nicht herabsetzt.",
    "show_ref": false
  },
  {
    "src": "Appropriate care should be exercised when initiating Sitaxentan in patients who discontinued other endothelin receptor antagonists due to liver enzyme abnormalities (see section 4.8).",
    "display_src": "Appropriate care should be exercised when initiating Sitaxentan in patients who discontinued other endothelin receptor antagonists due to liver enzyme abnormalities (see section 4.8).",
    "ref": "Bei Patienten, bei denen andere Endothelin-Rezeptor-Antagonisten wegen Ver\u00e4nderungen der Leberenzyme abgesetzte wurden, sollte der Behandlungsbeginn mit Sitaxentan nur unter entsprechenden Vorsichtsma\u00dfnahmen erfolgen (siehe Abschnitt 4.8).",
    "show_ref": false
  },
  {
    "src": "Intact CYSTAGON hard capsules should not be administered to children under the age of approximately 6 years due to risk of aspiration (see section 4.2).",
    "display_src": "Intact CYSTAGON hard capsules should not be administered to children under the age of approximately 6 years due to risk of aspiration (see section 4.2).",
    "ref": "3 Kinder unter sechs Jahren d\u00fcrfen wegen der Aspirationsgefahr keine intakten CYSTAGON Hartkapseln erhalten (siehe Abschnitt 4.2).",
    "show_ref": false
  },
  {
    "src": "If you notice after 12 hours, then skip the intake and take the next doses as usual.",
    "display_src": "If you notice after 12 hours, then skip the intake and take the next doses as usual.",
    "ref": "Wenn Sie dies erst nach 12 Stunden bemerken, dann lassen Sie diese Einnahme aus und nehmen Sie die n\u00e4chste Dosis wie gew\u00f6hnlich ein.",
    "show_ref": false
  },
  {
    "src": "55 It is important that you contact your doctor immediately if you experience pain in the upper left side of the abdomen or left shoulder pain since this may relate to a problem with your spleen.",
    "display_src": "55 It is important that you contact your doctor immediately if you experience pain in the upper left side of the abdomen or left shoulder pain since this may relate to a problem with your spleen.",
    "ref": "Es ist wichtig, dass Sie sich unverz\u00fcglich mit Ihrem Arzt in Verbindung setzen, wenn es bei Ihnen zu Schmerzen im linken Oberbauch oder an der linken Schulter kommt, da dies in Zusammenhang mit einem Problem mit Ihrer Milz stehen k\u00f6nnte.",
    "show_ref": false
  },
  {
    "src": "Simulect 10 mg powder and solvent for solution for injection or infusion basiliximab",
    "display_src": "Simulect 10 mg powder and solvent for solution for injection or infusion basiliximab",
    "ref": "Simulect 10 mg Pulver und L\u00f6sungsmittel zur Herstellung einer Injektionsl\u00f6sung oder Infusionsl\u00f6sung Basiliximab",
    "show_ref": false
  },
  {
    "src": "Elderly No specific studies have been performed in the elderly, but according to clinical experience dosage adjustment is not required when treating otherwise healthy, elderly patients.",
    "display_src": "Elderly No specific studies have been performed in the elderly, but according to clinical experience dosage adjustment is not required when treating otherwise healthy, elderly patients.",
    "ref": "\u00c4ltere Menschen Es wurden keine spezifischen Studien mit \u00e4lteren Patienten durchgef\u00fchrt, aber aufgrund der klinischen Erfahrung ist bei der Behandlung ansonsten gesunder \u00e4lterer Menschen keine Dosisanpassung erforderlich.",
    "show_ref": false
  },
  {
    "src": "Therapy should be continued only when adequate response is observed.",
    "display_src": "Therapy should be continued only when adequate response is observed.",
    "ref": "Die Behandlung sollte nur fortgesetzt werden, wenn eine ausreichende Wirkung erzielt wird.",
    "show_ref": false
  },
  {
    "src": "Microcrystalline cellulose Hydrogenated vegetable oil Sodium laurilsulfate.",
    "display_src": "Microcrystalline cellulose Hydrogenated vegetable oil Sodium laurilsulfate.",
    "ref": "Mikrokristalline Cellulose Hydriertes pflanzliches \u00d6l Natriumdodecylsulfat",
    "show_ref": false
  },
  {
    "src": "If you have any questions, please talk to a doctor, nurse or pharmacist who is familiar with Enbrel.",
    "display_src": "If you have any questions, please talk to a doctor, nurse or pharmacist who is familiar with Enbrel.",
    "ref": "373 Wenn Sie Fragen haben, sprechen Sie bitte mit einem Arzt, einer medizinischen Fachkraft oder einem Apotheker, die/der mit der Enbrel-Behandlung vertraut ist.",
    "show_ref": false
  },
  {
    "src": "Arixtra is available in pack sizes of 2, 7, 10 and 20 pre-filled syringes.",
    "display_src": "Arixtra is available in pack sizes of 2, 7, 10 and 20 pre-filled syringes.",
    "ref": "Arixtra ist in Packungsgr\u00f6\u00dfen zu 2, 7, 10 und 20 Fertigspritzen zugelassen.",
    "show_ref": false
  },
  {
    "src": "Orlistat has no influence on the ability to drive and use machines.",
    "display_src": "Orlistat has no influence on the ability to drive and use machines.",
    "ref": "Orlistat hat keinen Einfluss auf die Verkehrst\u00fcchtigkeit und die F\u00e4higkeit zum Bedienen von Maschinen.",
    "show_ref": false
  },
  {
    "src": "Genotypic analysis of 203 evaluable sample pairs with HBV DNA \u2265 1,000 copies/ ml at week 104 demonstrated that the primary mutation associated with telbivudine resistance was rtM204I, often associated with mutations rtL180M and rtL80I/ V and infrequently with rtV27A, rtL82M, rtV173L, rtT184I and rtA200V.",
    "display_src": "Genotypic analysis of 203 evaluable sample pairs with HBV DNA \u2265 1,000 copies/ ml at week 104 demonstrated that the primary mutation associated with telbivudine resistance was rtM204I, often associated with mutations rtL180M and rtL80I/ V and infrequently with rtV27A, rtL82M, rtV173L, rtT184I and rtA200V.",
    "ref": "Eine genotypische Analyse von 203 auswertbaren Probenpaaren mit einer HBV-DNA \u2265 1.000 Kopien/ml in Woche 104 zeigte, dass prim\u00e4r die Mutation rtM204I mit einer Telbivudin- 13 Resistenz einherging, h\u00e4ufig in Verbindung mit den Mutationen rtL180M sowie rtL80I/V und gelegentlich mit rtV27A, rtL82M, rtV173L, rtT184I und rtA200V.",
    "show_ref": false
  },
  {
    "src": "Support services work programme covers a wide range of activities crucial to the effective and efficient functioning of the Agency.",
    "display_src": "Support services work programme covers a wide range of activities crucial to the effective and efficient functioning of the Agency.",
    "ref": "Das Arbeitsprogramm des Bereichs Dienstleistungen umfa\u00dft eine breite Palette von T\u00e4tigkeiten, die f\u00fcr den effektiven und effizienten Betrieb der Agentur sehr wichtig sind.",
    "show_ref": false
  },
  {
    "src": "Caution is needed in these patients.",
    "display_src": "Caution is needed in these patients.",
    "ref": "Bei diesen Patienten ist Vorsicht erforderlich.",
    "show_ref": false
  },
  {
    "src": "The marketing authorisation holder is Apotex Europe B. V.",
    "display_src": "The marketing authorisation holder is Apotex Europe B. V.",
    "ref": "Der Inhaber der Zulassung ist Apotex Europe B.V.",
    "show_ref": false
  },
  {
    "src": "It is contained in a clear flexible polyolefine bag with aluminium overpouch containing 100 ml solution.",
    "display_src": "It is contained in a clear flexible polyolefine bag with aluminium overpouch containing 100 ml solution.",
    "ref": "Das Arzneimittel enth\u00e4lt 100 ml L\u00f6sung in einem durchsichtigen, flexiblen Polyolefin-Beutel mit Aluminium Umverpackung.",
    "show_ref": false
  },
  {
    "src": "OLANZAPINE NEOPHARMA 2.5 mg coated tablets OLANZAPINE NEOPHARMA 5 mg coated tablets OLANZAPINE NEOPHARMA 7.5 mg coated tablets OLANZAPINE NEOPHARMA 10 mg coated tablets OLANZAPINE NEOPHARMA 15 mg coated tablets olanzapine",
    "display_src": "OLANZAPINE NEOPHARMA 2.5 mg coated tablets OLANZAPINE NEOPHARMA 5 mg coated tablets OLANZAPINE NEOPHARMA 7.5 mg coated tablets OLANZAPINE NEOPHARMA 10 mg coated tablets OLANZAPINE NEOPHARMA 15 mg coated tablets olanzapine",
    "ref": "OLANZAPIN NEOPHARMA 2,5 mg \u00fcberzogene Tabletten OLANZAPIN NEOPHARMA 5 mg \u00fcberzogene Tabletten OLANZAPIN NEOPHARMA 7,5 mg \u00fcberzogene Tabletten OLANZAPIN NEOPHARMA 10 mg \u00fcberzogene Tabletten OLANZAPIN NEOPHARMA 15 mg \u00fcberzogene Tabletten Olanzapin",
    "show_ref": false
  },
  {
    "src": "Elderly Although higher ciprofloxacin serum levels are found in the elderly, no adjustment of dosage is necessary.",
    "display_src": "Elderly Although higher ciprofloxacin serum levels are found in the elderly, no adjustment of dosage is necessary.",
    "ref": "\u00c4ltere Auch wenn bei \u00c4lteren h\u00f6here Ciprofloxacin-Serumspiegel vorhanden sind, ist keine Anpassung der Dosierung erforderlich.",
    "show_ref": false
  },
  {
    "src": "Dose adjustment of Mimpara may be necessary (see section 4.5).",
    "display_src": "Dose adjustment of Mimpara may be necessary (see section 4.5).",
    "ref": "Eine Dosisanpassung von Mimpara kann notwendig sein (siehe Abschnitt 4.5).",
    "show_ref": false
  },
  {
    "src": "Gliolan contains a substance called aminolevulinic acid hydrochloride (5-ALA).",
    "display_src": "Gliolan contains a substance called aminolevulinic acid hydrochloride (5-ALA).",
    "ref": "Gliolan enth\u00e4lt eine Substanz namens 5-Amino-4-oxopentans\u00e4ure-hydrochlorid (5-ALA).",
    "show_ref": false
  },
  {
    "src": "This bacterium is often present with Pasteurella multocida and makes the disease worse.",
    "display_src": "This bacterium is often present with Pasteurella multocida and makes the disease worse.",
    "ref": "Dieses Bakterium ist oft zusammen mit Pasteurella multocida vorhanden und verschlimmert die Erkrankung.",
    "show_ref": false
  },
  {
    "src": "No dose adjustment is necessary in patients with mild to moderate hepatic impairment (see sections 4.4 and 5.2).",
    "display_src": "No dose adjustment is necessary in patients with mild to moderate hepatic impairment (see sections 4.4 and 5.2).",
    "ref": "Bei Patienten mit leichter bis m\u00e4\u00dfiger Leberfunktionsst\u00f6rung ist keine Dosisanpassung erforderlich (siehe Abschnitt 4.4 und 5.2).",
    "show_ref": false
  },
  {
    "src": "1.3 Adjusting the internal structure of the EMEA",
    "display_src": "1.3 Adjusting the internal structure of the EMEA",
    "ref": "1.3 Anpassung des internen Aufbaus der Agentur",
    "show_ref": false
  },
  {
    "src": "Graduate in biochemistry and pharmacology from Leeds University.",
    "display_src": "Graduate in biochemistry and pharmacology from Leeds University.",
    "ref": "Abschluss in Biochemie und Pharmakologie an der Universit\u00e4t Leeds.",
    "show_ref": false
  },
  {
    "src": "When paclitaxel is given before cisplatin, the safety profile of paclitaxel is consistent with that reported for single-agent use.",
    "display_src": "When paclitaxel is given before cisplatin, the safety profile of paclitaxel is consistent with that reported for single-agent use.",
    "ref": "Wenn Paclitaxel vor der Cisplatingabe verabreicht wird, entspricht die Vertr\u00e4glichkeit der, die \u00fcber Paclitaxel als Monotherapie berichtet wurde.",
    "show_ref": false
  },
  {
    "src": "Zidovudine has no effect on the pharmacokinetics of lamivudine (see section 5.2).",
    "display_src": "Zidovudine has no effect on the pharmacokinetics of lamivudine (see section 5.2).",
    "ref": "Zidovudin hat keine Auswirkungen auf die Pharmakokinetik von Lamivudin (siehe Abschnitt 5.2).",
    "show_ref": false
  },
  {
    "src": "If you are allergic (hypersensitive) to stavudine or any of the other ingredients of Zerit.",
    "display_src": "If you are allergic (hypersensitive) to stavudine or any of the other ingredients of Zerit.",
    "ref": "Zerit darf nicht eingenommen werden, wenn Sie \u00fcberempfindlich (allergisch) gegen Stavudin oder einen der sonstigen Bestandteile von Zerit sind.",
    "show_ref": false
  },
  {
    "src": "This was followed by monotherapy TMZ (150 - 200 mg/m2) on Days 1 - 5 of every 28-day cycle for up to 6 cycles, starting 4 weeks after the end of RT.",
    "display_src": "This was followed by monotherapy TMZ (150 - 200 mg/m2) on Days 1 - 5 of every 28-day cycle for up to 6 cycles, starting 4 weeks after the end of RT.",
    "ref": "Danach folgte, 4 Wochen nach dem Ende der RT beginnend, eine TMZ-Monotherapie (150 \u2013 200 mg/m2) an den Tagen 1-5 jedes 28-t\u00e4gigen Zyklus, \u00fcber bis zu 6 Zyklen.",
    "show_ref": false
  },
  {
    "src": "For skin disinfection use an appropriate disinfectant.",
    "display_src": "For skin disinfection use an appropriate disinfectant.",
    "ref": "Verwenden Sie zur Hautdesinfektion ein geeignetes Desinfektionsmittel.",
    "show_ref": false
  },
  {
    "src": "In the studies looking at Cholestagel taken alone, more than half of the patients receiving 3.8 or 4.5 g Cholestagel (about six to seven tablets) had a decrease in LDL cholesterol levels of 15 to 18% after six weeks.",
    "display_src": "In the studies looking at Cholestagel taken alone, more than half of the patients receiving 3.8 or 4.5 g Cholestagel (about six to seven tablets) had a decrease in LDL cholesterol levels of 15 to 18% after six weeks.",
    "ref": "In den Studien an Cholestagel allein wies die H\u00e4lfte der Patienten, die 3,8 oder 4,5 g Cholestagel erhielten (etwa sechs bis sieben Tabletten), nach sechs Wochen eine Senkung des LDL-Cholesterin- Spiegels um 15 bis 18% auf.",
    "show_ref": false
  },
  {
    "src": "If a bisphosphonate or sodium fluoride is used concomitantly, this preparation should be administered at least three hours before the intake of Calcitugg (and associated names) since gastrointestinal absorption may be reduced.",
    "display_src": "If a bisphosphonate or sodium fluoride is used concomitantly, this preparation should be administered at least three hours before the intake of Calcitugg (and associated names) since gastrointestinal absorption may be reduced.",
    "ref": "Bei gleichzeitiger Behandlung mit Biphosphonat- oder Natriumfluorid-Pr\u00e4paraten sollten diese wegen des Risikos einer eingeschr\u00e4nkten Resorption im Gastrointestinaltrakt mindestens drei Stunden vor Calcitugg eingenommen werden.",
    "show_ref": false
  },
  {
    "src": "\u2022 The CHMP agreed on the indication:",
    "display_src": "\u2022 The CHMP agreed on the indication:",
    "ref": "\u2022 Der CHMP einigte sich auf die Indikation:",
    "show_ref": false
  },
  {
    "src": "Achieving a radiological objective response or maintaining progression-free status was strongly associated with maintained or improved quality of life.",
    "display_src": "Achieving a radiological objective response or maintaining progression-free status was strongly associated with maintained or improved quality of life.",
    "ref": "Ein radiologisch gesichertes, objektives Ansprechen oder eine Aufrechterhaltung des progressionsfreien Zustandes war eng mit einer Aufrechterhaltung oder einer Verbesserung der Lebensqualit\u00e4t assoziiert.",
    "show_ref": false
  },
  {
    "src": "Sufficient experience is still lacking in the treatment of patients with severe (NYHA IV) heart failure immediately after myocardial infarction.",
    "display_src": "Sufficient experience is still lacking in the treatment of patients with severe (NYHA IV) heart failure immediately after myocardial infarction.",
    "ref": "Die Erfahrung bei der Behandlung von Patienten mit schwerer Herzinsuffizienz (NYHA IV) unmittelbar nach einem Myokardinfarkt ist begrenzt.",
    "show_ref": false
  },
  {
    "src": "Latvija Abbott Laboratories Baltics Vien\u012b bas 87h LV-1004 R\u012b ga Tel: + 371 67605580 Lietuva Abbott Laboratories Baltics Vien\u012b bas 87h LV-1004 R\u012b ga Latvija Tel: + 371 67605580",
    "display_src": "Latvija Abbott Laboratories Baltics Vien\u012b bas 87h LV-1004 R\u012b ga Tel: + 371 67605580 Lietuva Abbott Laboratories Baltics Vien\u012b bas 87h LV-1004 R\u012b ga Latvija Tel: + 371 67605580",
    "ref": "Latvija Abbott Laboratories Baltics Vien\u012b bas 87h LV-1004 R\u012b ga Tel: + 371 67605580",
    "show_ref": false
  },
  {
    "src": "The maximum retrievable dose is 125 mg per 1.25 ml of Raptiva.",
    "display_src": "The maximum retrievable dose is 125 mg per 1.25 ml of Raptiva.",
    "ref": "Die maximal entnehmbare Menge ist 125 mg pro 1,25 ml Raptiva.",
    "show_ref": false
  },
  {
    "src": "Although gag reflex may be absent in deeply comatose patients, even unconscious patients may become combative to intubation, and rapid sequence induction (without the use of sedative) should be considered.",
    "display_src": "Although gag reflex may be absent in deeply comatose patients, even unconscious patients may become combative to intubation, and rapid sequence induction (without the use of sedative) should be considered.",
    "ref": "Obwohl der W\u00fcrgereflex bei tief komat\u00f6sen Patienten m\u00f6glicherweise nicht mehr vorhanden ist, k\u00f6nnen selbst bewusstlose Patienten aggressiv auf eine Intubation reagieren; daher sollte eine schnelle Einleitung (ohne Anwendung eines Sedativums) erfolgen.",
    "show_ref": false
  },
  {
    "src": "containing 75 mg 13C-urea powder for oral solution Labelled sample glass or plastic containers for sampling, storing and transporting the breath samples for analysis:",
    "display_src": "containing 75 mg 13C-urea powder for oral solution Labelled sample glass or plastic containers for sampling, storing and transporting the breath samples for analysis:",
    "ref": "Schnappdeckel) mit 75 mg 13C-Harnstoff Pulver zur Herstellung einer L\u00f6sung zum Einnehmen Etikettierte Glas- oder Plastikbeh\u00e4ltnisse zur Aufnahme, Aufbe- wahrung und Transport der Atemproben zur Analyse:",
    "show_ref": false
  },
  {
    "src": "Studies in new-born infants or infants and toddlers under 2 years of age have not been conducted.",
    "display_src": "Studies in new-born infants or infants and toddlers under 2 years of age have not been conducted.",
    "ref": "Studien bei Neugeborenen oder S\u00e4uglingen und Kleinkindern unter 2 Jahren wurden nicht durchgef\u00fchrt.",
    "show_ref": false
  },
  {
    "src": "People with Pompe disease have low levels of an enzyme called \u03b1 -glucosidase.",
    "display_src": "People with Pompe disease have low levels of an enzyme called \u03b1 -glucosidase.",
    "ref": "Patienten, die unter Morbus Pompe leiden, haben niedrige Konzentrationen eines Enzyms namens \u03b1 - Glucosidase.",
    "show_ref": false
  },
  {
    "src": "In the adolescent population (n=83) (aged from 12 to < 18 years), significantly more patients treated with adefovir dipivoxil achieved the primary efficacy endpoint and obtained significant reductions in serum HBV DNA (23%) compared to placebo-treated patients (0%).",
    "display_src": "In the adolescent population (n=83) (aged from 12 to < 18 years), significantly more patients treated with adefovir dipivoxil achieved the primary efficacy endpoint and obtained significant reductions in serum HBV DNA (23%) compared to placebo-treated patients (0%).",
    "ref": "Bei Jugendlichen (n=83) im Alter von 12 bis < 18 Jahren erreichten signifikant mehr Patienten, die mit Adefovirdipivoxil behandelt wurden den prim\u00e4ren Endpunkt und zeigten eine signifikante Reduktion der Serum-HBV-DNA (23%) verglichen mit den mit Placebo behandelten Patienten (0%).",
    "show_ref": false
  },
  {
    "src": "The full EPAR for Ovitrelle is available here.",
    "display_src": "The full EPAR for Ovitrelle is available here.",
    "ref": "Den vollst\u00e4ndigen Wortlaut des EPAR f\u00fcr Ovitrelle finden Sie hier.",
    "show_ref": false
  },
  {
    "src": "Powder for solution for injection Yellow lyophilised powder.",
    "display_src": "Powder for solution for injection Yellow lyophilised powder.",
    "ref": "Pulver zur Herstellung einer Injektionsl\u00f6sung Gelbes lyophilisiertes Pulver.",
    "show_ref": false
  },
  {
    "src": "Apparent local reactions after intradermal administration were more frequent than after the comparator vaccine administered intramuscularly.",
    "display_src": "Apparent local reactions after intradermal administration were more frequent than after the comparator vaccine administered intramuscularly.",
    "ref": "Sichtbare Lokalreaktionen waren nach intradermaler Verabreichung h\u00e4ufiger als beim Vergleichsimpfstoff, der intramuskul\u00e4r verabreicht wurde.",
    "show_ref": false
  },
  {
    "src": "In a study in healthy subjects, daily administration of etoricoxib 120 mg did not alter hepatic CYP3A4 activity as assessed by the erythromycin breath test.",
    "display_src": "In a study in healthy subjects, daily administration of etoricoxib 120 mg did not alter hepatic CYP3A4 activity as assessed by the erythromycin breath test.",
    "ref": "In einer Studie an gesunden Probanden ver\u00e4nderte die t\u00e4gliche Anwendung von Etoricoxib 120 mg die hepatische CYP3A4-Aktivit\u00e4t nicht, wie mittels des Erythromycin-Atemtests gemessen wurde.",
    "show_ref": false
  },
  {
    "src": "Each vial contains doripenem monohydrate equivalent to",
    "display_src": "Each vial contains doripenem monohydrate equivalent to",
    "ref": "Jede Durchstechflasche enth\u00e4lt Doripenem-Monohydrat",
    "show_ref": false
  },
  {
    "src": "conduction times or corrected QT intervals;",
    "display_src": "conduction times or corrected QT intervals;",
    "ref": "oder intraventrikul\u00e4re Erregungsleitungszeiten oder korrigierte QT-Intervalle;",
    "show_ref": false
  },
  {
    "src": "38.17 \u00b5g) of the pooled fine particle dose for stages 3/ 4/ 5.",
    "display_src": "38.17 \u00b5g) of the pooled fine particle dose for stages 3/ 4/ 5.",
    "ref": "38,17 \u00b5g) zu der Feinpartikeldosis in den gruppierten Stufen 3/4/5.",
    "show_ref": false
  },
  {
    "src": "Active tuberculosis or other severe infections such as sepsis, and opportunistic infections (see section 4.4).",
    "display_src": "Active tuberculosis or other severe infections such as sepsis, and opportunistic infections (see section 4.4).",
    "ref": "Aktive Tuberkulose oder andere schwere Infektionen wie Sepsis und opportunistische Infektionen (siehe Abschnitt 4.4).",
    "show_ref": false
  },
  {
    "src": "However, a number of concerns were raised by the objecting CMS which did not consider the second renewal acceptable.",
    "display_src": "However, a number of concerns were raised by the objecting CMS which did not consider the second renewal acceptable.",
    "ref": "Allerdings wurde von den Einspruch erhebenden betroffenen Mitgliedstaaten (CMS), die eine zweite Verl\u00e4ngerung als nicht akzeptabel betrachteten, eine Reihe von Fragen aufgeworfen.",
    "show_ref": false
  },
  {
    "src": "The Committee recommended that Stocrin be given marketing authorisation.",
    "display_src": "The Committee recommended that Stocrin be given marketing authorisation.",
    "ref": "Der Ausschuss empfahl, die Genehmigung f\u00fcr das Inverkehrbringen von Stocrin zu erteilen.",
    "show_ref": false
  },
  {
    "src": "- asthma or other breathing problems,",
    "display_src": "- asthma or other breathing problems,",
    "ref": "- ein Asthma bronchiale oder sonstige Atemprobleme vorliegen.",
    "show_ref": false
  },
  {
    "src": "CVMP decided not to review the ecotoxicity, as this was considered not applicable in the framework of the procedure.",
    "display_src": "CVMP decided not to review the ecotoxicity, as this was considered not applicable in the framework of the procedure.",
    "ref": "Der CVMP kam \u00fcberein, die \u00d6kotoxizit\u00e4t nicht zu pr\u00fcfen, da dies im Rahmen des Verfahrens als nicht durchf\u00fchrbar erachtet wurde.",
    "show_ref": false
  },
  {
    "src": "If these signs occur, tell your doctor immediately, or visit the casualty department at your nearest hospital.",
    "display_src": "If these signs occur, tell your doctor immediately, or visit the casualty department at your nearest hospital.",
    "ref": "Wenn diese Symptome auftreten, informieren Sie unverz\u00fcglich Ihren Arzt oder gehen Sie in die n\u00e4chste Krankenhaus-Notaufnahme.",
    "show_ref": false
  },
  {
    "src": "r ge Tel: + 371 7312687 lv-epasts@gsk.com",
    "display_src": "r ge Tel: + 371 7312687 lv-epasts@gsk.com",
    "ref": "Tel: + 371 7312687 lv-epasts@gsk.com Ar",
    "show_ref": false
  },
  {
    "src": "Each tablet contains 1 mg sirolimus.",
    "display_src": "Each tablet contains 1 mg sirolimus.",
    "ref": "Jede Tablette Rapamune enth\u00e4lt 1 mg Sirolimus.",
    "show_ref": false
  },
  {
    "src": "71 The following side effects have been reported with Cozaar:",
    "display_src": "71 The following side effects have been reported with Cozaar:",
    "ref": "\u00dcber folgende Nebenwirkungen wurde bei < Cozaar > berichtet:",
    "show_ref": false
  },
  {
    "src": "- the potentially life threatening condition,",
    "display_src": "- the potentially life threatening condition,",
    "ref": "- des potentiell lebensbedrohlichen Zustands,",
    "show_ref": false
  },
  {
    "src": "Patients taking CellCept should have complete blood counts weekly during the first month, twice monthly for the second and third months of treatment, then monthly through the first year.",
    "display_src": "Patients taking CellCept should have complete blood counts weekly during the first month, twice monthly for the second and third months of treatment, then monthly through the first year.",
    "ref": "Bei Patienten, die mit CellCept behandelt werden, soll ein komplettes Blutbild w\u00e4hrend des ersten Monats der Behandlung w\u00f6chentlich, w\u00e4hrend des zweiten und dritten Monats der Behandlung zweimal pro Monat und dann monatlich f\u00fcr die restlichen 9 Monate des ersten Behandlungsjahres erhoben werden.",
    "show_ref": false
  },
  {
    "src": "Atripla is not recommended for patients who have moderate or severe problems with their kidneys.",
    "display_src": "Atripla is not recommended for patients who have moderate or severe problems with their kidneys.",
    "ref": "Atripla wird nicht empfohlen bei Patienten mit mittelgradigen oder schweren Nierenproblemen.",
    "show_ref": false
  },
  {
    "src": "Liver function test abnormalities or hepatitis**",
    "display_src": "Liver function test abnormalities or hepatitis**",
    "ref": "Abweichungen der Leberwerte oder Hepatitis**",
    "show_ref": false
  },
  {
    "src": "Antiemetics and Antinauseants, ATCvet code:",
    "display_src": "Antiemetics and Antinauseants, ATCvet code:",
    "ref": "Antiemetika und Mittel gegen \u00dcbelkeit, ATCvet-Code:",
    "show_ref": false
  },
  {
    "src": "For polyarticular juvenile idiopathic arthritis, Humira was compared with placebo, alone or as an add- on to methotrexate, in one main study involving 171 patients aged between four and 17 years.",
    "display_src": "For polyarticular juvenile idiopathic arthritis, Humira was compared with placebo, alone or as an add- on to methotrexate, in one main study involving 171 patients aged between four and 17 years.",
    "ref": "Bei polyartikul\u00e4rer juveniler idiopathischer Arthritis wurde Humira als Monotherapie oder als Zusatztherapie zu Methotrexat in einer Hauptstudie an 171 Patienten im Alter zwischen vier und 17 Jahren mit Placebo verglichen.",
    "show_ref": false
  },
  {
    "src": "Hepsera is not recommended for use in patients with severe kidney disease or who are on dialysis (a blood clearing technique) \u2013 its use should only be considered in these patients if its potential benefits are greater than its potential risks.",
    "display_src": "Hepsera is not recommended for use in patients with severe kidney disease or who are on dialysis (a blood clearing technique) \u2013 its use should only be considered in these patients if its potential benefits are greater than its potential risks.",
    "ref": "Hepsera wird nicht empfohlen f\u00fcr Patienten mit schweren Nierenerkrankungen oder Dialyse-Patienten (die Dialyse ist ein Blutreinigungsverfahren) \u2013 bei diesen Patienten sollte die Anwendung des Arzneimittels nur in Erw\u00e4gung gezogen werden, wenn die potenziellen Vorteile gegen\u00fcber den potenziellen Risiken \u00fcberwiegen.",
    "show_ref": false
  },
  {
    "src": "Percentage change in PSA from baseline by treatment group until day 56 (median with interquartile ranges).",
    "display_src": "Percentage change in PSA from baseline by treatment group until day 56 (median with interquartile ranges).",
    "ref": "Prozentuale Ver\u00e4nderung des PSA-Wertes f\u00fcr beide Gruppen von Baseline bis Tag 56 (Median mit interquartilen Bereichen).",
    "show_ref": false
  },
  {
    "src": "The effect of bodyweight on the clearance of imatinib is such that for a patient weighing 50 kg the mean clearance is expected to be 8.5 l/ h, while for a patient weighing 100 kg the clearance will rise to 11.8 l/ h.",
    "display_src": "The effect of bodyweight on the clearance of imatinib is such that for a patient weighing 50 kg the mean clearance is expected to be 8.5 l/ h, while for a patient weighing 100 kg the clearance will rise to 11.8 l/ h.",
    "ref": "Der Einfluss des K\u00f6rpergewichts auf die Clearance von Imatinib zeigt sich darin, dass bei einem Patienten von 50 kg eine mittlere Clearance von 8,5 l/h erwartet werden kann, w\u00e4hrend bei einem Patienten von 100 kg die Clearance auf 11,8 l/h ansteigt.",
    "show_ref": false
  },
  {
    "src": "- Blood test results show higher levels of liver enzymes, amylase, lipase or creatine kinase",
    "display_src": "- Blood test results show higher levels of liver enzymes, amylase, lipase or creatine kinase",
    "ref": "- Erh\u00f6hte Konzentrationen an Leberenzymen, Amylase, Lipase oder Kreatinkinase im Rahmen",
    "show_ref": false
  },
  {
    "src": "ad hoc group on osteoporosis treatment and prevention of osteoporosis in women.",
    "display_src": "ad hoc group on osteoporosis treatment and prevention of osteoporosis in women.",
    "ref": "Ad-hoc-Arbeitsgruppe f\u00fcr Pr\u00e4vention und Behandlung der Osteoporose bei Frauen.",
    "show_ref": false
  },
  {
    "src": "This randomised study compared the combination of cetuximab and radiation therapy (211 patients) with radiation therapy alone (213 patients) in patients with locally advanced squamous cell cancer of the head and neck.",
    "display_src": "This randomised study compared the combination of cetuximab and radiation therapy (211 patients) with radiation therapy alone (213 patients) in patients with locally advanced squamous cell cancer of the head and neck.",
    "ref": "In dieser randomisierten Studie wurde bei Patienten mit lokal fortgeschrittenem Plattenepithelkarzinom im Kopf- und Halsbereich die Kombination von Cetuximab und einer Strahlentherapie (211 Patienten) verglichen mit einer alleinigen Strahlentherapie (213 Patienten).",
    "show_ref": false
  },
  {
    "src": "Relationship between concentration and effect Fosaprepitant is a prodrug of aprepitant.",
    "display_src": "Relationship between concentration and effect Fosaprepitant is a prodrug of aprepitant.",
    "ref": "Konzentrations-Wirkungsbeziehung Fosaprepitant ist eine Vorstufe (Prodrug) von Aprepitant.",
    "show_ref": false
  },
  {
    "src": "7 90% of cytarabine was excreted by day 4 and an additional 2.7% by 21 days.",
    "display_src": "7 90% of cytarabine was excreted by day 4 and an additional 2.7% by 21 days.",
    "ref": "Tag wurden mehr als 90% des Cytarabins ausgeschieden und weitere 2,7% bis Tag 21.",
    "show_ref": false
  },
  {
    "src": "Infanrix hexa is available in packs of 1, 10, 20 and 50 with or without needles.",
    "display_src": "Infanrix hexa is available in packs of 1, 10, 20 and 50 with or without needles.",
    "ref": "Infanrix hexa ist in Einzel-, Zehner-, Zwanziger- und F\u00fcnfzigerpackungen mit oder ohne Nadeln/Kan\u00fclen erh\u00e4ltlich.",
    "show_ref": false
  },
  {
    "src": "The studies showed that the vaccine is safe for sheep and cattle and that it reduces the signs of the disease and viraemia in animals from one month of age that are infected with bluetongue virus serotype 8.",
    "display_src": "The studies showed that the vaccine is safe for sheep and cattle and that it reduces the signs of the disease and viraemia in animals from one month of age that are infected with bluetongue virus serotype 8.",
    "ref": "Die Studien zeigten, dass der Impfstoff f\u00fcr Rinder und Schafe sicher ist und Krankheitsanzeichen und Vir\u00e4mie bei Tieren ab einem Alter von einem Monat, die mit dem Blauzungenvirus Serotyp 8 infiziert sind, verringert.",
    "show_ref": false
  },
  {
    "src": "For restless legs syndrome, Mirapexin should be taken once a day, two to three hours before going to bed.",
    "display_src": "For restless legs syndrome, Mirapexin should be taken once a day, two to three hours before going to bed.",
    "ref": "Beim Restless-Legs-Syndrom sollte Mirapexin einmal t\u00e4glich zwei bis drei Stunden vor dem Schlafengehen eingenommen werden.",
    "show_ref": false
  },
  {
    "src": "The capsule shell consists of gelatine, iron oxide black, red and yellow (E172), indigocarmine (E132), titanium dioxide (E171), and the printing ink contains titanium dioxide (E 171), shellac, soya lecithin, polydimethylsiloxane.",
    "display_src": "The capsule shell consists of gelatine, iron oxide black, red and yellow (E172), indigocarmine (E132), titanium dioxide (E171), and the printing ink contains titanium dioxide (E 171), shellac, soya lecithin, polydimethylsiloxane.",
    "ref": "Die Kapselh\u00fclle besteht aus Gelatine, Eisenoxidhydrat (E 172), Eisen(II,III)-oxid (E 172), Eisen(III)-oxid (E 172), Indigocarmin (E 132), Titandioxid (E 171), und die Drucktinte enth\u00e4lt Titandioxid (E 171), Schellack, Soja-Lecithin und Polydimethylsiloxan.",
    "show_ref": false
  },
  {
    "src": "No drug interaction study has been performed for the co-administration of Agenerase with benzodiazepines.",
    "display_src": "No drug interaction study has been performed for the co-administration of Agenerase with benzodiazepines.",
    "ref": "Es wurde keine Interaktionsstudie zur gleichzeitigen Anwendung von Agenerase mit Benzodiazepinen durchgef\u00fchrt.",
    "show_ref": false
  },
  {
    "src": "Dose titration and maintenance therapy The patch should be replaced every 72 hours.",
    "display_src": "Dose titration and maintenance therapy The patch should be replaced every 72 hours.",
    "ref": "Dosistitration und Erhaltungstherapie Das Pflaster sollte alle 72 Stunden ersetzt werden.",
    "show_ref": false
  },
  {
    "src": "- painful eye movement,",
    "display_src": "- painful eye movement,",
    "ref": "- schmerzhafte Augenbewegungen,",
    "show_ref": false
  },
  {
    "src": "Therefore, patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.",
    "display_src": "Therefore, patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.",
    "ref": "Patienten mit der seltenen, heredit\u00e4ren Fructose- / Galactose- Intoleranz, einer Glucose-Galactose-Malabsorption oder einer Sucrase-Isomaltase-Insuffizienz sollten dieses Arzneimittel nicht anwenden.",
    "show_ref": false
  },
  {
    "src": "No survival benefit or other clinically relevant effects of the treatment have been demonstrated in patients with EGFR- negative tumours (see section 5.1).",
    "display_src": "No survival benefit or other clinically relevant effects of the treatment have been demonstrated in patients with EGFR- negative tumours (see section 5.1).",
    "ref": "Bei Patienten mit EGFR-negativen Tumoren konnten weder ein \u00dcberlebensvorteil noch andere klinisch relevante Wirkungen durch die Behandlung gezeigt werden (siehe Abschnitt 5.1).",
    "show_ref": false
  },
  {
    "src": "Livezeni, Nr 7A T\u00e2rgu Mure\u015f 540472 \u2013 RO Tel: + 40 265 208 120",
    "display_src": "Livezeni, Nr 7A T\u00e2rgu Mure\u015f 540472 \u2013 RO Tel: + 40 265 208 120",
    "ref": "Livezeni, Nr 7A T\u00e2rgu Mure\u015f 540472 \u2013 - RO Tel: + 40 265 208 120",
    "show_ref": false
  },
  {
    "src": "Torrent i Farnell worked in internal medicine and clinical pharmacology in Spain and was Assistant Professor of Pharmacology at UAB.",
    "display_src": "Torrent i Farnell worked in internal medicine and clinical pharmacology in Spain and was Assistant Professor of Pharmacology at UAB.",
    "ref": "Torrent i Farnell in Spanien im Bereich der inneren Medizin und klinischen Pharmakologie sowie als Assistenzprofessor f\u00fcr Pharmakologie an der UAB t\u00e4tig.",
    "show_ref": false
  },
  {
    "src": "House, 97/ 107 Uxbridge Road, Ealing London W5 5TL, United Kingdom",
    "display_src": "House, 97/ 107 Uxbridge Road, Ealing London W5 5TL, United Kingdom",
    "ref": "House, 97/107 Uxbridge Road, Ealing London W5 5TL, Vereinigtes K\u00f6nigreich",
    "show_ref": false
  },
  {
    "src": "Caution should be exercised in patients at risk, such as elderly patients or patients concomitantly treated with medications known to cause hyponatraemia.",
    "display_src": "Caution should be exercised in patients at risk, such as elderly patients or patients concomitantly treated with medications known to cause hyponatraemia.",
    "ref": "Bei Risikopatienten wie \u00e4lteren Patienten oder Patienten, die gleichzeitig mit Arzneimitteln behandelt werden, von denen bekannt ist, dass sie Hyponatri\u00e4mie verursachen, sollte mit Vorsicht vorgegangen werden.",
    "show_ref": false
  },
  {
    "src": "Hypersensitivity Reactions Postmarketing reports of serious hypersensitivity reactions in patients treated with Januvia have been reported.",
    "display_src": "Hypersensitivity Reactions Postmarketing reports of serious hypersensitivity reactions in patients treated with Januvia have been reported.",
    "ref": "\u00dcberempfindlichkeitsreaktionen Nach Markteinf\u00fchrung wurde bei Patienten unter Januvia \u00fcber schwerwiegende \u00dcberempfindlichkeitsreaktionen berichtet.",
    "show_ref": false
  },
  {
    "src": "Always use EVRA exactly as described in this leaflet. \u2022 If you do not, you may increase your risk of getting pregnant \u2022 Check with your doctor or pharmacist if you are not sure \u2022 Always keep non-hormonal contraceptives (such as condoms, foam or sponge) as a back-up in case you make a mistake when using the patch.",
    "display_src": "Always use EVRA exactly as described in this leaflet. \u2022 If you do not, you may increase your risk of getting pregnant \u2022 Check with your doctor or pharmacist if you are not sure \u2022 Always keep non-hormonal contraceptives (such as condoms, foam or sponge) as a back-up in case you make a mistake when using the patch.",
    "ref": "Wenden Sie EVRA immer genau wie in dieser Packungsbeilage beschrieben an. \u2022 Wenn Sie das nicht tun, erh\u00f6hen Sie Ihr Risiko, schwanger zu werden \u2022 Bitte fragen Sie Ihren Arzt oder Apotheker, wenn Sie sich nicht ganz sicher sind \u2022 Halten Sie immer nicht-hormonelle Verh\u00fctungsmittel (wie zum Beispiel Kondome, Schaum oder Schwamm) vorr\u00e4tig, falls Sie bei der Anwendung des Pflasters einen Fehler machen.",
    "show_ref": false
  },
  {
    "src": "Therefore, men being treated with gemcitabine are advised not to father a child during and up to 6 months after treatment and to seek further advice regarding cryoconservation of sperm prior to treatment because of the possibility of infertility due to therapy with gemcitabine.",
    "display_src": "Therefore, men being treated with gemcitabine are advised not to father a child during and up to 6 months after treatment and to seek further advice regarding cryoconservation of sperm prior to treatment because of the possibility of infertility due to therapy with gemcitabine.",
    "ref": "Daher wird M\u00e4nnern empfohlen, w\u00e4hrend der Behandlung mit Gemcitabin und bis zu 6 Monate danach kein Kind zu zeugen und sich wegen der M\u00f6glichkeit der Infertilit\u00e4t durch eine Gemcitabin-Therapie \u00fcber eine Kryokonservierung von Sperma beraten zu lassen.",
    "show_ref": false
  },
  {
    "src": "This combination of salmeterol and fluticasone propionate when used regularly prevents asthma attacks occurring.",
    "display_src": "This combination of salmeterol and fluticasone propionate when used regularly prevents asthma attacks occurring.",
    "ref": "Diese Kombination von Salmeterol und Fluticasonpropionat verhindert Asthmaanf\u00e4lle, wenn sie regelm\u00e4\u00dfig angewendet wird.",
    "show_ref": false
  },
  {
    "src": "Based on non-clinical findings, male and female fertility may be compromised by treatment with SUTENT (see section 5.3).",
    "display_src": "Based on non-clinical findings, male and female fertility may be compromised by treatment with SUTENT (see section 5.3).",
    "ref": "Aufgrund pr\u00e4klinischer Ergebnisse besteht die M\u00f6glichkeit, dass die m\u00e4nnliche und weibliche Fruchtbarkeit durch eine Behandlung mit SUTENT beeintr\u00e4chtigt wird (siehe Abschnitt 5.3).",
    "show_ref": false
  },
  {
    "src": "Before you inject Zarzio you must do the following:",
    "display_src": "Before you inject Zarzio you must do the following:",
    "ref": "Bevor Sie Zarzio injizieren, m\u00fcssen Sie Folgendes tun:",
    "show_ref": false
  },
  {
    "src": "7 AVAGLIM Data from double-blind studies confirm that the safety profile of concomitant rosiglitazone and glimepiride is similar to that of the combined adverse reaction profile for the two active substances.",
    "display_src": "7 AVAGLIM Data from double-blind studies confirm that the safety profile of concomitant rosiglitazone and glimepiride is similar to that of the combined adverse reaction profile for the two active substances.",
    "ref": "AVAGLIM Daten aus Doppelblindstudien best\u00e4tigen, dass das Sicherheitsprofil der gleichzeitigen Anwendung von Rosiglitazon und Glimepirid dem kombinierten Nebenwirkungsprofil der beiden Wirkstoffe \u00e4hnlich ist.",
    "show_ref": false
  },
  {
    "src": "Patients taking ORENCIA also had a greater improvement in physical function after 6 months.",
    "display_src": "Patients taking ORENCIA also had a greater improvement in physical function after 6 months.",
    "ref": "Patienten unter ORENCIA wiesen nach sechsmonatiger Behandlung au\u00dferdem eine deutlichere Verbesserung der Gelenkfunktionen auf.",
    "show_ref": false
  },
  {
    "src": "Pfizer NV/SA Rijksweg 12 B-2870 Puurs Belgium",
    "display_src": "Pfizer NV/SA Rijksweg 12 B-2870 Puurs Belgium",
    "ref": "Pfizer NV/SA Rijksweg 12 B-2870 Puurs Belgien",
    "show_ref": false
  },
  {
    "src": "Somatropin is a polypeptide hormone of recombinant DNA origin.",
    "display_src": "Somatropin is a polypeptide hormone of recombinant DNA origin.",
    "ref": "Somatropin ist ein Polypeptidhormon, das aus rekombinanter DNA hergestellt wird.",
    "show_ref": false
  },
  {
    "src": "Nespo (SureClick) is supplied ready for use in a pre-filled pen.",
    "display_src": "Nespo (SureClick) is supplied ready for use in a pre-filled pen.",
    "ref": "Nespo (SureClick) ist gebrauchsfertig i n einem vorgef\u00fcllten Injektor erh\u00e4ltlich.",
    "show_ref": false
  },
  {
    "src": "If you take Agopton on a long -term basis (longer than 1 year) your doctor will probably keep you under regular surveillance.",
    "display_src": "If you take Agopton on a long -term basis (longer than 1 year) your doctor will probably keep you under regular surveillance.",
    "ref": "Wenn Sie Agopton als Langzeittherapie einnehmen (l\u00e4nger als 1 Jahr) wird Ihr Arzt Sie wahrscheinlich regelm\u00e4\u00dfig untersuchen.",
    "show_ref": false
  },
  {
    "src": "If you forget to use Puregon",
    "display_src": "If you forget to use Puregon",
    "ref": "Wenn Sie die Anwendung von Puregon vergessen haben",
    "show_ref": false
  },
  {
    "src": "Additional messages regarding the transition plan for replacement of ReFacto with ReFacto AF in the Member State(s).",
    "display_src": "Additional messages regarding the transition plan for replacement of ReFacto with ReFacto AF in the Member State(s).",
    "ref": "\u2022 zus\u00e4tzliche Mitteilungen hinsichtlich der \u00dcbergangspl\u00e4ne, um ReFacto in den Mitgliedsstaaten/im Mitgliedsstaat durch ReFacto AF zu ersetzen.",
    "show_ref": false
  },
  {
    "src": "You will also find this information in the Patient Alert Card you have been given by your doctor.",
    "display_src": "You will also find this information in the Patient Alert Card you have been given by your doctor.",
    "ref": "26 Sie finden diese Informationen auch in Ihrem Patientenpass, den Sie von Ihrem Arzt erhalten haben.",
    "show_ref": false
  },
  {
    "src": "Treatment should be continued as long as the patient is deriving benefit.",
    "display_src": "Treatment should be continued as long as the patient is deriving benefit.",
    "ref": "Die Behandlung sollte so lange fortgesetzt werden, wie sich diese f\u00fcr den Patienten als n\u00fctzlich erweist.",
    "show_ref": false
  },
  {
    "src": "It is not recommended to combine INTELENCE with any of the following medicines:",
    "display_src": "It is not recommended to combine INTELENCE with any of the following medicines:",
    "ref": "Es wird nicht empfohlen, INTELENCE mit einem der folgenden Arzneimittel zu kombinieren:",
    "show_ref": false
  },
  {
    "src": "Revatio should not be taken with nitrates (a group of medicines used to treat angina), with ketoconazole or itraconazole (anti-fungal medicines), or with ritonavir (used to treat HIV infection).",
    "display_src": "Revatio should not be taken with nitrates (a group of medicines used to treat angina), with ketoconazole or itraconazole (anti-fungal medicines), or with ritonavir (used to treat HIV infection).",
    "ref": "Revatio darf nicht zusammen mit Nitraten (einer Gruppe von Arzneimitteln zur Behandlung von Angina pectoris) oder mit Ketoconazol oder Itraconazol (Arzneimittel gegen Pilzinfektionen) oder Ritonavir (zur Behandlung von HIV- Infektionen) eingenommen werden.",
    "show_ref": false
  },
  {
    "src": "There is a dose- proportionate increase in Cmax and AUC values following multiple doses ranging from 0.1-1 mg.",
    "display_src": "There is a dose- proportionate increase in Cmax and AUC values following multiple doses ranging from 0.1-1 mg.",
    "ref": "Es gibt einen Dosis-proportionalen Anstieg der Cmax und AUC- Werte nach Gabe multipler Dosen im Bereich von 0,1 - 1 mg.",
    "show_ref": false
  },
  {
    "src": "Criteria for women of non-childbearing potential:",
    "display_src": "Criteria for women of non-childbearing potential:",
    "ref": "Kriterien f\u00fcr nicht geb\u00e4rf\u00e4hige Frauen:",
    "show_ref": false
  },
  {
    "src": "In cases of renal impairment (creatinine clearance < 60 ml/ min) the initial perindopril dosage should be adjusted according to the patient\u2019 s creatinine clearance (see 4.2 \u201c Posology and method of administration\u201d) and then as a function of the patient\u2019 s response to treatment.",
    "display_src": "In cases of renal impairment (creatinine clearance < 60 ml/ min) the initial perindopril dosage should be adjusted according to the patient\u2019 s creatinine clearance (see 4.2 \u201c Posology and method of administration\u201d) and then as a function of the patient\u2019 s response to treatment.",
    "ref": "Bei F\u00e4llen von eingeschr\u00e4nkter Nierenfunktion (Kreatinin-Clearance < 60 ml / min) muss die Initialdosis von Perindopril der Kreatinin-Clearance (siehe 4.2 \u201e Dosierung, Art und Dauer der Anwendung\u201c) sowie dem Ansprechen des Patienten auf die Therapie angepasst werden.",
    "show_ref": false
  },
  {
    "src": "Clinical manifestations of anaphylaxis may appear similar to clinical manifestations of the cytokine release syndrome (described above).",
    "display_src": "Clinical manifestations of anaphylaxis may appear similar to clinical manifestations of the cytokine release syndrome (described above).",
    "ref": "Klinische Manifestationen einer Anaphylaxie k\u00f6nnen denen eines Zytokin- Freisetzungs-Syndroms (Beschreibung siehe oben) \u00e4hnlich sein.",
    "show_ref": false
  },
  {
    "src": "Revlimid 5 mg hard capsules lenalidomide",
    "display_src": "Revlimid 5 mg hard capsules lenalidomide",
    "ref": "Revlimid 5 mg Hartkapseln Lenalidomid",
    "show_ref": false
  },
  {
    "src": "Mitotane has been shown to have an inductive effect on cytochrome P450 enzymes.",
    "display_src": "Mitotane has been shown to have an inductive effect on cytochrome P450 enzymes.",
    "ref": "Eine induktive Wirkung von Mitotan auf Cytochrom P450 Enzyme ist beobachtet worden.",
    "show_ref": false
  },
  {
    "src": "Do not microwave.",
    "display_src": "Do not microwave.",
    "ref": "Nicht im Mikrowellenofen erw\u00e4rmen.",
    "show_ref": false
  },
  {
    "src": "EU/ 1/ 97/ 030/ 041 (1 vial of 10 ml) EU/ 1/ 97/ 030/ 042 (5 vials of 10 ml)",
    "display_src": "EU/ 1/ 97/ 030/ 041 (1 vial of 10 ml) EU/ 1/ 97/ 030/ 042 (5 vials of 10 ml)",
    "ref": "EU/1/97/030/041 (1 Durchstechflasche mit 10 ml) EU/1/97/030/042 (5 Durchstechflaschen zu je 10 ml)",
    "show_ref": false
  },
  {
    "src": "Each vial contains 25 mg sucrose.",
    "display_src": "Each vial contains 25 mg sucrose.",
    "ref": "Jede Durchstechflasche enth\u00e4lt 25 mg Sucrose",
    "show_ref": false
  },
  {
    "src": "Population pharmacokinetic analyses revealed that there was a trend toward higher clearance of abatacept with increasing body weight.",
    "display_src": "Population pharmacokinetic analyses revealed that there was a trend toward higher clearance of abatacept with increasing body weight.",
    "ref": "Populationspharmakokinetische Untersuchungen zeigten eine Tendenz zu einer h\u00f6heren Abatacept- Clearance mit steigendem K\u00f6rpergewicht.",
    "show_ref": false
  },
  {
    "src": "Five metabolites have been identified in man.",
    "display_src": "Five metabolites have been identified in man.",
    "ref": "Beim Menschen wurden f\u00fcnf Metaboliten identifiziert.",
    "show_ref": false
  },
  {
    "src": "For the 60 re-treatments on study, the ORR was 38% (CI95% 26% \u2013 51%; 10% CR, 28% PR) with a projected median TTP for responding patients of 17.8 months (range 5.4 \u2013 26.6).",
    "display_src": "For the 60 re-treatments on study, the ORR was 38% (CI95% 26% \u2013 51%; 10% CR, 28% PR) with a projected median TTP for responding patients of 17.8 months (range 5.4 \u2013 26.6).",
    "ref": "F\u00fcr die 60 Behandlungswiederholungen im Rahmen der Studie betrug die ORR 38% (CI95% 26% - 51%; CR 10%, PR 28%) mit einer projizierten medianen TTP von 17,8 Monaten (Bereich 5,4 \u2013 26,6) bei Patienten, die auf die Behandlung ansprachen.",
    "show_ref": false
  },
  {
    "src": "If you feel unwell tell your doctor immediately, even if your symptoms are different from those just described.",
    "display_src": "If you feel unwell tell your doctor immediately, even if your symptoms are different from those just described.",
    "ref": "Wenn Sie sich unwohl f\u00fchlen, informieren Sie bitte sofort Ihren Arzt, auch wenn Ihre Symptome von den oben beschriebenen abweichen.",
    "show_ref": false
  },
  {
    "src": "There have been reports of agglutination of red blood cells in the tube/ syringe with the administration of BeneFIX.",
    "display_src": "There have been reports of agglutination of red blood cells in the tube/ syringe with the administration of BeneFIX.",
    "ref": "Es wurde w\u00e4hrend der Verabreichung von BeneFIX \u00fcber Agglutination von roten Blutk\u00f6rperchen im Schlauchsystem oder der Spritze berichtet.",
    "show_ref": false
  },
  {
    "src": "Vectibix is for use in adults 18 years and over.",
    "display_src": "Vectibix is for use in adults 18 years and over.",
    "ref": "Vectibix ist zur Anwendung bei Erwachsenen (18 Jahre und \u00e4lter) bestimmt.",
    "show_ref": false
  },
  {
    "src": "25/ 64 PARTICULARS TO APPEAR ON THE OUTER PACKAGE Dicural 50 mg Coated tablets CARTON OF 10 TABLETS / 20 TABLETS / 100 TABLETS",
    "display_src": "25/ 64 PARTICULARS TO APPEAR ON THE OUTER PACKAGE Dicural 50 mg Coated tablets CARTON OF 10 TABLETS / 20 TABLETS / 100 TABLETS",
    "ref": "26/67 ANGABEN AUF DER \u00c4USSEREN UMH\u00dcLLUNG Dicural 50 mg \u00fcberzogene Tabletten Karton mit 10 Tabletten / 20 Tabletten / 100 Tabletten",
    "show_ref": false
  },
  {
    "src": "Even doses several fold higher than the recommended clinical dose (related to body weight) failed to demonstrate any acute or subacute toxic effects for KOGENATE Bayer in laboratory animals (mouse, rat, rabbit, and dog).",
    "display_src": "Even doses several fold higher than the recommended clinical dose (related to body weight) failed to demonstrate any acute or subacute toxic effects for KOGENATE Bayer in laboratory animals (mouse, rat, rabbit, and dog).",
    "ref": "Auch das Mehrfache der empfohlenen therapeutischen Dosis (bezogen auf das K\u00f6rpergewicht) zeigte bei verschiedenen Tierspezies (Maus, Ratte, Kaninchen und Hund) keine akuten oder subakuten toxischen Effekte von KOGENATE Bayer.",
    "show_ref": false
  },
  {
    "src": "If you take more Neoclarityn orodispersible tablet than you should Take Neoclarityn orodispersible tablet only as prescribed for you.",
    "display_src": "If you take more Neoclarityn orodispersible tablet than you should Take Neoclarityn orodispersible tablet only as prescribed for you.",
    "ref": "Wenn Sie eine gr\u00f6\u00dfere Menge von Neoclarityn Schmelztablette eingenommen haben, als Sie sollten Nehmen Sie Neoclarityn Schmelztablette nur wie Ihnen verordnet ein.",
    "show_ref": false
  },
  {
    "src": "musculoskeletal discomfort, myalgia, back pain, limb pain, peripheral swelling, arthralgia, joint swelling",
    "display_src": "musculoskeletal discomfort, myalgia, back pain, limb pain, peripheral swelling, arthralgia, joint swelling",
    "ref": "muskuloskeletale Beschwerden, Myalgie, R\u00fcckenschmerzen, Schmerzen in den Gliedma\u00dfen, periphere Schwellungen, Arthralgie, Anschwellen der Gelenke",
    "show_ref": false
  },
  {
    "src": "If your child stops taking Diacomit Your child must not stop taking this medicine unless the doctor tells you to.",
    "display_src": "If your child stops taking Diacomit Your child must not stop taking this medicine unless the doctor tells you to.",
    "ref": "Wenn Ihr Kind die Einnahme von Diacomit abbricht Ihr Kind darf die Einnahme dieses Arzneimittels nicht abbrechen, au\u00dfer wenn der Arzt diese Entscheidung trifft.",
    "show_ref": false
  },
  {
    "src": "Miss Leivers joined the EMEA in February 1996 and was appointed Deputy Head of Sector in June 2001.",
    "display_src": "Miss Leivers joined the EMEA in February 1996 and was appointed Deputy Head of Sector in June 2001.",
    "ref": "Melanie Leivers ist seit Februar 1996 bei der EMEA und wurde im Juni 2001 zur stellvertretenden Bereichsleiterin ernannt.",
    "show_ref": false
  },
  {
    "src": "The {pharmaceutical form} may be taken without regard to mealtime. >",
    "display_src": "The {pharmaceutical form} may be taken without regard to mealtime. >",
    "ref": "Die {Darreichungsform} kann unabh\u00e4ngig von den Mahlzeiten eingenommen werden. >",
    "show_ref": false
  },
  {
    "src": "Protaphane was effective for both type 1 and type 2 diabetes, and when using a standard injection or one of the pens.",
    "display_src": "Protaphane was effective for both type 1 and type 2 diabetes, and when using a standard injection or one of the pens.",
    "ref": "Protaphane war sowohl beim Typ-1- als auch beim Typ-2-Diabetes und bei \u00fcblicher Injektion mittels Spritze oder mit einem der Pens wirksam.",
    "show_ref": false
  },
  {
    "src": "EU/ 1/ 97/ 046/ 007-009 EU/ 1/ 97/ 046/ 012 EU/ 1/ 97/ 046/ 015",
    "display_src": "EU/ 1/ 97/ 046/ 007-009 EU/ 1/ 97/ 046/ 012 EU/ 1/ 97/ 046/ 015",
    "ref": "EU/1/97/046/007-009 EU/1/97/046/012 EU/1/97/046/015",
    "show_ref": false
  },
  {
    "src": "Use the spoon as follows:",
    "display_src": "Use the spoon as follows:",
    "ref": "Der Messl\u00f6ffel ist folgenderma\u00dfen anzuwenden:",
    "show_ref": false
  },
  {
    "src": "As for any vaccine, adequate treatment provisions, including adrenaline, should be available for immediate use should an anaphylactic or anaphylactoid reaction occur.",
    "display_src": "As for any vaccine, adequate treatment provisions, including adrenaline, should be available for immediate use should an anaphylactic or anaphylactoid reaction occur.",
    "ref": "Wie bei allen Impfstoffen sollten geeignete Behandlungsma\u00dfnahmen, einschlie\u00dflich Adrenalin, zur sofortigen Verwendung zur Verf\u00fcgung stehen, falls anaphylaktische oder anaphylaktoide Reaktionen auftreten.",
    "show_ref": false
  },
  {
    "src": "1 ml contains 100 mg sugammadex (as sodium salt).",
    "display_src": "1 ml contains 100 mg sugammadex (as sodium salt).",
    "ref": "1 ml enth\u00e4lt 100 mg Sugammadex (als Natriumsalz).",
    "show_ref": false
  },
  {
    "src": "HYCAMTIN 4 mg vials must be reconstituted with 4 ml water for injections.",
    "display_src": "HYCAMTIN 4 mg vials must be reconstituted with 4 ml water for injections.",
    "ref": "Der Inhalt einer HYCAMTIN 4 mg-Durchstechflasche muss mit 4 ml Wasser f\u00fcr Injektionszwecke rekonstituiert werden.",
    "show_ref": false
  },
  {
    "src": "Tablet core Microcrystalline cellulose Povidone (K30) Sodium starch glycolate (Type A) Magnesium stearate",
    "display_src": "Tablet core Microcrystalline cellulose Povidone (K30) Sodium starch glycolate (Type A) Magnesium stearate",
    "ref": "Tablettenkern Mikrokristalline Cellulose Povidon (K30) Carboxymethylst\u00e4rke-Natrium (Typ A) Magnesiumstearat",
    "show_ref": false
  },
  {
    "src": "See also the warning in 2 Before you use Monotard. rod",
    "display_src": "See also the warning in 2 Before you use Monotard. rod",
    "ref": "Beachten Sie auch die er Warnung unter 2 Was m\u00fcssen Sie vor der Anwendung von Monotard beachten?. ng Geschwollene Gelenke.",
    "show_ref": false
  },
  {
    "src": "VISTIDE 75 mg/ ml concentrate for solution for infusion Cidofovir For intravenous infusion only.",
    "display_src": "VISTIDE 75 mg/ ml concentrate for solution for infusion Cidofovir For intravenous infusion only.",
    "ref": "VISTIDE 75 mg / ml Konzentrat zur Herstellung einer Infusionsl\u00f6sung Cidofovir Nur zur intraven\u00f6sen Infusion.",
    "show_ref": false
  },
  {
    "src": "The association between the cumulative incidence of VFD as a function of cumulative vigabatrin dose was investigated in a cohort of 291 patients.",
    "display_src": "The association between the cumulative incidence of VFD as a function of cumulative vigabatrin dose was investigated in a cohort of 291 patients.",
    "ref": "Der Zusammenhang zwischen der kumulativen Inzidenz von Gesichtsfeldausf\u00e4llen in Abh\u00e4ngigkeit von der kumulativen Vigabatrin-Dosis wurde in einer Kohorte von 291 Patienten untersucht.",
    "show_ref": false
  },
  {
    "src": "The overall selection frequency for M184V or M184I was high (54%), and less common was the selection of L74V (5%), K65R (1%) and Y115F (1%) (see Table).",
    "display_src": "The overall selection frequency for M184V or M184I was high (54%), and less common was the selection of L74V (5%), K65R (1%) and Y115F (1%) (see Table).",
    "ref": "Die Gesamt-Selektionsh\u00e4ufigkeit f\u00fcr M184V- oder M184I-Mutationen war hoch (54%), dagegen war die Selektion von L74V- (5%), K65R- (1%) und Y115F-Mutationen (1%) weniger h\u00e4ufig (siehe Tabelle).",
    "show_ref": false
  },
  {
    "src": "Pregnancy You must avoid becoming pregnant for 3 months after Foscan treatment.",
    "display_src": "Pregnancy You must avoid becoming pregnant for 3 months after Foscan treatment.",
    "ref": "31 Schwangerschaft Sie m\u00fcssen f\u00fcr 3 Monate nach der Foscanbehandlung Ma\u00dfnahmen zum Verh\u00fcten einer Schwangerschaft befolgen.",
    "show_ref": false
  },
  {
    "src": "The other four studies compared the effects of Jalra, taken at doses of 50 or 100 mg a day for 24 weeks, with those of placebo, when used as an add-on to existing treatment with metformin (544 patients), pioglitazone (a thiazolidinedione, 463 patients), glimepiride (a sulphonylurea, 515 patients) or insulin (296 patients).",
    "display_src": "The other four studies compared the effects of Jalra, taken at doses of 50 or 100 mg a day for 24 weeks, with those of placebo, when used as an add-on to existing treatment with metformin (544 patients), pioglitazone (a thiazolidinedione, 463 patients), glimepiride (a sulphonylurea, 515 patients) or insulin (296 patients).",
    "ref": "In den anderen vier Studien wurde Jalra 24 Wochen lang in einer Dosis von 50 mg oder 100 mg pro Tag zus\u00e4tzlich zu einer laufenden Therapie mit Metformin (544 Patienten), Pioglitazon (einem Thiazolidindion, 463 Patienten), Glimepirid (einem Sulfonylharnstoff, 515 Patienten) oder Insulin (296 Patienten) verabreicht und die Wirkung wurde jeweils mit der von Placebo verglichen.",
    "show_ref": false
  },
  {
    "src": "- digoxin (medicine to treat certain heart disorders)",
    "display_src": "- digoxin (medicine to treat certain heart disorders)",
    "ref": "- Digoxin (Arzneimittel gegen bestimmte Herzerkrankungen)",
    "show_ref": false
  },
  {
    "src": "Similarly, treatment combining rehydration solution and Novem was shown to be superior to rehydration solution alone.",
    "display_src": "Similarly, treatment combining rehydration solution and Novem was shown to be superior to rehydration solution alone.",
    "ref": "In \u00e4hnlicher Weise erwies sich die Kombination von Fl\u00fcssigkeitstherapie und Novem der alleinigen Fl\u00fcssigkeitstherapie als \u00fcberlegen.",
    "show_ref": false
  },
  {
    "src": "OUTER CARTON TEXT Puregon 75 IU/ 0.5 ml 1 vial",
    "display_src": "OUTER CARTON TEXT Puregon 75 IU/ 0.5 ml 1 vial",
    "ref": "TEXT FALTSCHACHTEL Puregon 75 IE/0,5 ml 1 Durchstechflasche",
    "show_ref": false
  },
  {
    "src": "How much Volibris to take The usual dose of Volibris is one 5 mg tablet, once a day.",
    "display_src": "How much Volibris to take The usual dose of Volibris is one 5 mg tablet, once a day.",
    "ref": "Wieviel Volibris Sie einnehmen sollen Die \u00fcbliche Dosis von Volibris ist eine 5 mg-Tablette einmal t\u00e4glich.",
    "show_ref": false
  },
  {
    "src": "There are no adequate data from the use of hydroxocobalamin in pregnant women and the potential risk for humans is unknown.",
    "display_src": "There are no adequate data from the use of hydroxocobalamin in pregnant women and the potential risk for humans is unknown.",
    "ref": "5 von Hydroxocobalamin bei Schwangeren vor und das potentielle Risiko f\u00fcr den Menschen ist nicht bekannt.",
    "show_ref": false
  },
  {
    "src": "However, cases of life threatening pulmonary oedema have been reported with vasodilators (mainly prostacyclin) when used in those patients.",
    "display_src": "However, cases of life threatening pulmonary oedema have been reported with vasodilators (mainly prostacyclin) when used in those patients.",
    "ref": "Allerdings wurden f\u00fcr die Anwendung von Vasodilatatoren (haupts\u00e4chlich Prostacyclin) bei solchen Patienten F\u00e4lle von lebensbedrohlichen Lungen\u00f6demen beschrieben.",
    "show_ref": false
  },
  {
    "src": "This medicinal product does not require any special storage conditions dic",
    "display_src": "This medicinal product does not require any special storage conditions dic",
    "ref": "zu F\u00fcr dieses Arzneimittel sind keine besonderen Lagerungsbedingungen erforderlich.",
    "show_ref": false
  },
  {
    "src": "In women not already taking an inducer of lamotrigine glucuronidation and taking a hormonal contraceptive that includes one week of inactive treatment (for example \"pill-free week\"), gradual transient increases in lamotrigine levels will occur during the week of inactive treatment (see section 4.2).",
    "display_src": "In women not already taking an inducer of lamotrigine glucuronidation and taking a hormonal contraceptive that includes one week of inactive treatment (for example \"pill-free week\"), gradual transient increases in lamotrigine levels will occur during the week of inactive treatment (see section 4.2).",
    "ref": "Bei Frauen, die nicht bereits einen Induktor der Glucuronidierung von Lamotrigin einnehmen und ein orales Kontrazeptivum anwenden, bei dem eine Woche des Zyklus\u2019 aus einer inaktiven Behandlung besteht (zum Beispiel \"pillenfreie Woche\"), kommt es w\u00e4hrend dieser Woche der inaktiven Behandlung zu graduellen vor\u00fcbergehenden Anstiegen der Lamotriginspiegel.",
    "show_ref": false
  },
  {
    "src": "3 Cognitive and neuropsychiatric adverse reactions, particularly confusion, are common in patients treated with ziconotide.",
    "display_src": "3 Cognitive and neuropsychiatric adverse reactions, particularly confusion, are common in patients treated with ziconotide.",
    "ref": "Unerw\u00fcnschte kognitive und neuropsychiatrische Wirkungen, insbesondere Verwirrung, sind bei mit Ziconotid behandelten Patienten h\u00e4ufig.",
    "show_ref": false
  },
  {
    "src": "In severe kidney disease, the usual starting dose is just 1 tablet MIRAPEXIN 0.088 mg a day.",
    "display_src": "In severe kidney disease, the usual starting dose is just 1 tablet MIRAPEXIN 0.088 mg a day.",
    "ref": "Bei schwerer Nierenerkrankung betr\u00e4gt die \u00fcbliche Anfangsdosis 1 x t\u00e4glich eine Tablette MIRAPEXIN 0,088 mg.",
    "show_ref": false
  },
  {
    "src": "What Levemir is and what it is used for 2.",
    "display_src": "What Levemir is and what it is used for 2.",
    "ref": "Was ist Levemir und wof\u00fcr wird es angewendet?",
    "show_ref": false
  },
  {
    "src": "Kentera was as effective as tolterodine, both treatments decreasing the number of episodes by about 3 per day.",
    "display_src": "Kentera was as effective as tolterodine, both treatments decreasing the number of episodes by about 3 per day.",
    "ref": "Kentera erwies sich als genauso wirksam wie Tolterodin; bei beiden Behandlungsmethoden ging die Anzahl der Inkontinenzepisoden um etwa 3 pro Tag zur\u00fcck.",
    "show_ref": false
  },
  {
    "src": "When reconstituted with 8 ml water for injections each ml contains 1,000 U tenecteplase",
    "display_src": "When reconstituted with 8 ml water for injections each ml contains 1,000 U tenecteplase",
    "ref": "Nach Rekonstitution mit 8 ml Wasser f\u00fcr Injektionszwecke enth\u00e4lt jeder ml 1.000 U Tenecteplase",
    "show_ref": false
  },
  {
    "src": "Renal impairment - Fondaparinux should not be used in patients with creatinine clearance < 20 ml/ min",
    "display_src": "Renal impairment - Fondaparinux should not be used in patients with creatinine clearance < 20 ml/ min",
    "ref": "Bei Patienten mit einer Kreatinin-Clearance < 20 ml/min sollte Fondaparinux nicht angewendet werden.",
    "show_ref": false
  },
  {
    "src": "As reported in a recent publication 21 of these 65 patients also achieved complete molecular remission with a median follow-up of 28 months (range 13-67 months).",
    "display_src": "As reported in a recent publication 21 of these 65 patients also achieved complete molecular remission with a median follow-up of 28 months (range 13-67 months).",
    "ref": "Wie in einer k\u00fcrzlich ver\u00f6ffentlichten Publikation berichtet, erzielten 21 dieser 65 Patienten auch eine komplette molekulare Remission mit einem medianen Follow-up von 28 Monaten (13-67 Monate).",
    "show_ref": false
  },
  {
    "src": "Timely reports will be presented to management to ensure effective and efficient use of financial resources.",
    "display_src": "Timely reports will be presented to management to ensure effective and efficient use of financial resources.",
    "ref": "Zur Gew\u00e4hrleistung einer effektiven und effizienten Nutzung der finanziellen Ressourcen werden der Managementebene rechtzeitig Berichte vorgelegt.",
    "show_ref": false
  },
  {
    "src": "Repeat every 12-24 hours.",
    "display_src": "Repeat every 12-24 hours.",
    "ref": "Wiederholung der Infusion alle 12 - 24 Stunden.",
    "show_ref": false
  },
  {
    "src": "For the full list of all side effects reported with Neoclarityn, see the Package Leaflet.",
    "display_src": "For the full list of all side effects reported with Neoclarityn, see the Package Leaflet.",
    "ref": "Die vollst\u00e4ndige Auflistung der im Zusammenhang mit Neoclarityn berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.",
    "show_ref": false
  },
  {
    "src": "3 Vaccinations It is recommended that live viral or live bacterial vaccines (such as Bacillus of Calmette and Gu\u00e9rin (BCG)) should not be given concurrently with STELARA.",
    "display_src": "3 Vaccinations It is recommended that live viral or live bacterial vaccines (such as Bacillus of Calmette and Gu\u00e9rin (BCG)) should not be given concurrently with STELARA.",
    "ref": "Impfungen Es wird nicht empfohlen, Lebendvirusimpfstoffe oder Lebendbakterienimpfstoffe (wie Bacillus Calmette Gu\u00e9rin (BCG)) gleichzeitig mit STELARA zu verabreichen.",
    "show_ref": false
  },
  {
    "src": "1 ml of suspension in a vial (type I glass) for 2 doses with a stopper (rubber butyl) in the following pack sizes: \u2013 pack size of 1 vial of powder plus 1 vial of suspension na",
    "display_src": "1 ml of suspension in a vial (type I glass) for 2 doses with a stopper (rubber butyl) in the following pack sizes: \u2013 pack size of 1 vial of powder plus 1 vial of suspension na",
    "ref": "1,0 ml Suspension in einem Glasfl\u00e4schchen (Glas Typ I) f\u00fcr 2 Impfdosen mit Stopfen (aus Butylgummi) in den folgenden Packungsgr\u00f6\u00dfen:",
    "show_ref": false
  },
  {
    "src": "Resistance In vitro selection of darunavir-resistant virus from wild type HIV-1 was lengthy (> 3 years).",
    "display_src": "Resistance In vitro selection of darunavir-resistant virus from wild type HIV-1 was lengthy (> 3 years).",
    "ref": "Resistenz Die In-vitro-Selektion von Darunavir-resistenten Viren vom Wildtyp HIV-1 dauerte sehr lange (> 3 Jahre).",
    "show_ref": false
  },
  {
    "src": "The response rate of other acute myelogenous leukaemia subtypes to TRISENOX has not been examined.",
    "display_src": "The response rate of other acute myelogenous leukaemia subtypes to TRISENOX has not been examined.",
    "ref": "Das Ansprechen anderer Subtypen der akuten myeloischen Leuk\u00e4mie auf TRISENOX wurde nicht untersucht.",
    "show_ref": false
  },
  {
    "src": "Therefore no dosage recommendation can be made and the use of Xigris is not recommended in children below the age of 18 (see section 4.4).",
    "display_src": "Therefore no dosage recommendation can be made and the use of Xigris is not recommended in children below the age of 18 (see section 4.4).",
    "ref": "Es kann daher keine Dosierungsempfehlung gegeben werden und die Anwendung von Xigris bei Kindern unter 18 Jahren wird nicht empfohlen (siehe Abschnitt 4.4).",
    "show_ref": false
  },
  {
    "src": "Nonetheless, there is a potential risk of selection of HIV strains resistant to adefovir with possible cross-resistance to other antiviral medicinal products.",
    "display_src": "Nonetheless, there is a potential risk of selection of HIV strains resistant to adefovir with possible cross-resistance to other antiviral medicinal products.",
    "ref": "5 Dennoch besteht das potenzielle Risiko einer Selektion von Adefovir-resistenten HIV-St\u00e4mmen mit einer m\u00f6glichen Kreuzresistenz gegen andere antivirale Arzneimittel.",
    "show_ref": false
  },
  {
    "src": "Luxembourg/ Luxemburg Bayer SA-NV 143 Avenue Louise B\u2013 1050 Bruxelles/ Br\u00fcssel Belgique/ Belgien T\u00e9l/ Tel: +32 2 535 66 54",
    "display_src": "Luxembourg/ Luxemburg Bayer SA-NV 143 Avenue Louise B\u2013 1050 Bruxelles/ Br\u00fcssel Belgique/ Belgien T\u00e9l/ Tel: +32 2 535 66 54",
    "ref": "143 Avenue Louise B\u2013 1050 Bruxelles/Br\u00fcssel Belgique/Belgien T\u00e9l/Tel: +32 2 535 66 54",
    "show_ref": false
  },
  {
    "src": "As Aerinaze contains pseudoephedrine, it is also contraindicated in patients who are receiving monoamine oxidase (MAO) inhibitor therapy or during the 2 weeks following the stopping of such treatment.",
    "display_src": "As Aerinaze contains pseudoephedrine, it is also contraindicated in patients who are receiving monoamine oxidase (MAO) inhibitor therapy or during the 2 weeks following the stopping of such treatment.",
    "ref": "Da Aerinaze Pseudoephedrin enth\u00e4lt, ist das Arzneimittel ebenfalls kontraindiziert bei Patienten, die mit einem Monoaminoxidase (MAO)-Hemmer behandelt werden bzw. innerhalb der 2 Wochen nach Beendigung einer solchen Therapie.",
    "show_ref": false
  },
  {
    "src": "Silapo 4000 IU/0.4ml solution for injection in pre-filled syringe",
    "display_src": "Silapo 4000 IU/0.4ml solution for injection in pre-filled syringe",
    "ref": "Silapo 4000 I.E./0,4 ml Injektionsl\u00f6sung in Fertigspritze",
    "show_ref": false
  },
  {
    "src": "- if you are being treated or have been treated for blood clots.",
    "display_src": "- if you are being treated or have been treated for blood clots.",
    "ref": "- wenn Sie gegen Blutgerinnsel behandelt werden oder wurden.",
    "show_ref": false
  },
  {
    "src": "Aclasta is not recommended for anyone under 18 years of age.",
    "display_src": "Aclasta is not recommended for anyone under 18 years of age.",
    "ref": "Aclasta wird nicht empfohlen f\u00fcr Kinder und Jugendliche unter 18 Jahren.",
    "show_ref": false
  },
  {
    "src": "For Hepatitis B surface antigen:",
    "display_src": "For Hepatitis B surface antigen:",
    "ref": "F\u00fcr das Hepatitis B-Oberfl\u00e4chenantigen:",
    "show_ref": false
  },
  {
    "src": "The dose, duration of treatment and frequency will depend on the weight and type of animal and condition to be treated.",
    "display_src": "The dose, duration of treatment and frequency will depend on the weight and type of animal and condition to be treated.",
    "ref": "Dosis, Behandlungsdauer und -h\u00e4ufigkeit richten sich nach dem Gewicht und der Art des Tieres sowie der zu behandelnden Erkrankung.",
    "show_ref": false
  },
  {
    "src": "Patients were randomized to receive either 20 mg/ kg or 40 mg/ kg every two weeks for a period of 52 weeks.",
    "display_src": "Patients were randomized to receive either 20 mg/ kg or 40 mg/ kg every two weeks for a period of 52 weeks.",
    "ref": "Die Patienten wurden randomisiert und erhielten \u00fcber einen Zeitraum von 52 Wochen alle zwei Wochen entweder 20 mg/kg oder 40 mg/kg Myozyme.",
    "show_ref": false
  },
  {
    "src": "The European Commission granted a marketing authorisation valid throughout the European Union for Herceptin to Roche Registration Limited on 28 August 2000.",
    "display_src": "The European Commission granted a marketing authorisation valid throughout the European Union for Herceptin to Roche Registration Limited on 28 August 2000.",
    "ref": "August 2000 erteilte die Europ\u00e4ische Kommission dem Unternehmen Roche Registration Limited eine Genehmigung f\u00fcr das Inverkehrbringen von Herceptin in der gesamten Europ\u00e4ischen Union.",
    "show_ref": false
  },
  {
    "src": "You must wait at least 14 days after you have stopped taking an MAOI before you can take ARICLAIM.",
    "display_src": "You must wait at least 14 days after you have stopped taking an MAOI before you can take ARICLAIM.",
    "ref": "Wenn Sie einen MAO-Hemmer eingenommen haben, m\u00fcssen Sie nach Beendigung der Einnahme noch mindestens 14 Tage warten, bevor Sie ARICLAIM einnehmen.",
    "show_ref": false
  },
  {
    "src": "The strengthening of the links between EU topic leaders, the CPMP Working Parties and the CPMP itself will be assured by the Secretariat.",
    "display_src": "The strengthening of the links between EU topic leaders, the CPMP Working Parties and the CPMP itself will be assured by the Secretariat.",
    "ref": "Die St\u00e4rkung der Kontakte zwischen Sachgebietsleitern der EU, den Arbeitsgruppen des CPMP und dem CPMP selbst wird durch das Sekretariat gew\u00e4hrleistet.",
    "show_ref": false
  },
  {
    "src": "Overdose following clopidogrel administration may lead to prolonged bleeding time and subsequent bleeding complications.",
    "display_src": "Overdose following clopidogrel administration may lead to prolonged bleeding time and subsequent bleeding complications.",
    "ref": "Eine Clopidogrel-\u00dcberdosis kann zu verl\u00e4ngerter Blutungszeit und anschlie\u00dfenden Blutungskomplikationen f\u00fchren.",
    "show_ref": false
  },
  {
    "src": "The maximum dose is 750 mg twice a day.",
    "display_src": "The maximum dose is 750 mg twice a day.",
    "ref": "Die H\u00f6chstdosis betr\u00e4gt 750 mg zweimal t\u00e4glich.",
    "show_ref": false
  },
  {
    "src": "Aerius 2.5 mg tablets has not been evaluated in paediatric patients however in conjunction with the dose finding studies in paediatrics, the pharmacokinetics data for Aerius orodispersible tablets supports the use of the 2.5 mg dose in paediatric patients 6 to 11 years of age.",
    "display_src": "Aerius 2.5 mg tablets has not been evaluated in paediatric patients however in conjunction with the dose finding studies in paediatrics, the pharmacokinetics data for Aerius orodispersible tablets supports the use of the 2.5 mg dose in paediatric patients 6 to 11 years of age.",
    "ref": "Aerius 2,5 mg Tabletten wurden nicht an p\u00e4diatrischen Patienten untersucht, in Verbindung mit den Dosisfindungsstudien bei Kindern unterst\u00fctzen jedoch die pharmakokinetischen Daten f\u00fcr Aerius Schmelztabletten die Verwendung der 2,5 mg Dosierung bei Kindern von 6 bis 11 Jahren.",
    "show_ref": false
  },
  {
    "src": "The MAH must ensure that the system of pharmacovigilance, as described in version 1.0 (24/ 05/ 2007) and included in the Type II variation EMEA/ H/ C/ 419/ II/ 075 and subsequent updates, is in place and functioning before and whilst the product is on the market.",
    "display_src": "The MAH must ensure that the system of pharmacovigilance, as described in version 1.0 (24/ 05/ 2007) and included in the Type II variation EMEA/ H/ C/ 419/ II/ 075 and subsequent updates, is in place and functioning before and whilst the product is on the market.",
    "ref": "Der Inhaber der Zulassung muss gew\u00e4hrleisten, dass das Pharmakovigilanzsystem, wie in Version 1.0 (24.05.2007) beschrieben und in den Typ II \u00c4nderungsantrag EMEA/H/C/419/II/075 integriert sowie entsprechend allen weiteren Aktualisierungen vorgelegt, etabliert und funktionsf\u00e4hig ist, bevor das Arzneimittel in Verkehr gebracht wird und so lange es im Verkehr ist.",
    "show_ref": false
  },
  {
    "src": "Masitinib treatment should only be used in dogs with non-resectable mast cell tumours and which express the mutated c-kit tyrosine kinase receptor.",
    "display_src": "Masitinib treatment should only be used in dogs with non-resectable mast cell tumours and which express the mutated c-kit tyrosine kinase receptor.",
    "ref": "Die Behandlung mit Masitinib sollte nur bei Hunden mit nicht resezierbarem Mastzelltumor, der den mutierten c-Kit-Tyrosinkinase-Rezeptor exprimiert, angewendet werden.",
    "show_ref": false
  },
  {
    "src": "\u2022 22.08.01 \u2022 OJ L227, 23.08.2001, p.",
    "display_src": "\u2022 22.08.01 \u2022 OJ L227, 23.08.2001, p.",
    "ref": "22.08.01 OJ L227, 23.08.2001, p.",
    "show_ref": false
  },
  {
    "src": "Therefore, you should not breast-feed while using Soliris.",
    "display_src": "Therefore, you should not breast-feed while using Soliris.",
    "ref": "Deshalb sollten Sie w\u00e4hrend der Anwendung von Soliris nicht stillen.",
    "show_ref": false
  },
  {
    "src": "Patients \u2265 75 years old The use of Efient in patients \u2265 75 years of age is generally not recommended.",
    "display_src": "Patients \u2265 75 years old The use of Efient in patients \u2265 75 years of age is generally not recommended.",
    "ref": "2 Patienten \u2265 75 Jahre Im Allgemeinen wird die Efient-Behandlung von Patienten, die 75 Jahre und \u00e4lter sind, nicht empfohlen.",
    "show_ref": false
  },
  {
    "src": "In children it is used with ribavirin. rod",
    "display_src": "In children it is used with ribavirin. rod",
    "ref": "Bei Kindern wird es mit Ribavirin kombiniert.",
    "show_ref": false
  },
  {
    "src": "1.3 Scientific resources at the disposal of the EMEA",
    "display_src": "1.3 Scientific resources at the disposal of the EMEA",
    "ref": "1.3 Der EMEA zur Verf\u00fcgung stehende wissenschaftliche Ressourcen",
    "show_ref": false
  },
  {
    "src": "Appropriate antihypertensive drug must usually replace Irbesartan Hydrochlorothiazide Winthrop before starting a pregnancy.",
    "display_src": "Appropriate antihypertensive drug must usually replace Irbesartan Hydrochlorothiazide Winthrop before starting a pregnancy.",
    "ref": "Vor einer Schwangerschaft muss f\u00fcr gew\u00f6hnlich von Irbesartan Hydrochlorothiazide Winthrop auf eine geeignete Behandlung des Bluthochdruckes umgestellt werden.",
    "show_ref": false
  },
  {
    "src": "the last dose of TYSABRI, since side effects may occur even after you have stopped treatment.",
    "display_src": "the last dose of TYSABRI, since side effects may occur even after you have stopped treatment.",
    "ref": "letzten Dosis TYSABRI mit sich f\u00fchren, da Nebenwirkungen auch nach Ende der Behandlung mit TYSABRI auftreten k\u00f6nnen.",
    "show_ref": false
  },
  {
    "src": "Capsule shell: gelatin, sodium lauryl sulphate, titanium dioxide (E171), indigo carmine (E132), iron oxide yellow (E172) (60 mg only) and edible green ink (30 mg) or edible white ink (60 mg).",
    "display_src": "Capsule shell: gelatin, sodium lauryl sulphate, titanium dioxide (E171), indigo carmine (E132), iron oxide yellow (E172) (60 mg only) and edible green ink (30 mg) or edible white ink (60 mg).",
    "ref": "Gelatine, Natriumdodecylsulfat, Titandioxid (E 171), Indigocarmin (E 132), Eisen(III)- hydroxid-oxid x H2O (E 172) (nur f\u00fcr 60 mg) und essbare Drucktinte gr\u00fcn (nur f\u00fcr 30 mg) oder essbare Bedruckungstinte wei\u00df (nur f\u00fcr 60 mg).",
    "show_ref": false
  },
  {
    "src": "Pregnancy and breast-feeding Talk with your doctor before taking Tredaptive if: \u2022 You are pregnant or plan to become pregnant.",
    "display_src": "Pregnancy and breast-feeding Talk with your doctor before taking Tredaptive if: \u2022 You are pregnant or plan to become pregnant.",
    "ref": "Schwangerschaft und Stillzeit Wenden Sie sich an Ihren Arzt, bevor Sie Tredaptive einnehmen, falls: \u2022 Sie schwanger sind oder eine Schwangerschaft planen.",
    "show_ref": false
  },
  {
    "src": "The European Commission granted a marketing authorisation valid throughout the European Union for Avastin to Roche Registration Limited on 12 January 2005.",
    "display_src": "The European Commission granted a marketing authorisation valid throughout the European Union for Avastin to Roche Registration Limited on 12 January 2005.",
    "ref": "Januar 2005 erteilte die Europ\u00e4ische Kommission dem Unternehmen Roche Registration Limited eine Genehmigung f\u00fcr das Inverkehrbringen von Avastin in der gesamten Europ\u00e4ischen Union.",
    "show_ref": false
  },
  {
    "src": "INTEGRILIN should be given intravenously (into a vein) by a doctor who has experience in the management of heart conditions.",
    "display_src": "INTEGRILIN should be given intravenously (into a vein) by a doctor who has experience in the management of heart conditions.",
    "ref": "INTEGRILIN sollte von einem Arzt mit Erfahrung in der Behandlung von Herzkrankheiten intraven\u00f6s (in eine Vene) verabreicht werden.",
    "show_ref": false
  },
  {
    "src": "from baseline to one year was shown for ACOMPLIA 20 mg versus a mean weight loss of 1.6 kg for placebo (Difference -4.9 kg CI95% -5.3; -4.4, p < 0.001).",
    "display_src": "from baseline to one year was shown for ACOMPLIA 20 mg versus a mean weight loss of 1.6 kg for placebo (Difference -4.9 kg CI95% -5.3; -4.4, p < 0.001).",
    "ref": "n Gewichtsreduktion nach einem Jahr betrug f\u00fcr ACOMPLIA 20 mg 6,5 kg, bezogen auf den Ausgangswert, gegen\u00fcber 1,6 kg f\u00fcr die Placebogruppe (Differenz -4,9 kg CI95% -5,3; -4,4, p < 0,001).",
    "show_ref": false
  },
  {
    "src": "Important information about some of the ingredients of Lansoprazol-ratiopharm This medicine contains sucrose.",
    "display_src": "Important information about some of the ingredients of Lansoprazol-ratiopharm This medicine contains sucrose.",
    "ref": "Wichtige Informationen \u00fcber bestimmte sonstige Bestandteile von Lansoprazol-ratiopharm 15 mg Dieses Arzneimittel enth\u00e4lt Sucrose.",
    "show_ref": false
  },
  {
    "src": "CELSENTRI 150 mg and 300 mg film-coated tablets are supplied in bottles of 180 tablets or in blister packs of 30, 60, 90 film-coated tablets and multipacks containing 180 (2 packs of 90) film-coated tablets.",
    "display_src": "CELSENTRI 150 mg and 300 mg film-coated tablets are supplied in bottles of 180 tablets or in blister packs of 30, 60, 90 film-coated tablets and multipacks containing 180 (2 packs of 90) film-coated tablets.",
    "ref": "CELSENTRI-150 mg-Filmtabletten und CELSENTRI-300 mg-Filmtabletten sind in Flaschen mit 180 Tabletten oder in Blisterpackungen mit 30, 60, 90 Filmtabletten und in B\u00fcndelpackungen mit 180 Filmtabletten (2 Schachteln \u00e0 90) erh\u00e4ltlich.",
    "show_ref": false
  },
  {
    "src": "33 (0) 4 92 08 73 00 Rom\u00e2nia VIRBAC S. A.",
    "display_src": "33 (0) 4 92 08 73 00 Rom\u00e2nia VIRBAC S. A.",
    "ref": "33 (0) 4 92 08 73 00 Rom\u00e2nia VIRBAC S.A.",
    "show_ref": false
  },
  {
    "src": "InductOs is indicated for the treatment of acute tibia fractures in adults, as an adjunct to standard care using open fracture reduction and intramedullary unreamed nail fixation.",
    "display_src": "InductOs is indicated for the treatment of acute tibia fractures in adults, as an adjunct to standard care using open fracture reduction and intramedullary unreamed nail fixation.",
    "ref": "InductOs ist angezeigt zur Behandlung von akuten Frakturen der Tibia bei Erwachsenen, als Erg\u00e4nzung der aus Reposition und ungebohrter intramedull\u00e4rer Nagelosteosynthese offener Br\u00fcche bestehenden Standardtherapie.",
    "show_ref": false
  },
  {
    "src": "0.99, 1.18; 42 trials and 8167 patients).",
    "display_src": "0.99, 1.18; 42 trials and 8167 patients).",
    "ref": "0,99, 1,18; 42 Studie n und 8167 Patienten).",
    "show_ref": false
  },
  {
    "src": "The use of PegIntron in combination with ribavirin had no observable negative impact on the control of HIV viraemia during therapy or follow-up.",
    "display_src": "The use of PegIntron in combination with ribavirin had no observable negative impact on the control of HIV viraemia during therapy or follow-up.",
    "ref": "Die Anwendung von PegIntron in Kombination mit Ribavirin hatte keinen erkennbaren negativen Einfluss auf die Kontrolle der HIV-Vir\u00e4mie w\u00e4hrend der Therapie oder der Follow-up- Phase.",
    "show_ref": false
  },
  {
    "src": "\u2022 23.4.1999 \u2022 5.12.2001 \u2022 283 days \u2022 674 days",
    "display_src": "\u2022 23.4.1999 \u2022 5.12.2001 \u2022 283 days \u2022 674 days",
    "ref": "23.4.1999 5.12.2001 283 days 674 days",
    "show_ref": false
  },
  {
    "src": "All findings in the preclinical safety programme were related to the pharmacological effect of NovoSeven.",
    "display_src": "All findings in the preclinical safety programme were related to the pharmacological effect of NovoSeven.",
    "ref": "28 Alle Ergebnisse der pr\u00e4klinischen Sicherheitsuntersuchungen sind auf die pharmakologischen Effekte von NovoSeven zur\u00fcckzuf\u00fchren.",
    "show_ref": false
  },
  {
    "src": "Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed \u201c acute painful neuropathy\u201d, which is usually reversible.",
    "display_src": "Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed \u201c acute painful neuropathy\u201d, which is usually reversible.",
    "ref": "Erkrankungen des Nervensystems Gelegentlich - Periphere Neuropathie Eine rasche Besserung der Blutzuckerkontrolle kann mit Beschwerden verbunden sein, die als akute schmerzhafte Neuropathie bezeichnet werden und normalerweise reversibel sind.",
    "show_ref": false
  },
  {
    "src": "Pregnancy where the embryo is implanted outside the womb (ectopic pregnacy) may occur especially in women with a history of prior tubal disease.",
    "display_src": "Pregnancy where the embryo is implanted outside the womb (ectopic pregnacy) may occur especially in women with a history of prior tubal disease.",
    "ref": "Eine Schwangerschaft, bei der sich der Embryo au\u00dferhalb der Geb\u00e4rmutter einnistet (Eileiterschwangerschaft) kann insbesondere bei Frauen mit einer Erkrankung der Eileiter in der Vorgeschichte auftreten.",
    "show_ref": false
  },
  {
    "src": "< Isotretinoin > < Scheritonin > < Rexidal > < Lurantal > < Trivane > < 5mg > < 10mg > < 20mg > Soft Capsules",
    "display_src": "< Isotretinoin > < Scheritonin > < Rexidal > < Lurantal > < Trivane > < 5mg > < 10mg > < 20mg > Soft Capsules",
    "ref": "< Isotretinoin > < Scheritonin > < Rexidal > < Lurantal > < Trivane > < 5 mg > < 10 mg > < 20 mg > Weichkapseln",
    "show_ref": false
  },
  {
    "src": "The CHMP agreed with the harmonised text but maintained its lower age limit of 2 years.",
    "display_src": "The CHMP agreed with the harmonised text but maintained its lower age limit of 2 years.",
    "ref": "Der CHMP stimmte dem harmonisierten Text zu, erhielt aber seine niedrigere Altersgrenze von 2 Jahren aufrecht.",
    "show_ref": false
  },
  {
    "src": "What ABILIFY looks like and contents of the pack ABILIFY 15 mg tablets are round and yellow, marked with A-009 and 15 on one side.",
    "display_src": "What ABILIFY looks like and contents of the pack ABILIFY 15 mg tablets are round and yellow, marked with A-009 and 15 on one side.",
    "ref": "Wie ABILIFY aussieht und Inhalt der Packung ABILIFY 15 mg Tabletten sind rund und gelb, mit Pr\u00e4gung von A-009 und 15 auf einer Seite.",
    "show_ref": false
  },
  {
    "src": "No clinical studies have been conducted in patients with severe hepatic impairment or children and adolescents.",
    "display_src": "No clinical studies have been conducted in patients with severe hepatic impairment or children and adolescents.",
    "ref": "Es wurden keine klinischen Studien bei Patienten mit schwerer Leberfunktionsst\u00f6rung sowie bei Kindern und Jugendlichen durchgef\u00fchrt.",
    "show_ref": false
  },
  {
    "src": "As for all vaccines, if Rotarix is used in very premature babies, there is a risk of the babies experiencing apnoea (brief pauses in breathing).",
    "display_src": "As for all vaccines, if Rotarix is used in very premature babies, there is a risk of the babies experiencing apnoea (brief pauses in breathing).",
    "ref": "Wie bei allen Impfstoffen besteht bei Rotarix, wenn es bei Fr\u00fchgeborenen angewendet wird, das Risiko einer Apnoe (kurzzeitiger Atemstillstand).",
    "show_ref": false
  },
  {
    "src": "The activity administered must be such that the resulting radiation dose is as low as reasonably achievable bearing in mind the need to obtain the intended therapeutic result.",
    "display_src": "The activity administered must be such that the resulting radiation dose is as low as reasonably achievable bearing in mind the need to obtain the intended therapeutic result.",
    "ref": "Die anzuwendende Aktivit\u00e4t ist so zu w\u00e4hlen, dass die resultierende Strahlendosis so niedrig wie m\u00f6glich ist, um die beabsichtigte therapeutische Wirkung zu erzielen.",
    "show_ref": false
  },
  {
    "src": "Solution for injection Solution is clear and colourless.",
    "display_src": "Solution for injection Solution is clear and colourless.",
    "ref": "Injektionsl\u00f6sung Die L\u00f6sung ist klar und farblos.",
    "show_ref": false
  },
  {
    "src": "4-17 months)] and resulted in a greater incidence of haematologic toxicity (see 4.8) than in Studies 1 and 2.",
    "display_src": "4-17 months)] and resulted in a greater incidence of haematologic toxicity (see 4.8) than in Studies 1 and 2.",
    "ref": "4-17 Monate)]; die Behandlung war mit einer h\u00f6heren Inzidenz h\u00e4matologischer Toxizit\u00e4t als in Studie 1 und 2 verbunden (siehe 4.8).",
    "show_ref": false
  },
  {
    "src": "When warfarin or other oral anticoagulants are coadministered with Telzir a reinforced monitoring of INR (International Normalised Ratio) is recommended (see section 4.5).",
    "display_src": "When warfarin or other oral anticoagulants are coadministered with Telzir a reinforced monitoring of INR (International Normalised Ratio) is recommended (see section 4.5).",
    "ref": "Wenn Warfarin oder andere orale Antikoagulanzien zusammen mit Telzir gegeben werden, wird eine verst\u00e4rkte Kontrolle der INR (International Normalised Ratio) empfohlen (siehe Abschnitt 4.5).",
    "show_ref": false
  },
  {
    "src": "Rarely, inhibitors may develop after the first 100 exposure days.",
    "display_src": "Rarely, inhibitors may develop after the first 100 exposure days.",
    "ref": "In seltenen F\u00e4llen k\u00f6nnen sich Inhibitoren nach den ersten 100 Expositionstagen bilden.",
    "show_ref": false
  },
  {
    "src": "Some patients have experienced severe back cramps or pain, which led to hospitalisation.",
    "display_src": "Some patients have experienced severe back cramps or pain, which led to hospitalisation.",
    "ref": "Einige Patienten hatten schwere R\u00fcckenkr\u00e4mpfe oder \u2013 schmerzen, die zu einem Krankenhaus- aufenthalt f\u00fchrten.",
    "show_ref": false
  },
  {
    "src": "In the case of the following haemorrhagic events, the factor VIII activity should not fall below the given plasma levels (in% of normal or in IU/ dl) in the corresponding period.",
    "display_src": "In the case of the following haemorrhagic events, the factor VIII activity should not fall below the given plasma levels (in% of normal or in IU/ dl) in the corresponding period.",
    "ref": "Bei den nachfolgend aufgef\u00fchrten Blutungsereignissen sollte die Faktor VIII-Aktivit\u00e4t nicht unter die angegebenen Plasmaspiegel (in% des Normbereiches oder in I.E./dl) im angegebenen Behandlungszeitraum abfallen.",
    "show_ref": false
  },
  {
    "src": "7 transdermal patches 30 transdermal patches",
    "display_src": "7 transdermal patches 30 transdermal patches",
    "ref": "7 transdermale Pflaster 30 transdermale Pflaster",
    "show_ref": false
  },
  {
    "src": "waters may have a higher concentration of calcium and therefore should not be used.",
    "display_src": "waters may have a higher concentration of calcium and therefore should not be used.",
    "ref": "hingewiesen, dass einige Mineralw\u00e4sser einen hohen Calciumgehalt haben k\u00f6nnen und daher nicht verwendet werden d\u00fcrfen.",
    "show_ref": false
  },
  {
    "src": "You may need blood tests for several months after treatment.",
    "display_src": "You may need blood tests for several months after treatment.",
    "ref": "Nach der Behandlung brauchen Sie m\u00f6glicherweise f\u00fcr mehrere Monate Blutuntersuchungen.",
    "show_ref": false
  },
  {
    "src": "Severe gastrointestinal haemorrhage occurred in 4% of patients and generally required treatment interruption and transfusions.",
    "display_src": "Severe gastrointestinal haemorrhage occurred in 4% of patients and generally required treatment interruption and transfusions.",
    "ref": "Schwere gastrointestinale H\u00e4morrhagien traten bei 4% der Patienten auf und erforderten im Allgemeinen eine Unterbrechung der Behandlung und Bluttransfusionen.",
    "show_ref": false
  },
  {
    "src": "Hypospadias is a relatively common malformation.",
    "display_src": "Hypospadias is a relatively common malformation.",
    "ref": "Die Hypospadie ist eine relativ h\u00e4ufige Fehlbildung.",
    "show_ref": false
  },
  {
    "src": "Tel.: +351 (0)21 46 43 650 Rom\u00e2nia KRKA, d. d., Novo mesto Reprezentan\u0163 a pentru Rom\u00e2nia Tel.: +402 (0)1 310 66 05",
    "display_src": "Tel.: +351 (0)21 46 43 650 Rom\u00e2nia KRKA, d. d., Novo mesto Reprezentan\u0163 a pentru Rom\u00e2nia Tel.: +402 (0)1 310 66 05",
    "ref": "Tel.: +351 (0)21 46 43 650 Rom\u00e2nia KRKA, d.d., Novo mesto Reprezentan\u0163 a pentru Rom\u00e2nia Tel.:+402 (0)1 310 66 05",
    "show_ref": false
  },
  {
    "src": "PritorPlus once daily produces effective and smooth reductions in blood pressure across the therapeutic dose range.",
    "display_src": "PritorPlus once daily produces effective and smooth reductions in blood pressure across the therapeutic dose range.",
    "ref": "Die einmal t\u00e4gliche Gabe von PritorPlus f\u00fchrt zu einer wirksamen und gleichm\u00e4\u00dfigen Blutdrucksenkung \u00fcber den therapeutischen Dosisbereich.",
    "show_ref": false
  },
  {
    "src": "Kineret treatment should be started and supervised by a doctor who has experience in the treatment of rheumatoid arthritis.",
    "display_src": "Kineret treatment should be started and supervised by a doctor who has experience in the treatment of rheumatoid arthritis.",
    "ref": "Die Behandlung mit Kineret sollte von einem Arzt, der \u00fcber Erfahrung in der Behandlung der rheumatoiden Arthritis verf\u00fcgt, eingeleitet und \u00fcberwacht werden.",
    "show_ref": false
  },
  {
    "src": "18 If you have had an allergic reaction in the past to SonoVue or any other ultrasound contrast agent tell your doctor.",
    "display_src": "18 If you have had an allergic reaction in the past to SonoVue or any other ultrasound contrast agent tell your doctor.",
    "ref": "Wenn Sie in der Vergangenheit eine \u00dcberempfindlichkeitsreaktion gegen SonoVue oder ein anderes Ultraschallkontrastmittel gezeigt haben, teilen Sie dies bitte Ihrem Arzt mit.",
    "show_ref": false
  },
  {
    "src": "As there is no experience in pregnant women, entacapone should not be used during pregnancy.",
    "display_src": "As there is no experience in pregnant women, entacapone should not be used during pregnancy.",
    "ref": "Da bei schwangeren Frauen keine Erfahrungen vorliegen, darf Entacapon in der Schwangerschaft nicht angewendet werden.",
    "show_ref": false
  },
  {
    "src": "Consult your doctor before you take Soliris to be sure that you receive vaccination against Neisseria meningitidis, an organism that causes meningitis, at least 2 weeks before beginning therapy, or that your current meningitis vaccination is up to date.",
    "display_src": "Consult your doctor before you take Soliris to be sure that you receive vaccination against Neisseria meningitidis, an organism that causes meningitis, at least 2 weeks before beginning therapy, or that your current meningitis vaccination is up to date.",
    "ref": "22 Wenden Sie sich an Ihren Arzt, bevor Sie Soliris anwenden, um sicherzustellen, dass Sie mindestens 2 Wochen vor Beginn Ihrer Therapie gegen Neisseria meningitidis, einen Erreger der Meningitis, geimpft werden, oder dass Ihr aktueller Impfschutz gegen Meningitis vollst\u00e4ndig ist.",
    "show_ref": false
  },
  {
    "src": "To continue to monitor patient exposure to etoricoxib in GPRD and evaluate potential contribution of observational study(-ies).",
    "display_src": "To continue to monitor patient exposure to etoricoxib in GPRD and evaluate potential contribution of observational study(-ies).",
    "ref": "Fortlaufende \u00dcberwachung der Patientenexposition mit Etoricoxib in der GPRD-Datenbank (General Practice Research Database) und Evaluierung des potenziellen Beitrags einer (von) Beobachtungsstudie(n).",
    "show_ref": false
  },
  {
    "src": "You should tell your doctor if you notice similar symptoms in your child after vaccination.",
    "display_src": "You should tell your doctor if you notice similar symptoms in your child after vaccination.",
    "ref": "Informieren Sie Ihren Arzt, wenn Sie bei Ihrem Kind nach der Impfung \u00e4hnliche Symptome bemerken.",
    "show_ref": false
  },
  {
    "src": "- foscarnet, ganciclovir, cidofovir (medicines for viral infections)",
    "display_src": "- foscarnet, ganciclovir, cidofovir (medicines for viral infections)",
    "ref": "- Foscarnet, Ganciclovir, Cidofovir (Mittel gegen Virusinfektionen)",
    "show_ref": false
  },
  {
    "src": "Safety and effectiveness of Rapilysin in children have not been established.",
    "display_src": "Safety and effectiveness of Rapilysin in children have not been established.",
    "ref": "Zur Sicherheit und Wirksamkeit von Rapilysin bei Kindern liegen keine Erfahrungen vor.",
    "show_ref": false
  },
  {
    "src": "Skin and subcutaneous tissue disorders Severe skin reactions, including desquamation and bullous skin eruptions, Lyell\u2019s Syndrome, Steven- Johnson Syndrome",
    "display_src": "Skin and subcutaneous tissue disorders Severe skin reactions, including desquamation and bullous skin eruptions, Lyell\u2019s Syndrome, Steven- Johnson Syndrome",
    "ref": "Erkrankungen der Haut und des Unterhautzellgewebes Schwere Hautreaktionen, einschlie\u00dflich Abschuppung und Ausschlag mit Blasenbildung, Lyell Syndrom, Steven-Johnson Syndrom",
    "show_ref": false
  },
  {
    "src": "Antagonism may be observed with nitrofurantoin.",
    "display_src": "Antagonism may be observed with nitrofurantoin.",
    "ref": "Antagonismus ist m\u00f6glicherweise mit Nitrofurantoin zu beobachten.",
    "show_ref": false
  },
  {
    "src": "4 Excipients This medicinal product contains lactose and sucrose.",
    "display_src": "4 Excipients This medicinal product contains lactose and sucrose.",
    "ref": "Sonstige Bestandteile Dieses Arzneimittel enth\u00e4lt Lactose und Sucrose.",
    "show_ref": false
  },
  {
    "src": "This medicinal product should not be mixed with Heparin and/ or acetylsalicylic acid.",
    "display_src": "This medicinal product should not be mixed with Heparin and/ or acetylsalicylic acid.",
    "ref": "Dieses Arzneimittel sollte nicht mit Heparin und/oder Acetylsalicyls\u00e4ure gemischt werden.",
    "show_ref": false
  },
  {
    "src": "Stalevo should not be used in people who may be hypersensitive (allergic) to levodopa, carbidopa, entacapone or any of the other ingredients.",
    "display_src": "Stalevo should not be used in people who may be hypersensitive (allergic) to levodopa, carbidopa, entacapone or any of the other ingredients.",
    "ref": "Stalevo darf nicht bei Patienten angewendet werden, die m\u00f6glicherweise \u00fcberempfindlich (allergisch) gegen Levodopa, Carbidopa, Entacapon oder einen der sonstigen Bestandteile sind.",
    "show_ref": false
  },
  {
    "src": "Other information about Irbesartan Krka:",
    "display_src": "Other information about Irbesartan Krka:",
    "ref": "Weitere Informationen \u00fcber Irbesartan Krka:",
    "show_ref": false
  },
  {
    "src": "The dosage is determined by the indication, the severity and the site of the infection, the susceptibility to ciprofloxacin of the causative organism(s), the renal function of the patient and, in children and adolescents the body weight.",
    "display_src": "The dosage is determined by the indication, the severity and the site of the infection, the susceptibility to ciprofloxacin of the causative organism(s), the renal function of the patient and, in children and adolescents the body weight.",
    "ref": "Die Dosierung wird durch die Indikation, die Schwere und den Ort der Infektion, die Ciprofloxacin Empfindlichkeit der(s) verursachenden Erreger(s), der Nierenfunktion des Patienten und dem K\u00f6rpergewicht bei Kindern und Jugendlichen bestimmt.",
    "show_ref": false
  },
  {
    "src": "As with all vaccines, Ambirix cannot completely prevent infections with hepatitis A or B viruses, even after you have/ your child has received both doses.",
    "display_src": "As with all vaccines, Ambirix cannot completely prevent infections with hepatitis A or B viruses, even after you have/ your child has received both doses.",
    "ref": "Wie bei allen Impfstoffen kann Ambirix nicht vollst\u00e4ndig vor einer Infektion mit Hepatitis-A- oder Hepatitis-B-Virus sch\u00fctzen, auch wenn die vollst\u00e4ndige Impfserie mit 2 Dosen abgeschlossen wurde.",
    "show_ref": false
  },
  {
    "src": "- The active substance is doxorubicin hydrochloride.",
    "display_src": "- The active substance is doxorubicin hydrochloride.",
    "ref": "- Der Wirkstoff ist Doxorubicin-Hydrochlorid.",
    "show_ref": false
  },
  {
    "src": "Catalent UK Packaging Ltd Wingates Industrial Park, Westhoughton, Bolton, Lancs, BL5 3XX United Kingdom",
    "display_src": "Catalent UK Packaging Ltd Wingates Industrial Park, Westhoughton, Bolton, Lancs, BL5 3XX United Kingdom",
    "ref": "Catalent UK Packaging Ltd Wingates Industrial Park, Westhoughton, Bolton, Lancs, BL5 3XX Vereinigtes K\u00f6nigreich",
    "show_ref": false
  },
  {
    "src": "- children and adolescents under 18 years of age.",
    "display_src": "- children and adolescents under 18 years of age.",
    "ref": "- Kinder und Jugendliche unter 18 Jahre.",
    "show_ref": false
  },
  {
    "src": "Calcium treatment because of the risk of precipitation of ceftriaxone-calcium salt in term newborn.",
    "display_src": "Calcium treatment because of the risk of precipitation of ceftriaxone-calcium salt in term newborn.",
    "ref": "Calciumbehandlung bei termingerechten Neugeborenen wegen des Risikos der Ausf\u00e4llung von Ceftriaxon-Calciumsalz.",
    "show_ref": false
  },
  {
    "src": "comtess 200 mg [folding box only]",
    "display_src": "comtess 200 mg [folding box only]",
    "ref": "comtess 200 mg [nur auf dem Umkarton]",
    "show_ref": false
  },
  {
    "src": "The daily dose of Zalasta is between 5 \u2013 20 mg.",
    "display_src": "The daily dose of Zalasta is between 5 \u2013 20 mg.",
    "ref": "Die t\u00e4gliche Zalasta Dosis betr\u00e4gt zwischen 5 und 20 mg.",
    "show_ref": false
  },
  {
    "src": "There are insufficient data to provide information on inhibitor incidence in PUPs.",
    "display_src": "There are insufficient data to provide information on inhibitor incidence in PUPs.",
    "ref": "Es gibt keine ausreichenden Daten \u00fcber das Auftreten von Inhibitoren bei PUPs.",
    "show_ref": false
  },
  {
    "src": "Repeated dose toxicity studies in animals identified major target organs as the liver, retina, thyroid gland and kidney.",
    "display_src": "Repeated dose toxicity studies in animals identified major target organs as the liver, retina, thyroid gland and kidney.",
    "ref": "59 In tierexperimentellen Toxizit\u00e4tsstudien mit wiederholter Gabe erwiesen sich Leber, Netzhaut, Schilddr\u00fcse und Nieren als die wichtigsten Zielorgane.",
    "show_ref": false
  },
  {
    "src": "Treatment of major depressive episodes in adults",
    "display_src": "Treatment of major depressive episodes in adults",
    "ref": "Behandlung von Episoden einer Major Depression bei Erwachsenen.",
    "show_ref": false
  },
  {
    "src": "EU/ 1/ 98/ 077/ 010-012 EU/ 1/ 98/ 077/ 015",
    "display_src": "EU/ 1/ 98/ 077/ 010-012 EU/ 1/ 98/ 077/ 015",
    "ref": "EU/1/98/077/010-012 EU/1/98/077/015",
    "show_ref": false
  },
  {
    "src": "diagnosis of PWS should be confirmed by appropriate genetic testing.",
    "display_src": "diagnosis of PWS should be confirmed by appropriate genetic testing.",
    "ref": "Die Diagnose des PWS sollte durch geeignete genetische Tests best\u00e4tigt sein.",
    "show_ref": false
  },
  {
    "src": "It is not known whether aprepitant is excreted in human milk.",
    "display_src": "It is not known whether aprepitant is excreted in human milk.",
    "ref": "Es ist nicht bekannt, ob Aprepitant beim Menschen in die Muttermilch \u00fcbergeht.",
    "show_ref": false
  },
  {
    "src": "Both, the teat and the udder should be adequately cleansed and the teat end disinfected before using Pirsue.",
    "display_src": "Both, the teat and the udder should be adequately cleansed and the teat end disinfected before using Pirsue.",
    "ref": "Sowohl die Zitze als auch das Euter sollten gr\u00fcndlich gereinigt und die Zitzenspitze desinfiziert werden, bevor Pirsue angewendet wird.",
    "show_ref": false
  },
  {
    "src": "Current treatment guidelines should be consulted as to whether a liver biopsy is needed prior to commencing treatment.",
    "display_src": "Current treatment guidelines should be consulted as to whether a liver biopsy is needed prior to commencing treatment.",
    "ref": "Aktuelle Behandlungsrichtlinien sollten zu Rate gezogen werden, ob eine Leberbiopsie vor Behandlungsbeginn erforderlich ist.",
    "show_ref": false
  },
  {
    "src": "The safety of this medicinal product for use in human pregnancy has not been established.",
    "display_src": "The safety of this medicinal product for use in human pregnancy has not been established.",
    "ref": "\u00dcber die Unbedenklichkeit dieses Arzneimittels bei der Anwendung w\u00e4hrend der Schwangerschaft beim Menschen liegen bisher noch keine Erkenntnisse vor.",
    "show_ref": false
  },
  {
    "src": "Elderly patients A population pharmacokinetic analysis of patient data indicated a trend for clearance to decrease with age (19% per decade based on Phase III population pharmacokinetic analysis of patients aged 60\u2013 89 years), see section 4.2.",
    "display_src": "Elderly patients A population pharmacokinetic analysis of patient data indicated a trend for clearance to decrease with age (19% per decade based on Phase III population pharmacokinetic analysis of patients aged 60\u2013 89 years), see section 4.2.",
    "ref": "\u00c4ltere Patienten Eine pharmakokinetische Populationsanalyse von Patientendaten zeigte, dass die Clearance mit steigendem Alter tendenziell abnimmt (um 19% pro Jahrzehnt, basierend auf einer pharmakokinetischen Populationsanalyse von Phase-III-Daten bei Patienten im Alter von 60 bis 89 Jahren), siehe Abschnitt 4.2.",
    "show_ref": false
  },
  {
    "src": "1 jar, as part of a multicomponent kit with sample tubes",
    "display_src": "1 jar, as part of a multicomponent kit with sample tubes",
    "ref": "1 Weithalsgef\u00e4\u00df, als Teil eines mehrteiligen diagnostischen Test-Kits mit Probenr\u00f6hrchen",
    "show_ref": false
  },
  {
    "src": "Medicine will not flow into the syringe unless you keep the bottle in its upright position (See Figure 2).",
    "display_src": "Medicine will not flow into the syringe unless you keep the bottle in its upright position (See Figure 2).",
    "ref": "Das Arzneimittel flie\u00dft nur dann in die Spritze, wenn Sie die Flasche aufrecht halten (siehe Abbildung 2).",
    "show_ref": false
  },
  {
    "src": "The following adverse reactions have been identified during post-approval use of SUTENT.",
    "display_src": "The following adverse reactions have been identified during post-approval use of SUTENT.",
    "ref": "Die nachfolgenden Nebenwirkungen wurden nach der Markteinf\u00fchrung von SUTENT beobachtet.",
    "show_ref": false
  },
  {
    "src": "In randomised clinical studies, a subcutaneous dose of 23 MU/ m2/ day (230 \u03bc g/ m2/ day) or rather 0.4 - 0.84 MU/ kg/ day (4 - 8.4 \u03bc g/ kg/ day) was used.",
    "display_src": "In randomised clinical studies, a subcutaneous dose of 23 MU/ m2/ day (230 \u03bc g/ m2/ day) or rather 0.4 - 0.84 MU/ kg/ day (4 - 8.4 \u03bc g/ kg/ day) was used.",
    "ref": "In randomisierten klinischen Studien wurde eine subkutane Dosis von 23 Mio.E./m2/Tag (230 \u03bc g/m2/Tag) beziehungsweise 0,4 - 0,84 Mio.E./kg/Tag (4 - 8,4 \u03bc g/kg/Tag) verwendet.",
    "show_ref": false
  },
  {
    "src": "Check with your doctor before you receive any vaccines.",
    "display_src": "Check with your doctor before you receive any vaccines.",
    "ref": "Bitte beraten Sie sich mit Ihrem Arzt, bevor Sie irgendwelche Impfungen erhalten.",
    "show_ref": false
  },
  {
    "src": "This section contains information on how to give yourself an injection of Aranesp.",
    "display_src": "This section contains information on how to give yourself an injection of Aranesp.",
    "ref": "Dieser Abschnitt enth\u00e4lt Informationen dar\u00fcber, wie Sie sich Aranesp selbst spritzen k\u00f6nnen.",
    "show_ref": false
  },
  {
    "src": "Danmark sanofi-aventis Denmark A/ S",
    "display_src": "Danmark sanofi-aventis Denmark A/ S",
    "ref": "se Danmark sanofi-aventis Denmark A/S",
    "show_ref": false
  },
  {
    "src": "Any person intending to import, sell, supply and/ or use the veterinary medicinal product must be authorised by the competent authority of the Member State. o tn",
    "display_src": "Any person intending to import, sell, supply and/ or use the veterinary medicinal product must be authorised by the competent authority of the Member State. o tn",
    "ref": "einzuf\u00fchren, zu verkaufen, abzugeben und/oder anzuwenden, ben\u00f6tigt die Genehmigung der zust\u00e4ndigen Beh\u00f6rde des Mitgliedsstaates. itte",
    "show_ref": false
  },
  {
    "src": "IntronA 10 million IU/ml solution for injection or infusion interferon alfa-2b",
    "display_src": "IntronA 10 million IU/ml solution for injection or infusion interferon alfa-2b",
    "ref": "IntronA 10 Millionen I.E./ml Injektions- oder Infusionsl\u00f6sung Interferon alfa-2b",
    "show_ref": false
  },
  {
    "src": "Your doctor will advise you if you can still have STAMARIL based on the results of your blood tests.",
    "display_src": "Your doctor will advise you if you can still have STAMARIL based on the results of your blood tests.",
    "ref": "Ihr Arzt wird Sie beraten, ob Sie auf Grund der Ergebnisse Ihrer Blutuntersuchungen dennoch mit STAMARIL geimpft werden k\u00f6nnen.",
    "show_ref": false
  },
  {
    "src": "Having considered the grounds for the referral, the CHMP, during its May 2006 plenary meeting, requested the MAH to address the major objection to public health and adopted a List of Questions.",
    "display_src": "Having considered the grounds for the referral, the CHMP, during its May 2006 plenary meeting, requested the MAH to address the major objection to public health and adopted a List of Questions.",
    "ref": "Nach Pr\u00fcfung der Begr\u00fcndung f\u00fcr das Verfahren forderte der CHMP auf seiner Plenarsitzung im Mai 2006 den Inhaber der Genehmigung f\u00fcr das Inverkehrbringen auf, auf den schwerwiegenden Einwand bez\u00fcglich der \u00f6ffentlichen Gesundheit einzugehen, und verabschiedete eine Fragenliste.",
    "show_ref": false
  },
  {
    "src": "Percentages of dogs per weight loss category for mitratapide versus placebo:",
    "display_src": "Percentages of dogs per weight loss category for mitratapide versus placebo:",
    "ref": "Prozentualer Anteil der Hunde (%) pro Gewichtsabnahmekategorie f\u00fcr Mitratapid im Vergleich zu Placebo:",
    "show_ref": false
  },
  {
    "src": "Eesti Allergan Ltd 1st Floor Marlow International The Parkway Marlow Bucks, SL7 1YL-UK \u00dchendkuningriik Tel: + 44 (0)1628 494026 E-mail: uk_medinfo@allergan. com",
    "display_src": "Eesti Allergan Ltd 1st Floor Marlow International The Parkway Marlow Bucks, SL7 1YL-UK \u00dchendkuningriik Tel: + 44 (0)1628 494026 E-mail: uk_medinfo@allergan. com",
    "ref": "Eesti Allergan Ltd 1st Floor Marlow International The Parkway Marlow Bucks, SL7 1YL-UK \u00dchendkuningriik Tel: + 44 (0)1628 494026 E-mail: uk_medinfo@allergan.com",
    "show_ref": false
  },
  {
    "src": "This indication is based on histological, virological, biochemical and serological responses mainly in adult nucleoside-na\u00efve patients with HBeAg positive and HBeAg negative chronic hepatitis B with compensated liver function.",
    "display_src": "This indication is based on histological, virological, biochemical and serological responses mainly in adult nucleoside-na\u00efve patients with HBeAg positive and HBeAg negative chronic hepatitis B with compensated liver function.",
    "ref": "Diese Indikation basiert auf histologischem, virologischem, biochemischem und serologischem Ansprechen haupts\u00e4chlich bei erwachsenen Patienten mit HBeAg-positiver und HBeAg-negativer chronischer Hepatitis B mit kompensierter Leberfunktion, die zuvor nicht mit Nukleosiden behandelt worden waren.",
    "show_ref": false
  },
  {
    "src": "Leucopoenia Bleeding time prolonged",
    "display_src": "Leucopoenia Bleeding time prolonged",
    "ref": "Leukopenie Verl\u00e4ngerte Blutungszeit",
    "show_ref": false
  },
  {
    "src": "The free drug clearance of imatinib is probably similar between patients with renal impairment and those with normal renal function, since renal excretion represents only a minor elimination pathway for imatinib (see sections 4.2 and 4.4).",
    "display_src": "The free drug clearance of imatinib is probably similar between patients with renal impairment and those with normal renal function, since renal excretion represents only a minor elimination pathway for imatinib (see sections 4.2 and 4.4).",
    "ref": "Die Clearance von ungebundenem Imatinib ist wahrscheinlich vergleichbar zwischen Patienten mit Niereninsuffizienz und Patienten mit normaler Nierenfunktion, da die renale Ausscheidung nur einen unbedeutenden Eliminationsweg f\u00fcr Imatinib darstellt (siehe Abschnitte 4.2 und 4.4).",
    "show_ref": false
  },
  {
    "src": "Driving and using machines You might experience dizziness or sleepiness which could affect your ability to drive or operate machinery.",
    "display_src": "Driving and using machines You might experience dizziness or sleepiness which could affect your ability to drive or operate machinery.",
    "ref": "Verkehrst\u00fcchtigkeit und das Bedienen von Maschinen Es kann bei Ihnen zu Schwindelgef\u00fchl oder Schl\u00e4frigkeit kommen, was Ihre Verkehrst\u00fcchtigkeit und F\u00e4higkeit zum Bedienen von Maschinen beeintr\u00e4chtigen kann.",
    "show_ref": false
  },
  {
    "src": "Positive genotoxic effects were obtained for imatinib in an in vitro mammalian cell assay (Chinese hamster ovary) for clastogenicity (chromosome aberration) in the presence of metabolic activation.",
    "display_src": "Positive genotoxic effects were obtained for imatinib in an in vitro mammalian cell assay (Chinese hamster ovary) for clastogenicity (chromosome aberration) in the presence of metabolic activation.",
    "ref": "Positive genotoxische Effekte wurden f\u00fcr Imatinib in einem in vitro S\u00e4ugetierzelltest (Ovarialzellen des Chinesischen Hamsters) auf klastogene Effekte (Chromosomenaberrationen) bei Vorliegen einer metabolischen Aktivierung gefunden.",
    "show_ref": false
  },
  {
    "src": "Repeated-dose studies of up to 3-months duration have been conducted in rat and dog.",
    "display_src": "Repeated-dose studies of up to 3-months duration have been conducted in rat and dog.",
    "ref": "Bei Ratten und Hunden sind Studien mit Mehrfachdosierung \u00fcber einen Zeitraum von bis zu 3 Monaten durchgef\u00fchrt worden.",
    "show_ref": false
  },
  {
    "src": "How has Crixivan been studied?",
    "display_src": "How has Crixivan been studied?",
    "ref": "Wie wurde Crixivan untersucht?",
    "show_ref": false
  },
  {
    "src": "Danmark ScanVet Animal Health A/ S 66 Kongevejen DK 3480 - Fredensborg Tlf: + 45 48 48 43 17",
    "display_src": "Danmark ScanVet Animal Health A/ S 66 Kongevejen DK 3480 - Fredensborg Tlf: + 45 48 48 43 17",
    "ref": "Danmark ScanVet Animal Health A/S 66 Kongevejen DK 3480 - Fredensborg Tlf: + 45 48 48 43 17",
    "show_ref": false
  },
  {
    "src": "The active substance in Sprimeo, aliskiren, is a renin inhibitor.",
    "display_src": "The active substance in Sprimeo, aliskiren, is a renin inhibitor.",
    "ref": "Der Wirkstoff in Sprimeo, Aliskiren, ist ein Renin-Inhibitor.",
    "show_ref": false
  },
  {
    "src": "Treatment should continue as long as the medicine has a benefit, but the dose can be reduced or treatment interrupted if the patient has side effects.",
    "display_src": "Treatment should continue as long as the medicine has a benefit, but the dose can be reduced or treatment interrupted if the patient has side effects.",
    "ref": "Die Behandlung sollte solange fortgesetzt werden, wie das Arzneimittel von Nutzen ist, allerdings kann die Dosis reduziert oder die Behandlung unterbrochen werden, falls Nebenwirkungen auftreten.",
    "show_ref": false
  },
  {
    "src": "Auditory and ophthalmic testing (including fundoscopy) is recommended before the start of treatment and at regular intervals thereafter (every 12 months).",
    "display_src": "Auditory and ophthalmic testing (including fundoscopy) is recommended before the start of treatment and at regular intervals thereafter (every 12 months).",
    "ref": "Ein H\u00f6rtest und eine augen\u00e4rztliche Untersuchung (einschlie\u00dflich Spiegelung des Augenhintergrunds) werden vor Einleitung der Behandlung und danach in regelm\u00e4\u00dfigen Abst\u00e4nden (alle 12 Monate) empfohlen.",
    "show_ref": false
  },
  {
    "src": "At the end of treatment (over 6 or 8 weeks), significant efficacy of agomelatine 25-50 mg was demonstrated in 3 of the six short-term double-blind placebo-controlled studies.",
    "display_src": "At the end of treatment (over 6 or 8 weeks), significant efficacy of agomelatine 25-50 mg was demonstrated in 3 of the six short-term double-blind placebo-controlled studies.",
    "ref": "Nach dem Ende der Behandlung (\u00fcber 6 oder 8 Wochen) wurde die signifikante Wirksamkeit von Agomelatin 25-50 mg in drei dieser sechs Placebo-kontrollierten Doppelblindstudien nachgewiesen.",
    "show_ref": false
  },
  {
    "src": "Other information about Silgard:",
    "display_src": "Other information about Silgard:",
    "ref": "Weitere Informationen \u00fcber Silgard:",
    "show_ref": false
  },
  {
    "src": "INTELENCE 100 mg tablets etravirine",
    "display_src": "INTELENCE 100 mg tablets etravirine",
    "ref": "INTELENCE 100 mg Tabletten Etravirin",
    "show_ref": false
  },
  {
    "src": "An environmental risk was detected during the risk assessment Phase II Tier A for dung fauna organisms;",
    "display_src": "An environmental risk was detected during the risk assessment Phase II Tier A for dung fauna organisms;",
    "ref": "W\u00e4hrend der Risikobewertung der Phase II, Stufe A wurde f\u00fcr Dungfaunaorganismen ein Umweltrisiko festgestellt;",
    "show_ref": false
  },
  {
    "src": "There is no indication that any of the members within this class differs with respect to efficacy and safety, and Vantas seems to be no exception in that respect.",
    "display_src": "There is no indication that any of the members within this class differs with respect to efficacy and safety, and Vantas seems to be no exception in that respect.",
    "ref": "Nichts deutet darauf hin, dass sich die Produkte innerhalb dieser Klasse in Bezug auf Wirksamkeit und Sicherheit unterscheiden, und Vantas scheint in dieser Hinsicht keine Ausnahme zu bilden.",
    "show_ref": false
  },
  {
    "src": "After completion of a four dose primary course (i. e at month 7), 90.9% of Fendrix recipients were seroprotected (\u2265 10 mIU/ ml) against hepatitis B, in comparison with 84.4% in a control group who received the commercially available hepatitis B vaccine.",
    "display_src": "After completion of a four dose primary course (i. e at month 7), 90.9% of Fendrix recipients were seroprotected (\u2265 10 mIU/ ml) against hepatitis B, in comparison with 84.4% in a control group who received the commercially available hepatitis B vaccine.",
    "ref": "Nach Beendigung der Impfserie nach dem Vier-Dosen-Impfschema (d. h. im Monat 7) zeigten 90,9% der Fendrix-Gruppe eine Seroprotektion (\u2265 10 mIU/ml) im Vergleich zu 84,4% einer Kontrollgruppe.",
    "show_ref": false
  },
  {
    "src": "Do not use Liprolog Mix50 Pen after the expiry date which is stated on the label and the carton.",
    "display_src": "Do not use Liprolog Mix50 Pen after the expiry date which is stated on the label and the carton.",
    "ref": "Sie d\u00fcrfen Liprolog Mix50 Pen nach dem auf dem Etikett und dem Umkarton angegebenen Verfalldatum nicht mehr anwenden.",
    "show_ref": false
  },
  {
    "src": "Oral ingestion of the fentanyl-containing gel may cause life-threatening hypoventilation or death.",
    "display_src": "Oral ingestion of the fentanyl-containing gel may cause life-threatening hypoventilation or death.",
    "ref": "Eine orale Aufnahme des Fentanyl-haltigen Gels kann zu lebensbedrohlicher Hypoventilation oder zum Tode f\u00fchren.",
    "show_ref": false
  },
  {
    "src": "Do not use in piglets of less than 4 weeks of age.",
    "display_src": "Do not use in piglets of less than 4 weeks of age.",
    "ref": "Nicht anwenden bei Ferkeln im Alter von unter vier Wochen.",
    "show_ref": false
  },
  {
    "src": "Monoclonal antibodies are proteins which specifically recognise and bind to other unique proteins in the body.",
    "display_src": "Monoclonal antibodies are proteins which specifically recognise and bind to other unique proteins in the body.",
    "ref": "Monoklonale Antik\u00f6rper sind Eiwei\u00dfstoffe, die andere, ganz bestimmte Eiwei\u00dfstoffe im K\u00f6rper erkennen und an sie binden.",
    "show_ref": false
  },
  {
    "src": "Mental impairment Polyneuropathy Movement disorder Dizziness Headache",
    "display_src": "Mental impairment Polyneuropathy Movement disorder Dizziness Headache",
    "ref": "mentale Beeintr\u00e4chtigung Polyneuropathie Bewegungsst\u00f6rungen Schwindelgef\u00fchl Kopfschmerzen",
    "show_ref": false
  },
  {
    "src": "No significant differences occurred in the exposure to other metabolites (5'-DFCR, 5'-DFUR, and 5-FU).",
    "display_src": "No significant differences occurred in the exposure to other metabolites (5'-DFCR, 5'-DFUR, and 5-FU).",
    "ref": "Hinsichtlich der Plasmaspiegel anderer Metaboliten (5\u2019-DFCR, 5\u2019-DFUR und 5-FU) traten keine signifikanten Unterschiede auf.",
    "show_ref": false
  },
  {
    "src": "By contrast, in non-infected subjects, transient increases in WBC count were seen 24 hours after LeukoScan administration.",
    "display_src": "By contrast, in non-infected subjects, transient increases in WBC count were seen 24 hours after LeukoScan administration.",
    "ref": "Im Gegensatz dazu wurden bei nicht-infizierten Patienten 24 Stunden nach der Anwendung von LeukoScan vor\u00fcbergehende Erh\u00f6hungen im wei\u00dfen Blutbild festgestellt.",
    "show_ref": false
  },
  {
    "src": "7 film-coated tablets 14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 56 film-coated tablets 90 film-coated tablets 98 film-coated tablets 280 film-coated tablets 56 x 1 film-coated tablet (unit dose) 98 x 1 film-coated tablet (unit dose) 280 x 1 film-coated tablet (unit dose)",
    "display_src": "7 film-coated tablets 14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 56 film-coated tablets 90 film-coated tablets 98 film-coated tablets 280 film-coated tablets 56 x 1 film-coated tablet (unit dose) 98 x 1 film-coated tablet (unit dose) 280 x 1 film-coated tablet (unit dose)",
    "ref": "7 Filmtabletten 14 Filmtabletten 28 Filmtabletten 30 Filmtabletten 56 Filmtabletten 90 Filmtabletten 98 Filmtabletten 280 Filmtabletten 56 x 1 Filmtablette (Einzeldosis) 98 x 1 Filmtablette (Einzeldosis) 280 x 1 Filmtablette (Einzeldosis)",
    "show_ref": false
  },
  {
    "src": "Intracellular ara-GTP concentrations in leukaemic blasts were quantifiable for a prolonged period after nelarabine administration.",
    "display_src": "Intracellular ara-GTP concentrations in leukaemic blasts were quantifiable for a prolonged period after nelarabine administration.",
    "ref": "Die intrazellul\u00e4ren ara-GTP-Konzentrationen in leuk\u00e4mischen Blasten waren \u00fcber einen l\u00e4ngeren Zeitraum nach der Gabe von Nelarabin quantifizierbar.",
    "show_ref": false
  },
  {
    "src": "Norge Biovitrum AB (publ) C. J.",
    "display_src": "Norge Biovitrum AB (publ) C. J.",
    "ref": "Norge Biovitrum AB (publ) C.J.",
    "show_ref": false
  },
  {
    "src": "- Ulcers (bleeding) in the stomach, gullet or intestines; or rupture of the intestine (can cause stomach",
    "display_src": "- Ulcers (bleeding) in the stomach, gullet or intestines; or rupture of the intestine (can cause stomach",
    "ref": "- Geschw\u00fcre (Blutungen) in Magen, Speiser\u00f6hre oder Darm oder Einrisse im Darm, die",
    "show_ref": false
  },
  {
    "src": "Therefore, any abrupt dosage reduction or withdrawal of levodopa should be carefully observed, particularly in patients who are also receiving neuroleptics.",
    "display_src": "Therefore, any abrupt dosage reduction or withdrawal of levodopa should be carefully observed, particularly in patients who are also receiving neuroleptics.",
    "ref": "Daher sollte jede abrupte Dosisminderung oder abruptes Absetzen von Levodopa engmaschig \u00fcberwacht werden, insbesondere bei Patienten, die zus\u00e4tzlich Neuroleptika erhalten.",
    "show_ref": false
  },
  {
    "src": "au Please tell your doctor if you are taking or have recently taken any other medecines, including medicines obtained without a prescription, as some of them could have an interaction with Levviax.",
    "display_src": "au Please tell your doctor if you are taking or have recently taken any other medecines, including medicines obtained without a prescription, as some of them could have an interaction with Levviax.",
    "ref": "Bitte informieren Sie Ihren Arzt, wenn Sie andere Arzneimittel einnehmen/anwenden bzw. vor kurzem eingenommen/angewendet haben, auch wenn es sich um nicht verschreibungspflichtige Arzneimittel handelt, da einige davon Wechselwirkungen mit Levviax haben k\u00f6nnten. itte",
    "show_ref": false
  },
  {
    "src": "Single intramuscular injection at a dosage of 0.4 mg meloxicam/ kg body weight (i. e.",
    "display_src": "Single intramuscular injection at a dosage of 0.4 mg meloxicam/ kg body weight (i. e.",
    "ref": "Einmalige intramuskul\u00e4re Injektion von 0,4 mg Meloxicam/kg K\u00f6rpergewicht (entspr.",
    "show_ref": false
  },
  {
    "src": "There are minimal data on the use of Tracleer in pregnant women.",
    "display_src": "There are minimal data on the use of Tracleer in pregnant women.",
    "ref": "Es liegen sehr wenige Daten zur Anwendung von Tracleer bei Schwangeren vor..",
    "show_ref": false
  },
  {
    "src": "Akathisia/ Psychomotor restlessness, Convulsion, Manic reaction",
    "display_src": "Akathisia/ Psychomotor restlessness, Convulsion, Manic reaction",
    "ref": "Akathi- sie/Psych omotori- sche Un- ruhe, Krampf- anf\u00e4lle, Manie",
    "show_ref": false
  },
  {
    "src": "The most common side effects are hypercalcaemia (increased blood calcium), hypercalciuria (increased urine calcium), and nausea (feeling sick).",
    "display_src": "The most common side effects are hypercalcaemia (increased blood calcium), hypercalciuria (increased urine calcium), and nausea (feeling sick).",
    "ref": "Die h\u00e4ufigsten Nebenwirkungen sind Hyperkalz\u00e4mie (erh\u00f6hter Calciumgehalt im Blut), Hyperkalzurie (erh\u00f6hter Calciumgehalt im Urin) sowie \u00dcbelkeit (Unwohlsein).",
    "show_ref": false
  },
  {
    "src": "Consequently, concomitant administration of tipranavir, co-administered with low dose ritonavir, and these glucocorticoids is not recommended unless the potential benefit of treatment outweighs the risk of systemic corticosteroid effects (see section 4.4).",
    "display_src": "Consequently, concomitant administration of tipranavir, co-administered with low dose ritonavir, and these glucocorticoids is not recommended unless the potential benefit of treatment outweighs the risk of systemic corticosteroid effects (see section 4.4).",
    "ref": "14 dessen wird die gleichzeitige Anwendung von Tipranavir in Kombination mit niedrig dosiertem Ritonavir und diesen Glucocorticoiden nicht empfohlen, sofern nicht der m\u00f6gliche Nutzen die Risiken der systemischen Corticosteroid-Wirkungen \u00fcberwiegt (siehe Abschnitt 4.4).",
    "show_ref": false
  },
  {
    "src": "What Cyanokit is and what it is used for 2.",
    "display_src": "What Cyanokit is and what it is used for 2.",
    "ref": "Was ist Cyanokit und wof\u00fcr wird es angewendet?",
    "show_ref": false
  },
  {
    "src": "The company that makes Karvezide has agreed that its scientific data can be used for Irbesartan Hydrochlorothiazide BMS.",
    "display_src": "The company that makes Karvezide has agreed that its scientific data can be used for Irbesartan Hydrochlorothiazide BMS.",
    "ref": "Der Hersteller von Karvezide hat zugestimmt, dass seine wissenschaftlichen Daten f\u00fcr Irbesartan Hydrochlorothiazide BMS verwendet werden k\u00f6nnen.",
    "show_ref": false
  },
  {
    "src": "There are no studies completed assessing long-term cardiovascular outcome in patients receiving rosiglitazone.",
    "display_src": "There are no studies completed assessing long-term cardiovascular outcome in patients receiving rosiglitazone.",
    "ref": "Es liegen keine abgeschlossenen Studien zu kardiovaskul\u00e4ren Langzeitergebnissen bei Patienten vor, die Rosiglitazon erhalten haben.",
    "show_ref": false
  },
  {
    "src": "Inject the insulin by using your thumb, if possible, to push in the injection button completely.",
    "display_src": "Inject the insulin by using your thumb, if possible, to push in the injection button completely.",
    "ref": "Injizieren Sie das Insulin, indem Sie den Injektionsknopf wenn m\u00f6glich mit dem Daumen vollst\u00e4ndig durchdr\u00fccken.",
    "show_ref": false
  },
  {
    "src": "Rare and very rare ADRs cannot be detected based on the number of patients included in the DUET trials.",
    "display_src": "Rare and very rare ADRs cannot be detected based on the number of patients included in the DUET trials.",
    "ref": "Seltene und sehr seltene UAWs k\u00f6nnen aufgrund der Anzahl der Patienten, die in den DUET-Studien eingeschlossen waren, nicht nachgewiesen werden.",
    "show_ref": false
  },
  {
    "src": "Loratyn 10 mg - Brausetablette n",
    "display_src": "Loratyn 10 mg - Brausetablette n",
    "ref": "Loratyn 10 mg - Brausetablett en",
    "show_ref": false
  },
  {
    "src": "Please read the following instructions carefully before using your Actraphane 10 NovoLet.",
    "display_src": "Please read the following instructions carefully before using your Actraphane 10 NovoLet.",
    "ref": "Bitte lesen Sie die folgende Bedienungsanleitung vor der Benutzung von Actraphane 10 NovoLet sorgf\u00e4ltig durch.",
    "show_ref": false
  },
  {
    "src": "However, based on the minimal extent of pimecrolimus absorption after topical application of < Invented Name >, (see Section 5.2 \u201cPharmacokinetic properties\u201d), the potential risk for humans is considered limited.",
    "display_src": "However, based on the minimal extent of pimecrolimus absorption after topical application of < Invented Name >, (see Section 5.2 \u201cPharmacokinetic properties\u201d), the potential risk for humans is considered limited.",
    "ref": "Wegen der minimalen Resorptionsrate von Pimecrolimus nach topischer Anwendung von {(Name (Phantasiebezeichnung)} wird jedoch das potentielle Risiko beim Menschen als gering angesehen (siehe Abschnitt 5.2 \u201ePharmakokinetische Eigenschaften\u201c).",
    "show_ref": false
  },
  {
    "src": "30 PARTICULARS TO APPEAR ON BLISTERS (boxes of 7, 14, 28 or 84 tablets)",
    "display_src": "30 PARTICULARS TO APPEAR ON BLISTERS (boxes of 7, 14, 28 or 84 tablets)",
    "ref": "34 MINDESTANGABEN AUF BLISTERPACKUNGEN (Faltschachteln mit 7, 14, 28 oder 84 Tabletten)",
    "show_ref": false
  },
  {
    "src": "Non-clinical data reveal no special hazard for humans based on conventional studies of single and repeated dose toxicity and genotoxicity additional to that already stated in other sections of this SPC.",
    "display_src": "Non-clinical data reveal no special hazard for humans based on conventional studies of single and repeated dose toxicity and genotoxicity additional to that already stated in other sections of this SPC.",
    "ref": "Basierend auf den konventionellen Studien zur akuten Toxizit\u00e4t, Toxizit\u00e4t bei wiederholter Gabe und Genotoxizit\u00e4t lassen die pr\u00e4klinischen Daten keine besonderen Gefahren f\u00fcr den Menschen erkennen, welche sich zus\u00e4tzlich zu den bereits in anderen Abschnitten dieser Arzneimittelinformation erw\u00e4hnten Eigenschaften ergeben w\u00fcrden.",
    "show_ref": false
  },
  {
    "src": "Pelzont should not be used in people who may be hypersensitive (allergic) to nicotinic acid, laropiprant or any of the other ingredients.",
    "display_src": "Pelzont should not be used in people who may be hypersensitive (allergic) to nicotinic acid, laropiprant or any of the other ingredients.",
    "ref": "Pelzont darf nicht bei Patienten angewendet werden, die m\u00f6glicherweise \u00fcberempfindlich (allergisch) gegen Nicotins\u00e4ure, Laropiprant oder einen der sonstigen Bestandteile sind.",
    "show_ref": false
  },
  {
    "src": "In the pivotal clinical field study, dogs of various breeds, ranging in age from two to seventeen years, were randomly treated with Masivet at a dose of 12.5 mg/ kg or with a placebo.",
    "display_src": "In the pivotal clinical field study, dogs of various breeds, ranging in age from two to seventeen years, were randomly treated with Masivet at a dose of 12.5 mg/ kg or with a placebo.",
    "ref": "8 In der ausschlaggebenden klinischen Feldstudie wurden Hunde verschiedener Rassen im Alter von zwei bis siebzehn Jahren randomisiert entweder mit Masivet in einer Dosis von 12,5 mg/kg K\u00f6rpergewicht oder mit Placebo behandelt.",
    "show_ref": false
  },
  {
    "src": "Take special care with Rasilez HCT",
    "display_src": "Take special care with Rasilez HCT",
    "ref": "Besondere Vorsicht bei der Einnahme von Rasilez HCT ist erforderlich,",
    "show_ref": false
  },
  {
    "src": "As an aid in the treatment of separation-related disorders in combination with behavioural modification techniques.",
    "display_src": "As an aid in the treatment of separation-related disorders in combination with behavioural modification techniques.",
    "ref": "Zur Unterst\u00fctzung bei der Behandlung von trennungsbedingten Verhaltensauff\u00e4lligkeiten in Kombination mit einer Verhaltenstherapie.",
    "show_ref": false
  },
  {
    "src": "Silapo 10000 IU/1.0ml solution for injection in pre-filled syringe",
    "display_src": "Silapo 10000 IU/1.0ml solution for injection in pre-filled syringe",
    "ref": "Silapo 10000 I.E./1,0 ml Injektionsl\u00f6sung in Fertigspritze",
    "show_ref": false
  },
  {
    "src": "Kit - Store in a refrigerator (2\u00baC - 8\u00baC).",
    "display_src": "Kit - Store in a refrigerator (2\u00baC - 8\u00baC).",
    "ref": "Markierungsbesteck - im K\u00fchlschrank lagern (bei 2-8\u00b0C).",
    "show_ref": false
  },
  {
    "src": "When the chickens are exposed to this attenuated virus, this small exposure helps the chickens\u2019 immune systems to recognise and attack the IBV virus.",
    "display_src": "When the chickens are exposed to this attenuated virus, this small exposure helps the chickens\u2019 immune systems to recognise and attack the IBV virus.",
    "ref": "Wenn die H\u00fchner diesem attenuierten Virus ausgesetzt werden, bewirkt dieser geringf\u00fcgige Kontakt mit den Erregern, dass das Immunsystem der H\u00fchner das IBV-Virus erkennt und bek\u00e4mpft.",
    "show_ref": false
  },
  {
    "src": "Neoclarityn syrup contains sucrose and sorbitol.",
    "display_src": "Neoclarityn syrup contains sucrose and sorbitol.",
    "ref": "Neoclarityn Sirup enth\u00e4lt Saccharose und Sorbitol.",
    "show_ref": false
  },
  {
    "src": "Palifermin is a 140 amino acid protein with a molecular weight of 16.3 kilodaltons.",
    "display_src": "Palifermin is a 140 amino acid protein with a molecular weight of 16.3 kilodaltons.",
    "ref": "Entgiftungsmittel f\u00fcr die Behandlung mit Zytostatika, ATC-Code V03AF08 Palifermin ist ein Protein bestehend aus 140 Aminos\u00e4uren und einem Molekulargewicht von 16,3 kDa.",
    "show_ref": false
  },
  {
    "src": "Antibodies against components of fibrin sealant/ haemostatic products may occur rarely.",
    "display_src": "Antibodies against components of fibrin sealant/ haemostatic products may occur rarely.",
    "ref": "Antik\u00f6rper gegen Komponenten von Fibrinkleberprodukten/H\u00e4mostatika k\u00f6nnen in seltenen F\u00e4llen auftreten.",
    "show_ref": false
  },
  {
    "src": "Antacid: the effect of an aluminum hydroxide and magnesium hydroxide-containing antacid on the pharmacokinetics of capecitabine was investigated.",
    "display_src": "Antacid: the effect of an aluminum hydroxide and magnesium hydroxide-containing antacid on the pharmacokinetics of capecitabine was investigated.",
    "ref": "Der Einfluss eines Aluminiumhydroxid- und Magnesiumhydroxid-haltigen Antazidums auf die Pharmakokinetik von Capecitabin wurde untersucht.",
    "show_ref": false
  },
  {
    "src": "In patients insufficiently controlled with 150 mg once daily, the dose of Irbesartan Krka can be increased to 300 mg, or other anti-hypertensive agents can be added.",
    "display_src": "In patients insufficiently controlled with 150 mg once daily, the dose of Irbesartan Krka can be increased to 300 mg, or other anti-hypertensive agents can be added.",
    "ref": "Bei Patienten, deren Blutdruck mit 150 mg ein Mal t\u00e4glich nur unzureichend eingestellt werden kann, kann die Dosierung von Irbesartan Krka auf 300 mg erh\u00f6ht werden oder es k\u00f6nnen andere Antihypertonika zus\u00e4tzlich verabreicht werden.",
    "show_ref": false
  },
  {
    "src": "1.5 ml of solution for injection in 3 ml cartridge (Type I glass), with a plunger stopper (halobutyl rubber) and an aluminium crimp cap with a black rubber inlay.",
    "display_src": "1.5 ml of solution for injection in 3 ml cartridge (Type I glass), with a plunger stopper (halobutyl rubber) and an aluminium crimp cap with a black rubber inlay.",
    "ref": "1,5 ml Injektionsl\u00f6sung in einer 3 ml Zylinderampulle (Typ I Glas), verschlossen mit einem Kolbenstopfen (Halogenbutylgummi) und einer geb\u00f6rdelten Aluminiumkappe mit einem schwarzen Gummieinsatz.",
    "show_ref": false
  },
  {
    "src": "In addition, findings on clinical pharmacology were introduced in the sections on special warnings and precautions for use (4.4), interaction with other medicinal products and other forms of interaction (4.5) and the section on pharmacokinetic properties (5.2).",
    "display_src": "In addition, findings on clinical pharmacology were introduced in the sections on special warnings and precautions for use (4.4), interaction with other medicinal products and other forms of interaction (4.5) and the section on pharmacokinetic properties (5.2).",
    "ref": "Au\u00dferdem wurden Erkenntnisse der klinischen Pharmakologie in die Abschnitte \u00fcber Besondere Warnhinweise und Vorsichtsma\u00dfnahmen f\u00fcr die Anwendung (4.4), Wechselwirkungen mit anderen Arzneimitteln und sonstige Wechselwirkungen (4.5) sowie in den Abschnitt \u00fcber die pharmakokinetischen Eigenschaften (5.2) aufgenommen.",
    "show_ref": false
  },
  {
    "src": "When applying Panretin gel, 69.1% of patients experienced adverse drug reactions at the application site.",
    "display_src": "When applying Panretin gel, 69.1% of patients experienced adverse drug reactions at the application site.",
    "ref": "Bei der Anwendung von Panretin Gel traten bei 69,1% der Patienten unerw\u00fcnschte Arzneimittelwirkungen an der Anwendungsstelle auf.",
    "show_ref": false
  },
  {
    "src": "Desiccant should not be swallowed.",
    "display_src": "Desiccant should not be swallowed.",
    "ref": "Das Trockenmittel nicht schlucken.",
    "show_ref": false
  },
  {
    "src": "Use during lactation Abatacept has been shown to be present in rat milk.",
    "display_src": "Use during lactation Abatacept has been shown to be present in rat milk.",
    "ref": "Anwendung w\u00e4hrend der Stillzeit Abatacept wurde in der Muttermilch von Ratten nachgewiesen.",
    "show_ref": false
  },
  {
    "src": "Other side effects that have been reported are:",
    "display_src": "Other side effects that have been reported are:",
    "ref": "Andere Nebenwirkungen, \u00fcber die berichtet wurde:",
    "show_ref": false
  },
  {
    "src": "It is available as blue, diamond- shaped tablets (25, 50 or 100 mg).",
    "display_src": "It is available as blue, diamond- shaped tablets (25, 50 or 100 mg).",
    "ref": "Es ist als blaue rautenf\u00f6rmige Tabletten (25, 50 oder 100 mg) erh\u00e4ltlich.",
    "show_ref": false
  },
  {
    "src": "Transferring a patient to another type or brand of insulin should be done under strict medical supervision as this may result in a change in dosage. al",
    "display_src": "Transferring a patient to another type or brand of insulin should be done under strict medical supervision as this may result in a change in dosage. al",
    "ref": "21 Die Umstellung eines Patienten auf einen anderen Insulintyp oder ein anderes Insulinpr\u00e4parat sollte stets nur unter enger medizinischer Kontrolle erfolgen, da es zu Ver\u00e4nderungen bei der Dosis kommen kann.",
    "show_ref": false
  },
  {
    "src": "9 The necessity of resuspending the NovoMix 30 suspension immediately before use is to be stressed to the patient.",
    "display_src": "9 The necessity of resuspending the NovoMix 30 suspension immediately before use is to be stressed to the patient.",
    "ref": "Der Patient ist gezielt auf die Notwendigkeit hinzuweisen, die NovoMix 30 Suspension unmittelbar vor Gebrauch zu resuspendieren.",
    "show_ref": false
  },
  {
    "src": "If you do not feel well at the end of the prescribed treatment course or even feel worse during treatment you should talk to your doctor.",
    "display_src": "If you do not feel well at the end of the prescribed treatment course or even feel worse during treatment you should talk to your doctor.",
    "ref": "Wenn Sie sich am Ende der verschriebenen Behandlungsdauer noch schlecht f\u00fchlen oder sich der Zustand w\u00e4hrend der Behandlung verschlimmert, informieren Sie Ihren Arzt.",
    "show_ref": false
  },
  {
    "src": "25 mg disperzibilne/\u017e ve\u010d ljive tablete",
    "display_src": "25 mg disperzibilne/\u017e ve\u010d ljive tablete",
    "ref": "Lamictal 25 mg disperzibilne /\u017e ve\u010d ljiv e tablete",
    "show_ref": false
  },
  {
    "src": "Medicines before you receive Busilvex:",
    "display_src": "Medicines before you receive Busilvex:",
    "ref": "29 Arzneimittel vor der Behandlung mit Busilvex:",
    "show_ref": false
  },
  {
    "src": "Anaerobes Bacteroides fragilis* Bacteroides caccae* Bacteroides ovatus Bacteroides uniformis* Bacteroides thetaiotaomicron* Bacteroides vulgatus* Bilophila wadsworthia Peptostreptococcus magnus Peptostreptococcus micros* Porphyromonas spp.",
    "display_src": "Anaerobes Bacteroides fragilis* Bacteroides caccae* Bacteroides ovatus Bacteroides uniformis* Bacteroides thetaiotaomicron* Bacteroides vulgatus* Bilophila wadsworthia Peptostreptococcus magnus Peptostreptococcus micros* Porphyromonas spp.",
    "ref": "Bacteroides fragilis* Bacteroides caccae* Bacteroides ovatus Bacteroides uniformis* Bacteroides thetaiotaomicron* Bacteroides vulgatus* Bilophila wadsworthia Peptostreptococcus magnus Peptostreptococcus micros* Porphyromonas spp.",
    "show_ref": false
  },
  {
    "src": "Each package has 14 tablets, corresponding to 2 tablets per day for 7 days.",
    "display_src": "Each package has 14 tablets, corresponding to 2 tablets per day for 7 days.",
    "ref": "Jede Packung enth\u00e4lt 14 Tabletten, also 2 Tabletten pro Tag f\u00fcr 7 Tage.",
    "show_ref": false
  },
  {
    "src": "These symptoms can temporally deteriorate or can even arise after discontinuation of treatment.",
    "display_src": "These symptoms can temporally deteriorate or can even arise after discontinuation of treatment.",
    "ref": "Nach Abbruch der Behandlung k\u00f6nnen sich diese Symptome kurzzeitig verschlechtern oder k\u00f6nnen sogar erst auftreten.",
    "show_ref": false
  },
  {
    "src": "Tadalafil Lilly should not be taken with nitrates (medicines used to treat angina).",
    "display_src": "Tadalafil Lilly should not be taken with nitrates (medicines used to treat angina).",
    "ref": "Tadalafil Lilly darf nicht zusammen mit Nitraten (Arzneimittel zur Behandlung von Angina pectoris) eingenommen werden.",
    "show_ref": false
  },
  {
    "src": "In vitro, sorafenib has been shown to inhibit the transport protein p-glycoprotein (P- gp).",
    "display_src": "In vitro, sorafenib has been shown to inhibit the transport protein p-glycoprotein (P- gp).",
    "ref": "In vitro konnte gezeigt werden, dass Sorafenib das Transportprotein P-Glykoprotein (P-Gp) hemmt.",
    "show_ref": false
  },
  {
    "src": "This does not mean that the capsules aren\u2019t working.",
    "display_src": "This does not mean that the capsules aren\u2019t working.",
    "ref": "Das bedeutet nicht, dass die Kapseln nicht wirken.",
    "show_ref": false
  },
  {
    "src": "The recommended Humira induction dose regimen for adult patients with severe Crohn\u2019 s disease is 80 mg at Week 0 followed by 40 mg at Week 2.",
    "display_src": "The recommended Humira induction dose regimen for adult patients with severe Crohn\u2019 s disease is 80 mg at Week 0 followed by 40 mg at Week 2.",
    "ref": "Die empfohlene Induktionsdosis f\u00fcr Humira betr\u00e4gt bei Erwachsenen mit schwergradigem Morbus Crohn 80 mg in Woche 0, gefolgt von 40 mg in Woche 2.",
    "show_ref": false
  },
  {
    "src": "Stop breast-feeding when you start Ventavis treatment.",
    "display_src": "Stop breast-feeding when you start Ventavis treatment.",
    "ref": "Stillen Sie ab, wenn Sie mit der Anwendung von Ventavis beginnen.",
    "show_ref": false
  },
  {
    "src": "To help reduce these symptoms your doctor may advise you to take a fever-reducing painkiller before a dose of Rebif and then for 24 hours after each injection.",
    "display_src": "To help reduce these symptoms your doctor may advise you to take a fever-reducing painkiller before a dose of Rebif and then for 24 hours after each injection.",
    "ref": "124 Ihnen Ihr Arzt die Einnahme eines fiebersenkenden Schmerzmittels vor Verabreichung einer Dosis von Rebif und sodann f\u00fcr 24 Stunden nach jeder Injektion verordnen.",
    "show_ref": false
  },
  {
    "src": "Treatment with INCRELEX is a long-term therapy.",
    "display_src": "Treatment with INCRELEX is a long-term therapy.",
    "ref": "Die Behandlung mit INCRELEX ist eine Langzeittherapie.",
    "show_ref": false
  },
  {
    "src": "Therefore, varenicline can effectively block nicotine's ability to fully activate \u03b1 4\u03b2 2 receptors and the mesolimbic dopamine system, the neuronal mechanism underlying reinforcement and reward experienced upon smoking.",
    "display_src": "Therefore, varenicline can effectively block nicotine's ability to fully activate \u03b1 4\u03b2 2 receptors and the mesolimbic dopamine system, the neuronal mechanism underlying reinforcement and reward experienced upon smoking.",
    "ref": "Daher kann Vareniclin die F\u00e4higkeit von Nikotin, die \u03b1 4\u03b2 2-Rezeptoren voll zu aktivieren und damit das mesolimbische Dopamin-System zu stimulieren, wirksam blockieren; also den neuronalen Mechanismus, der dem beim Rauchen versp\u00fcrten Verst\u00e4rkungs- und Belohnungseffekt zugrunde liegt.",
    "show_ref": false
  },
  {
    "src": "Sodium chloride Phenol Polysorbate 20 Sodium citrate and citric acid anhydrous Water for injections",
    "display_src": "Sodium chloride Phenol Polysorbate 20 Sodium citrate and citric acid anhydrous Water for injections",
    "ref": "Natriumchlorid Phenol Polysorbat 20 Natriumcitrat und Wasserfreie Citronens\u00e4ure Wasser f\u00fcr Injektionszwecke",
    "show_ref": false
  },
  {
    "src": "Vascular effects \u2022 High blood pressure (hypertension): rare (children); common (adults)",
    "display_src": "Vascular effects \u2022 High blood pressure (hypertension): rare (children); common (adults)",
    "ref": "Wirkungen auf die Gef\u00e4\u00dfe \u2022 Hoher Blutdruck (Hypertonie): selten (Kinder); h\u00e4ufig (Erwachsene)",
    "show_ref": false
  },
  {
    "src": "Before the first use store your Liprolog Mix25 KwikPen in a refrigerator (2\u00b0C \u2013 8\u00b0C).",
    "display_src": "Before the first use store your Liprolog Mix25 KwikPen in a refrigerator (2\u00b0C \u2013 8\u00b0C).",
    "ref": "Lagern Sie Liprolog Mix25 KwikPen vor dem ersten Gebrauch im K\u00fchlschrank (2\u00b0C - 8\u00b0C).",
    "show_ref": false
  },
  {
    "src": "The film-coated, scored capsule shaped tablets are yellow and engraved with \u2018 GX 623 \u2019 on both sides.",
    "display_src": "The film-coated, scored capsule shaped tablets are yellow and engraved with \u2018 GX 623 \u2019 on both sides.",
    "ref": "Die kapself\u00f6rmigen Filmtabletten mit Bruchrille sind gelb und auf beiden Seiten mit der Gravur \u201e GX 623\u201c versehen.",
    "show_ref": false
  },
  {
    "src": "The bacterium has been inactivated (treated to make it unable to cause an illness).",
    "display_src": "The bacterium has been inactivated (treated to make it unable to cause an illness).",
    "ref": "Das Bakterium wurde inaktiviert (abget\u00f6tet, so dass es keine Krankheit mehr verursachen kann).",
    "show_ref": false
  },
  {
    "src": "The study compared the effectiveness of switching to Atripla tablets, taken on an empty stomach, with that of remaining on the successful HIV treatment combination.",
    "display_src": "The study compared the effectiveness of switching to Atripla tablets, taken on an empty stomach, with that of remaining on the successful HIV treatment combination.",
    "ref": "Die Studie verglich die Wirksamkeit der Umstellung auf Atripla-Tabletten bei Einnahme auf n\u00fcchternen Magen mit der Wirksamkeit bei Fortsetzung der erfolgreichen HIV-Kombinationsbehandlung.",
    "show_ref": false
  },
  {
    "src": "It also stops air entering the Pen and your needle clogging.",
    "display_src": "It also stops air entering the Pen and your needle clogging.",
    "ref": "Es ver- hindert ebenso ein Eindringen von Luft in den Pen und ein Verstopfen der Nadel.",
    "show_ref": false
  },
  {
    "src": "This can help the flow of blood to the heart to be maintained in patients with angina or who are having a heart attack and can improve the effectiveness of PCI.",
    "display_src": "This can help the flow of blood to the heart to be maintained in patients with angina or who are having a heart attack and can improve the effectiveness of PCI.",
    "ref": "Dies kann bei Patienten mit Angina oder Herzanfall zur Aufrechterhaltung des Blutflusses zum Herzen beitragen und die Wirksamkeit einer PCI erh\u00f6hen.",
    "show_ref": false
  },
  {
    "src": "Gemfibrozil increases the risk of myopathy when given concomitantly with some HMG-CoA reductase inhibitors.",
    "display_src": "Gemfibrozil increases the risk of myopathy when given concomitantly with some HMG-CoA reductase inhibitors.",
    "ref": "Gemfibrozil erh\u00f6ht das Riskio eine Myopathie, wenn es gemeinsam mit bestimmten HMG-CoA- Reduktase-Hemmern gegeben wird.",
    "show_ref": false
  },
  {
    "src": "If you take less Liprolog than you need, a high blood sugar may occur.",
    "display_src": "If you take less Liprolog than you need, a high blood sugar may occur.",
    "ref": "225 Wenn Sie die Anwendung von Liprolog abbrechen Wenn Sie sich weniger Liprolog spritzen, als Sie sollten, kann es zu einem hohen Blutzuckerspiegel kommen.",
    "show_ref": false
  },
  {
    "src": "The labelling will be completed nationally",
    "display_src": "The labelling will be completed nationally",
    "ref": "Etikettierung werden national vollst\u00e4ndig ausgef\u00fcllt",
    "show_ref": false
  },
  {
    "src": "As ibuprofen may decrease the clearance of aminoglycosides, strict surveillance of their serum levels is recommended during co-administration with ibuprofen.",
    "display_src": "As ibuprofen may decrease the clearance of aminoglycosides, strict surveillance of their serum levels is recommended during co-administration with ibuprofen.",
    "ref": "Da Ibuprofen m\u00f6glicherweise die Clearance von Aminoglykosiden verringert, wird eine strikte \u00dcberwachung der Serum-Spiegel bei gleichzeitiger Gabe von Ibuprofen empfohlen.",
    "show_ref": false
  },
  {
    "src": "These results indicate that abacavir has a weak potential to cause chromosomal damage both in vitro and in vivo at high test concentrations.",
    "display_src": "These results indicate that abacavir has a weak potential to cause chromosomal damage both in vitro and in vivo at high test concentrations.",
    "ref": "Die Ergebnisse zeigen, dass Abacavir sowohl in vitro als auch in vivo in hohen Konzentrationen ein niedriges Potenzial aufweist, chromosomale Sch\u00e4den zu verursachen.",
    "show_ref": false
  },
  {
    "src": "Like all medicines, Luminity can cause side effects, although not everybody gets them.",
    "display_src": "Like all medicines, Luminity can cause side effects, although not everybody gets them.",
    "ref": "Wie alle Arzneimittel kann Luminity Nebenwirkungen haben, die aber nicht bei jedem auftreten m\u00fcssen.",
    "show_ref": false
  },
  {
    "src": "Atripla (n=203) Metabolism and nutrition disorders:",
    "display_src": "Atripla (n=203) Metabolism and nutrition disorders:",
    "ref": "Atripla (n=203) Stoffwechsel- und Ern\u00e4hrungsst\u00f6rungen:",
    "show_ref": false
  },
  {
    "src": "After reconstitution, each ml of solution contains approximately 125 IU moroctocog alfa.",
    "display_src": "After reconstitution, each ml of solution contains approximately 125 IU moroctocog alfa.",
    "ref": "Nach Rekonstitution enth\u00e4lt jeder ml der L\u00f6sung etwa 125 I.E. / Moroctocog alfa.",
    "show_ref": false
  },
  {
    "src": "A total of 321 patients (162 R-CVP, 159 CVP) received therapy and were analysed for efficacy.",
    "display_src": "A total of 321 patients (162 R-CVP, 159 CVP) received therapy and were analysed for efficacy.",
    "ref": "Insgesamt wurden 321 Patienten (162 R-CVP, 159 CVP) behandelt und auf Wirksamkeit untersucht.",
    "show_ref": false
  },
  {
    "src": "\u2022 ovarian cysts \u2022 headache",
    "display_src": "\u2022 ovarian cysts \u2022 headache",
    "ref": "\u2022 Eierstockzysten \u2022 Kopfschmerzen.",
    "show_ref": false
  },
  {
    "src": "ed Trudexa 40 mg solution for injection Adalimumab",
    "display_src": "ed Trudexa 40 mg solution for injection Adalimumab",
    "ref": "en Trudexa 40 mg Injektionsl\u00f6sung Adalimumab",
    "show_ref": false
  },
  {
    "src": "94 As with other similar chemotherapeutic agents, caution is recommended to avoid extravasation.",
    "display_src": "94 As with other similar chemotherapeutic agents, caution is recommended to avoid extravasation.",
    "ref": "Wie bei anderen, \u00e4hnlichen Chemotherapeutika wird zur Vorsicht geraten, um eine Extravasation zu vermeiden.",
    "show_ref": false
  },
  {
    "src": "Patients continued their lamivudine-regimen and were assigned to add either entecavir 1 mg once daily (n = 51) or placebo (n = 17) for 24 weeks followed by an additional 24 weeks where all received entecavir.",
    "display_src": "Patients continued their lamivudine-regimen and were assigned to add either entecavir 1 mg once daily (n = 51) or placebo (n = 17) for 24 weeks followed by an additional 24 weeks where all received entecavir.",
    "ref": "Die Patienten setzten das Lamivudin-Behandlungsschema fort und erhielten randomisiert entweder f\u00fcr 24 Wochen Entecavir 1 mg einmal t\u00e4glich (n = 51) oder Placebo (n = 17).",
    "show_ref": false
  },
  {
    "src": "DRAXXIN is given as a single injection of 2.5 mg per kilogram body weight.",
    "display_src": "DRAXXIN is given as a single injection of 2.5 mg per kilogram body weight.",
    "ref": "DRAXXIN wird als einmalige Injektion von 2,5 mg pro kg K\u00f6rpergewicht verabreicht.",
    "show_ref": false
  },
  {
    "src": "In all studies, the vaccine was compared with a placebo (a dummy vaccine).",
    "display_src": "In all studies, the vaccine was compared with a placebo (a dummy vaccine).",
    "ref": "In allen Studien wurde der Impfstoff mit einem Placebo (Scheinimpfstoff) verglichen.",
    "show_ref": false
  },
  {
    "src": "Paediatric population (< 18 years) Jalra is not recommended for use in children and adolescents due to a lack of data on safety and efficacy.",
    "display_src": "Paediatric population (< 18 years) Jalra is not recommended for use in children and adolescents due to a lack of data on safety and efficacy.",
    "ref": "P\u00e4diatrische Population (< 18 Jahre) Jalra wird nicht empfohlen f\u00fcr die Anwendung bei Kindern und Jugendlichen aufgrund des Fehlens von Daten zur Unbedenklichkeit und Wirksamkeit.",
    "show_ref": false
  },
  {
    "src": "Ovitrelle is used to treat women who have received treatment to stimulate their ovaries, to trigger ovulation (the release of eggs by the ovaries) and the development of a special structure on the ovary (the corpus luteum) that helps pregnancy.",
    "display_src": "Ovitrelle is used to treat women who have received treatment to stimulate their ovaries, to trigger ovulation (the release of eggs by the ovaries) and the development of a special structure on the ovary (the corpus luteum) that helps pregnancy.",
    "ref": "Ovitrelle wird zur Behandlung von Frauen eingesetzt, die zur Stimulierung der Eierst\u00f6cke und Ausl\u00f6sung des Eisprungs (Ovulation) behandelt wurden und bei denen die Entwicklung eines speziellen Gebildes in den Eierst\u00f6cken, des Gelbk\u00f6rpers (Corpus luteum), gef\u00f6rdert werden soll, der die Schwangerschaft unterst\u00fctzt.",
    "show_ref": false
  },
  {
    "src": "The following statements reflect the pharmacokinetic properties of the individual active substances of Tandemact",
    "display_src": "The following statements reflect the pharmacokinetic properties of the individual active substances of Tandemact",
    "ref": "Die folgenden Angaben entsprechen den pharmakokinetischen Eigenschaften der einzelnen in Tandemact enthaltenen Wirkstoffe.",
    "show_ref": false
  },
  {
    "src": "a medicine used to prevent rejection of a transplanted organ (ciclosporin), or if you are taking some heart tablets such as diltiazem or verapamil.",
    "display_src": "a medicine used to prevent rejection of a transplanted organ (ciclosporin), or if you are taking some heart tablets such as diltiazem or verapamil.",
    "ref": "einer Pilzinfektion (Fluconazol) oder ein Arzneimittel zur Verhinderung der Absto\u00dfung eines transplantierten Organs (Ciclosporin) anwenden, oder wenn Sie bestimmte Herztabletten wie Diltiazem oder Verapamil einnehmen.",
    "show_ref": false
  },
  {
    "src": "\u039a\u03cd\u03c0\u03c1\u03bf\u03c2 sanofi -aventis Cyprus Ltd.",
    "display_src": "\u039a\u03cd\u03c0\u03c1\u03bf\u03c2 sanofi -aventis Cyprus Ltd.",
    "ref": "700 \u039a\u03cd\u03c0\u03c1\u03bf\u03c2 sanofi-aventis Cyprus Ltd.",
    "show_ref": false
  },
  {
    "src": "If you experience the following symptoms, contact your doctor immediately: large-scale skin reactions (rash and itching all over the body), severe swelling of skin or mucous membranes (angiooedema), shortness of breath, a fall in blood pressure with rapid heart beat and sweating.",
    "display_src": "If you experience the following symptoms, contact your doctor immediately: large-scale skin reactions (rash and itching all over the body), severe swelling of skin or mucous membranes (angiooedema), shortness of breath, a fall in blood pressure with rapid heart beat and sweating.",
    "ref": "Bei folgenden Beschwerden wenden Sie sich sofort an Ihren Arzt: gro\u00dffl\u00e4chige Hautreaktionen (Hautausschlag und Juckreiz am ganzen K\u00f6rper), starke Haut- und Schleimhautschwellungen (Angio\u00f6dem), Atemnot, Blutdruckabfall mit schnellem Puls und Schwitzen.",
    "show_ref": false
  },
  {
    "src": "A dosage reduction of CRIXIVAN to 600 mg every 8 hours should be considered when administering itraconazole or ketoconazole concurrently (see section 4.5).",
    "display_src": "A dosage reduction of CRIXIVAN to 600 mg every 8 hours should be considered when administering itraconazole or ketoconazole concurrently (see section 4.5).",
    "ref": "Spezielle Hinweise f\u00fcr die Dosierung bei Erwachsenen Bei gleichzeitiger Gabe von Itraconazol oder Ketoconazol sollte eine Dosisreduktion von CRIXIVAN auf 600 mg alle 8 Stunden in Betracht gezogen werden (siehe Abschnitt 4.5).",
    "show_ref": false
  },
  {
    "src": "Each dose contains 5 micrograms exenatide.",
    "display_src": "Each dose contains 5 micrograms exenatide.",
    "ref": "Jede Dosis enth\u00e4lt 5 Mikrogramm Exenatide.",
    "show_ref": false
  },
  {
    "src": "Decrease of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues (see Section 5.1).",
    "display_src": "Decrease of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues (see Section 5.1).",
    "ref": "Zur Senkung des Augeninnendrucks (IOD) bei Patienten mit Offenwinkelglaukom oder okul\u00e4rer Hypertension, die mit topischen Betablockern oder Prostaglandin-Analoga nicht ausreichend eingestellt sind (siehe Abschnitt 5.1).",
    "show_ref": false
  },
  {
    "src": "In children less than two years of age, the most common side effects are diarrhoea (3.7%), fever (2.3%) and insomnia (difficulty sleeping; 2.3%).",
    "display_src": "In children less than two years of age, the most common side effects are diarrhoea (3.7%), fever (2.3%) and insomnia (difficulty sleeping; 2.3%).",
    "ref": "Bei Kindern unter zwei Jahren sind die h\u00e4ufigsten Nebenwirkungen Durchfall (3,7%), Fieber (2,3%) und Schlaflosigkeit (Schlafprobleme; 2,3%).",
    "show_ref": false
  },
  {
    "src": "Volibris should not be used in people who may be hypersensitive (allergic) to soya, ambrisentan or any of the other ingredients.",
    "display_src": "Volibris should not be used in people who may be hypersensitive (allergic) to soya, ambrisentan or any of the other ingredients.",
    "ref": "Volibris darf nicht bei Patienten angewendet werden, die m\u00f6glicherweise \u00fcberempfindlich (allergisch) gegen Soja, Ambrisentan oder einen der sonstigen Bestandteile sind.",
    "show_ref": false
  },
  {
    "src": "Bioequivalence was established between the 200mg tablet and the 40 mg/ ml oral suspension when administered as a 200 mg dose.",
    "display_src": "Bioequivalence was established between the 200mg tablet and the 40 mg/ ml oral suspension when administered as a 200 mg dose.",
    "ref": "Eine Dosis von 200 mg der 40 mg / ml Suspension zum Einnehmen ist bio\u00e4quivalent mit der 200 mg Filmtablette.",
    "show_ref": false
  },
  {
    "src": "To help stop irritation, do not put the new patch on exactly the same area of your skin as your last patch.",
    "display_src": "To help stop irritation, do not put the new patch on exactly the same area of your skin as your last patch.",
    "ref": "Um Reizungen zu vermeiden, kleben Sie das neue Pflaster nicht genau auf dieselbe Hautstelle wie Ihr letztes Pflaster.",
    "show_ref": false
  },
  {
    "src": "Instructions for keeping track of your injection sites and dates Start with your first injection.",
    "display_src": "Instructions for keeping track of your injection sites and dates Start with your first injection.",
    "ref": "Anleitung zum F\u00fchren eines Tagebuchs \u00fcber Stelle und Datum der Injektionen Beginnen Sie mit der ersten Injektion.",
    "show_ref": false
  },
  {
    "src": "- feeling weak, tiredness and lack of energy",
    "display_src": "- feeling weak, tiredness and lack of energy",
    "ref": "- Schw\u00e4chegef\u00fchl, M\u00fcdigkeit und Antriebslosigkeit",
    "show_ref": false
  },
  {
    "src": "The following \u201c efficacy\u201d guidelines were adopted or released for consultation by the CPMP in 1996:",
    "display_src": "The following \u201c efficacy\u201d guidelines were adopted or released for consultation by the CPMP in 1996:",
    "ref": "Die folgenden Leitf\u00e4den zur \u201cWirksamkeit\u201d wurden 1996 vom Ausschu\u00df f\u00fcr Arzneispezialit\u00e4ten verabschiedet oder zur Stellungnahme herausgegeben:",
    "show_ref": false
  },
  {
    "src": "Hands should be washed and disinfected after vaccinating.",
    "display_src": "Hands should be washed and disinfected after vaccinating.",
    "ref": "Nach der Impfung sollen die H\u00e4nde gewaschen und desinfiziert werden.",
    "show_ref": false
  },
  {
    "src": "Hepatitis, abnormal liver function",
    "display_src": "Hepatitis, abnormal liver function",
    "ref": "Hepatitis, abnormale Leberfunktion",
    "show_ref": false
  },
  {
    "src": "No studies were performed that covered fertility and early embryonic development (see section 5.3).",
    "display_src": "No studies were performed that covered fertility and early embryonic development (see section 5.3).",
    "ref": "Es wurden keine Studien durchgef\u00fchrt, die die Fertilit\u00e4t und die fr\u00fche embryonale Entwicklung abdeckten (siehe Abschnitt 5.3).",
    "show_ref": false
  },
  {
    "src": "No malformations were observed in another study testing a higher dose of a different salt of duloxetine.",
    "display_src": "No malformations were observed in another study testing a higher dose of a different salt of duloxetine.",
    "ref": "In anderen Studien mit h\u00f6heren Dosen eines anderen Salzes von Duloxetin wurden keine Missbildungen beobachtet.",
    "show_ref": false
  },
  {
    "src": "This redness should disappear within several hours after removal of the patch.",
    "display_src": "This redness should disappear within several hours after removal of the patch.",
    "ref": "Diese R\u00f6tung sollte innerhalb einiger Stunden nach der Entfernung des Pflasters verschwinden.",
    "show_ref": false
  },
  {
    "src": "G17(9) gastrin- Diphtheria Toxoid Conjugate",
    "display_src": "G17(9) gastrin- Diphtheria Toxoid Conjugate",
    "ref": "G17(9) gastrin-Diphtheria Toxoid Conjugate",
    "show_ref": false
  },
  {
    "src": "Janumet 50 mg/1000 mg film-coated tablets sitagliptin/metformin hydrochloride",
    "display_src": "Janumet 50 mg/1000 mg film-coated tablets sitagliptin/metformin hydrochloride",
    "ref": "INFORMATION F\u00dcR DEN ANWENDER Janumet 50 mg/1000 mg Filmtabletten Sitagliptin/Metforminhydrochlorid",
    "show_ref": false
  },
  {
    "src": "Each pack type contains 60 film-coated tablets.",
    "display_src": "Each pack type contains 60 film-coated tablets.",
    "ref": "Jede Packung enth\u00e4lt 60 Filmtabletten.",
    "show_ref": false
  },
  {
    "src": "Ciprofloxacin Metabolites (M1-M4)",
    "display_src": "Ciprofloxacin Metabolites (M1-M4)",
    "ref": "Ciprofloxacin Metaboliten (M1-M4)",
    "show_ref": false
  },
  {
    "src": "Further data with respect to nelarabine and ara-G pharmacokinetics in the paediatric population are provided in other subsections.",
    "display_src": "Further data with respect to nelarabine and ara-G pharmacokinetics in the paediatric population are provided in other subsections.",
    "ref": "Weitere Daten zur Pharmakokinetik von Nelarabin und ara-G in der p\u00e4diatrischen Population sind in anderen Unterabschnitten enthalten.",
    "show_ref": false
  },
  {
    "src": "3 Gram-positive isolates with an MIC > 2 \u00b5g/ ml are to be considered resistant.",
    "display_src": "3 Gram-positive isolates with an MIC > 2 \u00b5g/ ml are to be considered resistant.",
    "ref": "Grampositive Erreger mit einem MHK-Wert > 2 \u00b5g/ml werden als resistent betrachtet.",
    "show_ref": false
  },
  {
    "src": "To date 4 marketing authorisations have been granted for orphan medicinal products:",
    "display_src": "To date 4 marketing authorisations have been granted for orphan medicinal products:",
    "ref": "Bis heute wurden 4 Genehmigungen f\u00fcr das Inverkehrbringen f\u00fcr Orphan Drugs erteilt.",
    "show_ref": false
  },
  {
    "src": "TESAVEL should not be used during breast-feeding.",
    "display_src": "TESAVEL should not be used during breast-feeding.",
    "ref": "Daher sollte TESAVEL w\u00e4hrend der Stillzeit nicht eingenommen werden.",
    "show_ref": false
  },
  {
    "src": "It is currently unclear whether Aclasta causes this irregular heart rhythm but you should report it to your doctor if you experience such symptoms after you have received Aclasta.",
    "display_src": "It is currently unclear whether Aclasta causes this irregular heart rhythm but you should report it to your doctor if you experience such symptoms after you have received Aclasta.",
    "ref": "Derzeit ist es unklar, ob Aclasta diesen unregelm\u00e4\u00dfigen Herzschlag verursacht, aber Sie sollten es Ihrem Arzt berichten, wenn Sie solche Symptome bei sich bemerken, nachdem Sie Aclasta erhalten haben.",
    "show_ref": false
  },
  {
    "src": "Each bottle contains 266 g or 532 g of granules.",
    "display_src": "Each bottle contains 266 g or 532 g of granules.",
    "ref": "Jede Flasche enth\u00e4lt 266 g oder 532 g Granulat.",
    "show_ref": false
  },
  {
    "src": "A procedure for the sampling and testing of products covered by the centralised authorisation system was commenced in collaboration with the European Department for the Quality of Medicines and the EU members of the Network of Official Medicines Control Laboratories, under the aegis of the European Pharmacopoeia.",
    "display_src": "A procedure for the sampling and testing of products covered by the centralised authorisation system was commenced in collaboration with the European Department for the Quality of Medicines and the EU members of the Network of Official Medicines Control Laboratories, under the aegis of the European Pharmacopoeia.",
    "ref": "Ein Verfahren f\u00fcr die Probennahme und Pr\u00fcfung von Produkten, die unter das zentralisierte Zulassungssystem fallen, wurde in Zusammenarbeit mit der Europ\u00e4ischen Abteilung f\u00fcr die Qualit\u00e4t von Arzneimitteln und den EU- Mitgliedern des Netzwerks Amtlicher Arzneimittelkontrollaboratorien unter der Schirmherrschaft der Europ\u00e4ischen Arzneibuchkommission in die Wege geleitet.",
    "show_ref": false
  },
  {
    "src": "V08CA05 Detection and characterisation",
    "display_src": "V08CA05 Detection and characterisation",
    "ref": "V08CA05 Dete ction and characterisation",
    "show_ref": false
  },
  {
    "src": "Before you use Quixidar",
    "display_src": "Before you use Quixidar",
    "ref": "Was m\u00fcssen Sie vor der Anwendung von Quixidar beachten?",
    "show_ref": false
  },
  {
    "src": "Do not use Irbesartan Hydrochlorothiazide Winthrop after the expiry date which is stated on the carton and on the blister after EXP.",
    "display_src": "Do not use Irbesartan Hydrochlorothiazide Winthrop after the expiry date which is stated on the carton and on the blister after EXP.",
    "ref": "100 Sie d\u00fcrfen Irbesartan Hydrochlorothiazide Winthrop nach dem auf dem Umkarton und dem Blister angegebenen Verfalldatum nicht mehr anwenden.",
    "show_ref": false
  },
  {
    "src": "If your levels of the red blood pigment (haemoglobin) are too high you should not receive Binocrit, since you have an increased risk of blood clotting after the surgery.",
    "display_src": "If your levels of the red blood pigment (haemoglobin) are too high you should not receive Binocrit, since you have an increased risk of blood clotting after the surgery.",
    "ref": "Wenn Ihre Werte des roten Blutfarbstoffs (H\u00e4moglobin) zu hoch sind, sollten Sie Binocrit nicht erhalten, da ein erh\u00f6htes Risiko f\u00fcr Blutpfropfbildung nach der Operation besteht.",
    "show_ref": false
  },
  {
    "src": "The effectiveness of the products against the specified parasites was investigated in laboratory studies.",
    "display_src": "The effectiveness of the products against the specified parasites was investigated in laboratory studies.",
    "ref": "Die Wirksamkeit des Tierarzneimittels gegen die angegebenen Parasiten wurde in Laborstudien untersucht.",
    "show_ref": false
  },
  {
    "src": "If patients with renal impairment receive transdermal fentanyl they should be observed carefully for signs of fentanyl toxicity and the dose reduced if necessary.",
    "display_src": "If patients with renal impairment receive transdermal fentanyl they should be observed carefully for signs of fentanyl toxicity and the dose reduced if necessary.",
    "ref": "Patienten mit eingeschr\u00e4nkter Nierenfunktion sollten, wenn sie mit dem transdermalen Fentanylpflaster behandelt werden, sorgf\u00e4ltig auf Anzeichen einer Intoxikation mit Fentanyl beobachtet und die Dosis n\u00f6tigenfalls reduziert werden.",
    "show_ref": false
  },
  {
    "src": "In overdose, QT-prolongation and convulsions have been reported.",
    "display_src": "In overdose, QT-prolongation and convulsions have been reported.",
    "ref": "Bei \u00dcberdosierung wurden QT-Verl\u00e4ngerung und Konvulsionen berichtet.",
    "show_ref": false
  },
  {
    "src": "Push it slowly and evenly, keeping the skin gently pinched \u2022 When the plunger is pushed as far as it will go, take out the needle and let go of the skin \u2022 Press an antiseptic swab over the injection site for a few seconds after the injection.",
    "display_src": "Push it slowly and evenly, keeping the skin gently pinched \u2022 When the plunger is pushed as far as it will go, take out the needle and let go of the skin \u2022 Press an antiseptic swab over the injection site for a few seconds after the injection.",
    "ref": "Dr\u00fccken Sie ihn langsam und gleichm\u00e4\u00dfig, wobei die Haut weiterhin leicht zusammengedr\u00fcckt bleibt. \u2022 Wenn der Kolben soweit heruntergedr\u00fcckt wurde, wie es geht, ziehen Sie die Nadel aus der Haut heraus und lassen Sie sie los. \u2022 Dr\u00fccken Sie nach der Injektion f\u00fcr ein paar Sekunden einen antiseptischen Tupfer auf die Injektionsstelle.",
    "show_ref": false
  },
  {
    "src": "0.5 mg 0.5 mg 0.5 mg 0.5 mg 1 mg 1 mg 1 mg 1 mg 2 mg 2 mg 2 mg 2 mg 2 mg 0.5 mg 1 mg",
    "display_src": "0.5 mg 0.5 mg 0.5 mg 0.5 mg 1 mg 1 mg 1 mg 1 mg 2 mg 2 mg 2 mg 2 mg 2 mg 0.5 mg 1 mg",
    "ref": "0,5 mg 0,5 mg 0,5 mg 0,5 mg 1 mg 1 mg 1 mg 1 mg 2 mg 2 mg 2 mg 2 mg 2 mg 0,5 mg 1 mg",
    "show_ref": false
  },
  {
    "src": "Avoid contact with eyes.",
    "display_src": "Avoid contact with eyes.",
    "ref": "Jeglichen Kontakt mit den Augen vermeiden.",
    "show_ref": false
  },
  {
    "src": "Thymanax 25- 50 mg once daily demonstrated a statistically significant superiority compared to placebo (p=0.0001) on the primary outcome measure, the prevention of depressive relapse, as measured by time to relapse.",
    "display_src": "Thymanax 25- 50 mg once daily demonstrated a statistically significant superiority compared to placebo (p=0.0001) on the primary outcome measure, the prevention of depressive relapse, as measured by time to relapse.",
    "ref": "Thymanax 25-50 mg einmal t\u00e4glich zeigte eine statistisch signifikante \u00dcberlegenheit gegen\u00fcber Placebo (p=0,0001) bezogen auf das prim\u00e4re Zielkriterium (Pr\u00e4vention eines depressiven R\u00fcckfalls), gemessen als Zeit bis zum Auftreten eines R\u00fcckfalls.",
    "show_ref": false
  },
  {
    "src": "Janssen Cilag, SA Paseo de las DoceEstrellas, 5-7 28042 Madrid, Spain",
    "display_src": "Janssen Cilag, SA Paseo de las DoceEstrellas, 5-7 28042 Madrid, Spain",
    "ref": "Janssen Cilag, SA Paseo de las DoceEstrellas, 5-7 28042 Madrid, Spanien",
    "show_ref": false
  },
  {
    "src": "- if you have liver disease or increased liver enzymes",
    "display_src": "- if you have liver disease or increased liver enzymes",
    "ref": "- wenn Sie eine Lebererkrankung oder erh\u00f6hte Leberenzymwerte haben",
    "show_ref": false
  },
  {
    "src": "In recent studies using human cord blood lymphocytes and human embryonic kidney 293 cells, EC50 values (50% inhibitory concentration) ranged from 14-302 nM against laboratory and clinical isolates of HIV-1.",
    "display_src": "In recent studies using human cord blood lymphocytes and human embryonic kidney 293 cells, EC50 values (50% inhibitory concentration) ranged from 14-302 nM against laboratory and clinical isolates of HIV-1.",
    "ref": "In fr\u00fcheren Studien mit Lymphozyten aus humanem 18 Nabelschnurblut und humanen embryonalen 293 Nierenzellen lagen die EC 50-Werte (50 %ige Hemmkonzentration) im Bereich von 14-302 nM gegen Labor- und Klinik-Isolate von HIV-1.",
    "show_ref": false
  },
  {
    "src": "Somatropin therapy should be discontinued if evidence of tumour growth develops. \u2022 During acute critical illness due to complications following open-heart or abdominal surgery, multiple accidental trauma, or in case of acute respiratory failure.",
    "display_src": "Somatropin therapy should be discontinued if evidence of tumour growth develops. \u2022 During acute critical illness due to complications following open-heart or abdominal surgery, multiple accidental trauma, or in case of acute respiratory failure.",
    "ref": "Die Therapie mit Somatropin muss abgebrochen werden, falls es Anzeichen gibt, dass der Tumor w\u00e4chst. \u2022 w\u00e4hrend akuter, schwerer Erkrankung aufgrund von Komplikationen nach einer Herz- oder Bauchoperation oder schweren Unfallverletzungen oder im Fall einer akuten, schweren Atem- st\u00f6rung.",
    "show_ref": false
  },
  {
    "src": "When used to treat rheumatoid arthritis, the most common side effect (seen in more than 1 patient in 10) is infection.",
    "display_src": "When used to treat rheumatoid arthritis, the most common side effect (seen in more than 1 patient in 10) is infection.",
    "ref": "Bei Anwendung zur Behandlung von rheumatoider Arthritis sind die h\u00e4ufigste Nebenwirkung (beobachtet bei mehr als 1 von 10 Patienten) Infektionen.",
    "show_ref": false
  },
  {
    "src": "Data are not available to indicate whether tipranavir inhibits or induces glucuronosyl transferases.",
    "display_src": "Data are not available to indicate whether tipranavir inhibits or induces glucuronosyl transferases.",
    "ref": "Es ist nicht gekl\u00e4rt, ob Glucuronosyltransferasen durch Tipranavir gehemmt oder aktiviert werden.",
    "show_ref": false
  },
  {
    "src": "In combination studies of emtricitabine with protease inhibitors, nucleoside, nucleotide and non-nucleoside analogue inhibitors of HIV reverse transcriptase, additive to synergistic effects were observed.",
    "display_src": "In combination studies of emtricitabine with protease inhibitors, nucleoside, nucleotide and non-nucleoside analogue inhibitors of HIV reverse transcriptase, additive to synergistic effects were observed.",
    "ref": "Im Rahmen von Kombinationsstudien mit Emtricitabin und Proteaseinhibitoren, nukleosidischen, nukleotidischen und nicht nukleosidischen Inhibitoren der Reversen Transkriptase von HIV wurden additive bis synergistische Effekte beobachtet.",
    "show_ref": false
  },
  {
    "src": "If elapsed time is greater than 45 minutes, the reconstituted suspension should be discarded appropriately and a new dose prepared.",
    "display_src": "If elapsed time is greater than 45 minutes, the reconstituted suspension should be discarded appropriately and a new dose prepared.",
    "ref": "Wenn mehr als 45 Minuten verstrichen sind, ist die rekonstituierte Suspension in geeigneter Weise zu entsorgen und eine neue Dosis zuzubereiten.",
    "show_ref": false
  },
  {
    "src": "Getting the Pen ready to use (Please see user manual) \u2022 First wash your hands. \u2022 Read the instructions on how to use your pre-filled insulin pen.",
    "display_src": "Getting the Pen ready to use (Please see user manual) \u2022 First wash your hands. \u2022 Read the instructions on how to use your pre-filled insulin pen.",
    "ref": "Vorbereitung des Pens (bitte Bedienungsanleitung lesen) \u2022 Waschen Sie zuerst Ihre H\u00e4nde. \u2022 Lesen Sie die Instruktionen, wie Ihr Fertigpen anzuwenden ist.",
    "show_ref": false
  },
  {
    "src": "See section 4.4 regarding combination with other medicinal products that affect the immune system and with vaccinations.",
    "display_src": "See section 4.4 regarding combination with other medicinal products that affect the immune system and with vaccinations.",
    "ref": "Siehe Abschnitt 4.4 zur Kombination mit anderen Arzneimitteln, die das Immunsystem beeintr\u00e4chtigen, und mit Impfungen.",
    "show_ref": false
  },
  {
    "src": "Further dosage reduction may be necessary.",
    "display_src": "Further dosage reduction may be necessary.",
    "ref": "Eine weitere Dosisreduktion kann notwendig sein.",
    "show_ref": false
  },
  {
    "src": "The table below provides dose interval adjustment guidelines for the 200 mg hard capsules according to the degree of renal insufficiency.",
    "display_src": "The table below provides dose interval adjustment guidelines for the 200 mg hard capsules according to the degree of renal insufficiency.",
    "ref": "Die folgende Tabelle dient als Richtlinie f\u00fcr die Anpassung des Dosisintervalls f\u00fcr die 200 mg-Hartkapseln in Abh\u00e4ngigkeit vom Ausma\u00df der Niereninsuffizienz.",
    "show_ref": false
  },
  {
    "src": "Metabolism Busulfan is metabolised mainly through conjugation with glutathione (spontaneous and glutathione-S- transferase mediated).",
    "display_src": "Metabolism Busulfan is metabolised mainly through conjugation with glutathione (spontaneous and glutathione-S- transferase mediated).",
    "ref": "Metabolismus Busulfan wird haupts\u00e4chlich durch Konjugation mit Glutathion metabolisiert (spontan und mittels Glutathion-S-Transferase).",
    "show_ref": false
  },
  {
    "src": "You should self assess for increased acne, increased hair growth on your face, loss of hair, deepening of your voice or enlargement of your clitoris, which all could be signs of adverse effects of testosterone, which is the active substance in Livensa.",
    "display_src": "You should self assess for increased acne, increased hair growth on your face, loss of hair, deepening of your voice or enlargement of your clitoris, which all could be signs of adverse effects of testosterone, which is the active substance in Livensa.",
    "ref": "Sie sollten auf ein vermehrtes Auftreten von Akne, eine Zunahme der Behaarung im Gesicht, Haarausfall, Tieferwerden der Stimme oder Vergr\u00f6\u00dferung der Klitoris achten, da all dies Zeichen von Nebenwirkungen von Testosteron, dem Wirkstoff in Livensa, sein k\u00f6nnten.",
    "show_ref": false
  },
  {
    "src": "Retacrit is presented as a clear and colourless solution for injection in a pre-filled syringe with a fixed injection needle.",
    "display_src": "Retacrit is presented as a clear and colourless solution for injection in a pre-filled syringe with a fixed injection needle.",
    "ref": "Retacrit ist eine klare, farblose Injektionsl\u00f6sung in einer Fertigspritze mit fest eingesetzter Injektionsnadel.",
    "show_ref": false
  },
  {
    "src": "A general dose reduction is not considered to be necessary unless indicated due to reduced renal function (see section 4.2).",
    "display_src": "A general dose reduction is not considered to be necessary unless indicated due to reduced renal function (see section 4.2).",
    "ref": "Eine grunds\u00e4tzliche Dosisreduktion gilt nicht als erforderlich, es sei denn, sie ist aufgrund eingeschr\u00e4nkter Nierenfunktion indiziert (siehe Abschnitt 4.2).",
    "show_ref": false
  },
  {
    "src": "Caution should be exercised in the handling and preparation of the MabCampath solution.",
    "display_src": "Caution should be exercised in the handling and preparation of the MabCampath solution.",
    "ref": "Bei der Handhabung und Zubereitung der MabCampath-L\u00f6sung ist entsprechende Sorgfalt erforderlich.",
    "show_ref": false
  },
  {
    "src": "EU/ 1/ 97/ 030/ 046 (1 vial of 10 ml) EU/ 1/ 97/ 030/ 047 (5 vials of 10 ml)",
    "display_src": "EU/ 1/ 97/ 030/ 046 (1 vial of 10 ml) EU/ 1/ 97/ 030/ 047 (5 vials of 10 ml)",
    "ref": "EU/1/97/030/046 (1 Durchstechflasche mit 10 ml) EU/1/97/030/047 (5 Durchstechflaschen zu je 10 ml)",
    "show_ref": false
  },
  {
    "src": "For the full list of all side effects reported with Efient, see the Package Leaflet.",
    "display_src": "For the full list of all side effects reported with Efient, see the Package Leaflet.",
    "ref": "Die vollst\u00e4ndige Auflistung der im Zusammenhang mit Efient berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.",
    "show_ref": false
  },
  {
    "src": "3 Produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology 4",
    "display_src": "3 Produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology 4",
    "ref": "3 Hergestellt in Hefezellen (Saccharomyces cerevisiae) durch rekombinante DNA-Technologie 4",
    "show_ref": false
  },
  {
    "src": "The full EPAR for Telzir can be found here.",
    "display_src": "The full EPAR for Telzir can be found here.",
    "ref": "Den vollst\u00e4ndigen Wortlaut des EPAR f\u00fcr Telzir finden Sie hier.",
    "show_ref": false
  },
  {
    "src": "Important information about some of the ingredients of DaTSCAN",
    "display_src": "Important information about some of the ingredients of DaTSCAN",
    "ref": "Wichtige Informationen \u00fcber bestimmte sonstige Bestandteile von DaTSCAN",
    "show_ref": false
  },
  {
    "src": "Your doctor will determine the exact dosage schedule and regimen according to your needs.",
    "display_src": "Your doctor will determine the exact dosage schedule and regimen according to your needs.",
    "ref": "Ihr Arzt wird die exakte Dosis und das Dosierungsschema Ihren Bed\u00fcrfnissen entsprechend festlegen.",
    "show_ref": false
  },
  {
    "src": "Treatment As rivastigmine has a plasma half-life of about 1 hour and a duration of acetylcholinesterase inhibition of about 9 hours, it is recommended that in cases of asymptomatic overdose no further dose of rivastigmine should be administered for the next 24 hours.",
    "display_src": "Treatment As rivastigmine has a plasma half-life of about 1 hour and a duration of acetylcholinesterase inhibition of about 9 hours, it is recommended that in cases of asymptomatic overdose no further dose of rivastigmine should be administered for the next 24 hours.",
    "ref": "Behandlung Da Rivastigmin eine Plasmahalbwertszeit von etwa 1 Stunde hat und die Acetylcholinesterase \u00fcber einen Zeitraum von etwa 9 Stunden hemmt, wird f\u00fcr den Fall einer asymptomatischen \u00dcberdosierung empfohlen, in den folgenden 24 Stunden die weitere Einnahme von Rivastigmin auszusetzen.",
    "show_ref": false
  },
  {
    "src": "Facilities for the treatment of such reactions should be immediately available.",
    "display_src": "Facilities for the treatment of such reactions should be immediately available.",
    "ref": "Medizinische Einrichtungen f\u00fcr eine Behandlung solcher Reaktionen m\u00fcssen sofort verf\u00fcgbar sein.",
    "show_ref": false
  },
  {
    "src": "Common side effects (These may affect between 1 and 10 in every 100 patients) Other common side effects in the eye reported to be possibly caused by the medicinal product or by the injection procedure include:",
    "display_src": "Common side effects (These may affect between 1 and 10 in every 100 patients) Other common side effects in the eye reported to be possibly caused by the medicinal product or by the injection procedure include:",
    "ref": "H\u00e4ufige Nebenwirkungen (diese k\u00f6nnen 1 bis 10 von 100 Patienten betreffen) Andere h\u00e4ufige Nebenwirkungen am Auge, \u00fcber die im Zusammenhang mit der Behandlung mit Lucentis oder der Injektion als solcher berichtet wurde, sind:",
    "show_ref": false
  },
  {
    "src": "Where should you give your injection?",
    "display_src": "Where should you give your injection?",
    "ref": "Wohin sollen Sie sich spritzen?",
    "show_ref": false
  },
  {
    "src": "These tables outline the time taken for both the EMEA evaluation and Commission decision-taking (see Annexes 7 and 8).",
    "display_src": "These tables outline the time taken for both the EMEA evaluation and Commission decision-taking (see Annexes 7 and 8).",
    "ref": "Diese Tabellen geben Auskunft \u00fcber die Zeit, die f\u00fcr die Beurteilung durch die EMEA und die Entscheidung der Kommission ben\u00f6tigte wurde (siehe Anh\u00e4nge 7 und 8).",
    "show_ref": false
  },
  {
    "src": "About 20% of the total quantity of perindopril absorbed is converted into perindoprilat, the active metabolite.",
    "display_src": "About 20% of the total quantity of perindopril absorbed is converted into perindoprilat, the active metabolite.",
    "ref": "Etwa 20% der gesamten resorbierten Menge an Perindopril wird in den aktiven Metaboliten Perindoprilat umgewandelt.",
    "show_ref": false
  },
  {
    "src": "Although not all of these side effects may occur, they may need medical attention if they do. no",
    "display_src": "Although not all of these side effects may occur, they may need medical attention if they do. no",
    "ref": "Obwohl nicht alle der genannten Nebenwirkungen auftreten m\u00fcs sen, so k\u00f6nnen Sie doch \u00e4rztlichen Rat ben\u00f6tigen, wenn sie auftreten.",
    "show_ref": false
  },
  {
    "src": "Viofar Epe Ethnikis Antistaseos & Trifyllias, Aharnai, 13671 Greece",
    "display_src": "Viofar Epe Ethnikis Antistaseos & Trifyllias, Aharnai, 13671 Greece",
    "ref": "Viofar Epe Ethnikis Antistaseos & Trifyllias, Aharnai, 13671 Griechenland",
    "show_ref": false
  },
  {
    "src": "Shelf-life of broached vial:",
    "display_src": "Shelf-life of broached vial:",
    "ref": "Dauer der Haltbarkeit von angebrochenen Flaschen:",
    "show_ref": false
  },
  {
    "src": "Each vial contains 100 mg TMZ.",
    "display_src": "Each vial contains 100 mg TMZ.",
    "ref": "Jede Durchstechflasche enth\u00e4lt 100 mg TMZ.",
    "show_ref": false
  },
  {
    "src": "The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient's overall risks (see sections 4.3 and 4.4).",
    "display_src": "The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient's overall risks (see sections 4.3 and 4.4).",
    "ref": "Bei der Entscheidung einen selektiven COX-2-Hemmer zu verschreiben, muss das individuelle Gesamtrisiko des Patienten (siehe Abschnitte 4.3 und 4.4) ber\u00fccksichtigt werden.",
    "show_ref": false
  },
  {
    "src": "As with other bisphosphonates, the kidney was identified to be the primary target organ of systemic toxicity.",
    "display_src": "As with other bisphosphonates, the kidney was identified to be the primary target organ of systemic toxicity.",
    "ref": "Wie bei anderen Bisphosphonaten wurde die Niere als das prim\u00e4re Zielorgan der systemischen Toxizit\u00e4t identifiziert.",
    "show_ref": false
  },
  {
    "src": "The soft tissue adjacent to the injection site had fibroplasia with accompanying mononuclear cell infiltration reflective of the ability of PDGF to stimulate connective tissue growth.",
    "display_src": "The soft tissue adjacent to the injection site had fibroplasia with accompanying mononuclear cell infiltration reflective of the ability of PDGF to stimulate connective tissue growth.",
    "ref": "Das an das Injektionsgebiet angrenzende Weichteilgewebe zeigte eine Fibroplasie mit begleitender mononukle\u00e4rer Zellinfiltration, die F\u00e4higkeit von PDGF widerspiegelnd, das Bindegewebswachstum zu stimulieren.",
    "show_ref": false
  },
  {
    "src": "\u2192 Ask your doctor or pharmacist for advice.",
    "display_src": "\u2192 Ask your doctor or pharmacist for advice.",
    "ref": "\u2192 Fragen Sie Ihren Arzt oder Apotheker um Rat.",
    "show_ref": false
  },
  {
    "src": "In a juvenile rat toxicity study, pups dosed from postnatal day 7 to 63 with 10, 25 and 50 mg/kg of ribavirin demonstrated a dose-related decrease in overall growth, which was subsequently manifested as slight decreases in body weight, crown-rump length and bone length.",
    "display_src": "In a juvenile rat toxicity study, pups dosed from postnatal day 7 to 63 with 10, 25 and 50 mg/kg of ribavirin demonstrated a dose-related decrease in overall growth, which was subsequently manifested as slight decreases in body weight, crown-rump length and bone length.",
    "ref": "In einer Studie an juvenilen Ratten, die von Tag 7 bis Tag 63 (postnatal) mit 10, 25 und 50 mg/kg Ribavirin behandelt wurden, zeigte sich eine dosisabh\u00e4ngige Abnahme des Gesamtwachstums, welches sich in einer leichten Reduktion des K\u00f6rpergewichts, der Scheitel-Stei\u00df-L\u00e4nge und der Knochenl\u00e4nge manifestierte.",
    "show_ref": false
  },
  {
    "src": "The mean \u00b1 SD steady-state clearance was 13.1 \u00b1 5.0 ml/ h, with a mean \u00b1 SD half-life of 16 \u00b1 4 days.",
    "display_src": "The mean \u00b1 SD steady-state clearance was 13.1 \u00b1 5.0 ml/ h, with a mean \u00b1 SD half-life of 16 \u00b1 4 days.",
    "ref": "Die mittlere \u00b1 SD Clearance im Steady-State betrug 13,1 \u00b1 5,0 ml/h mit einer mittleren \u00b1 SD Halbwertszeit von 16 \u00b1 4 Tagen.",
    "show_ref": false
  },
  {
    "src": "EMEA/MB/002/97 Priority number 9 remains difficult principally because of the limited available resources and has been the subject of a number of discussions at Management Board.",
    "display_src": "EMEA/MB/002/97 Priority number 9 remains difficult principally because of the limited available resources and has been the subject of a number of discussions at Management Board.",
    "ref": "EMEA/MB/002/97 Die Priorit\u00e4t Nummer 9 bereitet indessen vor allem aufgrund der begrenzten verf\u00fcgbaren Mittel weiterhin Schwierigkeiten und war Gegenstand einer Reihe von Beratungen im Verwaltungsrat.",
    "show_ref": false
  },
  {
    "src": "Overexpression of HER2 is observed in 20 %-30% of primary breast cancers.",
    "display_src": "Overexpression of HER2 is observed in 20 %-30% of primary breast cancers.",
    "ref": "Eine \u00dcberexpression von HER2 ist bei 20% bis 30% aller prim\u00e4ren Mammakarzinome zu beobachten.",
    "show_ref": false
  },
  {
    "src": "In monkeys, the adverse effects appeared at doses from 150 mg/ kg/ day (> 232-fold the systemic exposure seen at the clinical dose).",
    "display_src": "In monkeys, the adverse effects appeared at doses from 150 mg/ kg/ day (> 232-fold the systemic exposure seen at the clinical dose).",
    "ref": "Bei Affen traten diese Nebenwirkungen bei einer Dosierung von 150 mg/kg/Tag (entsprechend dem > 232fachen der systemischen Exposition der therapeutischen Dosis) auf.",
    "show_ref": false
  },
  {
    "src": "For prostate cancer, the premedication is oral dexamethasone 8 mg, 12 hours, 3 hours and 1 hour before the docetaxel infusion (see section 4.2).",
    "display_src": "For prostate cancer, the premedication is oral dexamethasone 8 mg, 12 hours, 3 hours and 1 hour before the docetaxel infusion (see section 4.2).",
    "ref": "Bei der Therapie des Prostatakarzinoms besteht die Pr\u00e4medikation aus Dexamethason oral 8 mg, jeweils 12 Stunden, 3 Stunden und 1 Stunde vor der Infusion von Docetaxel (siehe Abschnitt 4.2).",
    "show_ref": false
  },
  {
    "src": "Plasma total immunoglobulin concentrations, total lymphocytes counts, and white cells generally remained within normal limits following MabThera treatment, with the exception of a transient drop in white cells counts over the first four weeks following therapy.",
    "display_src": "Plasma total immunoglobulin concentrations, total lymphocytes counts, and white cells generally remained within normal limits following MabThera treatment, with the exception of a transient drop in white cells counts over the first four weeks following therapy.",
    "ref": "Die Gesamtkonzentration der Immunglobuline im Plasma, die Gesamtlymphozytenzahl sowie die Leukozyten blieben im Anschluss an eine Therapie mit MabThera im Allgemeinen im Normalbereich, mit Ausnahme eines vor\u00fcbergehenden R\u00fcckgangs der Leukozytenzahl in den ersten vier Wochen nach der Behandlung.",
    "show_ref": false
  },
  {
    "src": "Do not use Avamys if you are breast feeding unless your doctor or pharmacist tells you to.",
    "display_src": "Do not use Avamys if you are breast feeding unless your doctor or pharmacist tells you to.",
    "ref": "Wenden Sie Avamys nicht an, wenn Sie stillen, es sei denn Ihr Arzt oder Ihr Apotheker empfiehlt es Ihnen.",
    "show_ref": false
  },
  {
    "src": "The bioavailability of glimepiride after oral administration is complete.",
    "display_src": "The bioavailability of glimepiride after oral administration is complete.",
    "ref": "Die Bioverf\u00fcgbarkeit von Glimepirid nach oraler Gabe ist vollst\u00e4ndig.",
    "show_ref": false
  },
  {
    "src": "If PRES is diagnosed, adequate blood pressure and seizure control and immediate discontinuation of systemic tacrolimus is advised.",
    "display_src": "If PRES is diagnosed, adequate blood pressure and seizure control and immediate discontinuation of systemic tacrolimus is advised.",
    "ref": "Sollte PRES festgestellt werden, ist eine ad\u00e4quate therapeutische Kontrolle von Blutdruck und Kr\u00e4mpfen und ein sofortiges Absetzen der systemischen Tacrolimus-Behandlung angeraten.",
    "show_ref": false
  },
  {
    "src": "For the full list of all side effects reported with Livensa, see the Package Leaflet.",
    "display_src": "For the full list of all side effects reported with Livensa, see the Package Leaflet.",
    "ref": "Die vollst\u00e4ndige Auflistung der im Zusammenhang mit Livensa berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.",
    "show_ref": false
  },
  {
    "src": "What benefit has Prepandrix shown during the studies?",
    "display_src": "What benefit has Prepandrix shown during the studies?",
    "ref": "Welchen Nutzen hat Prepandrix in diesen Studien gezeigt?",
    "show_ref": false
  },
  {
    "src": "Insuman Basal is supplied in vials containing 10 ml suspension (400 IU).",
    "display_src": "Insuman Basal is supplied in vials containing 10 ml suspension (400 IU).",
    "ref": "Insuman Basal gibt es in Durchstechflaschen mit 10 ml Suspension (400 I.E.).",
    "show_ref": false
  },
  {
    "src": "Regulatory actions were also taken in some other EU Member States where the product is authorised and veralipride\u2019 s product information was restricted with the aim to reduce the risk of patients developing side effects.",
    "display_src": "Regulatory actions were also taken in some other EU Member States where the product is authorised and veralipride\u2019 s product information was restricted with the aim to reduce the risk of patients developing side effects.",
    "ref": "Auch in einigen anderen EU-Mitgliedstaaten, in denen das Produkt zugelassen ist, wurden regulierende Ma\u00dfnahmen ergriffen, und die Produktinformationen von Veraliprid wurden eingeschr\u00e4nkt, um das Risiko von Nebenwirkungen f\u00fcr die Patientinnen zu verringern.",
    "show_ref": false
  },
  {
    "src": "There is further increase in the risk of gastrointestinal adverse effects (gastrointestinal ulceration or other gastrointestinal complications), when parecoxib sodium istaken concomitantly with acetylsalicylic acid (even at low doses).",
    "display_src": "There is further increase in the risk of gastrointestinal adverse effects (gastrointestinal ulceration or other gastrointestinal complications), when parecoxib sodium istaken concomitantly with acetylsalicylic acid (even at low doses).",
    "ref": "Das Risiko gastrointestinaler Nebenwirkungen (Geschw\u00fcre und andere Komplikationen) erh\u00f6ht sich zus\u00e4tzlich bei gleichzeitiger Anwendung von Parecoxib-Natrium und Acetylsalicyls\u00e4ure (auch bei bei niedrig dosierter ASS).",
    "show_ref": false
  },
  {
    "src": "Eighty-nine percent (50/ 56) of patients who lost clinical response on infliximab 5 mg/ kg maintenance therapy after week 14 responded to treatment with infliximab 10 mg/ kg.",
    "display_src": "Eighty-nine percent (50/ 56) of patients who lost clinical response on infliximab 5 mg/ kg maintenance therapy after week 14 responded to treatment with infliximab 10 mg/ kg.",
    "ref": "89% (50/56) der Patienten, die unter einer Erhaltungstherapie mit 5 mg/kg Infliximab nach Woche 14 das klinische Ansprechen verloren hatten, sprachen auf eine Behandlung mit 10 mg/kg Infliximab wieder an.",
    "show_ref": false
  },
  {
    "src": "Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with Actos and insulin experienced the development of heart failure.",
    "display_src": "Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with Actos and insulin experienced the development of heart failure.",
    "ref": "66 Bei einigen Patienten mit langj\u00e4hrigem Typ 2 Diabetes mellitus und Herzkrankheit oder fr\u00fcherem Schlaganfall, die mit Actos und Insulin behandelt wurden, entwickelte sich eine Herzinsuffizienz.",
    "show_ref": false
  },
  {
    "src": "If you take more CELSENTRI than you should",
    "display_src": "If you take more CELSENTRI than you should",
    "ref": "Wenn Sie eine gr\u00f6\u00dfere Menge von CELSENTRI eingenommen haben, als Sie sollten",
    "show_ref": false
  },
  {
    "src": "Each pre-filled syringe of 0.5 ml solution contains 75 mg of omalizumab.",
    "display_src": "Each pre-filled syringe of 0.5 ml solution contains 75 mg of omalizumab.",
    "ref": "Jede Fertigspritze mit 0,5 ml L\u00f6sung enth\u00e4lt 75 mg Omalizumab.",
    "show_ref": false
  },
  {
    "src": "There are no interaction data available on the coadministration of indinavir/ ritonavir and amprenavir.",
    "display_src": "There are no interaction data available on the coadministration of indinavir/ ritonavir and amprenavir.",
    "ref": "Keine Interaktionsdaten zur Koadministration von Indinavir/Ritonavir und Amprenavir verf\u00fcgbar.",
    "show_ref": false
  },
  {
    "src": "Three studies were \u2018 open \u2019, meaning that the medicine was not compared to any other treatment and the patients knew that they were receiving Hycamtin.",
    "display_src": "Three studies were \u2018 open \u2019, meaning that the medicine was not compared to any other treatment and the patients knew that they were receiving Hycamtin.",
    "ref": "Drei Studien waren offene Studien, in der das Arzneimittel nicht mit einer anderen Behandlung verglichen wurde und die Patienten wussten, dass sie Hycamtin erhielten.",
    "show_ref": false
  },
  {
    "src": "The frequency categories are defined as follows: very common (\u2265 1/ 10); common (\u2265 1/ 100, < 1/ 10); uncommon (\u2265 1/ 1,000, < 1/ 100), rare (\u2265 1/ 10,000, < 1/ 1,000); very rare (< 1/ 10,000).",
    "display_src": "The frequency categories are defined as follows: very common (\u2265 1/ 10); common (\u2265 1/ 100, < 1/ 10); uncommon (\u2265 1/ 1,000, < 1/ 100), rare (\u2265 1/ 10,000, < 1/ 1,000); very rare (< 1/ 10,000).",
    "ref": "Sehr h\u00e4ufig (\u2265 1/10); H\u00e4ufig (\u2265 1/100, < 1/10); Gelegentlich (\u2265 1/1,000, < 1/100), Selten (\u2265 1/10,000, < 1/1,000); Sehr selten (< 1/10,000).",
    "show_ref": false
  },
  {
    "src": "No other thrombotic complications from overdose have been reported, not even after treatment of a 6 year old boy with haemophilia A with inhibitors with 8 - 10 times the recommended dose.",
    "display_src": "No other thrombotic complications from overdose have been reported, not even after treatment of a 6 year old boy with haemophilia A with inhibitors with 8 - 10 times the recommended dose.",
    "ref": "Kein anderer Fall einer durch \u00dcberdosierung ausgel\u00f6sten thrombotischen Komplikation wurde bekannt, selbst nicht nach Behandlung eines 6-j\u00e4hrigen Jungen mit H\u00e4mophilie A und Inhibitor mit dem 8- bis 10fachen der empfohlenen Dosis.",
    "show_ref": false
  },
  {
    "src": "CYP3A4 induction; decrease in efavirenz concentrations:",
    "display_src": "CYP3A4 induction; decrease in efavirenz concentrations:",
    "ref": "CYP3A4-Induktion; Abnahme der Efavirenz- Konzentrationen:",
    "show_ref": false
  },
  {
    "src": "Appropriate aseptic technique should be used.",
    "display_src": "Appropriate aseptic technique should be used.",
    "ref": "Es sollte ein geeignetes aseptisches Verfahren angewendet werden.",
    "show_ref": false
  },
  {
    "src": "It is not known whether irbesartan is excreted in human milk.",
    "display_src": "It is not known whether irbesartan is excreted in human milk.",
    "ref": "Es ist nicht bekannt, ob Irbesartan beim Menschen in die Muttermilch ausgeschieden wird.",
    "show_ref": false
  },
  {
    "src": "Opioids relieve pain by attaching to \u2018 opioid receptors \u2019 in the brain and spinal cord.",
    "display_src": "Opioids relieve pain by attaching to \u2018 opioid receptors \u2019 in the brain and spinal cord.",
    "ref": "Opioide lindern Schmerzen, indem sie sich an die sogenannten \u201e Opioidrezeptoren\u201c im Gehirn und R\u00fcckenmark binden.",
    "show_ref": false
  },
  {
    "src": "Approximately 6% of adults and children 2- to 11-year old are phenotypic poor metabolisers of desloratadine and exhibit a higher exposure (see section 5.2).",
    "display_src": "Approximately 6% of adults and children 2- to 11-year old are phenotypic poor metabolisers of desloratadine and exhibit a higher exposure (see section 5.2).",
    "ref": "Etwa 6% der Erwachsenen und Kinder zwischen 2 und 11 Jahren metabolisieren Desloratadin eingeschr\u00e4nkt und erfahren eine h\u00f6here Substanzbelastung (siehe unter Abschnitt 5.2).",
    "show_ref": false
  },
  {
    "src": "Servier Hellas Pharmaceuticals S. A.",
    "display_src": "Servier Hellas Pharmaceuticals S. A.",
    "ref": "Servier Hellas Pharmaceuticals S.A.",
    "show_ref": false
  },
  {
    "src": "Repeated dose ocular toxicity studies on GANFORT showed no special hazard for humans.",
    "display_src": "Repeated dose ocular toxicity studies on GANFORT showed no special hazard for humans.",
    "ref": "Toxizit\u00e4tsstudien mit wiederholter Anwendung von GANFORT am Auge ergaben keine besonderen Gefahren f\u00fcr den Menschen.",
    "show_ref": false
  },
  {
    "src": "All values returned to baseline levels upon therapy discontinuation.",
    "display_src": "All values returned to baseline levels upon therapy discontinuation.",
    "ref": "Nach Absetzen der Behandlung gingen alle Werte auf das Ausgangsniveau zur\u00fcck.",
    "show_ref": false
  },
  {
    "src": "Abseamed is given by injection into a vein (intravenously).",
    "display_src": "Abseamed is given by injection into a vein (intravenously).",
    "ref": "Abseamed wird als Injektion in eine Vene (intraven\u00f6s) gegeben.",
    "show_ref": false
  },
  {
    "src": "Malignancies and lymphoproliferative disorders:",
    "display_src": "Malignancies and lymphoproliferative disorders:",
    "ref": "Malignome und lymphoproliferative Erkrankungen:",
    "show_ref": false
  },
  {
    "src": "Imprida is available in packs containing 7, 14, 28, 30, 56, 90, 98 or 280 tablets and in multipacks comprising 4 cartons, each containing 70 tablets.",
    "display_src": "Imprida is available in packs containing 7, 14, 28, 30, 56, 90, 98 or 280 tablets and in multipacks comprising 4 cartons, each containing 70 tablets.",
    "ref": "Imprida ist in Packungen mit 7, 14, 28, 30, 56, 90, 98 oder 280 Tabletten und in Mehrfachpackungen mit 280 (4x70) Tabletten erh\u00e4ltlich.",
    "show_ref": false
  },
  {
    "src": "These pouches should stay in the bottle all the time and are not to be eaten.",
    "display_src": "These pouches should stay in the bottle all the time and are not to be eaten.",
    "ref": "Diese Beutel sollen immer in der Flasche bleiben und d\u00fcrfen nicht eingenommen werden.",
    "show_ref": false
  },
  {
    "src": "You must tell the doctor if:",
    "display_src": "You must tell the doctor if:",
    "ref": "Sie m\u00fcssen Ihren Arzt informieren, falls",
    "show_ref": false
  },
  {
    "src": "All cause mortality was similar (p=NS) in the valsartan (19.7%) and placebo (19.4%) groups.",
    "display_src": "All cause mortality was similar (p=NS) in the valsartan (19.7%) and placebo (19.4%) groups.",
    "ref": "Die Gesamtmortalit\u00e4t war in der Valsartan- (19,7%) und Placebogruppe (19,4%) vergleichbar (p= NS).",
    "show_ref": false
  },
  {
    "src": "During 1998 the working party continued to follow the developments of the VICH initiatives and provided comments on draft guidelines including those on the stability of new active substances, new products and premixes.",
    "display_src": "During 1998 the working party continued to follow the developments of the VICH initiatives and provided comments on draft guidelines including those on the stability of new active substances, new products and premixes.",
    "ref": "Im Laufe des Jahres 1998 verfolgte die Arbeitsgruppe weiterhin die Entwicklung der VICH-Initiativen mit und unterbreitete Anmerkungen zu Leitlinienentw\u00fcrfen, darunter zu den Leitlinien f\u00fcr die Stabilit\u00e4t neuer Substanzen, neuer Arzneimittel und Vormischungen.",
    "show_ref": false
  },
  {
    "src": "356.3 mg 168.6 mg 152.7 mg 59.6 mg 10.2 mg 4.1 mg",
    "display_src": "356.3 mg 168.6 mg 152.7 mg 59.6 mg 10.2 mg 4.1 mg",
    "ref": "356,3 mg 168,6 mg 152,7 mg 59,6 mg 10,2 mg 4,1 mg",
    "show_ref": false
  },
  {
    "src": "Once the patient \u2019 s hepatic transaminases are below 3 x ULN, treatment with RoActemra may recommence at 4 or 8 mg/ kg.",
    "display_src": "Once the patient \u2019 s hepatic transaminases are below 3 x ULN, treatment with RoActemra may recommence at 4 or 8 mg/ kg.",
    "ref": "Wenn die Lebertransaminasen des Patienten unter 3 x ULN gesunken sind, kann die Behandlung mit RoActemra in einer Dosierung von 4 oder 8 mg/kg wieder begonnen werden.",
    "show_ref": false
  },
  {
    "src": "Uncommon vision blurred Ear and labyrinth disorders:",
    "display_src": "Uncommon vision blurred Ear and labyrinth disorders:",
    "ref": "Gelegentlich Verschwommenes Sehen Erkrankungen des Ohrs und des Labyrinths:",
    "show_ref": false
  },
  {
    "src": "Also, be sure to read the \u201cDo not take\u201d section of the Package Leaflet for interferon alfa-2b.",
    "display_src": "Also, be sure to read the \u201cDo not take\u201d section of the Package Leaflet for interferon alfa-2b.",
    "ref": "Lesen Sie auch den Abschnitt \u201dDarf nicht angewendet werden\u201d in der Packungsbeilage von Interferon alfa -2b.",
    "show_ref": false
  },
  {
    "src": "Capsule content pregelatinised starch (maize)",
    "display_src": "Capsule content pregelatinised starch (maize)",
    "ref": "Kapselinhalt vorgelatinisierte St\u00e4rke (Mais)",
    "show_ref": false
  },
  {
    "src": "Doses up to 9 mg/ kg have been tested in clinical trials.",
    "display_src": "Doses up to 9 mg/ kg have been tested in clinical trials.",
    "ref": "In klinischen Studien wurden Dosierungen von bis zu 9 mg/kg KG untersucht.",
    "show_ref": false
  },
  {
    "src": "On 21 May 2007, Protherics PLC officially notified the Committee for Medicinal Products for Human Use (CHMP) that they wish to withdraw their application for a marketing authorisation for Voraxaze, for the adjunctive treatment of patients experiencing or at risk of methotrexate toxicity.",
    "display_src": "On 21 May 2007, Protherics PLC officially notified the Committee for Medicinal Products for Human Use (CHMP) that they wish to withdraw their application for a marketing authorisation for Voraxaze, for the adjunctive treatment of patients experiencing or at risk of methotrexate toxicity.",
    "ref": "Mai 2007 teilte Protherics PLC dem Ausschuss f\u00fcr Humanarzneimittel (CHMP) offiziell mit, dass das Unternehmen seinen Antrag auf Genehmigung f\u00fcr das Inverkehrbringen von Voraxaze zur Zusatzbehandlung von Patienten, die von einer Methotrexat-Toxizit\u00e4t betroffen bzw. dadurch gef\u00e4hrdet sind, zur\u00fcckzieht.",
    "show_ref": false
  },
  {
    "src": "Actrapid is administered subcutaneously (under the skin) by injection, usually into the abdominal wall (tummy).",
    "display_src": "Actrapid is administered subcutaneously (under the skin) by injection, usually into the abdominal wall (tummy).",
    "ref": "Actrapid wird im Allgemeinen subkutan (unter die Haut) in die Bauchwand injiziert.",
    "show_ref": false
  },
  {
    "src": "Whilst increasing the number of meetings was considered, this was felt inappropriate because of insufficient time for preparation of documents by members and full assessment and review.",
    "display_src": "Whilst increasing the number of meetings was considered, this was felt inappropriate because of insufficient time for preparation of documents by members and full assessment and review.",
    "ref": "Zwar wurde auch in Betracht gezogen, die Zahl der Sitzungen zu erh\u00f6hen, doch wurde dies letztlich als unzweckm\u00e4\u00dfig angesehen, da in diesem Fall zu wenig Zeit f\u00fcr die Vorbereitung von Dokumenten durch die Ausschu\u00dfmitglieder sowie die Bewertung und Pr\u00fcfung verbliebe.",
    "show_ref": false
  },
  {
    "src": "During treatment for chemotherapy induced nausea and vomiting (CINV), the 3-day 125 mg/ 80 mg regimen of aprepitant is a moderate inhibitor of CYP3A4.",
    "display_src": "During treatment for chemotherapy induced nausea and vomiting (CINV), the 3-day 125 mg/ 80 mg regimen of aprepitant is a moderate inhibitor of CYP3A4.",
    "ref": "Bei der Behandlung von \u00dcbelkeit und Erbrechen nach Chemotherapie (CINV) wirkt das 3-Tages Therapieschema 125 mg/80 mg Aprepitant moderat inhibitorisch auf CYP3A4.",
    "show_ref": false
  },
  {
    "src": "In cattle, seven main studies were carried out.",
    "display_src": "In cattle, seven main studies were carried out.",
    "ref": "Bei Rindern wurden sieben Hauptstudien durchgef\u00fchrt.",
    "show_ref": false
  },
  {
    "src": "agranulocytosis granulocytopenia pancytopenia haemolytic anaemia thrombocytopenia leukopenia erythrocytopenia",
    "display_src": "agranulocytosis granulocytopenia pancytopenia haemolytic anaemia thrombocytopenia leukopenia erythrocytopenia",
    "ref": "Agranulozytose Granulozytopenie Panzytopenie H\u00e4molytische An\u00e4mie Thrombozytopenie Leukopenie Erythrozytopenie",
    "show_ref": false
  },
  {
    "src": "For readministration see section 4.4.",
    "display_src": "For readministration see section 4.4.",
    "ref": "Zur wiederholten Verabreichung siehe Abschnitt 4.4.",
    "show_ref": false
  },
  {
    "src": "On 10 February 1997 France requested that the CPMP, under Article 12 of Council Directive 75/ 319/ EEC as amended, give an opinion on whether there is an unfavourable benefit/ risk ratio for terfenadine in relation to its arrhythmogenic potential and to its serious cardiac adverse effects.",
    "display_src": "On 10 February 1997 France requested that the CPMP, under Article 12 of Council Directive 75/ 319/ EEC as amended, give an opinion on whether there is an unfavourable benefit/ risk ratio for terfenadine in relation to its arrhythmogenic potential and to its serious cardiac adverse effects.",
    "ref": "Februar 1997 beantragte Frankreich, der CPMP m\u00f6ge gem\u00e4\u00df Artikel 12 der Richtlinie 75/319/EWG des Rates, einschlie\u00dflich \u00c4nderungen, ein Gutachten dar\u00fcber abgeben, ob ein ung\u00fcnstiges Nutzen-Risiko-Verh\u00e4ltnis f\u00fcr Terfenadin in bezug auf sein arrhythmogenes Potential und seine schweren kardialen Nebenwirkungen besteht.",
    "show_ref": false
  },
  {
    "src": "96 Information on how to use Protaphane NovoLet",
    "display_src": "96 Information on how to use Protaphane NovoLet",
    "ref": "104 Informationen \u00fcber die Bedienung von Protaphane NovoLet",
    "show_ref": false
  },
  {
    "src": "This was not seen at doses \u2264 20 mg/ kg.",
    "display_src": "This was not seen at doses \u2264 20 mg/ kg.",
    "ref": "Dies war bei Dosen \u2264 20 mg/kg nicht nachweisbar.",
    "show_ref": false
  },
  {
    "src": "It is used in breast cancer that is advanced or \u2018 metastatic\u2019 (has spread to other parts of the body), and in breast cancer that can be treated with surgery.",
    "display_src": "It is used in breast cancer that is advanced or \u2018 metastatic\u2019 (has spread to other parts of the body), and in breast cancer that can be treated with surgery.",
    "ref": "Es wird zur Behandlung von fortgeschrittenem oder metastasiertem Brustkrebs (\u201e metastasiert\u201c bedeutet, dass sich der Krebs auf andere K\u00f6rperteile ausgebreitet hat) angewendet.",
    "show_ref": false
  },
  {
    "src": "Use a different Enbrel pre-filled syringe, then contact your pharmacist for assistance.",
    "display_src": "Use a different Enbrel pre-filled syringe, then contact your pharmacist for assistance.",
    "ref": "Benutzen Sie eine andere Enbrel- Fertigspritze und bitten Sie dann Ihren Apotheker um Rat.",
    "show_ref": false
  },
  {
    "src": "Common side effects (which can occur in less than one in ten but in more than one in a hundred patients treated) are vomiting, abdominal pain, flatulence, tiredness, headache and rash.",
    "display_src": "Common side effects (which can occur in less than one in ten but in more than one in a hundred patients treated) are vomiting, abdominal pain, flatulence, tiredness, headache and rash.",
    "ref": "H\u00e4ufige Nebenwirkungen (die bei weniger als 1 von 10, aber bei mehr als 1 von 100 Behandelten auftreten k\u00f6nnen) sind Erbrechen, Bauchschmerzen, Bl\u00e4hungen, M\u00fcdigkeit, Kopfschmerzen und Hautausschlag.",
    "show_ref": false
  },
  {
    "src": "The currently available data both in vitro and in patients suggest that HBV expressing the adefovir- associated resistance mutation rtN236T is susceptible to lamivudine.",
    "display_src": "The currently available data both in vitro and in patients suggest that HBV expressing the adefovir- associated resistance mutation rtN236T is susceptible to lamivudine.",
    "ref": "12 Die derzeit verf\u00fcgbaren Daten deuten sowohl in vitro als auch bei Patienten darauf hin, dass HBV, die die mit Adefovir-assoziierte Resistenzmutation rtN236T entwickeln, gegen\u00fcber Lamivudin empfindlich sind.",
    "show_ref": false
  },
  {
    "src": "Insuman Comb 50 is a biphasic isophane insulin suspension consisting of 50% dissolved insulin and 50% crystalline protamine insulin.",
    "display_src": "Insuman Comb 50 is a biphasic isophane insulin suspension consisting of 50% dissolved insulin and 50% crystalline protamine insulin.",
    "ref": "Insuman Comb 50 ist eine biphasische Isophan-Insulin-Suspension mit 50% gel\u00f6stem Insulin und 50% kristallinem Protamin-Insulin.",
    "show_ref": false
  },
  {
    "src": "In repeated-dose toxicity studies in rabbits there was no significant evidence of systemic toxicity.",
    "display_src": "In repeated-dose toxicity studies in rabbits there was no significant evidence of systemic toxicity.",
    "ref": "Toxizit\u00e4tsstudien mit wiederholt verabreichten Dosen bei Kaninchen ergaben keine signifikanten Hinweise auf systemische Toxizit\u00e4t.",
    "show_ref": false
  },
  {
    "src": "Adequate intake of calcium and vitamin D is important in all patients.",
    "display_src": "Adequate intake of calcium and vitamin D is important in all patients.",
    "ref": "Eine ausreichende Zufuhr von Calcium und Vitamin D ist bei allen Patienten wichtig.",
    "show_ref": false
  },
  {
    "src": "What is Monotard used for? no",
    "display_src": "What is Monotard used for? no",
    "ref": "Wof\u00fcr wird Monotard angewendet?",
    "show_ref": false
  },
  {
    "src": "The Committee recommended that ECALTA be given marketing authorisation.",
    "display_src": "The Committee recommended that ECALTA be given marketing authorisation.",
    "ref": "Der Ausschuss empfahl, die Genehmigung f\u00fcr das Inverkehrbringen von ECALTA zu erteilen.",
    "show_ref": false
  },
  {
    "src": "This transporter is important in the hepatic elimination of rosuvastatin.",
    "display_src": "This transporter is important in the hepatic elimination of rosuvastatin.",
    "ref": "Dieser Transporter ist bei der Ausscheidung von Rosuvastatin \u00fcber die Leber wichtig.",
    "show_ref": false
  },
  {
    "src": "Their frequency is defined using the following conventions: common (\u2265 1/ 100 to < 1/ 10); uncommon (\u2265 1/ 1,000 to < 1/ 100); rare (\u2265 1/ 10,000 to < 1/ 1,000); very rare (< 1/ 10,000).",
    "display_src": "Their frequency is defined using the following conventions: common (\u2265 1/ 100 to < 1/ 10); uncommon (\u2265 1/ 1,000 to < 1/ 100); rare (\u2265 1/ 10,000 to < 1/ 1,000); very rare (< 1/ 10,000).",
    "ref": "Ihre H\u00e4ufigkeit ist definiert unter Verwendung der folgenden Einteilung: h\u00e4ufig (\u2265 1/100 bis < 1/10), gelegentlich (\u2265 1/1.000 bis < 1/100), selten (\u2265 1/10.000 bis < 1/1.000), sehr selten (< 1/10.000).",
    "show_ref": false
  },
  {
    "src": "What Clopidogrel BMS contains The active substance is clopidogrel.",
    "display_src": "What Clopidogrel BMS contains The active substance is clopidogrel.",
    "ref": "Was Clopidogrel BMS enth\u00e4lt Der Wirkstoff ist Clopidogrel.",
    "show_ref": false
  },
  {
    "src": "VIAGRA 50 mg film-coated tablets Sildenafil citrate",
    "display_src": "VIAGRA 50 mg film-coated tablets Sildenafil citrate",
    "ref": "VIAGRA 50 mg Filmtabletten Sildenafilcitrat",
    "show_ref": false
  },
  {
    "src": "What is Copalia used for?",
    "display_src": "What is Copalia used for?",
    "ref": "Wof\u00fcr wird Copalia angewendet?",
    "show_ref": false
  },
  {
    "src": "- If adults have been treated with growth hormone during childhood, they should be re-evaluated",
    "display_src": "- If adults have been treated with growth hormone during childhood, they should be re-evaluated",
    "ref": "- Falls Erwachsene in ihrer Kindheit mit Wachstumshormon behandelt worden sind, sollten sie",
    "show_ref": false
  },
  {
    "src": "FOSAVANCE is a tablet containing the two active substances, alendronate sodium trihydrate and colecalciferol known as vitamin D3.",
    "display_src": "FOSAVANCE is a tablet containing the two active substances, alendronate sodium trihydrate and colecalciferol known as vitamin D3.",
    "ref": "FOSAVANCE ist eine Tablette, die zwei arzneilich wirksame Bestandteile, Natriumalendronat 3 H2O und Colecalciferol, auch bekannt als Vitamin D3, enth\u00e4lt.",
    "show_ref": false
  },
  {
    "src": "Clearance of ranolazine is dose-dependent, decreasing with increased dose.",
    "display_src": "Clearance of ranolazine is dose-dependent, decreasing with increased dose.",
    "ref": "Die Clearance von Ranolazin ist dosisabh\u00e4ngig und nimmt mit steigender Dosis ab.",
    "show_ref": false
  },
  {
    "src": "In rheumatoid arthritis, psoriatic arthritis and Crohn's disease patients, there are indications that concomitant use of methotrexate and other immunomodulators reduces the formation of antibodies against infliximab and increases the plasma concentrations of infliximab.",
    "display_src": "In rheumatoid arthritis, psoriatic arthritis and Crohn's disease patients, there are indications that concomitant use of methotrexate and other immunomodulators reduces the formation of antibodies against infliximab and increases the plasma concentrations of infliximab.",
    "ref": "Bei Patienten mit rheumatoider Arthritis, Psoriasis-Arthritis und bei Morbus-Crohn-Patienten liegen Hinweise darauf vor, dass bei einer gleichzeitigen Behandlung mit Methotrexat oder sonstigen Immunmodulatoren die Bildung von Antik\u00f6rpern gegen Infliximab reduziert wird und dass die Plasmakonzentrationen von Infliximab ansteigen.",
    "show_ref": false
  },
  {
    "src": "Chemical and physical in-use stability of the reconstituted solution has been demonstrated for 3 hours at 25\u00baC and for 2 hours at 5\u00b0C.",
    "display_src": "Chemical and physical in-use stability of the reconstituted solution has been demonstrated for 3 hours at 25\u00baC and for 2 hours at 5\u00b0C.",
    "ref": "Die chemische und physikalische Stabilit\u00e4t der rekonstituierten L\u00f6sung wurde bei 25 \u00b0C f\u00fcr 3 Stunden und bei 5 \u00b0C f\u00fcr 2 Stunden nachgewiesen.",
    "show_ref": false
  },
  {
    "src": "The recommended dose of Avonex is 30 micrograms, given by injection into a muscle once a week.",
    "display_src": "The recommended dose of Avonex is 30 micrograms, given by injection into a muscle once a week.",
    "ref": "Die empfohlene Dosis von Avonex betr\u00e4gt 30 Mikrogramm und wird einmal w\u00f6chentlich in einen Muskel gespritzt.",
    "show_ref": false
  },
  {
    "src": "In addition, TOVIAZ 8 mg tablets are also packed in HDPE bottles containing 30 or 90 tablets.",
    "display_src": "In addition, TOVIAZ 8 mg tablets are also packed in HDPE bottles containing 30 or 90 tablets.",
    "ref": "Zus\u00e4tzlich sind TOVIAZ 8 mg Tabletten auch in HDPE- Flaschen mit 30 oder 90 Tabletten erh\u00e4ltlich.",
    "show_ref": false
  },
  {
    "src": "If you have difficulty swallowing, you can crush the tablet.",
    "display_src": "If you have difficulty swallowing, you can crush the tablet.",
    "ref": "Wenn Sie Schwierigkeiten mit dem Schlucken haben, k\u00f6nnen Sie die Tablette zerdr\u00fccken.",
    "show_ref": false
  },
  {
    "src": "- if you have excessive weakness of the muscles (myasthenia gravis)",
    "display_src": "- if you have excessive weakness of the muscles (myasthenia gravis)",
    "ref": "- wenn bei Ihnen eine extreme Muskelschw\u00e4che vorliegt (Myasthenia gravis)",
    "show_ref": false
  },
  {
    "src": "The medicine should be taken around the same time every day and the appropriateness of the once-a-day dosing should be re-assessed regularly.",
    "display_src": "The medicine should be taken around the same time every day and the appropriateness of the once-a-day dosing should be re-assessed regularly.",
    "ref": "Das Arzneimittel sollte jeden Tag ungef\u00e4hr um die gleiche Zeit eingenommen werden, und es sollte regelm\u00e4\u00dfig neu bewertet werden, ob die Dosierung von einmal t\u00e4glich angemessen ist.",
    "show_ref": false
  },
  {
    "src": "- if you are allergic (hypersensitive) to temozolomide or any of the other ingredients of Temodal.",
    "display_src": "- if you are allergic (hypersensitive) to temozolomide or any of the other ingredients of Temodal.",
    "ref": "- wenn Sie allergisch (\u00fcberempfindlich) gegen Temozolomid oder einen der sonstigen",
    "show_ref": false
  },
  {
    "src": "11-fold; (Relative to Indinavir 800 mg TID alone*) Ritonavir AUC:",
    "display_src": "11-fold; (Relative to Indinavir 800 mg TID alone*) Ritonavir AUC:",
    "ref": "11-fach; (Im Vergleich zu Indinavir 800 mg TID allein*) Ritonavir AUC:",
    "show_ref": false
  },
  {
    "src": "In a single dose, crossover study of desloratadine, the tablet and the syrup formulations were found to be bioequivalent.",
    "display_src": "In a single dose, crossover study of desloratadine, the tablet and the syrup formulations were found to be bioequivalent.",
    "ref": "In einer Einzeldosis-Crossover-Studie mit Desloratadin wurde bei der Tabletten- und Sirup- Formulierung Bio\u00e4quivalenz gefunden.",
    "show_ref": false
  },
  {
    "src": "Preclinical data for metformin reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction.",
    "display_src": "Preclinical data for metformin reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction.",
    "ref": "Basierend auf den konventionellen Studien zur Sicherheitspharmakologie, chronischen Toxizit\u00e4t, Genotoxizit\u00e4t, Reproduktionstoxizit\u00e4t und zum kanzerogenen Potential lassen die pr\u00e4klinischen Daten keine besonderen Gefahren f\u00fcr den Menschen erkennen.",
    "show_ref": false
  },
  {
    "src": "10 pre-filled syringes + 10 needles",
    "display_src": "10 pre-filled syringes + 10 needles",
    "ref": "10 Fertigspritzen + 10 Kan\u00fclen",
    "show_ref": false
  },
  {
    "src": "Tracleer should not be used concomitantly with glibenclamide, due to an increased risk of elevated liver aminotransferases (see section 4.5).",
    "display_src": "Tracleer should not be used concomitantly with glibenclamide, due to an increased risk of elevated liver aminotransferases (see section 4.5).",
    "ref": "Tracleer und Glibenclamid sollten wegen des erh\u00f6hten Risikos von Leber- Aminotransferaseerh\u00f6hungen nicht gleichzeitig angewendet werden (siehe Abschnitt 4.5).",
    "show_ref": false
  },
  {
    "src": "White to light beige, oval tablet marked with \u201c G\u201d and a score line.",
    "display_src": "White to light beige, oval tablet marked with \u201c G\u201d and a score line.",
    "ref": "Die Tablette ist wei\u00df bis hellbeige, oval, mit einem \u201e G\u201c gekennzeichnet und mit Bruchkerbe.",
    "show_ref": false
  },
  {
    "src": "Elderly Population pharmacokinetic analysis in HIV infected patients showed that darunavir pharmacokinetics are not considerably different in the age range (18 to 75 years) evaluated in HIV infected patients (see section 4.4).",
    "display_src": "Elderly Population pharmacokinetic analysis in HIV infected patients showed that darunavir pharmacokinetics are not considerably different in the age range (18 to 75 years) evaluated in HIV infected patients (see section 4.4).",
    "ref": "\u00c4ltere Patienten Eine populationsspezifische Analyse der Pharmakokinetik bei HIV-infizierten Patienten ergab keine wesentlichen Unterschiede der Pharmakokinetik von Darunavir in dem Altersbereich (18 bis 75 Jahre), der bei HIV-Patienten untersucht wurde (siehe Abschnitt 4.4).",
    "show_ref": false
  },
  {
    "src": "On the basis of drug exposure and tolerability, dosage adjustments are not required for elderly patients unless there is evidence of severe renal impairment (creatinine clearance below 30 ml/ min) (see section 4.2).",
    "display_src": "On the basis of drug exposure and tolerability, dosage adjustments are not required for elderly patients unless there is evidence of severe renal impairment (creatinine clearance below 30 ml/ min) (see section 4.2).",
    "ref": "Basierend auf systemischer Exposition und Vertr\u00e4glichkeit sind Dosisanpassungen bei \u00e4lteren Patienten nicht erforderlich, au\u00dfer es liegt eine schwere Niereninsuffizienz vor (Kreatinin-Clearance unter 30 ml/min) (siehe Abschnitt 4.2).",
    "show_ref": false
  },
  {
    "src": "Tablet film coat Titanium dioxide (E171) Macrogol Talc Hypromellose",
    "display_src": "Tablet film coat Titanium dioxide (E171) Macrogol Talc Hypromellose",
    "ref": "16 Film\u00fcberzug der Tabletten Titandioxid (E171) Macrogol Talkum Hypromellose",
    "show_ref": false
  },
  {
    "src": "with cisplatin and 5-fluorouracil.",
    "display_src": "with cisplatin and 5-fluorouracil.",
    "ref": "Kombination mit Cisplatin und 5-Fluorouracil gegeben.",
    "show_ref": false
  },
  {
    "src": "The following table presents the adverse drug reactions that were reported in placebo-controlled trials in which 1,965 hypertensive patients received irbesartan.",
    "display_src": "The following table presents the adverse drug reactions that were reported in placebo-controlled trials in which 1,965 hypertensive patients received irbesartan.",
    "ref": "Die folgende Tabelle zeigt die unerw\u00fcnschten Arzneimittelwirkungen, die in placebokontrollierten Studien berichtet wurden, in denen 1.965 hypertensive Patienten mit Irbesartan behandelt wurden.",
    "show_ref": false
  },
  {
    "src": "Prasugrel was associated with a 50% reduction in stent thrombosis through the 15 month follow-up period.",
    "display_src": "Prasugrel was associated with a 50% reduction in stent thrombosis through the 15 month follow-up period.",
    "ref": "Prasugrel war bis zum Ende der 15-monatigen Nachbeobachtungsphase mit einer 50% Reduktion der Stentthrombosen verbunden.",
    "show_ref": false
  },
  {
    "src": "SINGULAIR may be used during pregnancy only if it is considered to be clearly essential.",
    "display_src": "SINGULAIR may be used during pregnancy only if it is considered to be clearly essential.",
    "ref": "SINGULAIR darf w\u00e4hrend der Schwangerschaft nur eingenommen werden, wenn es als eindeutig erforderlich erachtet wird.",
    "show_ref": false
  },
  {
    "src": "In the study of patients with an inadequate response to TNF blockers in the past, adding ORENCIA to existing treatment led to 129 (50.4%) of the 256 patients having at least a 20% reduction in symptoms, compared with 26 (19.5%) of the 133 patients adding placebo.",
    "display_src": "In the study of patients with an inadequate response to TNF blockers in the past, adding ORENCIA to existing treatment led to 129 (50.4%) of the 256 patients having at least a 20% reduction in symptoms, compared with 26 (19.5%) of the 133 patients adding placebo.",
    "ref": "In der Studie mit Patienten, die in der Vergangenheit nur unzureichend auf TNF-Blocker angesprochen hatten, erbrachte die Erg\u00e4nzung der bestehenden Behandlung mit ORENCIA bei 129 (50,4%) von 256 Patienten eine Verringerung der Symptome um mindestens 20% im Vergleich zu der Placebo-Gruppe mit 26 (19,5%) von 133 Patienten.",
    "show_ref": false
  },
  {
    "src": "A reliable method of barrier contraception must be used in addition to oral contraceptives (see section 4.6).",
    "display_src": "A reliable method of barrier contraception must be used in addition to oral contraceptives (see section 4.6).",
    "ref": "Zur Empf\u00e4ngnisverh\u00fctung muss eine zuverl\u00e4ssige Barriere- Methode zus\u00e4tzlich zu oralen Kontrazeptiva angewendet werden (siehe Abschnitt 4.6).",
    "show_ref": false
  },
  {
    "src": "Medical devices for reconstitution and administration are provided with each package of Helixate NexGen 2000 IU.",
    "display_src": "Medical devices for reconstitution and administration are provided with each package of Helixate NexGen 2000 IU.",
    "ref": "Medizinprodukte zur Zubereitung und Anwendung liegen jeder Packung Helixate NexGen 2000 I.E. bei.",
    "show_ref": false
  },
  {
    "src": "3 In case of insufficient glucose control or a tendency to hyper- or hypoglycaemic episodes, the patient's adherence to the prescribed treatment regimen, injection sites and proper injection technique and all other relevant factors must be reviewed before dose adjustment is considered.",
    "display_src": "3 In case of insufficient glucose control or a tendency to hyper- or hypoglycaemic episodes, the patient's adherence to the prescribed treatment regimen, injection sites and proper injection technique and all other relevant factors must be reviewed before dose adjustment is considered.",
    "ref": "Bei ungen\u00fcgender Stoffwechseleinstellung oder Neigung zu Hyper- oder Hypoglyk\u00e4mien m\u00fcssen die Einhaltung des Therapieschemas durch den Patienten, die gew\u00e4hlten Injektionsstellen und die Injektionstechnik sowie alle anderen relevanten Faktoren \u00fcberpr\u00fcft werden, bevor eine Dosisanpassung in Erw\u00e4gung gezogen wird.",
    "show_ref": false
  },
  {
    "src": "Sanofi Pasteur SA Campus M\u00e9rieux 1541 Avenue Marcel M\u00e9rieux F-69280 Marcy L'Etoile",
    "display_src": "Sanofi Pasteur SA Campus M\u00e9rieux 1541 Avenue Marcel M\u00e9rieux F-69280 Marcy L'Etoile",
    "ref": "Sanofi Pasteur SA Campus M\u00e9rieux 1541 Avenue Marcel M\u00e9rieux F-69280 Marcy L\u2019 Etoile",
    "show_ref": false
  },
  {
    "src": "Rasilez HCT 300 mg/ 12.5 mg film-coated tablets Aliskiren/ hydrochlorothiazide",
    "display_src": "Rasilez HCT 300 mg/ 12.5 mg film-coated tablets Aliskiren/ hydrochlorothiazide",
    "ref": "Rasilez HCT 300 mg/12,5 mg Filmtabletten Aliskiren/Hydrochlorothiazid",
    "show_ref": false
  },
  {
    "src": "If you are taking ritonavir therapy for the treatment of HIV, you should not take Revatio.",
    "display_src": "If you are taking ritonavir therapy for the treatment of HIV, you should not take Revatio.",
    "ref": "Falls Sie Ritonavir zur Behandlung einer HIV-Infektion verwenden, d\u00fcrfen Sie Revatio nicht einnehmen.",
    "show_ref": false
  },
  {
    "src": "In the three placebo-controlled trials (n=963) 38% of patients had low titre anti-exenatide antibodies at 30 weeks.",
    "display_src": "In the three placebo-controlled trials (n=963) 38% of patients had low titre anti-exenatide antibodies at 30 weeks.",
    "ref": "In drei placebokontrollierten Studien (n = 963) hatten 38% der Patienten nach 30 Wochen einen niedrigen Titer von gegen Exenatide gerichteten Antik\u00f6rpern.",
    "show_ref": false
  },
  {
    "src": "Women receiving Volibris must be advised of the risk of foetal harm and alternative therapy initiated if pregnancy occurs (see sections 4.3, 4.4 and 5.3).",
    "display_src": "Women receiving Volibris must be advised of the risk of foetal harm and alternative therapy initiated if pregnancy occurs (see sections 4.3, 4.4 and 5.3).",
    "ref": "Frauen, die mit Volibris behandelt werden, m\u00fcssen auf das Risko einer Sch\u00e4digung des Fetus hingewiesen und im Falle einer Schwangerschaft muss eine alternative Therapie begonnen werden (siehe Abschnitte 4.3, 4.4 und 5.3).",
    "show_ref": false
  },
  {
    "src": "Mechanism of action Ceftriaxone has bactericidal activity that results from the inhibition of bacterial cell wall synthesis.",
    "display_src": "Mechanism of action Ceftriaxone has bactericidal activity that results from the inhibition of bacterial cell wall synthesis.",
    "ref": "Wirkmechanismus Die bakterizide Wirkung von Ceftriaxon ist auf die Hemmung der bakteriellen Zellwandsynthese zur\u00fcckzuf\u00fchren.",
    "show_ref": false
  },
  {
    "src": "In the two studies taken together, 240 (41.2%) of the 582 patients taking APTIVUS had achieved and maintained a reduction in viral load of at least 90%, compared with 109 (18.9%) of the 577 taking the comparator protease inhibitors.",
    "display_src": "In the two studies taken together, 240 (41.2%) of the 582 patients taking APTIVUS had achieved and maintained a reduction in viral load of at least 90%, compared with 109 (18.9%) of the 577 taking the comparator protease inhibitors.",
    "ref": "Betrachtet man die beiden Studien zusammen, so erreichten und hielten 240 (41,2%) der 582 Patienten unter APTIVUS eine Verringerung der Viruslast um mindestens 90%, wohingegen es bei den 577 Patienten, die den Vergleichs-Proteasehemmer einnahmen, lediglich 109 (18,9%) waren.",
    "show_ref": false
  },
  {
    "src": "AUC: \u2193 35% (\u2193 13 to \u2193 40) Cmax: \u2193 13% (\u2193 0 to \u2193 23) 4-hydroxy atorvastatin:",
    "display_src": "AUC: \u2193 35% (\u2193 13 to \u2193 40) Cmax: \u2193 13% (\u2193 0 to \u2193 23) 4-hydroxy atorvastatin:",
    "ref": "AUC: \u2193 35% (\u2193 13 bis \u2193 40) Cmax: \u2193 13% (\u2193 0 bis \u2193 23) 4-Hydroxyatorvastatin:",
    "show_ref": false
  },
  {
    "src": "In the case of the haemorrhagic events listed, the factor VIII activity should not fall below the given level (in% of normal) in the corresponding period:",
    "display_src": "In the case of the haemorrhagic events listed, the factor VIII activity should not fall below the given level (in% of normal) in the corresponding period:",
    "ref": "Bei den aufgef\u00fchrten Blutungsereignissen sollte die Faktor VIII-Aktivit\u00e4t im entsprechenden Zeitraum nicht unter die angegebenen Werte (in% der Norm) fallen.",
    "show_ref": false
  },
  {
    "src": "What benefit has ATryn shown during the studies?",
    "display_src": "What benefit has ATryn shown during the studies?",
    "ref": "Welchen Nutzen hat ATryn in diesen Studien gezeigt?",
    "show_ref": false
  },
  {
    "src": "500 ml of vaccine in high-density polyethylene bottles, closed with a nitrile rubber stopper and aluminium cap.",
    "display_src": "500 ml of vaccine in high-density polyethylene bottles, closed with a nitrile rubber stopper and aluminium cap.",
    "ref": "500 ml Impfstoff in HDLE -( hohe Dichte Polyethylen) Flaschen mit Nitril-Gummistopfen und Aluminiumkappe.",
    "show_ref": false
  },
  {
    "src": "For information on preparation of Lucentis, see section 6.6.",
    "display_src": "For information on preparation of Lucentis, see section 6.6.",
    "ref": "Informationen zur Zubereitung von Lucentis sind in Abschnitt 6.6 beschrieben.",
    "show_ref": false
  },
  {
    "src": "Darunavir/ritonavir increases the plasma concentrations of digoxin.",
    "display_src": "Darunavir/ritonavir increases the plasma concentrations of digoxin.",
    "ref": "Darunavir/Ritonavir erh\u00f6ht die Plasmakonzentration von Digoxin.",
    "show_ref": false
  },
  {
    "src": "Therefore, other substances that either share this metabolic pathway or modify CYP3A4 activity may influence the pharmacokinetics of indinavir.",
    "display_src": "Therefore, other substances that either share this metabolic pathway or modify CYP3A4 activity may influence the pharmacokinetics of indinavir.",
    "ref": "Deshalb k\u00f6nnen andere Stoffe, die \u00fcber den selben Weg metabolisiert werden oder die Aktivit\u00e4t von CYP3A4 ver\u00e4ndern, die Pharmakokinetik von Indinavir beeinflussen.",
    "show_ref": false
  },
  {
    "src": "Cortavance is used to treat inflamed and itchy skin conditions in dogs.",
    "display_src": "Cortavance is used to treat inflamed and itchy skin conditions in dogs.",
    "ref": "Cortavance wird zur Behandlung von entz\u00fcndlichen und juckenden Hauterkrankungen bei Hunden angewendet.",
    "show_ref": false
  },
  {
    "src": "It is not possible to establish a causal relationship, since cases typically involve other drug use or risk factors for spontaneous abortion (see section 4.6).",
    "display_src": "It is not possible to establish a causal relationship, since cases typically involve other drug use or risk factors for spontaneous abortion (see section 4.6).",
    "ref": "Ein kausaler Zusammenhang l\u00e4sst sich nicht herstellen, da diese F\u00e4lle \u00fcblicherweise mit dem Gebrauch anderer Arzneimittel und Risikofaktoren f\u00fcr eine Fehlgeburt verbunden sind (siehe Abschnitt 4.6).",
    "show_ref": false
  },
  {
    "src": "Depending on how your anaemia responds, the dose may be adjusted approximately every 4 weeks until your condition is controlled.",
    "display_src": "Depending on how your anaemia responds, the dose may be adjusted approximately every 4 weeks until your condition is controlled.",
    "ref": "Je nachdem wie Ihre An\u00e4mie auf die Behandlung anspricht, wird die Dosis in etwa vierw\u00f6chigen Abst\u00e4nden angepasst, bis Ihre An\u00e4mie unter Kontrolle ist.",
    "show_ref": false
  },
  {
    "src": "Radiolabelling must take place immediately after reconstitution of product.",
    "display_src": "Radiolabelling must take place immediately after reconstitution of product.",
    "ref": "Die Radiomarkierung muss unmittelbar nach der Rekonstitution des Produkts erfolgen.",
    "show_ref": false
  },
  {
    "src": "Any person intending to import, sell, supply and/ or use Suvaxyn Aujeszky 783 + OW must consult the relevant Member State\u2019 s competent authority on the current vaccination policies prior to the import, sale, supply and/ or use.",
    "display_src": "Any person intending to import, sell, supply and/ or use Suvaxyn Aujeszky 783 + OW must consult the relevant Member State\u2019 s competent authority on the current vaccination policies prior to the import, sale, supply and/ or use.",
    "ref": "Jede Person, die beabsichtigt, Suvaxyn Aujeszky 783 + O/W einzuf\u00fchren, zu verkaufen, zu liefern und/oder zu verwenden, muss die zust\u00e4ndigen Beh\u00f6rden der betreffenden Mitgliedstaaten bez\u00fcglich der geltenden Vorschriften \u00fcber Impfungen vor Einfuhr, Verkauf, Lieferung und/oder Verwendung konsultieren.",
    "show_ref": false
  },
  {
    "src": "If ALT/ AST measurements rise to the following levels then changes to the monitoring or treatment are given",
    "display_src": "If ALT/ AST measurements rise to the following levels then changes to the monitoring or treatment are given",
    "ref": "Sollten die ALT/AST-Messwerte auf die folgenden Werte ansteigen, sind \u00c4nderungen der \u00dcberwachung oder Behandlung angebracht.",
    "show_ref": false
  },
  {
    "src": "Use in patients with renal impairment:",
    "display_src": "Use in patients with renal impairment:",
    "ref": "Anwendung bei Patienten mit eingeschr\u00e4nkter Nierenfunktion:",
    "show_ref": false
  },
  {
    "src": "Before you drive a vehicle, use machinery, or carry out other activities that require concentration, you should make sure you know how you react to the effects of Enviage.",
    "display_src": "Before you drive a vehicle, use machinery, or carry out other activities that require concentration, you should make sure you know how you react to the effects of Enviage.",
    "ref": "Bevor Sie ein Fahrzeug f\u00fchren, eine Maschine bedienen oder eine andere T\u00e4tigkeit aus\u00fcben, die Konzentration erfordert, sollten Sie sichergehen, dass Sie wissen, wie Sie auf die Wirkung von Enviage reagieren.",
    "show_ref": false
  },
  {
    "src": "Serum sickness-like reaction Uncommon:",
    "display_src": "Serum sickness-like reaction Uncommon:",
    "ref": "Serumkrankheit-\u00e4hnliche Reaktionen Gelegentlich:",
    "show_ref": false
  },
  {
    "src": "A total of 145 patients were treated with Thelin 100 mg.",
    "display_src": "A total of 145 patients were treated with Thelin 100 mg.",
    "ref": "Insgesamt wurden 145 Patienten mit Thelin 100 mg behandelt.",
    "show_ref": false
  },
  {
    "src": "Titration pack comprising 4 triple packs, each containing:",
    "display_src": "Titration pack comprising 4 triple packs, each containing:",
    "ref": "DARREICHUNGSFORM UND INHALT Aufdosierungspackung bestehend aus 4 Dreierpackungen, jede davon mit:",
    "show_ref": false
  },
  {
    "src": "Most of the adverse events below come from two clinical trials (PROAB3001, PROAB3006) involving PI na\u00efve subjects receiving Agenerase 1200mg twice daily.",
    "display_src": "Most of the adverse events below come from two clinical trials (PROAB3001, PROAB3006) involving PI na\u00efve subjects receiving Agenerase 1200mg twice daily.",
    "ref": "Die meisten der unten genannten Nebenwirkungen stammen aus zwei klinischen Studien (PROAB3001, PROAB3006), in denen mit Proteasehemmern nicht vorbehandelte Patienten 1200 mg Agenerase zweimal t\u00e4glich erhielten.",
    "show_ref": false
  },
  {
    "src": "The pharmacokinetics of lumiracoxib have not been studied in patients with severe hepatic impairment (Child-Pugh > 9).",
    "display_src": "The pharmacokinetics of lumiracoxib have not been studied in patients with severe hepatic impairment (Child-Pugh > 9).",
    "ref": "Die Pharmakokinetik von Lumiracoxib wurde bei Patienten mit schwerer Leberfunktionsst\u00f6rung nicht untersucht (Child-Pugh \u2265 9).",
    "show_ref": false
  },
  {
    "src": "Since there are very limited data in patients with hepatitis B/ C co-infection, special caution should be exercised when treating these patients with CELSENTRI.",
    "display_src": "Since there are very limited data in patients with hepatitis B/ C co-infection, special caution should be exercised when treating these patients with CELSENTRI.",
    "ref": "Da f\u00fcr Patienten mit einer Hepatitis B / C Co-Infektion nur sehr begrenzte Daten vorliegen, d\u00fcrfen diese Patienten nur unter besonderer Vorsicht mit CELSENTRI behandelt werden.",
    "show_ref": false
  },
  {
    "src": "If Ambirix has to be given at the same time as or shortly before or after an injection of immunoglobulins, it is likely that you will still make a good immune response to the vaccine.",
    "display_src": "If Ambirix has to be given at the same time as or shortly before or after an injection of immunoglobulins, it is likely that you will still make a good immune response to the vaccine.",
    "ref": "Wenn Ambirix zur gleichen Zeit oder kurz vor oder nach einer Injektion von Immunglobulinen verabreicht werden soll, ist es wahrscheinlich, dass die Reaktion auf den Impfstoff trotzdem ausreichend sein wird.",
    "show_ref": false
  },
  {
    "src": "If not used immediately, the duration and conditions of storage prior to use are the user\u2019 s responsibility.",
    "display_src": "If not used immediately, the duration and conditions of storage prior to use are the user\u2019 s responsibility.",
    "ref": "Bei nicht sofortiger Verwendung liegen die Aufbewahrungszeit und die Aufbewahrungsbedingungen vor der Anwendung in der Verantwortung des Benutzers.",
    "show_ref": false
  },
  {
    "src": "Breast-feeding women must, therefore, not receive leflunomide.",
    "display_src": "Breast-feeding women must, therefore, not receive leflunomide.",
    "ref": "Deshalb d\u00fcrfen stillende Frauen kein Leflunomid erhalten.",
    "show_ref": false
  },
  {
    "src": "SonoVue improves display of the vascularity of liver and breast lesions during Doppler sonography, leading to more specific lesion characterisation.",
    "display_src": "SonoVue improves display of the vascularity of liver and breast lesions during Doppler sonography, leading to more specific lesion characterisation.",
    "ref": "SonoVue verbessert die Darstellung der Vaskularisierung von fokalen L\u00e4sionen der Leber und der Brust im Rahmen der Dopplersonographie, und f\u00fchrt zu einer spezifischeren Charakterisierung der L\u00e4sion.",
    "show_ref": false
  },
  {
    "src": "As limited information is available on the use of PREZISTA in patients aged 65 and over, caution should be exercised in the administration of PREZISTA in elderly patients, reflecting the greater frequency of decreased hepatic function and of concomitant disease or other therapy (see sections 4.2 and 5.2).",
    "display_src": "As limited information is available on the use of PREZISTA in patients aged 65 and over, caution should be exercised in the administration of PREZISTA in elderly patients, reflecting the greater frequency of decreased hepatic function and of concomitant disease or other therapy (see sections 4.2 and 5.2).",
    "ref": "Da zur Anwendung von PREZISTA bei Patienten ab 65 Jahren nur begrenzte Informationen verf\u00fcgbar sind, sollte PREZISTA bei \u00e4lteren Patienten mit Vorsicht angewendet werden, zumal bei diesen die H\u00e4ufigkeit von Einschr\u00e4nkungen der Leberfunktion sowie von Begleiterkrankungen und anderen Therapien erh\u00f6ht ist (siehe Abschnitte 4.2 und 5.2).",
    "show_ref": false
  },
  {
    "src": "Robenacoxib/ tablet 5 mg 10 mg 20 mg 40 mg",
    "display_src": "Robenacoxib/ tablet 5 mg 10 mg 20 mg 40 mg",
    "ref": "Robenacoxib/Tablette 5 mg 10 mg 20 mg 40 mg",
    "show_ref": false
  },
  {
    "src": "If an excessive response is obtained, treatment should be stopped and hCG withheld (see section headed \u2018 Possible Side Effects\u2019).",
    "display_src": "If an excessive response is obtained, treatment should be stopped and hCG withheld (see section headed \u2018 Possible Side Effects\u2019).",
    "ref": "Bei \u00fcberschie\u00dfender Reaktion ist die Behandlung zu beenden und kein hCG zu verabreichen (siehe Abschnitt \u201e Welche Nebenwirkungen sind m\u00f6glich ?\u201c).",
    "show_ref": false
  }
]
